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Summary 
 
 
The goal of this PhD thesis is the synthesis and photophysical studies of new ruthenium(II) 
complexes of polypyridine ligands with a long amino-substituted side chain with a potential 
application for molecular switches. 
 
Introduction a short summary of the chemical background and latest investigations 
on ruthenium(II) complexes of terpyridine ligands and their molecular switching properties. 
 
Chapter 1  describes the synthesis and characterisation of precursors and 
substituted terpyridine ligands. In this chapter, the original approach of the synthesis of the 
ruthenium(II) complexes with the long amino-chain via trans-esterification is used.  
 
Chapter 2  shows the synthetic strategy towards ruthenium(II) complexes with a 
side chain containing a triazole ring and a terminal amino group. Unfortunately such a 
ruthenium(II) complex was not successfully prepared. However, a useful application was 
found for its precursor, giving a new series of pytpy ligands with a side amino-chain linked 
via an ether. 
 
Chapter 3  reports several synthetic strategies towards 4’-(4-pyridyl)-2,2’:6’,2’’-
terpyridine ligands with a side amino-chain linked via an ester. 
 
Chapter 4  shows synthesis and characterisation of ruthenium(II) complexes with 
three or four protonation sites. A series of ruthenium(II) complexes with substituted  4'-
phenyl-2,2':6',2''-terpyridine ligands was prepared for a comparison with the Ru(II) 
complexes bearing pendant pyridyl units. 
 
Chapter 5  shows detailed photophysical properties of the ruthenium complexes 
from Chapter 4. 
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Chapter 6  reports acid and base NMR studies of ruthenium complexes and their 
free ligands with morpholino- and diethylamino-substituted side chains. These studies reveal 
and clarify that all the Ru(II) complexes with three or four protonation sites were synthesized 
and isolated already in the mono-protonated form - on the amino group of the side chain. 
 
Chapter 7  describes synthesis and characterisation of pytpy ligands with short (3 
and 5 carbon atoms) amino-substituted side chains. Numerous attempts to synthesize 
ruthenium(II) complexes of these ligands are reported. However, these led only to trace 
amounts of the desired products. 
 
Conclusion  summarises this PhD thesis, achieved results and outlook for further 
investigation of this topic.  
  
8 
 
Abbreviations 
 
 
1D  one dimensional 
2D  two dimensional 
Ac  acetyl 
Ar  aryl 
°C  degree Celsius 
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cat.  catalytic amount 
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MS  mass spectroscopy 
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pH  logarithmic measure of the acidity or basicity of an aqueous solution, log10(1/ 
aH+), aH+ is the hydrogen ion activity in a solution 
Ph  phenyl 
pK  logarithmic measure of the acid dissociation constant K, log10(1/Ka) (pKa - 
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TfOD  deuterated trifluoromethanesulfonic acid (CF3SO3D) 
THF  tetrahydrofuran 
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tpy  2,2':6',2''-terpyridine 
UV  ultraviolet light 
V  volt 
vis  visible 
vol.   volume 
wt%  weight % 
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Introduction 
 
 
Ruthenium is a rare transition metal from the platinum group of the periodic table. 
Ruthenium forms a very wide range of complexes with oligopyridine ligands such as 2,2’-
bipyridine (bpy), 1,10-phenanthroline (phen) or 2,2’;6,6’’-terpyridine (tpy). Terpyridine 
ligands are tridentate, have three nitrogen donor atoms with the metal coordinated in a 
perpendicular position to the central nitrogen donor. Ruthenium(II) complexes exhibit an 
octahedral molecular geometry (Figure 1).  
 
 
Figure 1: Octahedral ruthenium(II) complexes of bidentate ligands (bpy) and tridentate ligands 
(tpy)1 
 
 
 
Figure 2: Molecular orbital diagram for octahedral transition metal complexes2 
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Figure 2 displays a molecular orbital diagram for octahedral complexes of transition metals. 
These contain different types of atomic orbitals: strongly bonding ligand-centred orbital σL, 
bonding ligand-centred orbital πL, nonbonding metal-centred orbital πM of t2g symmetry, 
antibonding metal-centred orbital σM* of eg symmetry, antibonding ligand-centred orbital 
πL*, strongly antibonding metal-centred orbital σM*. The excited configuration is obtained 
from the ground state by promoting one electron from occupied to vacant MOs. The arrows 
indicate the four types of transitions possible based on localized molecular orbital 
configurations. The transitions are of these types: metal-centred (MC), ligand-centred (LC), 
ligand-to-metal charge-transfer (LMCT) and metal-to-ligand charge-transfer (MLCT). For 
octahedral complexes containing Ru(II) (d6) metal ion, the σL, and πL orbitals are fully 
occupied and the ground-state configuration is closed-shell since the HOMO πM (t2g)
6 is also 
completely occupied.2  
 
 
Figure 3: Excited state deactivation processes 3 
 
In photochemical and photophysical processes (Figure 3), a photon is absorbed by a 
molecule leading to the formation of an excited state. This exhibits high energy, which must 
undergo some type of deactivation, such as photochemical reaction, luminescence (light 
emission), radiationless deactivation (energy excess transform into heat) or quenching 
(interaction with other species).3  
Figure 4 compares energy diagrams of [Ru(bpy)3]
2+ and [Ru(tpy)2]
2+ and explains why 
[Ru(tpy)2]
2+ is not emissive compared to Ru(II) complexes of bpy ligands. [Ru(bpy)3]
2+ absorbs 
electrons (forms the excited state), either through LC or MLCT transitions. Once the electron 
13 
 
density reaches the 3LC or 3MLCT levels, radiationless deactivation to the 3MC (metal-
centred) state can occur; however no emission is observed. Emission would be observed, if 
the decay passed from the 3MLCT to the ground state. This depends on the energy gap (E) 
between the 3MC or 3MLCT levels. The 3MC level of [Ru(tpy)2]
2+ is located below the 3MLCT 
state, therefore radiationless decay to the 3MC is preferable and as a result  [Ru(tpy)2]
2+ is 
not emissive. 
 
 
Figure 4: Energy diagrams for [Ru(bpy)3]
2+ and [Ru(tpy)2]
2+  2 
 
However, once the tpy unit is substituted in the 4’-position with an appropriate functional 
group (such as pyridyl unit), the 3MC level can be shifted in a preferred way. As such Ru(II) 
complexes [Ru(pytpy)2]
2+ are emissive.4 Each pendant pyridyl position of [Ru(pytpy)2]
2+  has a 
basic nitrogen atom which can be protonated. Therefore, this complex can exist in 3 
different protonation states. Furthermore, it was observed that protonation of the pendant 
pyridyl unit significantly changes the photophysical properties of the Ru(II) complex.6 
Because upon protonation, the pyridyl substituent is changed to an electron-acceptor by 
lowering its π* orbital.  
The absorption spectrum of [Ru(pytpy)2]
2+ consists of two intense bands (LC transitions) in 
the UV region and a broad moderately intense band in the visible region (1MLCT transitions). 
Upon acid titration, the 1MLCT band absorption maximum is red-shifted from 489 nm to 505 
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nm and the absorption intensity increases (bis-protonated form: [Ru(Hpytpy)2]
4+). The 
luminescence spectrum of [Ru(pytpy)2]
2+ consists of a low intensity band with an emission 
maximum at 655 nm (Figure 5). Upon titration this becomes significantly more intense and 
red shifts to 723 nm indicating formation of the mono-protonated form 
[Ru(pytpy)(Hpytpy)]3+. With the second protonation, the emission intensity increases even 
more, however a slight blue-shift to 715 nm was observed. The first red-shift is due to the 
decrease in energy of the π* orbital of the (Hpytpy)+ unit which stabilises the MLCT levels. 
The small blue-shift in the second step is explained this way; in the mono-protonated form 
[Ru(pytpy)(Hpytpy)]3+, the electron-accepting character of (Hpytpy)+ is balanced by the 
enhanced electron-donating character of pytpy to the metal centre. However, such 
stabilization effects are not possible in the bis-protonated species, because both ligands are 
protonated.4 
Certain organic molecules can exhibit properties of so called molecular switches, a functional 
molecular device which can work as a molecular logic-gate. A molecular switch converts 
input stimulations into an output signal under the principals of Boolean binary logic.7, 8, 9 The 
most common Boolean functions are AND, OR, NOR, XOR, NAND, etc. (Table 1). A half adder 
is a combinatorial circuit, an ensemble of logic gates in which the output value depends on 
the 2 inputs. 
 
In. 1 In. 2 Out. 1 Out. 2 Out. 3 Out. 4 Out. 5 Out. 6 
0 0 0 0 1 1 0 1 
1 0 0 1 1 0 1 0 
0 1 0 1 1 0 1 0 
1 1 1 1 0 0 0 1 
  AND OR NAND NOR XOR XNOR 
Table 1: Truth tables of logic gates 
 
Inherent properties of molecules, such as conformation, redox properties, pH sensitivity or 
photo-induced electron transfer, forms the input and output of such a molecular device. 
However, not only organic molecules can work this way, but coordination compounds can 
play a role as in design of such devices. Lately molecular switching properties of 
[Ru(pytpy)2][PF6]2 have been reported.
5 The set consists of a reversible merocyanine-type 
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photoacid and this Ru(II) complex that works as a pH-controlled three-state luminescence 
switch. Upon application of light, the photo-acid releases a proton to control the state of the 
transition metal complex. These two molecular switching devices work together through the 
exchange of ionic signals and form an “optical-chemical-optical” double signal-transduction 
mechanism. Upon observing changes in the luminescence spectra for each of the 
protonation state of the Ru(II) complex, it is possible to construct logic gates (Figure 5). The 
proton aliquots form 2 inputs for the truth table, and upon setting threshold lines for a 
certain wavelength it is possible to perform the half-adder functions and obtain outputs. So 
then by setting the threshold line to 30% at 732 nm we obtain an OR gate, however for the 
threshold line at 70% at 732 nm we obtain an AND gate. The green threshold at 626 nm gave 
XNOR gate.  
 
 
Figure 5: Ru(II) complex[Ru(pytpy)2][PF6]2  and its protonated forms, luminescence spectra of the 
studied complexes, threshold and outputs lines indicated, truth tables for the constructed logic 
gates  
 
After successful application of Ru(II) complex of the pytpy ligand as a molecular half-adder, 
we decided to expand on these results and construct a so called full-adder. This would mean 
 (nm)
600 625 650
I
0.0
0.2
0.4
0.6
0.8
 (nm)
600 700 800 900
I
0
1
2
3
4
5
Ru RuH+ RuH2
2+
70%
30%
In. 1 = H+
In. 2 = H+
Out = h
In. 1 In. 2 Out. 1 Out. 2 Out. 3
0 0 0 0 1
1 0 0 1 0
0 1 0 1 0
1 1 1 1 1
AND OR XNOR
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to add a third input to the truth table. This is possible, when such molecule would contain 
third protonation site. My former co-workers Jonathon Beves and Emma Dunphy designed 
such molecule and the goal of this thesis is to expand on the initial synthetic results, develop 
synthetic strategies towards such a ruthenium(II) complex and examine its photophysical 
properties (Figure 6). The original idea was to synthesize Ru(II) complexs containing pytpy 
ligands which have linked long side chains with dialkyl-substituted amino groups. The amino 
group attached to the side chain and the two pendant pyridyl groups bring to the molecule 
three protonation sites. In the Ru(II) complexes with long side chains (7-12 carbon atoms), 
there is the possibility of photo-induced electron transfer or proton transfer, intra-molecular 
via the chain or through space (between the pendant pyridyl unit and the amino group), 
respectively. However, the Ru(II) complexes with an appropriately short side chain will only 
have the option of photo-induced electron transfer via the chain (i.e. not through space as 
the chain is too short). Upon addition of acid aliquots, the side amino unit should be 
protonated first, followed by protonation of the pendant pyridyl units, allowing the 
observation of such a complex in 4 protonation states (neutral, mono-, bis- and tris-
protonated). 
 
 
Figure 6: Proposed structure for a Ru(II) complex which would act as a molecular full-adder 
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Chapter 1 
 
Synthesis of ruthenium(II) complexes with side amino-
chain via trans-esterification strategy 
 
 
1.1 Introduction 
 
The work in this chapter is partly based on the early investigation of [Ru(pytpy)]2+ metal 
complexes and their photophysical and electronic properties.1 However, the main idea of 
this project begins in the previously reported molecular switching properties of a 
ruthenium(II) terpyridine metal complex done by Dr. Jonathon Beves and Dr. Emma Dunphy 
in collaboration with Prof. Alberto Credi.2 This work expanded on iron(II) complexes of 
methyl-substituted pytpy ligand done by Emma Dunphy in her PhD thesis, where the “full 
adder” idea originally comes from.3 The aim of this work is to develop such a synthetic route 
for ruthenium(II) terpyridine metal complexes modified with an attached side chain and 
explore their expected molecular switching properties. 
 
 
1.2 Synthesis - results and discussion 
 
1.2.1 Precursors and ligands for ruthenium(II) complexes 
The first strategy to synthesize such a ruthenium(II) terpyridine metal complex modified with 
an attached side chain starts with the previously reported methyl 4'-(pyridin-4-yl)-[2,2':6',2''-
terpyridine]-4-carboxylate. Its complexation leads to either a homoleptic or with 4'-(pyridin-
4-yl)-2,2':6',2''-terpyridine to a homoleptic metal complex. Further trans-esterification seems 
an ideal way to get a wide range of side chains with various lengths and bearing a terminal 
amine, which will bring a third protonation site to each ruthenium(II) complex (Scheme 1.1). 
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Scheme 1.1: Synthetic strategy towards Ru(II) complexes with a side chain 
 
Lately, the Kröhnke methodology is one of the most popular ways to synthesize in one step 
symmetric and asymmetric terpyridine ligands with various substituents, where an 
,-unsaturated ketone and a ketone activated as a pyridinium iodide salt react at reflux in a 
conjugate addition (Michael type) to give a 1,5-diketone, and in the presence of an excess of 
ammonium acetate in methanol followed by condensation and a ring closure (Scheme 1.2).4  
 
 
Scheme 1.2: Synthesis of terpyridines via the Kröhnke synthetic method 
 
For the synthesis of the desired methyl ester substituted ligand L2, chalcone P9 was used 
with an appropriately substituted pyridinium salt P5 (Scheme 1.3). Formation of the product 
L2 was observed during the reflux or upon chilling of the reaction mixture in a freezer. The 
white precipitate was isolated and washed with cold methanol, which gave analytically pure 
ligand L2.  
 
Scheme 1.3: Synthesis of the terpyridine L2 via the Kröhnke synthetic method 
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Both precursors, PPI salt P5 and chalcone P9, were synthesized according to published 
procedures. 5, 7 Commercially available methyl isonicotinate was acetylated in the 2- position 
and was separated with column chromatography from the 2,3- and 2,5-bisacetylated side 
products. The conversion of methyl 2-acetylisonicotinate P2 to the corresponding pyridinium 
salt P5 was performed as reported in the literature for 2-acetylpyridine. 
2-Acetylisonicotinate P2 reacts at reflux in a presence of 1 equivalent of iodine and pyridine, 
which serves as a reagent and solvent as well. A reaction time of 1 hour is longer than 
enough, because the product P5 is already observed at the beginning of the reflux period 
(Scheme 1.4). 
 
 
Scheme 1.4: Synthesis of the PPI salt P5 
 
The synthesis of the chalcone P9 was performed according to the reported procedure of 
Newkome. It involved microwave irradiation, as shown in the Scheme 1.5. 6 Reactants were 
dissolved in a suspension of tetrahydrofuran with alumina and irradiated in a domestic 
microwave oven. The presence of alumina seems to be necessary for the product formation, 
otherwise the reaction leads to multiple condensation products. A similar condensation 
product was observed by using classical conditions with KOH in a mixture of solvents 
(EtOH/H2O). 
7 The chalcone P9 turned out to be unstable upon storage at laboratory 
temperature, however it is stable in a freezer at -20 °C for a couple of years.  
 
 
Scheme 1.5: Synthesis of the chalcone P9 
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In order to prepare the heteroleptic complex with the methyl ester substituted ligand L2 as 
mentioned above in Scheme 1.1, it was necessary to prepare another ligand bearing the 
pendant pyridyl unit as a second protonation site. The second ligand may be functionalized, 
but it must be tolerant to the further trans-esterification, or it can be just simple pytpy L3 as 
shown in a Scheme 1.6. L3 was prepared following a procedure published by Hanan. 8 This is 
suitable for the synthesis of various symmetrical 4’-aryl- or heteroaryl substituted 
terpyridines in moderate to high yields. Condensation of the first equivalent of 
2-acetylpyridine with aldehyde under basic conditions of KOH is followed by conjugated 
addition of the second equivalent of 2-acetylpyridine and a ring closure in a presence of 
ammonia as a source of nitrogen atom. Among the advantages of this “one pot” method is 
the fact that the reaction proceeds at room temperature, without an inert atmosphere and 
the terpyridine product precipitates out from the reaction mixture, due to its insolubility in 
ethanol. Recrystallisation from MeOH/CHCl3 gives an analytically pure product L3. 
 
 
Scheme 1.6: Hanan’s synthesis of pytpy ligand L3 
 
Before complexation of L3, we decided to synthesize a model heteroleptic Ru(II) complex 
with 2,2':6',2''-terpyridine L1. Potts et al. (Scheme 1.7) reported in 1982 a synthetic route of 
ligand L1 which involves multiple steps via dithioacetal, followed by reduction of 
4’-(methylthio)‐2,2’:6’,2’’‐terpyridine with NiCl2/NaBH4 giving the product in 23% overall 
yield.9 We tried another method with only two steps (Scheme 1.7), which has been 
published by Jameson et al. in 1991.10 2-Acetylpyridine reacts with N,N‐dimethylformamide 
dimethylacetal in toluene, while azeotropic distillation of methanol moves the reaction in 
favour of the forming enaminone. In the next step, conjugated addition of the second 
equivalent of 2-acetylpyridine occurs and a ring closure in a presence of ammonium acetate. 
A disadvantage of Jameson’s method is the complicated work-up of the reaction mixture in 
the second reaction step, also the long reaction time (3 hours to 2 days) of the azeotropic 
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distillation in the first step and low yield. However, there has recently been published an 
elegant method for the enaminone synthesis without any solvent, involving a microwave 
irradiation and reaction time of only about 10 minutes.11 
 
 Scheme 1.7: Synthetis of tpy ligand L1 
 
 
 
1.2.2 Model ruthenium(II) complexes with tpy and pytpy ligands bearing long 
amino side-chains 
The first step of the L2 complexation is a conversion of ligands L1 and L3 to a ruthenium(III) 
trichloride complex of the general type [Ru(tpy)Cl3]. A commonly used method, which gives 
products in nearly quantitative yields, was reported by Sullivan et al. in 1980.12 As shown in 
Scheme 1.8, one equivalent of the tpy ligand is suspended in a solution of RuCl3*3H2O (1 eq.) 
in ethanol and refluxed for 3 hours. The products C1 and C2 precipitated out from the 
reaction mixture during the reflux as a dark brown or black powder and were used in the 
next steps without any further purification and analysis. 
 
Scheme 1.8: Complexation of ligands L1 and L3 to [Ru(L)Cl3] 
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For the complexation of L2 to prepare the model complex C3, conditions involving 
microwave irradiation (Scheme 1.9) were used because these had previously been 
successfully applied by Jonathon Beves for the synthesis of a wide range of Ru(II) 
complexes1, 2. L2 and C1 were suspended in ethylene glycol, which serves as a solvent and 
also as a reducing agent for conversion of Ru(III) to Ru(II), and heated at reflux for 2 minutes 
at the highest setting in the domestic microwave oven. A characteristic colour change of the 
reaction mixture from brown or black to deep red is typical for the formation of Ru(II) 
complexes with tpy ligands. C3 was precipitated out as a PF6
- salt and also purified with 
column chromatography on SiO2. For the separation of Ru(II) complexes, the most common 
solvent mixtures of MeCN/saturated aqueous KNO3/H2O in various polarity ratios were used 
as eluent, in this case 10:1.5:0.5. The Ru(II) complex C3 was isolated as a red powder in 
moderate yields 25-69%. In the 1H NMR spectrum of C3, we can observe characteristic shifts 
for protons A6, D6 and E6 to higher magnetic field in comparison with the free ligand L1 and 
L2. The signal of the methyl group has also been shifted, but to the lower field (Figure 1.1).  
 
 
Figure 1.1: 1H NMR (500 MHz, CD3CN) spectra of the complexed (black) and free ligand L2 (cyan) 
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Scheme 1.9: Synthesis of the model complex C3 
 
During the design of the long side chain we followed these main ideas: the chain a) has to 
bear a hydroxy group at one end to be able to perform trans-esterification, b) has an amino-
group at the other end as an additional proton acceptor site of the ruthenium(II) complex, c) 
has to be long enough to reach the nitrogen of the pendant pyridyl position for a possible 
proton exchange communication between these groups. According to a computer modelled 
structure, we found that a suitable amino alcohol has ca. 8 – 13 carbons. To avoid any 
possible side reactions, it was decided to synthetize amino alcohols with a tertiary amino 
group. A primary or a secondary amino group might lead during trans-esterification to the 
formation of dimers between two ligands via an ester and an amide (Scheme 1.10). 
 
Scheme 1.10: Non-desirable possible side product during trans-esterfication 
 
In 1974 Wetter et al. published a very facile two-step synthetic route to such amino alcohols, 
suitable for various chain lengths (Scheme 1.11).13 We started with methyl 
11-bromoundecanoate, which in the first step reacts with diethylamine, and this works both 
as a reagent and solvent. Bromine is quantitatively substituted with a diethylamino group. A 
white precipitate of diethylammonium bromide as a side product is simply filtered off. The 
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desired product P12 was purified using vacuum distillation. In the second step, the methyl 
ester group was reduced by LiAlH4 to a methylene hydroxy group. Sodium sulfate 
decahydrate was used as a suitable agent for quenching the reaction mixture. A precipitate 
of LiOH and an excess of sodium sulfate was filtered off and solvent removed under reduced 
pressure giving the amino alcohol P16 in an almost quantitative yield. Dodecanol was used 
for a model reaction. 
 
 
Scheme 1.11: Synthesis of amino alcohol P16 for a side chain 
 
The amino alcohol P16 was used as a suitable reagent to trans-esterify the methyl ester in 
the Ru(II) complex C3 to give a long amino side-chain. Commercially available dodecanol was 
used as an appropriate model alcohol for comparison with P16 (Scheme 1.12). 
 
 
Scheme 1.12: Trans-esterification of the model complex C3 
 
Conditions listed as Input 1 in the Table 1.1 show a first attempt of the trans-esterification 
shown in Scheme 1.12. Complex C3 with an excess of dodecanol and a catalytic amount of 
p-toluenesulfonic acid monohydrate were heated in DMF for 26 hours at 120 °C. A 
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conversion of complex C3 to the dodecyl substituted complex C4 was monitored with 1H 
NMR spectroscopy and with a TLC plate, eluted with a solvent mixture of MeCN/saturated 
aqueous KNO3/H2O = 10:1.5:0.5. Unfortunately only unreacted starting material C3 was 
recovered. However heating the reaction mixture at reflux for 23 hours gave the Ru(II) 
complex C4 in 33% yield (Table 1.1, Input 2). Trans-esterification of C3 with the amino 
alcohol P16 under the conditions of Input 2 gave the desired product C5 in a low 15% yield. 
It was possible to observe that both complexes C4 and C5 partly decompose to a free 
carboxylic acid, which displays a characteristic red band on the start of a TLC plate. We have 
also applied irradiation in a microwave reactor, but the product seemed to be completely 
unstable under these conditions (Table 1.1, Input 3).  
 
Input Place Temperature / °C Time / h Yield /% 
1 Fumehood 120 26 0 
2 Fumehood Reflux 23 33 
3 W reactor 200 3/4 0 
Table 1.1: Optimisation of synthesis of the complex C4 (Dodecanol, PTSA cat., DMF) 
 
 
1.2.3 Application to ruthenium(II) complexes with two pytpy ligands 
After the successful synthesis and analysis of the model complexes C3, C4 and C5 
bearing only one pendant pyridyl unit, we focused on the synthesis of complex C7 with 
ligands L2 and L3 bearing two pendant pyridyl units. 
 
Scheme 1.13: The first attempt to synthetize the complex C7 
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As the first attempt to synthetize Ru(II) complex C7, a microwave reactor was used (Scheme 
1.13). Methyl ester ligand L2 was converted to Ru(III) trichloride complex C6. We used either 
a conventional technique (reflux in ethanol for 3 hours) or microwave irradiation (120 °C for 
10 minutes) getting a dark brown precipitate. In the next step, C6 was heated with ligand L3 
in a microwave reactor in ethanol. N-Ethylmorpholine was used as a reducing agent to 
convert Ru(III) to Ru(II). Unfortunately, in both cases, heating at 140 °C for 15 minutes or at 
120 °C for 10 minutes, a black solid soluble only in DMF was isolated. 
 
 
Scheme 1.14: Optimisation of the complex C7 synthesis 
 
One option to improve the conditions in Scheme 1.13 is to increase the reactivity of C6. One 
common way to activate C6 is a counterion exchange in a presence of AgBF4 or AgPF6. A 
driving force of this process is a formation of an AgCl precipitate (Scheme 1.14). A black 
suspension of C6 in DMF was heated, AgPF6 added and the reaction mixture stirred in the 
dark, first for 5 minutes at 100 °C and then for 30 minutes at laboratory temperature, or for 
10 minutes at 130 °C in a microwave reactor. This process gives a dark brown solution with a 
characteristic grey-bluish precipitate of AgCl, which was filtered off. This way, activated C6 
was then used for the next step to form a complex with L3. The same conditions, heating for 
10 minutes at 120 °C or 140 °C (Scheme 1.14, 2A and 2B), gave a slightly reddish reaction 
mixture and we isolated at least a trace amount of C7. These conditions were optimized by 
increasing the temperature and using a longer reaction time. Heating at 150 °C for 20 
minutes gave C7 in 37% yield (Scheme 1.14, 2C). The best results were obtained with 
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irradiating at 160 °C for 15-25 minutes giving C7 in 43-66% yield (Scheme 1.14, 2D-E). 
However, besides the main product C7 we also isolated homoleptic Ru(II) complexes with 
ligands L2 and L3 as minor side products. 
Scheme 1.15 displays the conversion of the methyl ester complex C7 to the dodecyl ester 
C17 and diethylamino undecyl ester C18. Conditions for these reactions were the same as 
for C3, i.e. reflux in DMF for 23 hours in a presence of a catalytic amount of p-
toluenesulfonic acid monohydrate. In spite of many attempts, both complexes were 
obtained in quite low yields of 10-30%. In both cases, a free carboxylic acid as a product of 
ester hydrolysis was also detected. 
 
 
Scheme 1.15: Trans-esterification of the complex C7 
 
In the electrospray mass spectrum of C7, peaks with m/z = 390.1 (assigned to [M-2PF6]
2+) 
with 100% intensity and 925.3 (assigned to [M-PF6]
+) with intensity 50% were observed. In 
cases of C17 and C18 only one peak envelope was detected, the base peak with m/z = 467.2 
or 495.7 which belongs to [M-2PF6]
2+ and has a characteristic distribution of isotopes for 
ruthenium. 
Figure 1.2 compares the 1H NMR spectra of the Ru(II) complexes C7 (black), C17 (green) and 
C18 (red) measured in CD3CN. In the aromatic region it is possible to see a characteristic set 
of proton signals of the coordinated unsubstituted pytpy ligand L3 and of a ligand 
substituted with the electron withdrawing CO2R group. In the aliphatic part, a significant 
influence of the shielding effect of the long side chain in complexes C17 and C18 is observed. 
29 
 
Therefore, the triplet of the methylene group next to the carboxylic group is shifted to  4.33 
ppm in comparison with the singlet at 3.93 ppm for the methyl ester C7. 
 
 
Figure 1.2: 1H NMR (400 MHz, CD3CN) spectra of complexes C7 (black), C17 (green) and C18 (red) 
 
Previously reported reactions gave the desired Ru(II) complexes C7, C17 and C18 in very 
poor yields, therefore we considered all possible side product which could be formed 
besides the complex with a free carboxylic acid C17 – a product of the side chain cleavage. 
We detected the homoleptic Ru(II) complexes of ligands L2 and L3. On a TLC plate and on a 
chromatographic column, minor bands with a red-purple colour were also seen an the 
colours are typical for Ru(II) complexes with mono- or bisprotonated pendant pyridyl units, 
whereas deprotonated forms of Ru(II) complexes have a characteristic orange-red or deep-
red colour. 
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1.2.4 An Alternative route to ruthenium(II) complexes via methylated ligands 
Due to the reasons mentioned above, we applied an alternative route to obtain complexes 
C17 and C18 (Scheme 1.16). The idea was based on a four-step strategy. Ligands L2 and L3 
were methylated on the pendant pyridyl group, so that they are protected against possible 
side reactions and all reagents are then used selectively and specifically as planned. The 
N-methylated ligands are then complexed and trans-esterified. A final demethylation 
removes the protective groups from the pyridyl positions. 
 
Scheme 1.16: An alternative route to obtain complexes with a long side chain C17 and C18 
 
Ligands L3 or L2 were refluxed with an excess of iodomethane in acetonitrile for 7-16 
hours.14 The product precipitated out upon cooling the reaction mixture to room 
temperature and reducing the volume of solvent to one third. Ammonium 
hexafluorophosphate was added for a counterion exchange from iodide to 
hexafluorophosphate, and the colour of the precipitate changed from white to yellow or 
olive-green, respectively (Scheme 1.17). In the 1H NMR spectra of the methylated ligands, 
itwas possible to observe a significant chemical shift of the aromatic protons of the pendant 
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pyridyl unit to lower magnetic field, and this was especially noticeable for the protons in the 
meta-positions. 
 
Scheme 1.17: Synthesis of the N-methylated pytpy ligands as an alternative route 
 
Methylated ligand L5 was then quantitatively converted to the ruthenium(III) complex C9 
and in the next step, C9 was complexed with the methylated ligand L4. Reaction conditions 
used were those optimized above in Scheme 1.14 for the C7 synthesis (irradiation in the 
microwave reactor in EtOH at 160 °C for 20 minutes) giving complex C10 in 46% yield 
(Scheme 1.18, green route). The product has a red-purple colour, typical of Ru(II) complexes 
with a protonated or substituted pendant pyridyl ring. We have also applied a route using 
activated C9 with silver hexafluorophosphate, which slightly increased the yield of C10 to 
53% (Scheme 1.18, purple route). The product was purified on silica gel with a very polar 
solvent mixture of MeCN/saturated aqueous KNO3/H2O = 7:2:2. 
Scheme 1.18: Complexation of methylated ligands L4 and L5 to obtain C10 
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Figure 1.3 compares the 1H NMR spectra of the Ru(II) complex C7 and the methylated 
version C10. As for the free ligands L4 and L5, it is also possible in the complexes to observe 
the significant chemical shift of the meta-protons of the pendant pyridyl unit to lower 
magnetic field. 
 
Figure 1.3: 1H NMR (400 MHz, CD3CN) spectra of complexes C7 (black) and methylated C10 (purple) 
 
In the electrospray mass spectrum of C10, it was not possible to detect peaks for [M-PF6]
+ or 
[M-2PF6]
2+ characteristic of ruthenium complexes as in case of C7, but we found peaks 
assigned to both the methylated ligands m/z 325.2 [L4-PF6]
+ and 383.2 [L5-PF6]
+ with 
intensities of 100% or 25%. However, the MALDI TOF MS of C10 displays all the desired 
peaks 810.9 [M-4PF6]
+ (100%), 1099.6 [M-2PF6]
+. 
Trans-esterification of the complex C10 is the third step of the strategy shown above in 
Scheme 1.16. To convert the methylated complex C10 to the product with a long side amino 
chain, we used the same conditions for these reactions as for C3 and C7, i.e. reflux in DMF 
for 23 hours in a presence of a catalytic amount of p-toluenesulfonic acid monohydrate 
(Scheme 1.19). The product formation was monitored with TLC plates. Unfortunately, 
besides the target molecule and unreacted starting C10 we observed various side products 
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as well as products of decomposition, which made purification too complicated. Therefore, 
we gave up on this synthetic strategy and focused on another one. 
 
 
Scheme 1.19: Trans-esterification of the complex C10 
 
 
1.2.5 Reactivity of methyl ester substituted complex C7 in the presence of 
methyl 11-bromoundecanoate 
Another idea was to investigate the reactivity of C7 in the presence of methyl 
11-bromoundecanoate, and find out which main and side products would be formed. 
Scheme 1.20 shows the original idea, a product of trans-esterification and intramolecular 
cyclisation. 
 
Scheme 1.20: Reaction of C7 with methyl 11-bromoundecanoate 
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The reaction was monitored with TLC plates, eluting with a solvent mixture of 
MeCN/saturated aqueous KNO3/H2O = 10:1.5:0.5 and was complete in only 2 hours. There 
were observed only 2 main spots, with almost identical Rf (approx. 0.75) and a red-purple 
colour, characteristic for Ru(II) complexes with substituted pyridyl positions. A question 
arose: where would the long chain be connected and how? First we thought it might be 2 
complexes with mono- and bis- substituted pyridyl positions. So the reaction mixture was 
refluxed with another equivalent of methyl 11-bromoundecanoate, to convert the possible 
mono-substituted product to the bis-substituted one, however nothing changed. The two 
products were separated on a preparative TLC plate (SiO2) and characterised with 1D and 2D 
NMR spectroscopy and ESI MS. After careful comparison of the spectra, we were able to 
identify both products (Scheme 1.21). 
 
Scheme 1.21: Products of the reaction of C7 with methyl 11-bromoundecanoate 
 
The 1H NMR spectrum of the second product C13 clearly displays, one set of signals for a 
symmetrical N-substituted pytpy ligand (Figure 1.4). The aliphatic part of the 1H NMR spectra 
contains all the proton signals of a methyl undecanoate chain, which is linked by the first 
carbon to the nitrogen of the pyridyl position. This methylene group has chemical shift of 
 4.68 ppm. Formation of this homoleptic Ru(II) complex was supported by the ESI mass 
spectrum with peaks at 705.3 [M-2PF6]
2+ and 509.3 [L1-PF6]
+ with intensities of 29% and 
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100% respectively. C13 was presumably formed as a side product due to the presence of an 
impurity of the homoleptic complex C8 in the starting C7. 
 
 
Figure 1.4: Comparison of 1H NMR (500 MHz, CD3CN) spectra of C12 (blue) and C13 (cyan) 
 
However, the NMR spectrum of C13 was an important supporting piece of information 
during the solving of the structure of C12. Due to the higher Rf value on a TLC plate and two 
sets of aromatic signals in 1H NMR spectrum, it was possible to say that C12 is heteroleptic 
complex with 3 methyl undecanoate chains. Two of them are linked via a nitrogen atom of 
the pyridyl ring as in the complex C13 and one chain is linked via an ester to the atom D4 of 
the pyridyl ring D. The methylene group linked to this ester has a typical chemical shift of  
4.34 ppm in the 1H NMR spectrum. In the HMBC 2D NMR spectra characteristic crosspeaks 
of the carboxyl group with this methylene group were observed and also with protons D3 
and D5 (Figure 1.5). Formation of the heteroleptic Ru(II) complex C12 was confirmed with ESI 
MS spectra with peaks with m/z 751.5 [L2-PF6]
+ and 509.3 [L1-PF6]
+ with intensities of 60% 
and 35% respectively. Both suggested structures C12 and C13 were confirmed with 
elemental analysis. 
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Figure 1.5: HMBC NMR spectrum (500 MHz, CD3CN) of C12 
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1.3 Photophysical properties 
Figure 1.6: Comparison of UV/Vis absorption spectra (CH3CN, 310
-5M) of Ru(II) complexes C3, C4 
and C5 
 
Figure 1.7: Fluorescence spectra (CH3CN, 310
-5M) of Ru(II) complexes C3, C4 and C5, ext = 488 nm 
0
10000
20000
30000
40000
50000
60000
220 320 420 520 620 720
ε 
[d
m
3
 m
o
l-1
 c
m
-1
] 
Wavelength [nm] 
C3
C4
C5
0
0,002
0,004
0,006
0,008
0,01
0,012
0,014
510 560 610 660 710 760 810 860
In
te
n
si
ty
 /
 a
.u
. 
Wavelength [nm] 
C3
C4
C5
38 
 
Figure 1.6 compiles the absorption spectra of ester-substituted Ru(II) complexes C3-5. In the 
UV region of, intense bands around 290 nm and 310 nm were observed. These bands arise 
from ligand-centred * transitions. In the visible region, a broad and moderately intense 
band with a maximum at 464 nm, assigned to the MLCT (metal-to-ligand charge-transfer) 
excited state, was observed for each of the complexes C3-5. The luminescence spectrum 
(Figure 1.7) of C3-5 exhibits the typical low energy MLCT phosphorescence band of Ru 
polypyridine complexes with the emission maximum at 664 nm. The complexes C4 and C5 
substituted with the long side amino-chain have longer luminescence lifetime (Table 1.2). 
 
Complex MLCT [nm] max
em [nm]  [ns] 
C3 488 665 9 
C4 488 664 26 
C5 488 664 16 
C7 492 663  3 
C16 493 673 13 
C17 494 682 21 
C10 510 710 197 
C12 511 708 248 
C13 510 716 194 
Table 1.2: Photophysical properties of Ru(II) complexes, ext at MLCT 
 
Figure 1.8 displays a comparison of the absorption spectra of Ru(II) complexes C7 and the N-
alkylated complexes C10, C12 and C13. C7 has an MLCT band maximum at 492 nm, however 
the N-alkylated complexes show a strong red-shift to 510 nm and the extinction coefficient 
has increased. An even more significant red shift (from 663 to ca. 710 nm) and intensity 
increase due to the N-alkylation is observed in the emission spectra (Figure 1.9). All the N-
alkylated Ru(II) complexes C10, C12 and C13 are stronger emitters and longer lived (Table 
1.2). Quantum yield of all reported complexes is lower than 1%. Photophysical properties of 
C16-17 are reported in Chapter 5. 
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Figure 1.8: Absorption spectra (CH3CN, 310
-5M) of complexes C7 (black), methylated C10 (purple), 
alkylated C12 (blue) and C13 (cyan) 
 
 
Figure 1.9: Emission spectra (CH3CN) of complexes C7 (black), methylated C10 (purple), alkylated 
C12 (blue) and C13 (cyan), solutions (310-5M), ext = 492 nm (C10) and 510 nm (C10, C12, C13) 
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Chapter 2 
 
Towards ruthenium(II) complexes with an amino chain 
containing a triazole ring and pytpy ligands with a side 
chain linked via an ether 
 
 
2.1 Introduction 
A goal of this chapter was to investigate another synthetic route to obtain Ru(II) complexes 
of pytpy ligands with an amino side-chain. This time the chain would contain a triazole ring 
as a spacer and also linkers of various lengths (Figure 2.1). From a retrosynthetic view, these 
functionalities would allow us to start from precursors of a very wide range and use 
commonly known reactions (e.g. Sonogashira cross-coupling, “click reaction”). Therefore this 
will bring to the molecule a side chain with many functional groups and various amino 
substituents, which all will give us ruthenium complexes with different photophysical and 
electrochemical properties. 
 
 
Figure 2.1: Towards the Ru(II) complex with an amino chain containing a triazole ring 
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2.2 Results and Discussion 
 
2.2.1 Synthetic strategies 
It was very clear, that the synthetic paths to such molecules will contain many reaction 
steps, which will not be easy, therefore it was necessary prepare a careful synthetic plan. We 
had to also consider in which step the side chain, containing the triazole ring and the 
terminal tertiary amino group, will be constructed. There were three options: a) create it at 
the beginning on the pyridine precursor, b) on the ligand, or c) synthesize the chain on a 
complex. The version B seemed the most promising after considering all potential difficulties 
of these three possibilities.  
 
 
Scheme 2.1: The first synthetic approach via dialkyne towards the side amino chain with triazole 
 
Scheme 2.1 displays the first synthetic strategy via a dialkyne precursor, a linker which would 
contain two terminal triple bonds. The blue box lists the commercially available ones with 7 
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and 8 carbons and one which also contains an oxo group. Dialkyne 1, which has one triple 
bond protected with a trimethylsilyl group, reacts in the first step with halogen substituted 
pytpy L6 in a palladium catalysed Sonogashira cross-coupling reaction. After removal of the 
TMS protective group, terminal alkyne 3 reacts with the alkylazide in a cycloaddition reaction 
to give a 1,2,3-triazole 4, followed by Ru(II) complex 5 formation in the last step. The classic 
Huisgen 1,3-dipolar cycloaddition gives a mixture of regioisomers  4. The product formation 
can be controlled by selection of the catalyst. The copper-catalyzed reaction leads to the 1,4-
disubstituted regioisomers. A later developed ruthenium-catalyzed reaction gives the 1,5-
disubstituted triazoles. 
Due to the fact that the dialkyne linkers could polymerise during the side chain synthesis, we 
proposed another synthetic route (Scheme 2.2). In this case, 4-chloropytpy L6 reacts with 
propargyl alcohol in a palladium catalysed Sonogashira cross-coupling reaction. The 
synthesized methylene alcohol 6 can then react with a methylene-bromide substituted 
trizole ring 8 to form the pytpy 4 with the blue “ether-alkyne” linker. Synthesis of the triazole 
ring 8, decorated with methylene bromide and a long alkyl amine, starts with nucleophilic 
substitution of suitable amino alkyl halide or tosylate 7 with alkali azide. Amino alkylazide 
then reacts with propargyl bromide in a 1,3-dipolar cycloaddition reaction to give a 1,4- or 
1,5- substituted 1,2,3-triazole 8. 
 
 
Scheme 2.2: The second synthetic approach via propargyl alcohol towards the triazole side chain 
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2.2.2 Synthesis of L6 and its alkynylation 
4-Chloro substituted tpy L6 was prepared according to Scheme 2.3. In the first step 4-chloro-
2-pyridine carbonitrile was converted to 2-acetyl substituted pyridine P3. Addition of 
methylmagnesium iodide to the nitrile group leads to the formation of an organomagnesium 
species, which, after acid hydrolysis and neutralisation, is converted to an acetyl group. 
Purification with a chromatography column (SiO2, eluted with EtOAc/cyclohexane = 1:2) 
gives P3 as pale yellow crystals in high 78% yield as stated in a literature procedure.1 For the 
Kröhnke synthetic methodology of pytpy, it was necessary to activate ketone P3 as its 
corresponding pyridinium iodide salt P6. We used the same procedure as reported in 
chapter 1 for methyl ester substituted PPI salt P5.2, 3 P3 was refluxed for 1 hour in pyridine 
with 1 equivalent of iodine. Product P6 precipitated out from the reaction mixture as a dark 
brown powder in nearly quantitative yield and was used for the next step without further 
purification. Recrystallization attempts of P6 from hot ethanol containing 5% of activated 
charcoal led to keto-enol tautomerism, which partly deactivated the PPI salt for the next 
reaction. In the last step, chalcone P9 and PPI salt P6 reacted according to the Kröhnke 
method and gave L6 as a grey powder in very high (92%) yield. The product L6 was 
confirmed by microanalysis and also from the electrospray mass spectrum which showed 
peaks at m/z 367.1 for [M+Na]+ and 345.1 for [M+H]+ with intensities of 100% and 86%, 
respectively. 
 
Scheme 2.3: Synthesis of the 4-chloropytpy L6 
 
The Sonogashira cross-coupling reaction was first published by Kenkichi Sonogashira in 
1975.4 It is the formation of a new carbon-carbon bond between a terminal alkyne and an 
aryl or alkenyl halide. In comparison with the Heck or Suzuki reaction, Sonogashira cross-
coupling is revolutionary in affording products under much milder conditions, by using a 
palladium and copper catalyst simultaneously which increases the reactivity of the reagents 
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and therefore the reaction can be carried out at ambient temperature. The most commonly 
used palladium catalysts are Pd(PPh3)2Cl2, Pd(dppp)Cl2, and Pd(dppf)Cl2 together with 
copper(I) iodide as a co-catalyst, where dppp and dppf are diphosphine chelating ligands. 
Reactions are run under an inert atmosphere, due to the stability of Pd(0) catalysts and with 
an excess of a base, usually diethylamine or triethylamine, to neutralize the side product - 
hydrogen halide. Reactivity of aryl chlorides is much lower than of aryl bromides or iodides, 
therefore our alkynylation of pyterpy chloride L6 with propargyl alcohol had to be carried 
out at higher than room temperature (Scheme 2.4., Table 2.1). 
 
 
Scheme 2.4: Sonogashira cross-coupling reaction of L6 with propargyl alcohol 
 
Input W or hood T [°C] Time [Pd] Solvent 
1 W 70 45 min Pd(PPh3)2Cl2  (cat.) THF 
2 W 90 1 h Pd(PPh3)2Cl2  (cat.) THF 
3 hood 100 27 h Pd(PPh3)2Cl2  (cat.) DMF 
4 W 90 1 h Pd(dppf)Cl2  (cat.) THF 
5 W 110 2 h Pd(dppf)Cl2  (cat.) toluene 
6 W 140 1.5 h Pd(dppf)Cl2  (eq.) toluene 
7 hood 110 22 h Pd(dppf)Cl2  (eq.) toluene 
Table 2.1: Conditions for Sonogashira cross-coupling of L6 with propargyl alcohol 
 
Table 2.1 summarises all applied reaction conditions for alkynylation of L6 with propargyl 
alcohol. They vary in reaction temperature, time, palladium catalyst and solvent. There were 
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also reported conditions for Sonogashira cross-coupling carried out in a microwave reactor, 
therefore in five cases we applied microwave irradiation and two reactions were done 
conventionally in a fumehood.5 As a first attempt, the reaction was done with a catalytic 
amount of Pd(PPh3)2Cl2 in THF and heated in the microwave reactor at 70 °C for 45 minutes 
(Table 2.1, Input 1). The colour of the reaction mixture turned from brown to dark brown. 
The reaction was monitored with TLC plates and the product was purified using column 
chromatography (SiO2, gradient elution with EtOAc/cyclohexane = 1:2 to 3:1). Two fractions 
were collected. The first minor one was the product of self condensation of propargyl 
alcohol and the second major one was recovered starting L6, in 70% of the original amount. 
A 1H NMR spectrum of the second fraction was compared with the 1H NMR spectrum of the 
starting L6 and all their signals perfectly overlapped. As a second trial, the reaction 
temperature was increased to 90 °C and the time extended for one hour. We obtained a 
product which according to the 1H NMR spectrum was mostly starting L6, but we could also 
observe trace amount of a new aromatic signals. 
 
Figure 2.2: 13C NMR (126 MHz, CD3CN) and 
1H NMR (500 MHz, CD3CN) spectra of the product from 
the Input 3 vs. predicted chemical shifts of 6 
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As a third trial the reaction was run in DMF in a fume hood at 100 °C for one day (Table 2.1, 
Input 3). This time the crude reaction mixture was evaporated, diluted with toluene and 
extracted with saturated aqueous ammonium chloride to remove copper salts. 1D and 2D 
NMR spectra were measured. The major signals corresponded to starting L6, PPh3 and 
solvent but it was also possible to see minor signals of a singlet with a chemical shift  4.28 
ppm in a 1H NMR spectrum and  51 ppm in 13C NMR (Figure 2.2). These signals, according to 
NMR prediction, could belong to the CH2 group of the desired molecule 6. On the contrary, 
there were missing carbon signals of the triple bond, which were expected between  70 – 
90 ppm. However, it was hard to tell if they were overlapping with the signal of the solvent 
at  77.16 ppm or if they were missing due to the trace amount of the product. The very low 
yield did not look promising and alternative methods were therefore tried.  
The next four alkynylation attempts were done with Pd(dppf)Cl2 catalyst, which is more 
efficient for Sonogashira cross-coupling. Input 4 in Table 2.1 is a modification of Input 2. Two 
equivalents of propargyl alcohol were used instead of 1.1 equivalent and (as already 
mentioned) a different palladium catalyst. The reaction was monitored with TLC plates (SiO2, 
eluting with EtOAc/cyclohexane = 3:1 and EtOAc/MeOH = 10:1). The reaction mixture was 
purified with extraction from toluene - saturated aqueous NH4Cl. The 
1H NMR spectrum of 
the product showed again only signals of the recovered L6 (74% was received back) and a 
small amount of toluene. Low small intensity singlets at  4.28 and 4.60 ppm in the 1H NMR 
spectrum and a small signal for a CH2 group with a chemical shift  51 ppm in a 
13C dept NMR 
spectrum were observed. 
In Input 5 (Table 2.1) 2.4 equivalents of propargyl alcohol and toluene as a solvent were 
used. The reaction was carried out in the microwave reactor at 110 °C for 2 hours. Starting 
L6 was recovered in 68% yield. Once again, low intensity singlets at  4.28 and 4.60 ppm in 
1H NMR spectrum were observed. The Inputs 6 and 7 in Table 2.1 are modifications of Input 
5, but with an equimolar amount of catalyst, because there was a suspicion that the 
palladium catalyst could have been consumed by coordination to the 4-chloropytpy L6 in the 
previous reactions. Input 6 shows that the reaction was run in the microwave reactor at 
140 °C for 1.5 hour and Input 7, in a fume hood at 110 °C for 22 hours. Reaction mixtures 
were extracted from toluene - saturated aqueous NH4Cl and purified with column 
chromatography (SiO2, eluted with EtOAc/MeOH = 10:1). In both cases, several products 
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were obtained but with unknown structures. Unfortunately the desired product 6 was not 
obtained, neither was starting L6 recovered. 
 
 
2.2.3 Trans-halogenation of L6 
Before giving up the alkynylation strategy and finding another linker which would react with 
4-chloropytpy L6 and afford a suitable precursor for building the triazole ring, we decided to 
try a more reactive substrate for the Sonogashira reaction. Banwell et al. reported 
microwave assisted trans-halogenation of various chloro-, bromo- and 
trifluoromethanesulfonyloxy- substituted nitrogen-containing heterocyclic systems to 
corresponding iodo-derivatives by using sodium iodide and acetic anhydride or acetyl 
chloride as an activating agent.6 This seemed to be a suitable way to convert L6 to aryl iodide 
9, which would be a much more reactive substrate, since iodide is a better leaving group 
than chloride. 
 
 
Scheme 2.5: Microwave-assisted trans-halogenation of L6 
 
The first reaction was run under milder conditions (Scheme 2.5, A). L6 was reacted with 3 
equivalents of sodium iodide in acetonitrile in a presence of 2.5 equivalents of acetic 
anhydride as the activating agent. The brown suspension was heated at 130 °C for 2 hours 
and colour turned orange. The reaction was monitored with TLC plates and NMR 
spectroscopy. But after extraction and purification with column chromatography neither 
product 9 nor starting material was obtained. 
Route B in Scheme 2.5 represents more vigorous reaction conditions for less reactive 
substrates. 4-chloropytpy L6 with 10 equivalents of sodium iodide and in acetonitrile, 
activated with 1.5 equivalents of acetyl chloride was heated in a microwave reactor at 100 °C 
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for 3 hours. The orange reaction mixture was purified with extraction and column 
chromatography (SiO2, EtOAc/MeOH = 10:1) to give a grey oil. The NMR spectrum of the 
product seemed to be identical to that of starting L6 but sets of signals for both L6 and 9 in 
ratio 76:24% were found in ESI MS spectrum. ESI MS shows peaks at m/z 345.1 for [L6+H]+ 
and 437.0 for [9+H]+ with intensities of 100% and 31%, respectively. There were also peaks 
present corresponding to [L6+Na]+, [L6+K]+, [9+Na]+ and [9+K]+. As long as the conversion of 
L6 to 9 remained non-quantitative, the isolation of the desired molecule 9 could not be 
achieved. 
 
 
2.2.4 Ruthenium(II) complexes with L6 
Since the trans-halogenation of substrate L6 does not work as well as reported for other 
heterocycles in literature,6 we synthesized its homoleptic and heteroleptic Ru(II) complexes 
as another option for further alkynylation or alkylation (Scheme 2.6).  
 
 
Scheme 2.6: Ruthenium(II) complexes with L6 
 
A mixture of L6 with RuCl33H2O in ethylene glycol was reacted in a domestic microwave 
oven at 800W for 4 minutes to form [Ru(L6)Cl3]. Then a second equivalent of L6 or L3 was 
added and the black suspension was heated for 5 minutes more. The product was 
precipitated out using aqueous ammonium hexafluorophosphate and purified on a 
chromatography column (eluted with a solvent mixture MeCN/saturated aqueous KNO3/H2O 
= 7:2:2) to give the desired complexes C14 in 53% and C15 in 19% yields. Besides the target 
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molecules, formation of the homoleptic complex C8 was observed. The second step of 
complexation was also done in a microwave reactor in ethanol at 150 °C, but a long reaction 
time of 1 hour or more was needed. For further optimisation one can use silver 
hexafluorophosphate for activation or a different solvent, such as DMF, which allows one to 
increase the temperature and therefore shorten the reaction time to 10-20 minutes. 
Both complexes were characterised with elemental microanalysis. In the ESI mass spectra of 
C14 and of C15 peaks with characteristic m/z values of 378.1 and 395.1 for [M-2PF6]
2+ (100%) 
were observed as well as peaks corresponding to the ion [M-PF6]
+ with about 30% intensity. 
 
 
Figure 2.3: 1H NMR (500 MHz, CD3CN) spectrum of Ru(II) complex C15 
 
 
Complex MLCT [nm] em (ex) [nm]   [ns] QY [%] 
C14 490 658 (490) 4 < 1 
C15 492 666 (490) 9 < 1 
Table 2.2: Photophysical properties of Ru(II) complexes C14 and C15, (310-5M, CH3CN) 
 
Table 2.2 summarises the photophysical properties of ruthenium(II) complexes C14 and C15 
in acetonitrile [310-5M]. The MLCT absorption maxima were observed at  490 nm (Figure 
2.4), which is a characteristic value for Ru(II) complexes with pytpy ligands. The bands have a 
higher molar extinction coefficient compared with the methyl ester substituted C7 (Figure 
1.9, Chapter 1). The emission maximum, for excitation wavelength 490 nm, is for both 
complexes in the characteristic region ~ 660 nm. However both complexes are much less 
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emissive than C7 and the emission maximum of the homoleptic complex C15 is slightly red-
shifted in comparison with C14. 
 
 
Figure 2.4: Absorption spectrum (310-5M, CH3CN) of Ru(II) complexes C14 (orange) and C15 (green) 
 
 
2.3 Pytpy ligands with a side amino-chain linked via an ether 
 
 
Scheme 2.7: Towards pytpy ligands with an amino-chain linked via an ether unit to the pytpy 
domain 
 
In section 2.2 we focused on the synthesis of ruthenium(II) complexes with the amino-
substituted side chain containing an alkyne unit and a triazole ring. Unfortunately such a 
ruthenium(II) complex was not successfully prepared. However, a useful application was 
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found for its precursor, chloro-substituted pytpy ligand L6. The chloro group was substituted 
with an alkoxy or amino-alkoxy group giving a new series of pytpy ligands with a side amino-
chain linked via an ether L17-20 (Scheme 2.7). In this section 2.3, several synthetic strategies 
will be reported and their results discussed. 
 
2.3.1 Synthetic strategies 
 
 
Input Reaction conditions 
1 dodecanol, 2,6-lutidine, toluene, N2, reflux, 49 h 
2 dodecanol, nBuLi, THF, N2, 0 °C to RT, 1 h 
3 dodecanol, tBuLi, THF, N2, 0 °C to RT, 20 h 
4 1) AgOTf, toluene, N2, 80 °C, 40 min 
2) dodecanol, toluene, Et3N, 80 °C, N2, 20 h 
Scheme 2.8: Synthetic strategies towards the dodecyl ether-substituted pytpy L17 
 
A table in Scheme 2.8 summarises four different attempts to synthesize dodecyl oxy-
substituted pytpy L17, a model alkoxy-substituted pytpy. Dodecanol was used as a suitable 
commercially available reactant. The first trial to achieve the ether linkage was inspired by 
work in Chapter 3. Chloro-substituted L6 was refluxed with dodecanol in toluene in the 
presence of the base 2,6-lutidine. The reaction process was monitored with 1H NMR 
spectroscopy. The chemical shift of the first methylene group in ether L17 was expected to 
be around  4 ppm, considering the fact that in dodecyl ester the chemical shift of this CH2 
group comes at  4.44 ppm and in dodecanol at  3.69 ppm. However, even after 2 days any 
signals of the desired product L17 were not detected, and only peaks of unreacted starting 
reactants were observed (Input 1 in Scheme 2.8). Another option to synthetize L17 was via 
lithium alcoholate (Inputs 2 and 3). Dodecanol was stirred with nBuLi in dry THF for 15 
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minutes at 0 °C under an inert atmosphere. This reactive solution of lithium dodecanolate 
was then stirred for one hour at room temperature with a solution of L6 in THF. It was 
possible to see a colour change from bluish to ochre. This reaction was also repeated with 
tBuLi and with stirring for 20 hours at room temperature. Reactions were monitored with 
TLC plates (SiO2, eluted with EtOAc/MeOH/Et3N = 60:2:1), and one could observe formation 
of new bands. However, according to 1H NMR spectra and ESI MS spectra of both crude 
reaction mixtures, the target molecule L17 was not prepared. Being aware of the low 
reactivity of L6 and difficulties with the conversion to the more reactive aryl iodide, we 
considered an option to convert L6 to more reactive trifluoromethanesulfonate, using the 
formation of silver chloride precipitate is the driving force for the process (Input 4 in Scheme 
2.8). A brown suspension of L6 and silver triflate in toluene was heated at 80 °C for 40 
minutes in the dark under an inert atmosphere. Dodecanol and triethylamine were added 
and the reaction mixture was heated for 20 hours at 80 °C. Though the monitoring with TLC 
plates looked promising, the 1H NMR spectrum did not reveal any signals of the desired L17, 
and ESI MS spectrometric data were also inconclusive. 
There are two options for the synthesis of an aryl-alkyl ether (Scheme 2.9). The first one, 
discussed in Scheme 2.8, starts with an aryl halide which reacts with alkoxide ion, prepared 
immediately before the reaction, or generated in situ from alcohol. Another common option 
involves an aryl oxide ion, in our case generated from aryl alcohol 10, which reacts with an 
alkylating agent (alkyl halide). 
 
 
Scheme 2.9: Strategies towards alkoxy-substituted pytpy 11 
 
There were two options for the synthesis of hydroxy-substituted pytpy 10. One is synthesis 
from simple precursors, such as 2-acetylpyridine, involving many steps. The other one, worth 
trying first, involved substituting the chloro group in L6 by a hydroxyl group. We tried a 
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conversion method involving trialkylborate (Scheme 2.10). L6 was stirred with nBuLi in THF at 
-80 °C for 3 hours under an inert atmosphere. Triisopropyl borate was added and the 
reaction mixture was stirred overnight, allowed to slowly warm up to room temperature and 
the solvent removed in vacuo. For the last step we had two options for quenching of the 
crude reaction mixture, which currently was in a state of aryl diisopropyl borate. If we used 
HCl (aq.), we would obtain a pytpy substituted with boronic acid, pytpy-B(OH)2. In addition 
to this, the nitrogen atoms of the pendant pyridyl positions might be protonated in the 
presence of HCl. Therefore, a combination MeOH/H2O2 (2:1) was used, to directly lead to 
hydroxy pytpy 10. The residue from the crude reaction mixture was dissolved in methanol, 
cooled in an ice bath, and H2O2 (30%) was added. The mixture was stirred at 0 °C for 2 hours. 
Solvent was then evaporated and the residue extracted with DCM - NaHCO3 and water giving 
a yellow solid after evaporation. In the electrospray mass spectrum, two major peaks were 
observed. A peak with m/z = 326.2 with 37% intensity, which we could assign to [M]+ with M 
= 10. However, this was just a minor peak. The other was the base peak with m/z = 423.2, 
which could belong to [M-Me]+ with M = pytpy-B(OiPr)2, an intermediate in Scheme 4.4 
before quenching of the reaction mixture. However, no isopropyl signals were observed in 
the 1H NMR spectrum. 
 
 
Scheme 2.10: Conversion of L6 to hydroxy-substituted pytpy 10 via trialkylborate 
 
Another option to synthesize compound 10 was reduction of the methyl ester-group of L2 to 
the corresponding methylene alcohol 12 (Scheme 2.11).7 A suspension of L2 with LiAlH4 in 
THF was refluxed for 5.5 hours under an inert atmosphere. The reaction mixture was then 
cooled, placed in an ice bath and stirred overnight with sodium sulfate decahydrate. This 
was filtered and the yellow solution evaporated to dryness. In the electrospray mass 
spectrum, a peak with m/z = 363.2 (assigned to [M+Na]+) with 75% intensity was observed. 
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However, the 1H NMR spectrum indicated that the product was very impure. Instead of 
attempting purification, we focused on finding harsher conditions for the etherification of L6 
(Scheme 2.12).8 
 
 
Scheme 2.11: Reduction of the methyl ester group of L2 to methylene alcohol 
 
In 2001, Halcrow et al. reported successful harsh conditions of etherification of 4’-chloro-
2,2’:6’,2’’-terpyridine, which was a useful inspiration for the etherification of L6 (Scheme 
2.12).8 Freshly ground potassium hydroxide was suspended in DMSO, to which L6 and 
dodecanol were added and heated at 60 °C for 19 hours. This reddish-brown solution was 
then cooled to room temperature. Addition of ice-cold water gave a brownish mud-like 
precipitate, which was collected on a frit and washed with water, giving the desired model 
ligand L17 as a brown solid in 49% yield.  
 
 
Scheme 2.12: Successful harsher conditions towards alkoxy-substituted pytpy ligands L17-20 
 
The same reaction conditions were applied to the synthesis of amino ethers L18-20, where 
we used amino alcohols P16-18 with diethyl amine, piperidine or morpholine units 
(synthesis7 in Scheme 1.11 and 3.10). During work up, L18-20 formed as fine precipitates, 
which were very difficult to separate by filtration. Therefore these products were purified by 
extraction with chloroform-water. A large amount of water during extraction was necessary 
56 
 
for DMSO removal. However, a certain amount (10-50%) of unreacted alcohol was always 
detected, no matter which purification technique was used. Even purification on a 
chromatography column did not help to remove all the alcohol, which tended to elute 
together with products L17-20. However, this fact does not matter for complexation of the 
ligands, but isolation of pure products was crucial for further analysis. Therefore elemental 
analysis were not measured for any of L17-20. 
 
 
Figure 2.5: 1H NMR (400 MHz, CDCl3) spectra of ester L10 (dark blue) and ether L17 (green) 
 
Figure 2.5 compares the 1H NMR spectra of dodecyl ether-substituted L17 (green) and 
dodecyl ester L10 (blue). In the aromatic region it is possible to observe the characteristic 
shift of protons of the pyridyl unit D to the higher magnetic field, caused by the electron 
donating effect of the alkoxy group, in comparison to the electron withdrawing effect of the 
ester group. The same effect is observed in the aliphatic region. Methylene group 1 in the 
ester group of L10 has a chemical shift  4.43 ppm, and the methylene group 1 in the ether 
L17 is shifted to  4.15 ppm, as expected. Around  3.6 ppm is an impurity peak of unreacted 
starting dodecanol. In the electrospray mass spectra of L17-20, peaks assigned to [M+Na]+ 
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with 100% intensity and also peaks assigned to [M+H]+ and [M+K]+ with intensity 20-50% 
were observed. 
 
 
Conclusion 
We successfully synthesized and fully characterised chloro-substituted pytpy ligand L6. 
Unfortunately we did not manage to fulfil the proposed strategy to prepare the amino-
substituted side chain bearing an alkyne and triazole ring. However, another application was 
found for L6, namely the synthesis of ligands with an amino-substituted side chain linked via 
an ether L17-20 and also their ruthenium(II) complexes (Section 2.3 and Chapter 5). 
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Chapter 3 
 
4’-(4-Pyridyl)-2,2’:6’,2’’-terpyridine ligands with a side 
amino-chain linked via an ester 
 
3.1 Introduction 
In Chapter 1 we focused on the synthesis of ruthenium(II) complexes with pytpy ligands 
containing a long side amino-chain, which was introduced into the molecule via trans-
esterification from methyl ester-substituted complexes. This approach afforded such Ru(II) 
complexes in quite low yields. Therefore, we decided to investigate a synthetic route in 
which the long side amino-chain was linked via an ester attached to the pytpy ligand 
(Scheme 3.1). In this chapter, we report several synthetic strategies and discuss their relative 
merits. 
 
 
Scheme 3.1: Towards pytpy ligands with an amino-chain linked via an ester 
 
 
3.2 Results and Discussion 
 
3.2.1 Synthetic strategies 
Scheme 3.2 displays all the proposed routes B-E to synthetize pytpy ligands with the long 
side amino-chain linked via an ester L10-14 along with the original approach A from 
Chapter 1. Route B starts from methyl ester substituted pytpy L2, which is hydrolysed to a 
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free carboxylic acid L8, a suitable precursor for a wide range of esters and amides. Route C 
represents a “one-pot” esterification of L8 by an amino-alcohol mediated by DCC.1, 2 Option 
D is a two-step reaction in which L8 is converted to the acid chloride of the carboxylic acid 
and then to an ester.3, 4, 5 There is also a direct possibility E, trans-esterification of the methyl 
ester substituted pytpy L2 to L10-14. Route F represents another option to obtain the 
carboxylic acid-substituted pytpy L8. 4-Picoline is acetylated in the 2-position, then activated 
as a PPI salt, and with the Kröhnke synthetic method, the methyl substituted pytpy L7 is 
obtained. After reaction with an appropriate oxidation agent,10 this will lead to carboxylic 
acid L8.6 
 
Scheme 3.2: Synthetic strategies towards the pytpy ligands with an amino-chain linked via an ester 
 
 
3.2.2 Synthesis of the methyl-substituted pytpy L7 
Methyl-substituted ligand L7 was synthesized using strategy F (Scheme 3.2). Besides L2, L7 
was meant to be another source of carboxylic acid-substituted pytpy L8, a suitable precursor 
for all pytpy ligands with an amino chain linked via an ester L10-14. L7 would be oxidized 
with strong oxidizing agent (e.g. KMnO4)
10 to L8 (Scheme 3.2, route F). 
For the synthesis of L7, the same Kröhnke methodology was used as for the methyl ester-
substituted ligand L2 (Scheme 3.3).7-9 Commercially available 4-picoline was acetylated7, 8 in 
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the 2- position and the product P4 was separated with column chromatography from the 
2,3-, 2,5- and 3,5-bisacetylated side products. The formation of the side products was 
observed on TLC plates (SiO2, eluted with ethylacetate/cyclohexane = 1:2). P4 was isolated 
as yellow needle-like crystals in low 13-24% yields. The yields of P4 were always so low, in 
comparison with methyl ester substituted P2 (66%, Scheme 1.4), due to two facts: 1) methyl 
is an electron donating group, ortho- and para-directing, however CO2Me is an electron 
withdrawing group and meta-directing, 2) in case of CO2Me group, ortho- positions are 
actually partly sterically hindered in comparison with small size of the methyl group. 
However, the problem of EDG and EWG groups is the main reason, why the desired P4 is just 
the minor product alongside of the bisacetylated side products. 
 
Scheme 3.3: Synthetic approach to obtain L7 via methyl-substituted PPI salt P7 
 
The conversion of 2-acetyl-4-methylpyridine P4 to the corresponding pyridinium salt P7 was 
performed as reported in the literature for 2-acetylpyridine or 2-acetylisonicotinate P2 
(Scheme 3.3).7 However, the synthesis of the methyl-substituted PPI salt P7 was not as easy 
as in the case of the methyl ester-substituted PPI salt P5 or the chloro-substituted PPI salt P6 
(74% and 92%, respectively) and we obtained P7 as a black powder in only 9 - 36% yield. 
Chalcone P9 (Chapter 1, Scheme 1.5) 9 was used with P7 for the synthesis of methyl-
substituted ligand L7 via Kröhnke methodology. In the 1H NMR spectrum of PPI salt P7 many 
impurities were observed, which were difficult to separate, and we only obtained impure 
ligand L7, even after recryctallization. 
Due to the difficulties with the synthesis and purification of the PPI salt P7, preparation of L7 
the other way round seemed to be worth trying (Scheme 3.4). The methyl group would be 
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introduced into the ligand L7 via the methyl-substituted enone P10, which, when treated 
with PPI salt P8 via Kröhnke methodology would give L7. 
 
Scheme 3.4: Synthetic approach to obtain L7 via methyl-substituted enone P10 
 
For the synthesis of methyl-substituted enone P10, the same microwave assisted reaction 
conditions were applied as those successfully used for the synthesis of P9 in the Chapter 1 
(Scheme 3.5, green route). In 2006, Newkome reported the synthesis of various substituted 
azachalcones prepared by the Claisen-Schmidt aldol condensation by using microwave 
irradiation with a small amount of solvent in the presence of Al2O3 as a catalyst and solid 
support.9 However, in the case of P10, the product was obtained in very low yield (12%) 
along with unreacted starting aldehyde and ketone. Krebs reported another easy access to 
azachalcones, involving piperidinium acetate, which affords the product as orange crystals in 
30-40% yield.6 Using this approach, enones P9 and P10 were prepared as analytically pure 
pale orange crystals in 26% and 36% yield, respectively (Scheme 3.5, pink route). 
 
Scheme 3.5: Synthesis of enones P9 and P10 using microwave oven or piperidinium acetate  
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Figure 3.1 compares the 1H NMR spectra of azachalcones P9 (red) and P10 (blue). We could 
observe two characteristic doublets at  8.42 and 7.77 ppm with a large coupling constant 
(JA,B = 16.1 Hz), typical for a trans double bond. In the 
1H NMR spectrum of P10, it is possible 
to observe the influence of the methyl group on the protons labelled 3, 5 and 6, which are 
shifted to lower ppm values in comparison with P9. In the electrospray mass spectrum of 
P10, peaks with m/z = 225.1 (assigned to [M+H]+) with 100% intensity, and 247.0 (assigned 
to [M+Na]+) with intensity 9% were observed. 
 
Figure 3.1: Comparison of 1H NMR (400 MHz, CDCl3) spectra of azachalcones P9 (red) and P10 (blue) 
 
Following the reaction of the enone P10 with Kröhnke’s reagent P8 (consists of pyridinium 
iodide salt of 2-acetylpyridine) in the presence of an excess of ammonium acetate led to the 
desired methyl-substituted ligand L7 (Scheme 3.4). The product precipitated out from the 
reaction mixture as a pale brown powder in 93% yield. In the MALDI TOF mass spectrum of 
L7, a peak with m/z = 324.9 (assigned to [M]+) with intensity 78% was observed.  
Figure 3.2 shows a comparison of the 1H NMR spectra of the pytpy ligand L3 (red) and 
CO2Me-substituted pytpy L2 (green), chloro-substituted L6 (cyan) and Me-substituted L7 
(purple). The influence of the electron-donating and electron-withdrawing substituents on 
P9
P10
2‘
6

3
3‘
5
Me
6
2‘ 

3‘
5
43
63 
 
the chemical shift of protons (red letters) of the pendant pyridyl ring D can be observed. The 
methyl ester substituent of L2 (green) is typically electron-withdrawing by resonance, 
therefore all D-protons are shifted to higher ppm. However, the methyl substituent of L7 
(purple) is electron-donating by inductive effects, so the D-protons are shifted to lower ppm 
values. The chloro-substituent of ligand L6 (cyan) is electron-withdrawing inductively but 
electron-donating through resonance. After combining these two effects, one observes that 
the D-ring protons of L6 have similar chemical shifts as the A-ring protons (Figure 3.2). 
 
 
Figure 3.2: Comparison of the 1H NMR (500 MHz, CDCl3) spectra of substituted pytpy ligands L3 (H, 
red), L2 (CO2Me, green), L6 (Cl, cyan) and L7 (Me, purple) 
 
We decided not to continue with the further oxidation of L7 to L8, because synthetic routes 
B and D (Scheme 3.2) appeared to a better choice. Therefore, we focused on tuning the 
reaction conditions in routes B and D. We also had to consider the fact that synthese of 
precursors P2, P5 and P9 (Scheme 1.4, 1.5) gave the products in much higher yields (66-93%) 
in comparison with the synthese of precursors P4, P7 and P8 (24-36%), which are necessary 
for the synthese of L2 and L7, respectively. 
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3.2.3 Synthetic strategies C and D 
For synthetic strategy B (Scheme 3.2), conversion of the methyl ester-substituted L2 to the 
free acid L8 were used the same reaction conditions as those reported by Krebs (Scheme 
3.6).6 A mixture of L8 with 1M aqueous NaOH was refluxed overnight in methanol and the 
pH adjusted with HCl (0.5M) to a value of  3.5-4.0. A white mud-like precipitate formed, 
and this was collected on a frit, washed with water and air dried. The product L8 was 
isolated as an off-white powder in nearly quantitative yield and used for the next step 
without any further purification. 
 
Scheme 3.6: Hydrolysis of the methyl-ester substituted L2 to carboxylic acid L8 
 
 
Figure 3.3: 1H NMR (400 MHz, DMSO-d6) spectrum of L8 
 
An electrospray mass spectrum was recorded and microanalysis measured, and we found 
that the product L8 had been isolated in its protonated form with a chloride counterion 
(Scheme 3.6). In the MALDI TOF mass spectrum of L8, a peak with m/z = 780.2 (assigned to 
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[2M]+) with intensity 100% was observed, proving a presence of H+ and Cl-. Only a small peak 
354.1 (assigned to [M]+ of the neutral form L8n) with 5% intensity was found. Results from 
the elemental analysis were not possible to fit for the expected theoretical values of the 
neutral form (L8n). However, the experimental data from microanalysis fitted well for L8. 1D 
and 2D NMR spectra were measured and we could see that the protonation happens on the 
pendant pyridyl unit C (Figure 3.3). Protons labelled C2 and C3 are shifted to lower magnetic 
field, which is characteristic for N-protonated and N-alkylated pyridyl unit. The ligand L8 was 
synthesised several times and we always observed a slightly different chemical shift of 
protons labelled C2 and C3, according to the amount of the protonated form L8 vs. the 
neutral form. Around  13.9 ppm is possible to see a broad signal for the proton from the 
COOH group. 
 
Scheme 3.7: Steglich reaction – direct one step esterification of carboxylic acids 
 
One option to synthesize the pytpy ligand with a long side amino-chain is a direct 
esterification of the carboxylic acid substituted ligand L8 as reported by Steglich (Scheme 
3.2, route C).2 This is a one-pot esterification of a carboxylic acid by alcohols, mediated by 
N,N’-dicyclohexylcarbodiimide (DCC) and catalysed by dimethylamidopyridine (DMAP). A 
side-product is dicyclohexylurea (DCU). Reaction conditions are mild, because the reaction 
usually takes place at room temperature. Typically, the solvent is dichloromethane (Scheme 
3.7).1 After performing the Steglich reaction with substrate L8 and measuring the 1H NMR 
spectrum of the crude reaction mixture, we observed characteristic signals of the side 
product DCU and signals of unreacted 11-(diethylamino)undecan-1-ol P16, but only minor 
signals which could belong to the desired product L11. The DCU was then filtered off as a 
white powder and the rest was purified using a short chromatography column (Al2O3, eluted 
with EtOAc/cyclohexane = 2:1). Two bands were isolated. The first one was L11, however 
still very impure and in a trace amount. The second main fraction was the symmetrical 
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unsubstituted pytpy L3, a product of decomposition of L8. It appears that the failure of the 
Steglich reaction with substrate L8 lies in poor solubility in most solvents.  
 
 
Scheme 3.8: Esterification of L8 via the corresponding acid chloride 
 
Synthetic strategy C was abandoned and we focused on strategy D (Scheme 3.2). This 
involves esterification of L8 which was first converted to the corresponding acid chloride L8B 
(Scheme 3.8).3 L8 was refluxed in thionyl chloride for 3 hours under an inert atmosphere and 
the grey suspension turned to a yellowish solution. The excess of thionyl chloride was 
evaporated under reduced pressure and the residue dried. The acid chloride L8B was 
obtained as a yellowish powder, assumed to be formed in quantitative yield and 
immediately used for esterification without any further purification. 
L8B was then refluxed with amino alcohol P16 in toluene for 15 hours under nitrogen (Table 
3.1, Input 1). The crude reaction mixture was evaporated, dissolved in chloroform and 
extracted with saturated aqueous sodium hydrogen carbonate and water. Formation of the 
target esters L10-14 was monitored with the 1H NMR spectrum by the presence of the triplet 
(expected   4.4 ppm) of the first CH2 group next to the carboxyl group. In the 
1H NMR 
spectrum of the crude product of Input 1 (Table 3.1), were observed peaks of solvents, 
unreacted starting amino alcohol P16 and a trace amount of the desired L11. The poor yield 
has most likely this reason. The leftover trace amount of SOCl2 and also HCl (formed during 
the conversion of L8 to the acid chloride L8B) reacted with alcohol P16 to produce a 
chloroalkane. Therefore in the next attempts, acid chloride L8B was first dried properly on a 
high vacuum and then refluxed with base (1-5 eq.) and after that with amino alcohols (Table 
3.1, Input 2-10). 
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Input Base ROH Time / h Yield /% Product 
1 none Et2N(CH2)11OH 15 trace L11 
2 DMAP CH3(CH2)11OH 17 75 L10 
3 DMAP Et2N(CH2)11OH 15 10 L11 
4 DMAP CH3CH2(OCH2CH2)3OH 18 49 L12 
5 Et3N CH3(CH2)11OH 15 57-69 L10 
6 Et3N CH3CH2(OCH2CH2)3OH 16 54 L12 
7 Et3N Et2N(CH2)11OH 15 27-63 L11 
8 2,6-lutidine Et2N(CH2)11OH 21 58 L11 
9 2,6-lutidine 
 
15 41-52 L13 
10 2,6-lutidine 
 
17 34-45 L14 
Table 3.1: Reaction conditions towards ester-substituted ligands L10-14 (Scheme 3.8) 
 
In Input 2, acid chloride L8B was first refluxed for 30 minutes with DMAP and then overnight 
with commercially available dodecanol, as a model alcohol. The crude reaction mixture was 
purified by extraction with chloroform – sodium hydrogen carbonate and water. 
Crystallization from cold ethanol gave analytically pure L10 as an off-white powder in 75% 
yield. However, L11 was received in only 10% yield when these reaction conditions were 
applied with amino alcohol P16 (Input 3). When the same reaction conditions were repeated 
using tetraethyleneglycol monoethyl ether as the alcohol for esterification (Table 3.1, Input 
4), L12 was obtained in 49% yield. The side amino- or ether-chains make crystallisation of the 
products L11 and L12 difficult, therefore they were purified with a short chromatography 
column (SiO2, eluted with EtOAc/Et3N = 9:1 or EtOAc/MeOH/Et3N = 30:2:1). Triethylamine 
was used to assist elution of the products on the column, because the Rf values of L11 and 
L12 are very low, and also to avoid their decomposition on SiO2. In the 
1H NMR spectra we 
observed signals which were assigned to L11 and L12, but also peaks due to DMAP, which 
means that DMAP has a similar Rf value as ligands L11 and L12. Therefore Et3N was used as 
the base for the next reactions. This strong base has good advantages: an excess can be 
easily evaporated after the reaction and it is not toxic in contrast to DMAP. Inputs 5 – 7 
(Table 3.1) were done with triethylamine as a base and after several attempts, ligands L10, 
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L11 and L12 were isolated in very good (54 – 69%) yields. However the products L11 and L12 
were isolated in mixtures with unreacted starting alcohols, usually in a ratio 70:30 to 85:15. 
This impurity does not matter for the further complexation of the ligands. However the 
purity of the ligand is important for analysis and characterisation. One option to complete 
the conversion of esterification was to run the reaction with an excess of Et3N (5 eq.) (Input 
7 in Table 3.1), which increased the average yield of L11 only slightly. However, starting 
amino alcohol P16 was not recovered. 
Use of 2,6-lutidine, a sterically hindered mild base, was another option to force the 
esterification (Table 3.1, Input 8-10). It is possible to remove an excess of 2,6-lutidine under 
reduced pressure or to separate it on a chromatography column, because its Rf value is very 
high in comparison with those of the desired ligands. The reaction with amino alcohol P16 
and 2,6-lutidine (5 eq.) was tried 3 times and in all cases product L11 was isolated in good 
(57-58%) yields, pure or with only a trace amount of P16 (Table 3.1, Input 8). Esterification 
with 2,6-lutidine as a base was realized also with 11-(piperidin-1-yl)undecan-1-ol P17 and 
with 11-morpholinoundecan-1-ol P18. (Their synthesis11 is described in section 3.2.4). The 
ester-substituted ligands bearing a piperidine ring (L13) and a morpholine ring (L14) were 
obtained as ochre solids in 52% and 45% yields, respectively (Table 3.1, Input 9 - 10). 
All five new ester-substituted ligands L10-14 were characterised with 1H, 13C, COSY, HMQC 
and HMBC NMR spectra. In the aromatic part of each 1H NMR spectrum, it is possible to see 
the typical distribution of proton peaks of the ester-substituted pytpy, and this is nearly the 
same as for CO2Me-substituted L2 (Compare Figures 3.2 and 3.4). In the aliphatic part of the 
spectra of the dodecyl ester L10 and amines L11 and L13-14 a characteristic triplet of the CH2 
group 1 and a pentet of the CH2 group 2 were observed with chemical shifts of  4.43 ppm 
and 1.83 ppm, respectively. However, methylene protons 1 and 2 of L12, shielded by the 
oxygen atom from the ester and the ether group, resonate at lower field ( 4.58 and 3.90 
ppm, respectively), as well as all protons 4-10 of L12 ( 3.75 – 3.47 ppm) and methylene 
groups 14 ( 3.72 ppm) of the morpholine unit of L14. Methylene protons 11 and 13 in the 
neighbourhood of the amino group (L11 and L13-14) absorb typically around  2.4 ppm. 
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Figure 3.4: Comparison of the  1H NMR (400 MHz, CDCl3) spectra of ester-substituted pytpy ligands 
L10 (green), L11 (red), L12 (brown), L13 (violet) and L14 (pink) 
 
In the electrospray mass spectra of L11, L13 and L14 one peak was observed, with m/z 
580.4, 592.4 and 594.3, respectively (100% intensity), and was assigned to [M+H]+. In the ESI 
MS of L10 and L12 were not only peaks with m/z 523.4 and 515.3 (with intensity 45% and 
28%, respectively) were assigned to [M+H]+. Extra peaks with m/z 561.3 (27%) and 545.4 
(100%) for L10 and with m/z 553.2 (27%) and 537.3 (100%) for L12 were assigned to [M+K]+ 
and [M+Na]+. 
The electronic absorption spectra of acetonitrile solutions of ester-substituted pytpys L2, 
L10-14, together with pytpy L3, chloro-substituted pytpy L6 and Me-substituted L7 are 
shown in Figure 3.5. The ligands exhibit a series of high energy absorption bands around 
240 nm with high extinction coefficients (35 to 60103 dm3 mol-1 cm-1) and around 280 nm 
with a shoulder at 320 nm with lower extinction coefficients (10 to 30103 dm3 mol-1 cm-1). 
The bands arise from ligand-centred * transitions (Table 3.2). 
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Figure 3.5: UV/Vis absorption spectra (CH3CN) of 4-substituted pytpy ligands L2 (4.2210
-5M, black), 
L3 (5.9710-5M, blue), L6 (4.0810-5M, orange), L7 (4.8010-5M, cyan), L10 (4.3910-5M, green), L11 
(3.8310-5M, red), L12 (5.7610-5M, olive-green), L13 (4.1310-5M, violet) and L14 (3.9910-5M, pink) 
 
Ligand c / 10-5 mol dm-3 max/nm (max/10
3 dm3mol-1cm-1) 
L2 4.22 242 (33.3) 281 (16.3) 316 (9.6 sh) 
L3 5.97 242 (44.0) 277 (28.7) 314 (9.1) 
L6 4.08 244 (37.6) 276 (20.8) 313 (7.7) 
L7 4.80 243 (49.5) 277 (31.1) 315 (10.6) 
L10 4.39 243 (37.5) 281 (18.6) 317 (10.6 sh) 
L11 3.83 242 (52.1) 281 (25.2) 316 (14.8 sh) 
L12 5.76 243 (38.5) 283 (30.8)  
L13 4.13 242 (59.7) 281 (29.2) 316 (16.9 sh) 
L14 3.99 243 (51.2) 281 (25.0) 316 (14.5 sh) 
Table 3.2: UV/Vis absorption spectra (CH3CN) of 4-substituted pytpy ligands 
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3.2.4 Synthesis of amino alcohols P17 and P18 
In Scheme 1.11 in Chapter 1 a facile two-step synthetic route to obtain 11-
diethylaminoundecanoate P16 from methyl 11-bromoundecanoate was discussed. This 
synthetic strategy for a wide range of amino alcohols with various chain-lengths was 
published by Wetter et al. in 1974.11  In this chapter, we were interested to expand this 
method to other secondary amines besides diethylamine to obtain several amino alcohols 
with different chemical properties and afterwards Ru(II) complexes with diverse 
photophysical properties. A wide range of commercially available secondary amines exists, 
e.g. Me2NH, EtMeNH, Pr2NH, 
iPr2NH or cyclic amines such as pyrrolidine, piperidine and 
morpholine. We chose iPr2NH and piperidine (Scheme 3.9). Reaction conditions were applied 
the same as for diethylamine (Scheme 1.11). Methyl 11-bromoundecanoate was refluxed 
overnight with an excess of amine. However, in the case of iPr2NH the reaction did not 
proceed at all and the starting bromo-derivative was recovered in 75% of the original 
amount. On the contrary, due to too high a reaction temperature, the reaction with 
piperidine afforded not only the desired product P13 but the product P13b of a double-
substitution as the major product. Bromine was replaced by piperidine but also the methyl 
ester group converted to amide. 
 
Scheme 3.9: Towards other amino-alcohols besides P16 
 
The reaction with piperidine was repeated several times to optimize the reaction conditions. 
Stirring at 50-60 °C for 5-6 hours was found as an optimum, yielding P13 in 92%. The 
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reaction was repeated also with morpholine to give the corresponding tertiary amine P14 in 
99% yield. P12-14 were purified using vacuum distillation and obtained as yellowish oils. For 
the next step, the reducing agent LiAlH4 in THF was used for conversion of the methyl ester 
group of P13 and P14 to methylene alcohol, as in the case of P12 in Chapter 1. 
Corresponding amino alcohols P17 and P18 were obtained as yellowish oils in quantitative 
yields (Scheme 3.10). Figure 3.6 displays a comparison of their 1H NMR spectra. 
 
Scheme 3.10: Synthesis of amino alcohols P16-18 
 
 
Figure 3.6: Comparison of the 1H NMR (400 MHz, CDCl3) spectra of amino alcohols P16 (red), 
P17 (violet) and P18 (pink) 
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Conclusion 
In Scheme 3.2 were discussed theoretical possibilities to obtain ester-substituted pytpy 
ligands L10-14 with long aliphatic amino chains. After practical experiments, a combination 
of options B (hydrolysis of methyl ester L2 to L8) and D (esterification of L8 via acid chloride) 
was found to be ideal route. Route C (Steglich direct esterification of carboxylic acid L8) did 
not work due to the insolubility of L8. In route F, methyl-substituted pytpy L7 was prepared 
as an alternative source of L8, but was not followed up due to low yields during most of the 
reaction steps. We thought of an alternative E, trans-esterification of methyl ester L2, but 
have not tried this since the effective routes B and D worked so well. Complexation of 
ligands L10-14 (Chapter 4) is a more successful alternative to the original idea of complex 
synthesis by the trans-esterification of C7 (Chapter 1). 
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Chapter 4 
 
Ruthenium(II) complexes with three or four 
protonation sites 
 
4.1 Introduction 
In Chapters 2 and 3, ligands with a side amino-chain linked via an ester or an ether L10-14 
and L17-20 were prepared. In this chapter, ruthenium(II) complexes of these ligands are 
synthesized (Scheme 4.1). The amino group attached to the side chain and the two pendant 
pyridyl groups bring to the molecule three (or four, respectively) protonation sites. Several 
synthetic strategies, analysis and photochemical studies will be reported and their results 
discussed. 
 
Scheme 4.1: Towards ruthenium(II) complexes with a side chain linked via an ester or via an ether 
bearing three or four protonation sites 
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4.2 Results and Discussion 
 
4.2.1 Synthesis of heteroleptic ruthenium(II) complexes with pytpy ligands 
We had two options for the synthesis of heteroleptic ruthenium(II) complexes C17 (a model 
complex) and C18 (a complex with a N-diethylamino group as the third protonation site). It 
was important to find out which ligand to use in the first complexation step and which in the 
second one, i.e. in which order to introduce the symmetrical L3 and the asymmetrical L10 
and L11, respectively. 
 
Scheme 4.2: Synthetic strategies in the domestic microwave oven towards the ruthenium(II) 
complexes with three protonation sites 
 
Table 4.1: Reaction conditions for Scheme 4.2 
 
Input 2nd ligand Solvent Time / min Product /% Side products 
1 L10 ethylene glycol 2.5 C17 (3%) - C16, C16b, C8 
2 L10 ethylene glycol 1.5 C17 (25%) C28 (10%) - 
3 L10 ethylene glycol 2 C17 (13%) C28 (trace) - 
4 L11 ethylene glycol 2 C18 (-) C29 (-) C16, C16b, C8 
5 L10 AcOH 10 C17 (trace) C28 (trace) - 
6 L10 DMF 4 - - - 
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We started with L3 (Scheme 4.2). L3 was converted to Ru(L3)Cl3, complex C2, according to 
the procedure reported by Sullivan et al. in 1980 (Scheme 1.8 in Chapter 1) and collected as 
a black powder in a quantitative yield.1 C2 and L10 were suspended in ethylene glycol and 
irradiated in the domestic microwave oven at 750W for 2.5 minutes (Table 4.1, Input 1). 
During this period, the black suspension turned to a red solution, which signalled the 
formation a of Ru(II) complex. Aqueous ammonium hexafluorophosphate was added to 
precipitate the product as a PF6
- salt. The red precipitate which formed was collected on 
Celite®, washed with water and redissolved in acetonitrile. Solvent was removed in vacuo 
and the red residue purified on a chromatography column (SiO2, eluted with 
MeCN/saturated aqueous KNO3/H2O = 5:1:1). Three bands were observed. The first, minor 
one, was the target molecule C17 in 3% yield. The third fraction, which stayed on the 
column, was the COOH substituted complex C21, a product of decomposition. According to 
the NMR spectra and ESI MS, it was concluded that the second fraction was a product of 
transesterification with ethylene glycol C16. In the electrospray mass spectrum of C16, peaks 
with m/z = 405.1 (assigned to [M-2PF6]
2+) with 100% intensity and 955.2 (assigned to [M-
PF6]
+) with intensity 12% were observed. In the 1H NMR spectrum of C16, two triplets with  
4.39 and 3.79 ppm (assigned to the CH2 groups of the ester chain) were observed. The 
aromatic part has a characteristic set of peaks, identical with the dodecyl ester substituted 
complex C17. However, upon a closer comparison, one could observe that all the aromatic 
peaks are doubled. This gave us a hint that the fraction collected was a mixture of two or 
more products with the same Rf value on a TLC plate. In the electrospray mass spectrum, 
another two sets of peaks were assigned, for homoleptic complex C8 and for another 
product of trans-esterification with ethylene glycol C16b (Scheme 4.2, Table 4.1 Input 1). 
Peaks with m/z = 361.1 and 867.2 (assigned to [M-2PF6]
2+ and M-PF6]
+, respectively) with 
38% and 13% intensity were observed for C8 and a peak with m/z = 449.1 (assigned to [M-
2PF6]
2+) with 35% intensity was observed for C16b. 
To avoid the formation of the side products C16 and C16b, the reaction time was shortened 
to 1.5 and 2 minutes, respectively (Inputs 2 and 3, Table 4.1) and the model complex C17 
was obtained in 25% and 13% yield, respectively. However, the homoleptic complex C28 was 
also isolated as a side product, in 10% yield and a trace amount, respectively. These reaction 
conditions were also used with the N-diethylamino-substituted ligand L11 (Input 4, Table 
4.1). The reaction mixture was heated in a domestic microwave oven at 750W until the black 
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suspension turned red (2 minutes). However, only the products of trans-esterification with 
ethylene glycol C16 and C16b were obtained. A change of solvent was worth trying (Inputs 5 
and 6, Table 4.1). We used acetic acid and the reaction mixture was heated at the highest 
setting of the microwave oven. However, after 10 minutes the reaction mixture had turned 
only slightly red and product C17 was isolated in only a trace amount. The reaction in DMF in 
the domestic microwave oven did not proceed at all (Input 6, Table 4.1). 
 
 
Input 1st ligand 2nd ligand Product /% Side product 
1 L3 L10 C17 + C28 isolated in a mixture 
2 L10 L3 C17 (38%) C28 (trace) 
Scheme 4.3: Two options for a microwave reactor towards the model complex C17  
 
Considering the formation of C16 and C16b, for the next reactions we used microwave 
reactor conditions (Scheme 4.3 and 4.4), which worked well for the synthesis of C7 in DMF 
(Scheme 1.14, Chapter 1). These “one-pot” reaction conditions were used with the model 
complex C17 and involve four reaction steps, without isolation of intermediates (Scheme 
4.3). The first ligand is coordinated as a Ru(L)Cl3 complex, which is then activated with silver 
hexafluorophosphate. This reacts with the second ligand in a presence of a catalytic amount 
of N-ethylmorpholine, used as a reducing agent for Ru(III) to Ru(II). The product C17 is then 
precipitated as a PF6
- salt. Both options were tried, first to complex L3 and then L10 (Input 1, 
Scheme 4.3) and also the other way round (Input 2, Scheme 4.3). Crude products were 
purified with column chromatography (SiO2, eluted with MeCN/saturated aqueous 
KNO3/H2O = 10:1.5:0.5). In the first case, intensely coloured bands of both products (the 
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target molecule C17 and the side product C28) were observed. However, products were not 
separated even after two chromatography columns, due to the nearly identical Rf values of 
the two fractions (Input 1, Scheme 4.3). In the second option, the chromatography 
separation was much easier, because C17 was the major fraction (38% yield) and C28 was 
isolated in only trace amount (Input 2, Scheme 4.3). In both cases, the homoleptic complex 
C8 was also observed as a minor fraction. 
 
Scheme 4.4: Synthesis of ruthenium(II) complexes C18-20 with three protonation sites 
 
These conditions (Input 2 in Scheme 4.3) were also used for complexation of the ligands with 
the amino-substituted ester chains L11 and L13-14 to synthesize the Ru(II) complexes with 
three protonation sites C18-20 in 29%, 51% and 42% yield, respectively (Scheme 4.4). The 
formation of homoleptic complexes C8, C29, C19b and C20b as side products in a trace 
amount was also observed. The complexes were purified by column chromatography and 
also with preparative TLC plates (SiO2, eluted with MeCN/saturated aqueous KNO3/H2O = 
5:1:1 or 10:1.5:0.5). Although this resulted in a significant loss of material, the purity of the 
complexes is essential for further photochemistry studies. C18-20 were characterised with 
NMR spectroscopy, ESI mass spectrometry and elemental analysis. Upon careful examination 
of the spectra, we realized that all the complexes C18-20 are already mono-protonated on 
the pendant side amino-chain, instead of being in the deprotonated (i.e. neutral) state. The 
protonation was caused by the presence of NH4PF6 during the fourth reaction step and 
points at the basicity of the amino groups which seems to be even higher than we expected. 
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The fact, that all complexes C18-20 are already in the mono-protonated form, was proved 
with elemental analysis, mass spectrometry and with several NMR spectroscopy studies 
(Chapter 6). 
 
 
Figure 4.1: 1H NMR (500 MHz, CD3CN) spectra of ruthenium(II) complexes C17-20 linked via an ester 
 
Figure 4.1 compares the 1H NMR spectra of all four Ru(II) complexes C17-20. In the aromatic 
region it is possible to see the characteristic distribution of peaks for heteroleptic Ru(II) 
complex with a pytpy ligand substituted in the 4-position with an electron-withdrawing 
group. Methylene groups 1 and 2 next to the carboxyl group always have a chemical shift  
4.33 and 1.73 ppm and the methylene groups 3-9 are represented with broad signals in the 
region  1.4 - 0.9 ppm. The biggest difference between the 1H NMR spectra of complexes 
C18-20  and the free ligands L11, L13-14 (Figure 3.4 in Chapter 3), is in the chemical shift of 
the methylene groups 11, 13 and 14, which are in the closest neighbourhood of the nitrogen 
atom. The amino group of the ligands L11, L13-14 is in a deprotonated state, therefore the 
methylene groups 11, 13 have a chemical shift at about 2.35 ppm. However, the 
methylene groups 11, 13 of the Ru(II) complex C18 are shifted to  3.10 ppm due to the 
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protonation of the diethylamino group. In addition to this, C19 and C20 have a protonated 
cyclic amino group. This leads to the fact that each methylene group 13 and 14 has two 
peaks in the 1H NMR spectrum, because the axial and equatorial protons are non-equivalent 
(Figure 4.1). 
As a next series of heteroleptic ruthenium(II) complexes with three protonation sites, 
compounds C23-25 with a side amino-chain linked via an ether unit, and a model complex 
C22 substituted with a dodecyl ether were synthesized (Scheme 4.5). Both synthetic 
approaches (Table 4.2), first to complex the ether-substituted ligands L17-20 and then pytpy 
L3, or the other way round, were used. The importance of the products’ purity and also 
dealing with the formation of the homoleptic complexes as side products, require several 
sequential purification steps using column chromatography and preparative TLC plates. This 
results in only low yields of the desired molecules C22-25. In the first case (Inputs 1-4 in 
Table 4.2), ligands L17-20 were coordinated first, followed by L3. Competitive formation of 
the homoleptic complexes, resulted in C22-24 being obtained in only 10-13% yields and C25 
in 31% yield. Reactions with L17-19 were tried also the other way round (Inputs 5-7 in Table 
4.2) and complexes C22-24 were obtained in slightly higher (21-28%) yields. In this case, 
formation of the homoleptic complexes was observed in only trace amount, therefore 
purification of the products was easier. 
 
Scheme 4.5: Synthesis of ruthenium(II) complexes C22-25 with three protonation sites 
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Input 1st ligand 2nd ligand Product /%  
1 L17 L3 C22 (12%)  
2 L18 L3 C23 (10%)  
3 L19 L3 C24 (13%)  
4 L20 L3 C25 (31%)  
5 L3 L17 C22 (26%)  
6 L3 L18 C23 (21%)  
7 L3 L19 C24 (28%)  
Table 4.2: Reaction conditions for Scheme 4.5 
 
1H NMR spectra and elemental analysis revealed that complexes C23-25 were formed in the 
same state, i.e. protonated on the side amino unit, as we had observed for the complexes 
C18-20. Elemental analysis results for all complexes C17-20 and C22-25 were in most cases 
fitted with addition of 0.5-2 molecules of water or with a leftover amount of NH4PF6. The 
NH4
+ ion appears at a 1:1:1 non-binomial triplet at  6.5 ppm (coupling to 14N, I = 1). In the 
electrospray mass spectrum of C22, peaks with m/z = 1051.3 (assigned to [M-PF6]
+) with 
100% intensity and 453.2 (assigned to [M-2PF6]
2+) with intensity 25% were observed. In the 
electrospray mass spectrum of C23-25, the observed peaks were assigned to [M-PF6]
+, [M-
2PF6]
2+ and [M-3PF6]
3+. However, intense peaks assigned to [M-PF6]
+, [M-2PF6]
2+ for the 
deprotonated form of C23-25 were also observed. In the 1H NMR spectrum of C23-25 (Figure 
4.2), a significant change in the aromatic region was noticed, in comparison with the ester-
substituted C17-20 (Figure 4.1). All protons of the pyridyl unit D were, due to the electron-
donating effect of the alkoxy groups, shifted to higher magnetic field. The distribution of the 
peaks in the aliphatic region was nearly the same as for the ester-substituted C17-20. The 
only difference is that the methylene group 1 is shifted to  4.13 ppm. The chemical shift of 
the methylene groups 11, 13 and 14 is consistent with the protonated amino group. 
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Figure 4.2: 1H NMR (400 MHz, CD3CN) spectra of Ru(II) complexes C23-25 linked via an ether group 
 
 
4.2.2 Homoleptic ruthenium(II) complexes with pytpy ligands 
As a next series of Ru(II) complexes, homoleptic complexes with ligands L2, L10-11 and L17-
18 were synthesized. [Ru(DMSO)4Cl2] is a common suitable reactant for these reactions.
2 In 
comparison with RuCl33H2O, the metal ion in [Ru(DMSO)4Cl2] is already in oxidation state 
+II, so there is no need to include any reducing agents. It is possible to use mild conventional 
reaction conditions, (reflux in MeOH or EtOH in a fume hood) but this requires a long 
reaction time. Therefore, we tried irradiation in a microwave reactor in EtOH at 120 °C for 30 
minutes (Scheme 4.6). However, after further work-up, only a trace amount of C27 was 
obtained. This was confirmed with a MALDI TOF mass spectrum, where a peak with m/z = 
838.1 (assigned to [M-2PF6]
+) was observed. It seems that the unprotected pendant pyridyl 
position of L2 competes as a site of coordination with the terpyridine unit, and this leads to 
the formation of non-desired complexes. (Further reactions with [Ru(DMSO)4Cl2] are 
described in Chapter 7.) This also seems to be the case of failure, when L2 was heated with 
RuCl33H2O in DMF in the microwave reactor at 160 °C for 15 minutes (Scheme 4.6). 
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Scheme 4.6: Synthesis of the methyl ester-substituted homoleptic ruthenium(II) complex C27 
 
 
Scheme 4.7: Synthesis of the methyl ester-substituted homoleptic ruthenium(II) complex C27 
 
After these failures, the reaction conditions, which had successfully been used for synthesis 
of C17-C20 and C22-25, were applied (Scheme 4.7). The first equivalent of L2 is coordinated 
as a [Ru(L2)Cl3] complex, which is then activated with silver hexafluorophosphate. This reacts 
with the second equivalent of L2 in a presence of a catalytic amount of N-ethylmorpholine, 
used as a reducing agent for Ru(III) to Ru(II). The product C27 is then precipitated as a PF6
- 
salt, purified on a chromatography column (SiO2, eluted with MeCN/saturated aqueous 
KNO3/H2O = 10:0.5:1.5) and obtained in 35% yield. The homoleptic complex with COOH 
substituents (a side product of the methyl ester group cleavage) was also observed. In the 
electrospray mass spectrum of C27, peaks with m/z = 419.1 (assigned to [M-2PF6]
2+) with 
100% intensity and 983.0 (assigned to [M-PF6]
+) with intensity 12% were observed. 
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Scheme 4.8: Synthesis of homoleptic ruthenium(II) complexes C28-30 
 
The same conditions were also used for the synthesis of homoleptic Ru(II) complexes 
containing ligands with a side chain linked via an ester L10-11 and via an ether L17-18 
(Scheme 4.8). A model complex with two dodecyl ester side chains C28 was isolated in 38% 
yield. In the electrospray mass spectrum of C28, peaks with m/z = 573.2 (assigned to [M-
2PF6]
2+) with 100% intensity and 1291.3 (assigned to [M-PF6]
+) with intensity 2% were 
observed. A model complex with two dodecyl ether side chains C30 was isolated in a good 
59% yield. In the electrospray mass spectrum of C30, peaks with m/z = 545.2 (assigned to 
[M-2PF6]
2+) with 100% intensity and 1235.3 (assigned to [M-PF6]
+) with intensity 47% were 
observed. The ruthenium(II) complex with two diethylamino-substituted side chains linked 
via an ester (C29) was isolated in 37% yield. In the electrospray mass spectrum of C29, peaks 
with m/z = 776.3 (assigned to [M-2PF6]
2+) with 43% intensity and 1697.5 (assigned to [M-
PF6]
+) with intensity 2% were observed. A homoleptic complex with two diethylamino-
substituted side chains linked via an ether group was also synthesized. However purification 
and isolation of the product failed, because the side products had nearly the same Rf value 
on the TLC plate as the target molecule. 
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Figure 4.3: 1H NMR (400 MHz, CD3CN) spectra of the homoleptic ruthenium(II) complexes C27-30 
 
Figure 4.3 shows a comparison of 1H NMR spectra of homoleptic complexes C27-30. The 
aromatic region has one characteristic set of peaks, in comparison with all heteroleptic 
complexes C17-20 and C22-25 (Figures 4.1 and 4.2). A chemical shift of the D-ring protons 
(see Figure 4.3) naturally depends on the electron-withdrawing or electron-donating 
properties of the D-ring substituents. Protons D5 and D6 of all complexes C27-29 are 
represented with only one peak in the 1H NMR spectrum when measured at 400 MHz (Figure 
4.3). However, when these compounds were measured using a 500 MHz spectrometer, the 
peaks of the protons D5 and D6 split up to two characteristic doublets of doublets with 
chemical shifts  7.60 and 7.63 ppm, respectively. In the COSY NMR spectrum of C28, a 
cross-peak for protons D5 and D6 and also a small cross-peak for protons D3 and D5 was 
observed. In the HMQC NMR spectrum of C28, a characteristic C-H correlation signal for 
each of D5 and D6 group were found (Figure 4.4). D6 and D5 are in the 13C NMR spectrum 
represented with a chemical shift  154.6 and 127.4 ppm, respectively. 
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Figure 4.4: Detailed zoom on the COSY and HMQC NMR (500 MHz, CD3CN) spectra of the 
homoleptic ruthenium(II) complex C28 
 
 
4.2.3 Synthesis of ruthenium(II) complexes with 4'-phenyl-2,2':6',2''-
terpyridine ligands 
Scheme 4.9: Towards ruthenium(II) complexes with Phtpy ligands with a side amino chain linked 
via an ester or via an ether group bearing one protonation site 
 
As a next series of Ru(II) complexes, heteroleptic complexes C34-37 with substituted 4'-
phenyl-2,2':6',2''-terpyridine ligands L26-30 and a homoleptic complex C33 were synthesized 
(Scheme 4.9). These compounds were prepared for a comparison with previously 
synthesized Ru(II) complexes C17-25 with pendant pyridyl units. Complexes C35 and C37 
have a side amino chain linked via an ester or via an ether group, respectively. Therefore C35 
and C37 have just one protonation site in the molecule (the amino group), in comparison 
with C18 and C23 with pytpy ligands, bearing 3 protonation possibilities (one on the side 
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chain and two on the pendant pyridyl units). Photophysical studies carried out with Phtpy 
complexes C33-37 will be a very useful piece of information for a better understanding of 
the photophysical properties of complexes C17-25 with pytpy units. We would like to reveal 
the influence of the side chain, especially of the amino unit of C35 and C37, on the 
absorption and luminescence properties of the complexes. 
For the synthesis of azachalcone P11 (Scheme 4.10), the same microwave assisted reaction 
conditions were applied as those Newkome’s successfully used for the synthesis of P9 in the 
Chapter 1 (Scheme 1.5).3 However, the Claisen-Schmidt aldol condensation by using 
microwave irradiation with a small amount of solvent in the presence of Al2O3 as a catalyst 
and solid support, in case of azachalcone P11 did not work. By using classical conditions with 
KOH in a mixture of solvents (EtOH/H2O), azachalcone P11 was obtained as a yellowish 
powder in a nearly quantitative yield (97%). Synthesis of PPI salts P5, P6 and P8 (Kröhnke 
reagents) were reported in Chapters 1-3 (P5 – Scheme 1.4, P6 – Scheme 2.3, P8 – Scheme 
3.4).5 
 
 
Scheme 4.10: Synthesis of the azachalcone P11 
 
For the synthesis of the 4'-phenyl-2,2':6',2''-terpyridine L23 (Scheme 4.11), the same Hanan’s 
“one-pot” reaction conditions were applied as those successfully used for the synthesis of L3 
in the Chapter 1 (Scheme 1.6).6 These conditions, suitable for symmetrical 4-aryl- or 
heteroaryl substituted terpyridines, involve condensation of the first equivalent of 
2-acetylpyridine with aldehyde under basic conditions of KOH, followed by addition of the 
second equivalent of 2-acetylpyridine and a ring closure in a presence of ammonia as a 
source of nitrogen atom. However, even after several trials and with a use of freshly distilled 
benzaldehyde, L23 was obtained in only 17-21% yields and in a mixture of multiple 
condensation products. Kröhnke synthetic methodology turned out to be an appropriate 
option (Scheme 4.12).5 
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Scheme 4:11: Hanan’s synthesis of Phtpy ligand L23 
 
For synthesis of Phtpy ligand L23 and 4-substituted Phtpy ligands L24 and L28 (Scheme 4.12), 
the same Kröhnke methodology was applied as that succesfully used for the synthesis of 
pytpy L2 in the Chapter 1 (Scheme 1.3).5 For the synthesis of the desired Phtpy ligands L23, 
L24 and L28, azachalcone P11 was refluxed with an appropriately substituted pyridinium salt 
(P8, P5 and P6) in MeOH for 5-8 hours (Table 4.3, Inputs 1, 3 and 5).  
 
 
Scheme 4.12: Synthesis of the 4-phenyl-terpyridines L23, L24 and L28 via the Kröhnke synthetic 
methodology 
 
Input PPI salt Time [h] Product / yield (%) 
1 P8 8 L23 (18%) 
2 P8 19 L23 (49%) 
3 P5 5 L24 (9%) 
4 P5 16 L24 (33%) 
5 P6 7 L28 (24%) 
6 P6 23 L28 (37%) 
Table 4.3: Reaction conditions for Scheme 4.12 
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In comparison with the pytpy ligand L2, Phtpy ligands are more soluble in methanol. 
Therefore, formation of the precipitate of the desired Phtpy ligands was observed during the 
reflux in only a small amount. Even after reducing the solvent volume or upon chilling of the 
reaction mixture in a freezer, desired molecules L23, L24 and L28 were isolated in very low 
yields (9-24%, Table 4.3, Inputs 1, 3 and 5). To improve the yields of the products L23, L24 
and L28, the reaction time was prolonged to 16-23 hours and volume of methanol reduced 
to half. Ligands L23, L24 and L28 were then obtained in 33-49% yields (Table 4.3, Inputs 2, 4 
and 6). 
In the electrospray mass spectrum of L24, a peak with m/z = 368.0 (assigned to [M+H]+) with 
intensity 100% and also a peak with m/z = 390.0 (assigned to [M+Na]+) with intensity 24% 
were observed. In the electrospray mass spectrum of L28, a peak with m/z = 366.1 (assigned 
to [M+Na]+) with intensity 100% and also peaks with m/z = 383.1 and 344.1 (assigned to 
[M+K]+ and [M+H]+, respectively) with intensity 19% and 57%, respectively, were observed.  
 
 
Figure 4.5: 1H NMR spectra (400 MHz, CDCl3) of 4-substituted Phtpy ligands L23 (H, brown), L24 
(CO2Me, black) and L28 (Cl, blue) 
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Figure 4.5 shows a comparison of the 1H NMR spectra of the Phtpy ligand L23 (brown) and 
CO2Me-substituted Phtpy L24 (black) and chloro-substituted L28 (blue). The methyl ester 
substituent of L24 (black) is typically electron-withdrawing by resonance, therefore all D-
protons are shifted to higher ppm. However, the chloro-substituent of ligand L28 (blue) is 
electron-withdrawing inductively but electron-donating through resonance. After combining 
these two effects, one observes that the D-ring protons of L28 have similar chemical shifts as 
the A-ring protons. Protons of the phenyl ring C are represented with three multiplets with a 
chemical shift  7.91 ppm (HC2), 7.52 ppm (HC3) and 7.46 ppm (HC4) (Figure 4.5). 
 
 
Scheme 4.13: Esterification of L25 via the corresponding acid chloride 
 
For the synthesis of the Phtpy ligands with the side chain linked via an ester group L26-27 
(Scheme 4.13), the same reaction conditions were used as those successfully used for the 
synthesis of L10-11 in Chapter 3 (Scheme 3.6 and 3.8).7, 8 That is, the intermediates were an 
–COOH substituted tpy and the corresponding acid chloride. L24 was refluxed with 1M 
aqueous NaOH overnight in methanol and the pH was adjusted with HCl (0.5M) to a value of 
 3.5-4.0. A grey precipitate formed, and this was collected on a frit, washed with water and  
air dried. The product L25 was isolated as a grey powder in nearly quantitative yield and 
used for the next step without any further purification. In the MALDI TOF mass spectrum of 
L25, a peak with m/z = 353.8 (assigned to [M]+) with intensity 93% and also a peak with m/z 
= 309.8 (assigned to [M-CO2]
+) with intensity 100% were observed. In the 1H NMR spectrum 
of L25, a broad peak at  13.9 ppm, assigned to the proton from the COOH group, was 
observed (Figure 4.6). The chemical shifts of the aromatic protons in rings A, B and D 
correspond to that of the COOH-substituted pytpy L8. The chemical shifts of the C-ring 
protons of L25 correspond to that of the methyl ester-substituted Phtpy L24 (Figure 4.5). 
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Figure 4.6: 1H NMR spectrum (400 MHz, DMSO-d6) of COOH-substituted Phtpy ligand L25 
 
L25 was refluxed in thionyl chloride for 3 hours under an inert atmosphere to give a 
yellowish solution. The excess of thionyl chloride was evaporated under reduced pressure 
and the residue dried. The acid chloride was obtained as a yellowish powder, assumed to be 
formed in quantitative yield and immediately used for esterification without any further 
purification. This was then refluxed with the base 2,6-lutidine in toluene for 30 minutes 
under nitrogen. Dodecanol (or amino alcohol P16, respectively) was added and the reaction 
mixture was refluxed for 16 hours under nitrogen (Scheme 4.13). The crude reaction mixture 
was evaporated, dissolved in chloroform and extracted with saturated aqueous sodium 
hydrogen carbonate and water. Formation of the target esters L26-27 was monitored by 
recording the 1H NMR spectrum and looking for the triplet (expected   4.4 ppm) of the first 
CH2 group next to the carboxyl group. Dodecyl ester L26 was purified by crystallisation from 
cold EtOH and the product was obtained as an analytically pure pale brown powder in 78% 
yield. Diethylamino-substituted ester L27 was purified with a short chromatography column 
(SiO2, eluted with EtOAc/Et3N = 99:1) and the product obtained as a yellow oil in 57% yield. 
In the electrospray mass spectrum of L26, a peak with m/z = 544.2 (assigned to [M+Na]+) 
with intensity 100% and also a peak with m/z = 522.2 (assigned to [M+H]+) with intensity 
66% were observed. In the electrospray mass spectrum of L27, a peak with m/z = 579.2 
(assigned to [M+H]+) with intensity 100% and also a peak with m/z = 601.2 (assigned to 
[M+Na]+) with intensity 4% were observed. 
For the synthesis of the alkoxy-substituted Phtpy ligands L29-30, the same “harsh reaction 
conditions” (Scheme 4.14), reported by Halcrow et al. in 2001, were applied as those 
successfully used for the synthesis of L17-20 in Chapter 2 (Scheme 2.12).9 Freshly ground 
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potassium hydroxide was suspended in DMSO, to which L28 and dodecanol (or amino 
alcohol P16, respectively) were added and heated at 60 °C for 16 hours. This reddish-brown 
solution was then cooled to room temperature. Addition of ice-cold water gave a brown 
precipitate, which was purified by extraction with chloroform-water. A large amount of 
water during extraction was necessary for DMSO removal. However, a certain amount (19-
56%) of unreacted alcohol was always detected in the isolated products L29-30, no matter 
which purification technique was used (crystallisation or column chromatography). 
Therefore elemental analysis and absorption spectra were not measured for products L29-
30. In the electrospray mass spectrum of L29, a peak with m/z = 494.4 (assigned to [M+H]+) 
with intensity 100% and also a peak with m/z = 516.3 (assigned to [M+Na]+) with intensity 
34% were observed. In the electrospray mass spectrum of L30, a peak with m/z = 551.4 
(assigned to [M+H]+) with intensity 100% and also peaks with m/z = 573.2 and 589.2  
(assigned to [M+Na]+ and [M+K]+, respectively) with intensity 23% and 7%, respectively were 
observed. 
 
 
Scheme 4.14: Synthesis of the alkoxy-substituted Phtpy ligands L29-30 
 
Figure 4.7 compares the 1H NMR spectra of the ester-substituted Phtpy ligands L26 (green) 
and L27 (red) and the alkoxy-substituted Phtpy ligands L29 (cyan) and L30 (black). The 
aliphatic part of the 1H NMR spectra of all four Phtpy ligands has nearly the same 
distribution of peaks as that of the pytpy ligands L10-11 and L17-18 (see Chapter 3, Figure 
3.4, Chapter 2, Figure 2.5). The methylene group 1 next to the oxygen atom has a 
characteristic triplet at  4.43 ppm and 4.09 ppm, respectively. Methylene protons 11 and 13 
in the neighbourhood of the amino group (L27 and L30) have peaks around  2.4 ppm. 
Multiplets for the CH2 groups 2 and 3 were observed with chemical shifts of  1.83 ppm and 
1.50 ppm and all protons 4-10 resonated around  1.30 ppm. Protons of the pyridyl rings 
A, B and D have, in the aromatic part, the same set of peaks as those of pytpy ligands L10-11 
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and L17-18. However, protons of the phenyl ring C are represented with three multiplets in 
the region  7.90 – 7.45 ppm similar to those of the methyl ester-substituted Phtpy L24 
(Figure 4.5). 
 
 
Figure 4.7: 1H NMR spectra (500 MHz, CDCl3) of the ester-substituted Phtpy ligands L26 (green) and  
L27 (red) and the alkoxy-substituted Phtpy ligands L29 (cyan) and L30 (black) 
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Figure 4.8: UV/Vis absorption spectra (CH3CN) of the 4-substituted Phtpy ligands L23 (4.5510
-5M, 
orange), L24 (5.9710-5M, black), L26 (4.0810-5M, green), L27 (4.8010-5M, red), L28 (4.3910-5M, 
blue) 
 
Ligand c / 10-5 mol dm-3 max/nm (max/10
3 dm3mol-1cm-1) 
L23 4.55 252 (39.5) 276 (37.0) 313 (9.8 sh) 
L24 4.44 253 (35.0) 276 (26.6) 310 (12.6 sh) 
L26 4.26 254 (26.0) 280 (19.3) 310 (9.2 sh) 
L27 3.97 254 (31.9) 280 (24.4) 313 (11.7 sh) 
L28 3.88 254 (35.3) 276 (31.7) 313 (8.1 sh) 
Table 4.4: UV/Vis absorption spectra (CH3CN) of the 4-substituted Phtpy ligands 
 
The electronic absorption spectra of acetonitrile solutions of ester-substituted Phtpy ligands 
L24, L26-27, together with Phtpy L23 and chloro-substituted Phtpy L28 are shown in Figure 
4.8. The ligands exhibit a series of high energy absorption bands around 250 nm and around 
276 nm with high extinction coefficients (20 to 40103 dm3 mol-1 cm-1) with a shoulder at 
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about 313 nm with lower extinction coefficients (10103 dm3 mol-1 cm-1). The bands arise 
from ligand-centred * transitions (Table 4.4). 
 
Scheme 4.15: Synthesis of the ruthenium(II) complexes C33-37 with Phtpy ligands 
 
For the synthesis of the homoleptic Ru(II) complex C33 and heteroleptic Ru(II) complexes 
with Phtpy ligands C34-37 (Scheme 4.15), the same four-step “one-pot” reaction conditions 
were applied as those successfully used for the synthesis of C17-18 with pytpy ligands 
(Scheme 4.3 and 4.4). The first ligand (L23, L26-30) is coordinated as a Ru(L)Cl3 complex, 
which is then activated with silver hexafluorophosphate. This reacts with the second ligand 
(L3) in a presence of a catalytic amount of N-ethylmorpholine, used as a reducing agent to 
convert Ru(III) to Ru(II). The products C33-37 are then precipitated as PF6
- salts. C33 was 
purified by crystallisation from MeCN-Et2O and obtained 78% yield. Complexes C34-37 were 
purified by column chromatography (SiO2, eluted with MeCN/saturated aqueous KNO3/H2O 
= 10:0.5:0.5) and by crystallisation from MeCN-Et2O. Products C34-37 were obtained in 41-
51% yields. The complex C37 was isolated in a mixture with side products, which were 
impossible to separate, therefore C37 was excluded from further analysis and photophysical 
measurements. 
In the electrospray mass spectrum of the model complexes C34 and C36, peaks with m/z = 
1077.4 and 1049.4, respectively (assigned to [M-PF6]
+) with 100% intensity were observed. In 
the electrospray mass spectrum of C35, peaks with m/z = 1280.4 and 1134.4 (assigned to the 
deprotonated form of [M+H]+ and [M-PF6]
+, respectively) with intensity 100% and 20%, 
respectively, were observed. Elemental analysis results could only be fitted by allowing for 
the presence of a small amount of NH4PF6, which was consistent with the 
1H NMR spectra. 
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Figure 4.9 compares the 1H NMR spectra of the ester-substituted complexes Phtpy C34-35 
(green and red) and the dodecyloxy-substituted complex C36 (blue). The aliphatic part of the 
spectra of all three complexes is consistent with that of C17-18 and C22 with the pytpy 
ligands (Figure 4.1 and 4.3). Methylene protons 11 and 13 in the neighbourhood of the 
amino group of the complex C35 have peaks around  3.10 ppm. However protons 11 and 13 
of the free ligand L27 have a chemical shift around  2.40 ppm. This is one of the indications 
that the amino side chain of the complex C35 is protonated as well as the side chain of C18. 
The chemical shifts of the D-ring protons depend on the electronic properties of the D-ring 
substituents. Therefore the D-protons of C34-35 are shifted to lower magnetic field and the 
D-protons of C36 to higher magnetic field. The C-ring protons of the complexed ligand are 
shifted to higher ppm values ( 8.30 – 7.80 ppm), in comparison to those of the free ligands 
L26-27 ( 7.90 – 7.45 ppm) (Figure 4.7). 
 
 
Figure 4.9: 1H NMR spectra (500 MHz, CD3CN) of ruthenium(II) complexes with Phtpy ligands C34-36 
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4.2.4 Crystal structure of the homoleptic ruthenium(II) complex C27 
 
Compound C27 
Empirical Formula C94H75F24N19O9P4Ru2 
Formula Weight 2396.75 
Temperature / K 123 
Crystal System Monoclinic 
Space Group P2/c 
Unit cell 
dimensions:  
a / Å 9.5096 (7) 
 b / Å 11.2463 (8) 
 c / Å 25.5889 (15) 
 α / ° 90 
 β / ° 108.379 (4) 
 γ / ° 90 
Volume / Å3 2597.1 (3) 
Z 1 
Crystal Description red plate 
Crystal Size / mm3 0.03 × 0.15 × 0.30 
Density / Mg m-3 1.531 
Absorption Coefficient / mm-1 3.889 
Theta range for data collection / ° 4.33 to 66.52 
Reflections collected 13550 
Independent reflections 4533 
R(int) 0.0444 
Completeness to theta / ° (%) 66.52 (97.4) 
Parameters 439 
Goodness of fit 1.204 
wR2 0.1986 
Final R1 [I>2sigma(I)] 0.0777 
Table 4.5: Crystallographic data summary of the ruthenium(II) complex C27 
 
X-ray quality crystals of the homoleptic ruthenium(II) complex C27 were grown from a 
solution of C27 in acetonitrile by slow evaporation. Crystals grew as red plates. The complex 
C27 crystallized in the monoclinic crystal system in the space group P2/c. The R factor is high 
due to the crystals being very air sensitive, and also slightly twinned. The crystal data is 
shown in Table 4.5. In the asymmetric unit (Figure 4.10) there is half of the Ru cation, one 
PF6
- anion (rotationally disordered with partial occupancies of 54%/46%) and disordered 
solvent (75% of MeCN (disordered over 2 positions) and 25% H2O). The rest of the cation is 
generated by symmetry. The Ru atom is in an octahedral environment and coordinates two 
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methyl ester-substituted pytpy ligands via the N-donor terpyridine units orthogonally to 
each other (Figure 4.11). Bond lengths and angles are unexceptional. 
 
 
Figure 4.10: The asymmetric unit of the ruthenium(II) complex C27 contains half a cation, one PF6
- 
anion (disordered with partial occupancies of 54%/46%) and disordered solvent (75% of MeCN 
(disordered over 2 positions) and 25% H2O), H atoms omitted 
 
 
 
Figure 4.11: An ellipsoid display of the molecular structure of C27 in the X-ray crystal structure of 
C270.75MeCN0.25H2O. H atoms, solvent and anion disorder omitted. Selected bond lengths (in Å) 
and bond angles (in °): Ru1-N1: 2.071(4), Ru1-N2: 1.992(3), Ru1-N3 2.075(3), O1-C21: 1.215(7), O2-
C21: 1.325(7), O2-C22: 1.453(7), N1-C1: 1.353(6), C8-C18: 1.493(6), N4-C20: 1.328(8), N2-Ru1-N1: 
99.29(14), N1-Ru1-N1: 88.4(2), C21-O2-C22 116.6(5), C1-N1-C5: 118.7(4), C1-N1-Ru1: 127.1(4) 
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Figure 4.12: Display of packing interactions between molecules of C27, view down c-axis 
 
 
The methyl ester-substituted pytpy ligands are perpendiculary coordinated to the 
ruthenium(II) metal center along the c-axis (Figures 4.12 and 4.13). The molecules of the 
complex C27 pack together exhibiting two different intermolecular interactions. Therefore 
the molecules of C27 form a two dimensional network. “Face to face” - interactions 
(length 3.8 Å) between B and C-rings of the pytpy units form the first type of chain. H-
Bonding between the carboxyl group and the proton A4 of the tpy unit form the second type 
of chain (Figures 4.14 and 4.15) The H-bonds have a weak character due to the O – H atom 
distance 2.3 Å . Together these two packing interactions form a net. 
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Figure 4.13: C27 - Spacefill display of packing interactions between molecules of C27, viewed along 
the c-axis 
 
 
 
Figure 4.14: “face to face” - interactions between pytpy units of C27 form chains (red-blue), H-
bonding between the carboxyl group and the proton A4 of the tpy unit form chains orthogonally 
(black-green)  
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Figure 4.15: the distance between the - interacting pytpy units of C27 forming chains is 3.8 Å, 
weak H-bond interactions (length 2.3 Å) between the carboxyl group and the proton A4 of the tpy 
unit 
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Conclusion 
Heteroleptic and homoleptic ruthenium(II) complexes with pytpy ligands with an amino-
substituted side chain, linked via an ester or an ether group were successfully synthesized. 
So as to have a model compounds for use in the photophysical studies, ruthenium(II) 
complexes with Phtpy ligands with the same side chains were also prepared. All complexes 
were characterised with 1D and 2D NMR spectroscopy, electrospray or MALDI TOF mass 
spectrometry, infrared spectroscopy, elemental analysis, UV-vis and photoluminescence 
spectroscopy. Detailed photophysical studies were carried out in a collaboration with the 
photochemistry research group of Prof. Alberto Credi from the University of Bologna and 
these results are reported in Chapter 5. NMR titration studies with complexes C20 and C29 
are reported in Chapter 6. 
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Chapter 5 
 
Photophysical studies of ruthenium(II) complexes with 
a potential application as molecular switches 
 
 
5.1 Introduction 
In Chapter 4, a series of heteroleptic ruthenium(II) complexes with a long amino-substituted 
side chain linked via an ester C18-20, or via an ether C23-25 and the homoleptic 
ruthenium(II) complex C29 were synthesized, along with a series of methyl and dodecyl-
substituted model Ru(II) complexes (C7, C17, C22, C27, C28 and C30). The amino group 
attached to the side chain and the two pendant pyridyl groups bring three (or four, 
respectively) protonation sites to the molecule. A series of ruthenium(II) complexes C33-36 
with pendant phenyl units instead of the pendant pyridyl units were synthesized for 
comparison. 
In this chapter, photophysical studies of all these new Ru(II) complexes are reported and 
discussed. These measurements were carried out by Angelo Lanzilotto (supervised by Dr. 
Marek Oszajca and Prof. Alberto Credi, as part of a collaboration I am thankful for) in the 
photochemistry laboratories of Prof. Alberto Credi at the University of Bologna, Italy.4 It was 
found that some molecules exhibit unexpected abnormalities during those measurements. 
Namely, an unusual kinetic effect in the absorption and photoluminescence spectrum during 
titration of C20 with TfOH or not enough acid consumed to complete titrations of some 
complexes (C29). Therefore, in Chapter 6, we carried out NMR studies of C20 and C29 and of 
their free ligands L11 and L14 with TFA-d or TfOD and with K2CO3 and these experiments 
were monitored with 1H NMR spectrometry. These NMR studies revealed and clarified that 
all the Ru(II) complexes with three (or four, respectively) protonation sites were synthesized 
and isolated already in the mono-protonated form - on the amino group of the side chain 
(Scheme 5.1). This occurred due to the strong basicity of the side-chain amino units, when 
the complexes were precipitated as PF6
- salts in the last synthetic step with an aqueous 
solution of NH4PF6. Unfortunately, this fact was discovered nearly at the end of this work, 
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after all the photophysical studies were carried out. Therefore, there was not enough time 
to develop a sufficient methodology to convert the mono-protonated Ru(II) complexes to 
the de-protonated form. 
 
Scheme 5.1: Ruthenium(II) complexes C20 and C29 in the deprotonated (neutral) form (left) and 
monoprotonated form (right)  
 
 
5.2 Experimental part 
The UV-VIS and photoluminescence measurements were performed using a 
spectrophotometer Perkin-Elmer Lambda 45 and a Perkin-Elmer LS 50 spectrofluorometer. 
These measurements were carried out at room temperature with balanced solutions of 
spectroscopy grade acetonitrile (Fluka) in quartz cells with the optical path length 1 cm. The 
emission spectra were not corrected for the response of the monochromator/detector 
ensemble. The measures in rigid matrix were conducted in acetonitrile at 77 K. 
The molar absorption coefficient  was obtained by the interpolation of the data obtained 
from five solutions (by dilution of the stock solution). The dilution ratios (expressed as mL of 
the stock solution in mL of acetonitrile) were 0.4 : 2, 0.4 : 1.6, 0.5 : 1.5, 0.7 : 1.7 and 1 : 1. 
These dilutions correspond to ratios 1:6, 1:5, 1:4, 1:3, 1:2. According to the Lambert-Beer 
law A    b  c, where A is the absorbance,  the molar absorption coefficient, b the optical 
path and c is the concentration of the sample, the absorbance values are reported in the plot 
vs. concentration and this is interpolated by linear regression with the method of least 
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squares. The slope of the fitted line is used to find the value of the absorption coefficient 
and its standard deviation. 
The quantum yields, expressed in percentage, were calculated by integration of the emission 
spectra in the range 580-900 nm. A solution of [Ru(bpy)3Cl2] in degased acetonitrile was used 
as a standard, where the quantum yield is 1.25%. The solutions of our Ru(II) complex and of 
the standard were excited at the wavelength at which their absorbance is equal and less 
than 0.1 and emission spectra recorded. The excitation and emission slits were open up to 
15 nm, because all our Ru(II) complexes with polypyridine ligands are weak emitters. 
Quantum yields were calculated according to the equation: =s(I/Is), where s refers to the 
standard,  is quantum yield, and I is the integrated area under the emission curve. 
Luminescence lifetime (τ) measurements were carried out with a time-correlated single-
photon counting spectrofluorometer CD900 of Edinburgh Instruments equipped with a 
Hamamatsu R928 photomultiplier tube cooled to -30 °C. Measurements at room 
temperature were carried out with solutions in spectrofluorimetric cells and solutions for 
measurements at 77 K were placed in a capillary tube inserted in a Dewar flask containing 
liquid nitrogen. The excitation source was a pulsed diode laser at 405 nm. Solutions are 
required to have absorbance at the working wavelength of the laser lower than 0.1 to 
prevent photo-degradation of the probe. The decays were recorded with the program F900 
provided by the instrument company, as a linear combination of exponential functions and 
the partial components (τ1 τ2 or more) obtained from the decay, and their standard 
deviations from the fit and non-linear statistical weight of each component. The accuracy of 
the fit is expressed with χ2 value (the closer to 1 the better the fit is). The final lifetime is 
calculated from the partial decay components (τ1 and τ2) and their weights w1 and w2 
according to the equation τ = τ1w1 + τ2 w2. 
The titrations and experiments at variable pH with acid (or base, respectively), monitored 
with absorption and photoluminescence spectra, were performed by addition of small 
aliquots of 5  10-3 M solution of trifluoromethanesulfonic acid (CF3SO3H) (or phosphazene, 
respectively) in acetonitrile to the solution of a ruthenium(II) complex in a 
spectrofluorimetric cell. The additions were done via Hamilton microsyringes, until the 
spectroscopic plateau was reached. Titration curves form isosbestic points in the absorption 
spectra. The wavelength iso of the isosbestic point in the MLCT band of each Ru(II) complex 
is used as ex to monitor luminescence spectral changes. 
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5.3 Results and discussions 
All the ruthenium(II) complexes synthesized in Chapter 4, could be divided into characteristic 
groups for the photophysical studies according to numerous aspects, e.g. homoleptic and 
heteroleptic complexes, complexes with pendant pyridyl units or phenyl rings, complexes 
with a side chain linked via an ester group or an ether group. Then one could also create 
groups according to the substituents on the side chain, e.g. diethylamino-substituted 
complexes, piperidine-substituted complexes, etc. 
 
Compound λabs [nm] ε [L cm
-1 mol-1] λem [nm] QY [%] τ [ns] λiso τ 77K [s] 
C8 489 26000 657 0.008 4 492 6 
C8-1H 498 26000 751 0.042 98  7 
C8-2H 507 32000 743 0.082 138  7 
C17 493 20000 673 0.029 13 487  
C17-1H 506 24000 720 0.064 81   
C17-2H 508 28000 718 0.087 176   
C18 494 23000 682 0.029 21 491  
C18-1H 503 26000 723 0.070 118   
C18-2H 508 32000 717 0.109 176   
C19 494 23000 672 0.033 35 492  
C19-1H 502 26000 722 0.095 104   
C19-2H 508 31000 719 0.156 147   
C22 492 23000 681 0.024 9 496  
C22-1H 507 28000 730 0.029 23   
C22-2H 510 29000 761 0.042 61   
C23 491 23000 689 0.022 10 495 4 
C23-1H 504 26000 719 0.021 20  4 
C23-2H 511 29000 761 0.027 68  5 
C24 491 28000 675 0.019 19 495  
C24-1H 501 27000 709 0.011 33   
C24-2H 511 34000 723 0.017 62   
C27 497 28000 662 0.020 6 493  
C27-1H 506 33000 716 0.122 124   
C27-2H 509 39000 711 0.165 191   
C28 497 28000 663 0.024 8 494  
C28-1H 504 31000 717 0.117 153   
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C28-2H 508 38000 708 0.166 188   
C29 498 29000 667 0.236 7 494  
C29-1H 506 34000 717 0.129 112   
C29-2H 508 39000 709 0.173 185   
C30 493 29000 680 0.025 10 497  
C30-1H 505 29000 701 0.056 4   
C30-2H 514 36000 786 0.09 5   
C38 490 25000 644 0.004 2   
C33 488 24000 644 0.004 3   
C34 494 22000 673 0.015 4   
C35 494 22000 668 0.017 5   
C36 490 25000 652 0.006 3   
Table 5.1: Summary of photophysical properties of ruthenium(II) complexes 
 
 
5.3.1 Titrations of C17 and C24 with TfOH monitored by absorption and 
photoluminescence spectra 
Titrations of ruthenium(II) complexes with TfOH and monitored by absorption and 
photoluminescence spectra were performed for all Ru(II) complexes listed in Table 5.1. 
However, in this chapter results will be discussed for just two of them, dodecyl ester-
substituted complex C17 representing complexes with the side chain linked via an ester 
group and the complex C24 with the piperidine-substituted side chain linked via an ether 
group. Each complex and its corresponding protonation state were given abbreviations. 
Namely, C24 for the complex in isolated form (protonated on the side chain), [C24-1H]+ for 
the form protonated on one pendant pyridyl unit and [C17-2H]2+ for the form protonated on 
both pendant pyridyl units. 
Figure 5.1 shows the process of titration of the dodecyl ester-substituted Ru(II) complex C17 
with TfOH monitored by absorption spectra. In the top-right corner is a titration curve 
displayed for absorption at 507 nm, where one can see that the titration plateau was 
reached at approx. 2 equivalents of TfOH. In the UV region of C17 (red curve), 2 intense 
bands around 280 nm and 320 nm were observed. These bands arise from ligand-centred 
* transitions. Addition of first equivalent of TfOH caused a decrease of intensity and a 
red-shift to 340 nm. Due to the second aliquot of TfOH, this band is shifted to 350 nm and 
108 
 
the intensity increased. In the VIS region, a broad and moderately intense band with a 
maximum at 493 nm, assigned to the MLCT (metal-to-ligand charge-transfer) excited state, 
was observed. This band steadily increases upon titration and it is red-shifted to 508 nm. 
Even though C17 has the attached side chain, the shift of the MLCT band upon the titration 
corresponds to that of C8, reported in early investigations of the homolepetic Ru(II) 
complexes with pytpy ligands.1 The MLCT band of [C17-2H]2+ is red-shifted in comparison 
with C17, because protonation of the pyridyl units makes it an electron-acceptor and 
therefore the energy of the * orbital of the protonated pytpy is lowered and displayed as 
red-shift (Table 5.2, Figure 5.1). 
 
 
Figure 5.1: Absorption spectral changes of the ruthenium(II) complex C17 (c = 1.80  10-5 M, MeCN) 
upon addition of TfOH aliquots (MeCN, RT). The red line is the deprotonated state, the green line is 
the mono-protonated state and the blue line is the bis-protonated state. The inset shows the 
normalized titration curve obtained by monitoring the absorbance at 508 nm as a function of acid 
equivalents. 
 
Compound λabs [nm] ε [L cm
-1 mol-1] λem [nm] QY [%] τ [ns] λiso 
C17 493  20000 673  0.029 13 487 nm 
C17-1H 506  24000 720  0.068 81  
C17-2H 508  28000 718  0.084 176  
Table 5.2: Photophysical properties of the ruthenium(II) complex C17, (c = 1.80  10-5 M, MeCN) 
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Figure 5.2: Luminescence spectral changes of the ruthenium(II) complex C17 (c = 1.80  10-5 M, 
MeCN) upon addition of TfOH aliquots (MeCN, room temperature). Excitation was performed at 
the isosbestic point at iso = 487 nm. The red line is the deprotonated state, the green line is the 
mono-protonated state and the blue line is the bis-protonated state. The inset shows the 
normalized titration curve obtained by monitoring the luminescence at 640 nm as a function of acid 
equivalents. 
 
The luminescence spectrum (Figure 5.2, Table 5.2) of the deprotonated form of C17 exhibits 
the typical low energy MLCT phosphorescence band of Ru polypyridine complexes, which is 
red shifted and longer lived compared to the parent compounds [Ru(tpy)2]
2+ and 
[Ru(pytpy)2]
2+ (C8) because of the presence of the pendant pytpy unit and the attached 
dodecyl-substituted side chain. 1, 2 This emission increase of C17 and C8 compared to 
[Ru(tpy)2]
2+ is caused by the presence of the pendant pyridyl unit. The emission properties 
are affected by the thermally activated decay of the 3MLCT states to upper lying 3MC (metal-
centred) states which are highly distorted with respect to the ground state and appear with 
fast radiation decay. The smaller the energy difference between the 3MLCT and 3MC states, 
the faster the decay is. That is why [Ru(tpy)2]
2+ (E  1500 cm-1) is not luminescent.2 Upon 
titration of C17 with TfOH, the intensity of the luminescence band increases and the band is 
red-shifted to 720 nm until one equivalent of TfOH is added. Upon titration up to 2 eq. of 
TfOH the emission band intensity increases even more and it is slightly blue-shifted to 718 
nm (Figure 5.2). The red shift of the luminescence band of C17 in the mono-protonated state 
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[C17-1H], along with longer lifetime, is explained by decrease in energy of the * orbital of 
the protonated pytpy, which stabilises the MLCT levels. The thermally activated decay of the 
lowest 3MLCT state to the short-lived MC state is slowed due to stabilization of the MLCT 
and destabilization of the MC levels caused by the presence of the electron-accepting pyridyl 
units. Stabilisation of the MLCT levels is also enhanced by electron donation to the metal by 
the unprotonated pytpy ligand.2 However in the bis-protonated form of C17 [C17-2H] both 
ligands are protonated (electron-accepting), therefore such additional stabilisation is no 
longer possible, which explains the small blue-shift of the bis protonated form. The further 
increase of the luminescence lifetime is due to the further destabilisation of the 3MC levels 
effected by the two bis-protonated ligands.  
Figure 5.3 and Table 5.3 show absorption spectral changes of the amino-alkoxy-substituted 
ruthenium(II) complex C24 upon addition of TfOH aliquots. The starting form C24 is 
represented by the red line and with the structure shown, the mono-protonated form [C24-
1H] with the green line and the bis-protonated form [C24-2H] with the blue curve. The 
starting form C24 displays two intense bands around 270 nm and 320 nm in the UV region, 
assigned to ligand-centred * transitions, and one broad moderately intense band at 491 
nm, assigned to 1MLCT excited state. Upon titration with TfOH, the intensity of the band 
around 320 nm decreases and a new band around 345 nm appears with the formation of the 
[C24-2H] state.The MLCT band upon titration with 1 eq. of TfOH shifts to 501 nm. With the 
2nd aliquot of TfOH the absorption intensity increases, the absorption maximum is even 
more red-shifted (511 nm) and the absorption band is broadened. The inset in Figure 5.3 
displays the titration curve for absorbance at 511 nm as a function of acid aliquots. 
Luminescence spectral changes of the ruthenium(II) complex C24 upon addition of TfOH 
aliquots are shown in Figure 5.4. Excitation was performed at the wavelength of the MLCT 
absorption isosbestic point, iso = 495 nm. The inset in Figure 5.4 displays the titration curve 
for photoluminescence monitored at 740 nm as a function of acid aliquots. The emission 
spectrum of C24 displays one broad MLCT phosphorescence band with a weak intensity and 
the emission maximum at 675 nm. Upon titration with 1 eq. of TfOH [C24-1H] the emission 
intensity decreases and is red shifted (709 nm) and longer lived compared to the C24. With 
the 2nd aliquot of TfOH [C24-2H] the emission intensity increases and is longer lived, and the 
maximum is red shifted even more (723 nm) and broadened. 
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Compound λabs [nm] ε [L cm
-1 mol-1] λem [nm] QY [%] τ [ns] λiso 
C24 491 33000 675 0,019 19 495 nm 
C24-1H 501 33000 709 0,052 33  
C24-2H 511 42000 723 0,092 62  
Table 5.3: Photophysical properties of the ruthenium(II) complex C24 (c = 1.30  10-5 M, MeCN) 
 
 
Figure 5.3: Absorption spectral changes of the ruthenium(II) complex C24 (c = 1.30  10-5 M in 
MeCN) upon addition of TfOH aliquots (MeCN, RT). Red line: C24, green line: mono-protonated 
form, blue line: bis-protonated form. The inset shows the normalized titration curve obtained by 
monitoring the absorbance at 511 nm as a function of acid equivalents. 
 
Titration curves for absorption and emission reach the plateau around 2 eq. of TfOH (Figure 
5.3, 5.4). However, in comparison with the model complex C8,1 one does not observe the 
change of slopes at point of the 1st and at the point of the 2nd aliquot of acid and it is also 
obvious that the process of the titration monitored with emission spectra is not so 
monotonous. This indicates that the basicity of the pendant pyridyl units is not equal. 
300 350 400 450 500 550 600 650
0
0.2
0.4
0.6
0.8
1
1.2
 (nm)
A
0 1 2 3 4
0.4
0.6
0.8
1
equivalents of acid
A
(5
1
1
) 
/ 
A
m
a
x
C24
112 
 
 
Figure 5.4: Luminescence spectral changes of the ruthenium(II) complex C24 (c = 1.30  10-5 M in 
MeCN) upon addition of TfOH aliquots (MeCN, RT), excitation was performed in the isosbestic point 
at iso = 495 nm. Red line is deprotonated state, green line is the mono-protonated state and blue 
line is the bis-protonated state. The inset shows the normalized titration curve obtained by 
monitoring the luminescence at 740 nm as a function of acid equivalents. 
 
 
5.3.2 Model homoleptic ruthenium(II) complexes C8, C33 and C38  
In this section, photophysical properties of the model homoleptic ruthenium(II) complexes 
bearing various substituents in the 4-position of the tpy ligand, will be compared (Table 5.4, 
Figures 5.5 and 5.6). The complex C8 contains 2 pyridyl units with an electron-withdrawing 
character, C33 has 2 phenyl rings and C38 is p-tolyl-substituted with an electron-donating 
character (Scheme 5.2). 
 
Compound λabs [nm] ε [L cm
-1 mol-1] λem [nm] QY [%] τ [ns] 
C8 489 26000 657 0.0078 4 
C33 488 24000 644 0.0044 3 
C38 490 25000 644 0.0040 2 
Table 5.4: Photophysical properties of the model homoleptic ruthenium(II) complexes with different 
pendant units: C8 (pyridyl), C33 (phenyl), C38 (p-tolyl) 
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Scheme 5.2: Model homoleptic ruthenium(II) complexes with different substituents in the 4-
position of the tpy unit: C8 (pyridyl), C33 (phenyl), C38 (p-tolyl) 
 
 
Figure 5.5: Absorption spectra of the ruthenium(II) complexes C8 (c = 2.48  10-5 M in MeCN), C33 (c 
= 1.12  10-5 M in MeCN) and C38 (c = 0.83  10-5 M in MeCN). The inset shows the normalized 
titration curve obtained by monitoring the absorbance at 507 nm (C8) 498 nm (C33) and 490 nm 
(C38) as a function of acid equivalents. Solutions: 1.38  10-5 M, 0.64  10-5 M and 1.14  10-5 M in 
MeCN, respectively. 
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Figure 5.5 displays absorption spectra of the three homoleptic ruthenium(II) complexes C8, 
C33 and C38. The maximum of the MLCT band of all three complexes has almost the same 
wavelength (488-490 nm) with very similar values of the molar absorption coefficient and 
nearly the same broadness of the band. However, the effect of the substituent is observed in 
the UV region. Even the stronger effect of the substituents can be seen in the 
photoluminescence spectra (Figure 5.6). 
 
Figure 5.6: Normalized emission spectra of the ruthenium(II) complexes C8 (c = 1.38  10-5 M in 
MeCN, ex = 492 nm), C33 (c = 0.64  10
-5 M in MeCN, ex = 489 nm) and C38 (c = 1.14  10
-5 M in 
MeCN, ex = 490 nm). The inset shows the normalized titration curve obtained by monitoring the 
photoluminescence at 736 nm (C8) 636 nm (C33) and 647 nm (C38) as a function of acid equivalent. 
 
C8 is much more emissive and the emission maximum at 657 nm is red-shifted compared to 
that of C33 and C38 (both 644 nm), both due to the stabilisation effect of the pendant 
pyridyl units.1 C8 also has about double the luminescence lifetime value and it is about twice 
longer lived in comparison with C33 and C38 (Table 5.4). In the inset of Figures 5.5 and 5.6 
are normalized titration curves obtained by monitoring the absorbance at 507 nm (C8) or 
photoluminescence at 736 nm (C8), respectively, as a function of TfOH aliquots. The titration 
600 650 700 750 800 850 900
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
 (nm)
In
te
n
s
it
y
 /
 I
n
te
n
s
it
y m
a
x
 
 
C8
C33
C38
0 0.5 1 1.5 2 2.5 3 3.5 4
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
In
te
n
s
it
y
 /
 I
n
te
n
s
it
y m
a
x
equivalents of acid
 
 
C8
C33
C38
115 
 
of C8, bearing two protonation sites, is consistent with the published data.1 C33 and C38 
naturally do not have any protonation site, therefore their titration curves are approximately 
constant. 
 
 
5.3.3 Ruthenium(II) complexes C17-C19 with the side chain linked via an ester 
group 
 
 
Scheme 5.3: Ruthenium(II) complexes with the side chain linked via an ester group C17-19 
 
In this section, photophysical properties of ruthenium(II) complexes C18-19 of pytpy ligands 
with the amino-substituted side chain linked via an ester group, are reported and compared 
with those of C8 and the dodecyl ester-substituted complex C17 (Scheme 5.3). We were 
interested in the influence of the electron-withdrawing ester group and also the effect of the 
(protonated) amino unit on the spectroscopic properties of these molecules. Figures 5.7 and 
5.10 compile absorption and emission spectra of the Ru(II) complexes C8, and C17-19. 
Figures 5.8 and 5.11 compile absorption and emission spectra of the Ru(II) complexes in 
their mono-protonated form (C8-1H, C17-1H, C18-1H and C19-1H). Figures 5.9 and 5.12 
compare absorption and emission spectra of the Ru(II) complexes in their bis-protonated 
form (C8-2H, C17-2H, C18-2H and C19-2H). The most important results are summarised in 
Table 5.5. Figure 5.13 shows the normalized titration curves obtained by monitoring the 
absorbance at 507 nm (C8) and 508 nm (C17-19) as a function of acid aliquots and 
normalized titration curves obtained by monitoring the photoluminescence at 736 nm (C8, 
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ex = 492 nm), 729 nm (C17, ex = 487 nm), 718 nm (C18, ex = 491 nm) and 716 nm (C19, ex 
= 492 nm) as a function of TfOH equivalents. All the titration curves of C8, and C17-19 reach 
the spectroscopic plateau at approximately 2 equivalents of TfOH. 
 
Compound λabs [nm] ε [L cm
-1 mol-1] λem [nm] QY [%] τ [ns] λiso 
C8 489 26000 657 0.008 4 492 
C8-1H 498 26000 751 0.042 98  
C8-2H 507 32000 743 0.082 138  
C17 493 20000 673 0.029 13 487 
C17-1H 506 24000 720 0.064 81  
C17-2H 508 28000 718 0.087 176  
C18 494 23000 682 0.029 21 491 
C18-1H 503 26000 723 0.070 118  
C18-2H 508 32000 717 0.109 176  
C19 494 23000 672 0.033 35 492 
C19-1H 502 26000 722 0.095 104  
C19-2H 508 31000 719 0.156 147  
Table 5.5: Photophysical properties of the ruthenium(II) complexes C17-19 and C8 
 
Figure 5.7 compiles the absorption spectra of the Ru(II) complex C8, and the ester-
substituted complexes C17-19. C8 is represented in the VIS region with a moderately intense 
MLCT band with the absorption maximum at 489 nm (solid line). However, the MLCT band of 
the ester-substituted complexes C17-19 less intense and slightly red-shifted (around 494 
nm). Upon first protonation, all complexes are red-shifted (around 498-506 nm) with nearly 
the same molar extinction coefficient. Upon further protonation, all complexes have the 
absorption maximum at almost the same wavelength (507-508 nm).  
Figure 5.10 displays photoluminescence spectra of the Ru(II) complex C8, and the ester-
substituted complexes C17-19. The emission maximum of the series C17-19 is shifted to 
higher energies (672-682 nm) in comparison with C8 with the emission maximum em at 657 
nm. Also the ester-substituted complexes are more emissive and longer lived than C8. In the 
diethylamino-substituted complex C18 the emission band is broader and more red-shifted 
than C17 and C19. Upon protonation, a strong red-shift of the emission maxima of C8 to em 
= 751 nm is observed. The ester-substituted complexes are upon first protonation [C17-19-
1H] shifted to about the same wavelength em = 720 nm. The bisprotonated forms [C17-19-
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2H] are more strongly emissive and longer lived than the mono-protonated forms [C17-19-
1H], but the emission maxima appears slightly blue-shifted, as that of [C8-2] compared to its 
mono-protonated form [C8-1]. This trend was already observed and explained in Section 
5.3.1 and is consistent with the reported results for C8 protonation.1 Therefore, the effect of 
the ester-substitution has stronger influence on the luminescence spectra of the starting 
forms C17-19, however upon protonation the pyridyl substituent plays the main role. 
Table 5.5 compares quantum yields and luminescence lifetimes of all starting and 
protonated forms of all complexes. All ester-substituted complexes in the starting forms 
C17-19 are stronger emitters than C8. However, upon protonation, there are no longer any 
significant differences. 
 
 
Figure 5.7: Absorption spectra of the ruthenium(II) complexes C8 (c = 2.40 10-5 M, MeCN), C17 (c = 
1.80  10-5 M, MeCN), C18 (c = 2.35  10-5 M, MeCN) and C19 (c = 2.50  10-5 M, MeCN). 
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Figure 5.8: Absorption spectra of the ruthenium(II) complexes in their mono-protonated form: C8-
1H (c = 2.40  10-5 M, MeCN), C17-1H (c = 1.80  10-5 M, MeCN), C18-1H (c = 2.35  10-5 M, MeCN) 
and C19-1H (c = 2.50  10-5 M, MeCN). 
 
 
Figure 5.9: Absorption spectra of the ruthenium(II) complexes in their bis-protonated form: C8-2H (c 
= 2.40  10-5 M, MeCN), C17-2H (c = 1.80  10-5 M, MeCN), C18-2H (c = 2.35  10-5 M, MeCN) and 
C19-2H (c = 2.50  10-5 M, MeCN). 
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Figure 5.10: Normalized emission spectra of the ruthenium(II) complexes C8 (c = 2.40  10-5 M in 
MeCN, ex = 492 nm), C17 (c = 1.80  10
-5 M in MeCN, ex = 487 nm), C18 (c = 2.35  10
-5 M in MeCN, 
ex = 491 nm) and C19 (c = 2.21  10
-5 M in MeCN, ex = 492 nm). 
 
Figure 5.11: Normalized emission spectra of the ruthenium(II) complexes in their mono-protonated 
form: C8-1H (c = 1.38  10-5 M in MeCN, ex = 492 nm), C17-1H (c = 1.80  10
-5 M in MeCN, ex = 487 
nm), C18-1H (c = 2.35  10-5 M in MeCN, ex = 491 nm) and C19-1H (c = 2.21  10
-5 M in MeCN, ex = 
492 nm). 
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Figure 5.12: Normalized emission spectra of the ruthenium(II) complexes in their bis-protonated 
form: C8-2H (c = 1.38  10-5 M in MeCN, ex = 492 nm), C17-2H (c = 1.80  10
-5 M in MeCN, ex = 487 
nm), C18-2H (c = 2.35  10-5 M in MeCN, ex = 491 nm) and C19-2H (c = 2.21  10
-5 M in MeCN, ex = 
492 nm). 
 
 
Figure 5.13: Left: normalized titration curves obtained by monitoring the absorbance at 507 nm 
(C8) and 508 nm (C17-19) as a function of acid equivalents. Right: normalized titration curves 
obtained by monitoring the photoluminescence at 736 nm (C8, ex = 492 nm), 729 nm (C17, ex = 
487 nm), 718 nm (C18, ex = 491 nm) and 716 nm (C19, ex = 492 nm) as a function of TfOH 
equivalents. Solutions: 1.38  10-5 M, 1.80  10-5 M, 2.35  10-5 M and 2.21  10-5 M in MeCN, 
respectively. 
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5.3.4 Ruthenium(II) complexes C22-C24 with the side chain linked via an ether 
group 
 
 
Scheme 5.4: Ruthenium(II) complexes with the side chain linked via an ether group C22-24 
 
In this section, the photophysical properties of ruthenium(II) complexes C22-24 of pytpy 
ligands with the amino-substituted side chain linked via an ether group, are reported and 
compared with those of C8 and the dodecyloxy-substituted complex C22 (Scheme 5.4). We 
were interested to see the influence of the electron-donating ether group and also the effect 
of the (protonated) amino unit on the spectroscopic properties of these molecules. Figures 
5.14 and 5.17 compile absorption and emission spectra of the Ru(II) complexes C8, and C22-
24 in their starting forms. Figures 5.15 and 5.18 compile absorption and emission spectra of 
the Ru(II) complexes in their mono-protonated form (C8-1H, C22-1H, C23-1H and C24-1H). 
Figures 5.16 and 5.19 compare absorption and emission spectra of the Ru(II) complexes in 
their bis-protonated form (C8-2H, C22-2H, C23-2H and C24-2H). The most important results 
are summarised in Table 5.6. Figure 5.20 shows the normalized titration curves obtained by 
monitoring the absorbance at 507 nm (C8), 510 nm (C22) and at 511 nm (C23-24) as a 
function of acid aliquots and normalized titration curves obtained by monitoring the 
photoluminescence at 736 nm (C8, ex = 492 nm), 757 nm (C22, ex = 496 nm), 761 nm (C23, 
ex = 495 nm) and 800 nm (C24, ex = 495 nm) as a function of TfOH equivalents. All the 
titration curves of C8 and C22-24 reach the spectroscopic plateau at approximately 2 
equivalents of TFOH. 
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Compound λabs [nm] ε [L cm
-1 mol-1] λem [nm] QY [%] τ [ns] τ 77K [s] λiso 
C8 489 26000 657 0.008 4 6 492 
C8-1H 498 26000 751 0.042 98 7  
C8-2H 507 32000 743 0.082 138 7  
C22 492 23000 681 0.024 9  496 
C22-1H 507 28000 730 0.029 23   
C22-2H 510 29000 761 0.042 61   
C23 491 23000 689 0.022 10 4 495 
C23-1H 504 26000 719 0.021 20 4  
C23-2H 511 29000 761 0.027 68 5  
C24 491 28000 675 0.019 19  495 
C24-1H 501 27000 709 0.011 33   
C24-2H 511 34000 723 0.017 62   
Table 5.6: Photophysical properties of the ruthenium(II) complexes C22-24 and C8 
 
 
Figure 5.14: Absorption spectra of the ruthenium(II) complexes C8 (c = 2.40 10-5 M, MeCN), C22 (c 
= 0.80  10-5 M, MeCN), C23 (c = 0.82  10-5 M, MeCN) and C24 (c = 2.52  10-5 M, MeCN). 
 
 
Figure 5.14 displays absorption spectra of the starting complexes C8, and C22-24. All ether-
substituted complexes C22-24 have the MLCT band maximum slightly red-shifted to around 
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wavelength λabs 491 nm in comparison with C8. The piperidine–substituted complex C24 has 
the highest value of the molar absorption coefficient. Upon titration with the 1st aliquot of 
acid, the MLCT band maximum of all complexes was red-shifted. The value of the molar 
absorption coefficient of C22-1H and C23-1H increased compared to their starting forms C22 
and C23, however the molar absorption coefficient of C8-1H stayed the same and the molar 
absorption coefficient of C24-1H decreased compared to C24. Upon titration with the 2nd 
aliquot of TfOH, the absorption maximum of the MLCT band of all complexes was red-shifted 
even more. The molar absorption coefficient of C22-2H and C23-2H slightly increased 
compared to C22-1H and C23-1H. However, the molar absorption coefficient of C24-2H and 
C8-2H increased significantly. 
 
 
Figure 5.15: Absorption spectra of the ruthenium(II) complexes in their mono-protonated form:  C8-
1H(c = 2.40 10-5 M, MeCN), C22-1H (c = 0.80  10-5 M, MeCN), C23 -1H (c = 0.82  10-5 M, MeCN) 
and C24-1H (c = 2.52  10-5 M, MeCN). 
 
Figure 5.17 displays photoluminescence spectra of the starting complexes C8 and C22-24. All 
ether-substituted complexes C22-24 have the emission maximum red-shifted to λem around 
675-681 nm compared to C8 which has the emission maximum at 657 nm. They are also 
more emissive and longer lived than C8. Upon titration with the 1st aliquot of acid, the 
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emission maxima of all complexes were red-shifted, but not as much as the emission 
maximum of C8-1H. Moreover, the emission intensity of C22-24-1H decreased in comparison 
with C22-24. The quantum yields and luminescence lifetimes of C22-24-1H are much lower 
than those of C8-1H. Upon titration with the 2nd aliquot of acid, another interesting effect of 
the alkoxy-substituent is observed. The emission maxima C22-24-2H is red-shifted even 
more compared to the mono-protonated forms C22-24-1H.  However, emission maxima of 
C8-2H and ester-substituted C17-19-2H were slightly blue-shifted in comparison with their 
mono-protonated forms C8-1H and C17-19-1H. 
 
 
Figure 5.16: Absorption spectra of the ruthenium(II) complexes in their bis-protonated form:  C8-
2H(c = 2.40 10-5 M, MeCN), C22-2H (c = 0.80  10-5 M, MeCN), C23 -2H (c = 0.82  10-5 M, MeCN) 
and C24-2H (c = 2.52  10-5 M, MeCN). 
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Figure 5.17: Normalized emission spectra of the ruthenium(II) complexes C8 (c = 1.38  10-5 M in 
MeCN, ex = 492 nm), C22 (c = 0.95  10
-5 M in MeCN, ex = 496 nm), C23 (c = 1.07  10
-5 M in MeCN, 
ex = 495 nm) and C24  (c = 1.31  10
-5 M in MeCN, ex = 495 nm). 
 
Figure 5.18: Normalized emission spectra of the ruthenium(II) complexes in their mono-protonated 
form C8-1H (c = 1.38  10-5 M in MeCN, ex = 492 nm), C22-1H (c = 0.95  10
-5 M in MeCN, ex = 496 
nm), C23-1H (c = 1.07  10-5 M in MeCN, ex = 495 nm) and C24 -1H (c = 1.31  10
-5 M in MeCN, ex = 
495 nm). 
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Figure 5.19: Normalized emission spectra of the ruthenium(II) complexes in their bis-protonated 
form C8-2H (c = 1.38  10-5 M in MeCN, ex = 492 nm), C22-2H (c = 0.95  10
-5 M in MeCN, ex = 496 
nm), C23-2H (c = 1.07  10-5 M in MeCN, ex = 495 nm) and C24 -2H (c = 1.31  10
-5 M in MeCN, ex = 
495 nm). 
 
 
Figure 5.20: Left: Normalized titration curves obtained by monitoring the absorbance at 507 nm 
(C8), 510 nm (C22) and at 511 nm (C23-24) as a function of acid equivalents. Right: normalized 
titration curves obtained by monitoring the photoluminescence at 736 nm (C8, ex = 492 nm), 757 
nm (C22, ex = 496 nm), 761 nm (C23, ex = 495 nm) and 800 nm (C24, ex = 495 nm) as a function of 
TfOH equivalents. Solutions: 1.38  10-5 M, 0.95  10-5 M, 1.07  10-5 M and 1.31  10-5 M in MeCN, 
respectively. 
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5.3.5 Homoleptic ruthenium(II) complexes C27-C29 
 
 
Scheme 5.5: Homoleptic ruthenium(II) complexes C27 - C29 
 
In this section, photophysical properties of the homoleptic ruthenium(II) complex C29 with 
pytpy ligands with the diethylamino-substituted side chain linked via an ester group, are 
reported and compared with those of methyl ester-substituted homoleptic complex C27 and 
the dodecyl ester-substituted complex C28 (Scheme 5.5). We were interested to see the 
influence of two electron-withdrawing ester groups together with the effect of the 
(protonated) amino unit on the spectroscopic properties of these molecules, and compare 
these with spectroscopic properties of the heteroleptic complexes C17-18. Figures 5.21 and 
5.24 compile absorption and emission spectra of the Ru(II) complexes C27-29 in their 
starting forms. Figures 5.22 and 5.25 compare absorption and emission spectra of the Ru(II) 
complexes in their mono-protonated form (C27-1H, C28-1H and C29-1H). Figures 5.23 and 
5.26 compare absorption and emission spectra of the Ru(II) complexes in their bis-
protonated form (C27-2H, C28-2H and C29-2H). The most important results are summarised 
in Table 5.7. Figure 5.27 shows the normalized titration curves obtained by monitoring the 
absorbance at 507 nm (C27), at 509 nm (C28) and at 514 (C29) as a function of acid aliquots 
and normalized titration curves obtained by monitoring the photoluminescence at 736 nm 
(C27, ex = 492 nm), 709 nm (C28, ex = 493 nm) and 786 nm (C29, ex = 497 nm) as a 
function of TfOH equivalents. All the titration curves of C27-29 reach the spectroscopic 
plateau at approximately 2 equivalents of TfOH. 
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Compound λabs [nm] ε [L cm
-1 mol-1] λem [nm] QY [%] τ [ns] λiso 
C27 497 28000 662 0.020 6 493 
C27-1H 506 33000 716 0.122 124  
C27-2H 509 39000 711 0.165 191  
C28 497 28000 663 0.024 8 494 
C28-1H 504 31000 717 0.117 153  
C28-2H 508 38000 708 0.166 188  
C29 498 29000 667 0.236 7 494 
C29-1H 506 34000 717 0.129 112  
C29-2H 508 39000 709 0.173 185  
Table 5.7: Photophysical properties of the homoleptic ruthenium(II) complexes C27-29 
 
The absorption spectra of all three homoleptic complexes C27-29 are comparable and 
exhibit nearly the same absorption maxima in the UV and VIS – region as well as the same 
molar extinction coefficient (Figure 5.21). This behaviour was also observed during titration 
of C27-29 with TfOH. Upon addition of acid, the maxima of the MLCT bands are steadily red-
shifted and also the molar extinction coefficient increases (Figures 5.22 and 5.23). Therefore, 
it is obvious that the main influence leads from the pendant pyridyl units and the two ester 
substituents, not at all from the side chain substituent. This trend is nearly the same in the 
emission spectra (Figures 5.24 and 5.26). Upon titration up to 1st eq. of TfOH, the emission 
intensity increases and a strong red-shift of the emission maxima is observed. The emission 
intensity increases even more upon the 2nd aliquot of TfOH but the emission maxima of C27-
29-2H are slightly blue-shifted, as those of C8-2H and C17-19-2H. Also the quantum yields 
and luminescence lifetimes for each of the protonation forms are very similar and obey the 
trend which was also observed for protonation of the heteroleptic complexes C17-19. Also 
the shape and the slopes of the titration curves are nearly identical. Therefore it is obvious 
that in this case, only the presence of the two ester substituents determines the 
photophysical properties.  
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Figure 5.21: Absorption spectra of the Ru(II) complexes C27 (c = 1.10 10-5 M, MeCN), C28 (c = 0.93 
 10-5 M, MeCN) and C29 (c = 0.97  10-5 M, MeCN). 
 
 
Figure 5.22: Absorption spectra of the Ru(II) complexes in their mono-protonated form C27-1H (c = 
1.10 10-5 M, MeCN), C28-1H (c = 0.93  10-5 M, MeCN) and C29-1H (c = 0.97  10-5 M, MeCN). 
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Figure 5.23: Absorption spectra of the Ru(II) complexes in their bis-protonated form C27-2H (c = 
1.10 10-5 M, MeCN), C28-2H (c = 0.93  10-5 M, MeCN) and C29-2H (c = 0.97  10-5 M, MeCN). 
 
 
Figure 5.24: Normalized emission spectra of the ruthenium(II) complexes C27 (c = 1.10  10-5 M in 
MeCN, ex = 493 nm), C28 (c = 1.13  10
-5 M in MeCN, ex = 494 nm) and C29 (c = 0.97  10
-5 M in 
MeCN, ex = 494 nm). 
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Figure 5.25: Normalized emission spectra of the ruthenium(II) complexes in their mono-protonated 
forms C27-1H (c = 1.10  10-5 M in MeCN, ex = 493 nm), C28-1H (c = 1.13  10
-5 M in MeCN, ex = 
494 nm) and C29-1H (c = 0.97  10-5 M in MeCN, ex = 494 nm). 
 
Figure 5.26: Normalized emission spectra of the ruthenium(II) complexes in their bis-protonated 
forms C27-2H (c = 1.10  10-5 M in MeCN, ex = 493 nm), C28-2H (c = 1.13  10
-5 M in MeCN, ex = 
494 nm) and C29-2H (c = 0.97  10-5 M in MeCN, ex = 494 nm). 
 
550 600 650 700 750 800 850 900
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
 (nm)
In
te
n
s
it
y
 /
 I
n
te
n
s
it
y m
a
x
 
 
C27-1H
C28-1H
C29-1H
550 600 650 700 750 800 850 900
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
 (nm)
In
te
n
s
it
y
 /
 I
n
te
n
s
it
y m
a
x
 
 
C27-2H
C28-2H
C29-2H
132 
 
 
Figure 5.27: Left: Normalized titration curves obtained by monitoring the absorbance at 507 nm 
(C27), at 509 nm (C28) and at 514 (C29) as a function of acid aliquots. Right: Normalized titration 
curves obtained by monitoring the photoluminescence at 736 nm (C27, ex = 492 nm), 709 nm (C28, 
ex = 493 nm) and 786 nm (C29, ex = 497 nm) as a function of TfOH equivalents. All the titration 
curves of C27-29 reach the spectroscopic plateau at approximately 2 equivalents of TfOH. 
Solutions: 1.10  10-5 M, 1.13  10-5 M and 0.97  10-5 M in MeCN, respectively. 
 
 
5.3.6 Ruthenium(II) complexes C33-C36 with Phtpy ligands 
 
Scheme 5.6: Ruthenium(II) complexes C33-36 of Phtpy ligands 
 
In this section, photophysical properties of the ruthenium(II) complex C35 of Phtpy ligands 
with the diethylamino-substituted side chain linked via an ester group, are reported and 
compared with those of the model complex C33, dodecyl ester-substituted complex C34 and 
the dodecyl ether-substituted complex C36 (Scheme 5.6). These complexes were synthesized 
as model complexes for comparison with the Ru(II) complexes of pytpy ligands C17-18. In 
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comparison with C18, C35 has only one protonation side, on the side chain. We were 
interested to see if there was any influence of the (protonated) amino unit, other than the 
reported effect of the electron-withdrawing ester group or the electron-donating effect of 
the ether group and compare these results with the spectroscopic properties of the 
heteroleptic complexes of pytpy ligands C17-18. Figures 5.28 and 5.29 compile absorption 
and emission spectra of the Ru(II) complexes C33-36. Results are summarised in Table 5.8. 
 
Compound λabs [nm] ε [L cm
-1 mol-1] λem [nm] QY [%] τ [ns] 
C33 488 24000 644 0.004 3 
C34 494 22000 673 0.015 4 
C35 494 22000 668 0.017 5 
C36 490 25000 652 0.006 3 
Table 5.8: Photophysical properties of the ruthenium(II) complexes C33-36 of Phtpy ligands 
 
 
Figure 5.28: Absorption spectra of the Ru(II) complexes C33 (c = 1.12 10-5 M, MeCN), C34 (c = 1.20 
 10-5 M, MeCN), C35 (c = 1.17  10-5 M, MeCN) and C36 (c = 0.84  10-5 M, MeCN). 
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In the absorption spectra of C33-36 it was observed that functionalizing of the model 
complex C33 with an ether group (C36) caused a slight red-shift of the MLCT absorption 
band and even more with the ester group (C34-35) (Figure 5.28). The molar extinction 
coefficient value is similar for all compounds at their λabs. The substituent effect is also 
significant in the emission spectra (Figure 2.29). The emission maxima of the ester 
substituted complexes C34-35 are more red-shifted than that of the ether-substituted 
complex C36. Actually, complex C33 is almost not emissive at all, and the presence of the 
ether group does not cause any change compared with 36 (Table 5.8). Photophysical 
properties of C34-35 are comparable, therefore we can conclude that presence of the amino 
substituent on the long side chain does not cause any differences, however the ester group 
has the only effect on the spectral changes.  
 
 
Figure 5.29: Normalized emission spectra of the ruthenium(II) complexes C33 (c = 0.64  10-5 M in 
MeCN, ex = 489 nm), C34 (c = 0.50  10
-5 M in MeCN, ex = 494 nm), C35 (c = 0.46  10
-5 M in MeCN, 
ex = 494 nm) and C36 (c = 0.46  10
-5 M in MeCN, ex = 490 nm). 
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5.3.7 Truth tables 
Upon observing changes in the luminescence spectra for each of the protonation state of the 
dodecyl-oxy-substituted Ru(II) complex C22, it is possible to construct logic gates (Figure 
5.30). The proton aliquots form 2 inputs for the truth table, and upon setting threshold lines 
for a certain wavelength it is possible to perform the half-adder functions and obtain 
outputs. So then by setting the threshold line (violet, at 1 a.u.) at 680 nm we obtain an 
NAND gate, however for the same threshold line at 730 nm we obtain an AND gate. The red 
threshold at 762 nm gave an OR gate.  
 
 
Figure 5.30: Ru(II) complex C22  and its protonated forms, luminescence spectra of the studied 
complexes, threshold and outputs lines indicated, truth tables for the constructed logic gates  
 
Figure 5.31 shows protonation states of the piperidino-substituted Ru(II) complex C24 and 
their corresponding luminescence spectra. The proton aliquots form 3 inputs for the truth 
table, and upon setting threshold lines for a certain wavelength it is possible to perform the 
full-adder functions and obtain outputs. The pendant piperidine-unit was protonated already 
before performing the luminescence measurement, therefore the input 3 is always 1. So 
then by setting the threshold line (red, at 2 a.u.), at 690 nm we obtain an NAND gate. For the 
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purple threshold line at 690 nm we obtain an XNOR gate, however at 750 nm we obtain an 
AND gate.  
 
 
Figure 5.31: Ru(II) complex C24  and its protonated forms, luminescence spectra of the studied 
complexes, threshold and outputs lines indicated, truth tables for the constructed logic gates  
 
 
Conclusion 
Ruthenium(II) complexes were analysed in terms of their photophysical properties and 
compared in groups according to the pendant substituents of the tpy unit, according to the 
linker group of the side chain and also considering substituents on the side chains. The 
complexes with the ester linker exhibit similar behaviour in the absorption and emission 
spectra as reported for the model complex C8.1 Complexes with the ether linker appeared to 
be very weak emitters. However they exhibit continuous red shift in emission spectra during 
all acid titration, in contrast to complexes with ester linkers or C8. Complexes of Phtpy 
ligands were found to also be very weak emitters which corresponds with known 
ruthenium(II) complexes of tpy ligands.2 Homoleptic ruthenium(II) complexes of ester-
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substituted ligands exhibit the best photophysical properties of all the analysed complexes. 
Unfortunately, we were not able to investigate the actual effect of the amino-substituent on 
the side chain, due to the fact that such complexes were isolated in their side-chain 
protonated form. 
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Chapter 6 
 
Acid and base NMR studies of ruthenium(II) 
complexes and their free ligands with an amino-
substituted side chain 
 
6.1 Introduction 
In Chapter 4, a series of heteroleptic ruthenium(II) complexes with a long amino-substituted 
side chain linked via an ester C18-20, via an ether C23-25 and the homoleptic ruthenium(II) 
complex C29 were synthesized, along with a series of methyl and dodecyl-substituted model 
Ru(II) complexes (C7, C17, C22, C27, C28 and C30). The amino group attached to the side 
chain and the two pendant pyridyl groups bring three protonation sites to the molecule. In 
Chapter 5, photophysical studies of these Ru(II) complexes were reported and discussed. It 
was found that some molecules exhibit unexpected abnormalities during those 
measurements. Namely, an unusual kinetic effect in the absorption and photoluminescence 
spectrum during titration of C20 with TfOH or too small amount of acid consumed to 
complete titrations of some complexes (C29). 
 
Scheme 6.1: Ruthenium(II) complexes C20 and C29 and their free ligands L11 and L14 used for NMR 
studies carried out under acidic and basic conditions 
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Therefore, in this chapter we decided to carry out titrations of C20 and C29 with TFA-d and 
TfOD and to monitor the process of the protonation with 1H NMR spectra. We were 
investigating which nitrogen atom it is actually possible to protonate, and monitoring the 
sequence of their protonation. We were also interested to examine the stability of the side 
amino chains under these acidic conditions and to see if the side chains were cleaved or 
stayed attached to the Ru(II) complex. The results of these NMR studies are one of the most 
important and revolutionary piece of information. They reveal and clarify that all the Ru(II) 
complexes with three protonation sites were synthesized and isolated already in the mono-
protonated form - on the amino group of the side chain (Scheme 6.1). Due to this fact, until 
Section 6.2.3 we talk about the complexes C20 and C29 and display them in the 
deprotonated form (Scheme 6.2). 
 
Scheme 6.2: Ruthenium(II) complexes C20 and C29 in the deprotonated (neutral) form (left) and 
monoprotonated form (right)  
 
6.2 Results and Discussion 
 
6.2.1 NMR titrations of C20 and C29 with TFA-d or TfOD 
Homoleptic ruthenium(II) complex C29 was titrated with TFA-d (CF3COOD) and the process 
was monitored with 1H NMR spectra (Figure 6.1). The NMR tube contained a solution of C29 
in CD3CN (c = 4.3410
-3 mol/L, 4 mg in 0.5 mL of CD3CN). This was titrated in small aliquot 
dilute TFA-d (c = 21.5610-3 mol/L, 0.6 L in 0.3 mL of CD3CN) until 2.8 equivalents of TFA-d 
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had been added (Table 6.1, Spectra 1-15). Then we continued until 138 equivalents of 
concentrated TFA-d, when no more change of chemical shifts were observed in the 1H NMR 
spectrum (Table 6.1, Spectra 16-25). 
 
No. of 1H NMR 
spectrum 
1 2 3 4 5 6 7 8 9 10 11 12 13 
No. of eq. of TFA-d 0 0.2 0.4 0.6 0.8 1 1.2 1.4 1.6 1.8 2 2.2 2.4 
No. of 1H NMR 
spectrum 
14 15 16 17 18 19 20 21 22 23 24 25  
No. of eq. of TFA-d 2.6 2.8 6 9 12 15 21 30 48 75 102 138  
Table 6.1: Titration process of C29 with TFA-d, 1H NMR spectra displayed in Figure 6.1 
 
All 1H NMR spectra of the titration process were stacked together and chemical shifts of all 
protons compared. We were interested to see which nitrogen atoms of C29 are being 
protonated and in which order. The pendant pyridyl positions were expected to be 
protonated first, then the side chain amino unit. We were also investigating if the side chain 
under the acidic conditions stayed attached to the ruthenium(II) complex C29 or if it was 
cleaved. The protonation process of the pendant pyridyl units was monitored according to 
chemical shift of the peaks labelled C2 and C3 with  8.97 ppm and  8.20 ppm, respectively. 
The protonation of the side chain was monitored according to chemical shift of the peaks 
labelled 13 and 11 with  3.15 ppm and  3.03 ppm, respectively. Several facts are obvious 
from the 1H NMR spectra. Both side chains stayed attached to the complex and did not 
cleave, otherwise one would be able to see a change in the intensity or the chemical shift of 
the methylene group 1 and also differences in the aromatic region. However, there is not 
any significant change in any of the aliphatic peaks, but just in the aromatic region (C2 and 
C3 groups shifted to  9.07 ppm and  8.77 ppm, respectively). This means, that the 
protonation process was happening only on the pendant pyridyl units and the side chains 
stayed untouched. This gives rise to a question; are the side chain amino units of C29 really 
untouched or were the amino groups already protonated before we even started the 
titration? This was the subject of the further investigation (Sections 6.2.2 and 6.2.3). In the 
aromatic region is possible to see the smooth protonation process of the pendant pyridyl 
units (protons C2 and C3). The protonation has a stronger effect on the pyridyl protons C3  
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Figure 6.1: Stacked 1H NMR spectra (500 MHz, CD3CN) of titration of the homoleptic ruthenium(II) 
complex C29 with TFA-d, aromatic region (top), aliphatic region (bottom) 
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which are in the meta-position. The titration was done with slow increments of TFA-d until 
2.8 equivalents, when it looked like the titration process was nearly at an end. Then we 
continued with larger increments of the acid which caused the big jump in the chemical 
shifts and showed that the titration had not finished yet (Figure 6.1, Spectrum 15 and 16, 
aromatic region). The amount of acid needed to complete the titration indicates that TFA-d 
is strong enough to go from the deprotonated form to the mono-protonated form. However 
it is too weak to force the protonation process between the equilibrium of the de-, mono- 
and bis-protonated form towards the preferred final bis-protonated form. 
Heteroleptic ruthenium(II) complex C20 was also titrated with TFA-d (CF3COOD) at first and 
the process was monitored with 1H NMR spectra (Figure 6.2). The NMR tube contained a 
solution of C20 in CD3CN (c = 4.5810
-3 mol/L, 3.3 mg in 0.5 mL of CD3CN). This was titrated 
with small increments of diluted TFA-d (c = 29.7410-3 mol/L, 0.8 L in 0.3 mL of CD3CN) until 
4 equivalents of TFA-d (Table 6.2, Spectra 1-11). Then we continued until 142 equivalents 
with concentrated TFA-d, when no more change of chemical shifts were observed in the 1H 
NMR spectrum (Table 6.2, Spectra 12-20). The protonation process of the pendant pyridyl 
units was monitored according to chemical shift of the peaks labelled C2, G2 and C3, G3 at  
8.97 ppm,  8.21 ppm and  8.19 ppm, respectively. The protonation of the morpholine unit 
was monitored according to the chemical shift of the peaks 14, 13 and 11 between  4.00 - 
3.04 ppm. At this point, we still believed that C20 was in its deprotonated form. Therefore, 
the fact the protons 13 and 14 of the morpholine unit appear non-equivalent and are 
distributed as axial and equatorial signals in the 1H NMR spectrum, was accredited to the 
fact that the ligand was complexed. Also in this case, the protonation process was happening 
only on the pendant pyridyl units C and G, and the side chain remained untouched (Figure 
6.2). 
 
No. of 1H NMR spectrum 1 2 3 4 5 6 7 8 9 10 
No. of eq. of TFA-d 0 0.4 0.8 1.2 1.6 2 2.4 2.8 3.2 3.6 
No. of 1H NMR spectrum 11 12 13 14 15 16 17 18 19 20 
No. of eq. of TFA-d 4 6 10 14 20 30 46 78 110 142 
Table 6.2: Titration process of C20 with TFA-d, 1H NMR spectra displayed in Figure 6.2 
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Figure 6.2: Stacked 1H NMR spectra (500 MHz, CD3CN) of titration of the heteroleptic ruthenium(II) 
complex C20 with TFA-d, aromatic region (top), aliphatic region (bottom) 
 
C2,G2D3
B3
D6,D5C3,G3 A4,E4 A5,E5A3,E3 A6,E6B5 F3
C20 + TFA-d
1 13eq14eq 2  10 3 4-914ax 11,13ax
144 
 
To complete the titration of C20 with TFA-d, a large amount of acid was needed (about 100 
eq.). Therefore we decided to repeat this titration of C20 but with the much stronger 
deuterated trifluoromethanesulfonic acid (TfOD) (Figure 6.3, Table 6.3). The NMR tube 
contained a solution of C20 in CD3CN (c = 4.7210
-3 mol/L, 3.4 mg in 0.5 mL of CD3CN). This 
was titrated with small increments of diluted TfOD (c = 30.6510-3 mol/L, 0.8 L in 0.3 mL of 
CD3CN) until 3.5 equivalents of TfOD (Table 6.3, Spectra 1-12). Then we continued until 21.5 
equivalents with concentrated TfOD, when the solution in the NMR tube was acid-saturated 
(Table 6.2, Spectra 13-16). In comparison with Figure 6.2, TfOD is a much stronger acid than 
TFA-d and one can see that the titration is completed already at around 2.6 equivalents of 
TfOD (Spectrum 10, Table 6.3). The chemical shift of protons C2, G2 and C3, G3 stayed  8.95 
ppm and  8.80 ppm, respectively. Around 14 equivalents of TfOD, the NMR sample became 
saturated with the acid and all peaks broadened. No significant change was observed in the 
aliphatic part of the 1H NMR spectra. Some aliphatic impurities around  2.6 ppm were 
highlighted, but these were not assigned. 
 
No. of 1H NMR spectrum 1 2 3 4 5 6 7 8 
No. of eq. of TfOD 0 0.2 0.4 0.6 0.8 1 1.4 1.8 
No. of 1H NMR spectrum 9 10 11 12 13 14 15 16 
No. of eq. of TfOD 2.2 2.6 3 3.5 5.5 9.5 13.5 21.5 
Table 6.3: Titration process of C20 with TfOD, 1H NMR spectra displayed in Figure 6.3 
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Figure 6.3: Stacked 1H NMR spectra (500 MHz, CD3CN) of titration of the heteroleptic ruthenium(II) 
complex C20 with TfOD, aromatic region (top), aliphatic region (bottom) 
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B3
D6,D5C3,G3 A4,E4 A5,E5A3,E3 A6,E6B5 F3
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6.2.2 NMR studies with C20 and C29 under basic conditions 
For the next experiment to prove that C20 and C29 are in their deprotonated forms, a 1H 
NMR spectrum of C20 with an addition of a base was measured. We recorded a 1H NMR 
spectrum of the isolated complex C20 (Figure 6.4, red) and then 1H NMR spectrum of this 
same complex but with an addition of a small amount of K2CO3 (tip of spatula) (Figure 6.4, 
cyan). Under an ideal situation, these two spectra should exactly overlap. When comparing 
these two spectra, we observed only a small change in a chemical shift of the protons C3, G3 
and the rest of peaks stayed exactly the same (see also Figure 6.5, red and green).  
 
 
Figure 6.4: 1H NMR spectrum (400 MHz, CD3CN) of the heteroleptic ruthenium(II) complex C20 (red) 
overlapped with C20 +addition of K2CO3 (cyan) 
 
However, when a second aliquot of K2CO3 was added, a significant change in the aliphatic 
region of C20 was observed. All peaks of protons 14, 13 and 11 shifted to the lower ppm 
values and the distribution to axial and equatorial signals started disappearing (Figure 6.5, 
cyan). When a large excess of K2CO3 was added (Figure 6.5, purple), the peaks of protons 14, 
13 and 11 were shifted even more to the lower ppm values and were represented by only 3 
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peaks with nearly the same chemical shift values as the protons 14, 13 and 11 of the free 
ligand L14, in which the protons 14, 13 and 11 are equivalent (see Figure 3.4 in Chapter 3, 
pink). We can say that the side chain has stayed attached to the molecule C20, because the 
peak of the methylene group 1 has not been shifted. This discovery brought us to the only 
possible conclusion, that the amino unit of the side chain of the starting C20 was protonated 
and upon addition of K2CO3, was deprotonated. 
 
 
Figure 6.5: 1H NMR spectra (400 MHz, CD3CN) of the heteroleptic ruthenium(II) complex C20 (red) 
and with a sequent addition of K2CO3 (green, cyan) and with an excess of K2CO3 (purple) 
 
After this, we were curious to try this experiment with the homoleptic ruthenium(II) complex 
C29 containing diethylamino-substituted side chains. We measured a number of 1H NMR 
spectra with small, sequential increments of K2CO3 (Figure 6.6, olive, green, blue) and with 
an excess of K2CO3 (Figure 6.6, purple). We observed that all the typical protons of the amino 
group 14, 13, 11 and 10 were also shifted to the lower ppm values as were those in C20, with 
nearly the same ppm values as the protons of the free, neutral ligand L11 (see Figure 3.4 in 
Chapter 3, red). 
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Figure 6.6: 1H NMR spectra (400 MHz, CD3CN) of the homoleptic ruthenium(II) complex C29 (red) 
and with sequential addition of K2CO3 (olive, green, blue) and with an excess of K2CO3 (purple) 
 
 
6.2.3 NMR studies of the free ligands L11 and L14 with amino-substituted side 
chain under acidic conditions and their data fitting 
As the next experiment, to prove that C20 and C29 are in their monoprotonated forms, we 
measured 1H NMR spectrum of the morpholine-substituted free ligand L14 in CD3CN (Figure 
6.7, pink) and then also one 1H NMR spectrum with the addition of an excess of TfOD (Figure 
6.7, blue). We monitored the chemical shift of L14 in its protonated form and compared the 
spectrum with the 1H NMR spectrum of C20. Since an excess of TfOD was used, we expected 
that all nitrogen atoms of the ligand L14 would be protonated. In the aromatic region, a 
typical set of peaks of fully protonated pytpy ligand is observed. The pytpy protonation is 
obvious due to the fact that protons D6, A6 and C2 are represented by triplets (in 
comparison with L14 in the neutral form when these protons are doublets of doublets) and 
also all pytpy protons are shifted to higher ppm values. In the aliphatic region it is clearly 
possible to see that the morpholine unit was also protonated.  
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Figure 6.7: 1H NMR spectra (400 MHz, CD3CN) of the free ligand L14 (pink) and with an addition of 
TfOD (excess, blue) 
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All the typical protons of the amino group 14, 13, 11 and 10 were shifted to the higher ppm 
values as those in C20 and signals of the methylene groups 14 and 13 were split to axial and 
equatorial peaks as for non-equivalent protons. Figure 6.8 displays COSY-NMR spectrum of 
the protonated form of L14. There are intense interactions between the axial and equatorial 
protons 14 and between protons 11 and 13. We also observed weak interactions between 
the equatorial proton 14 and the axial proton 13, but not the other way round - between the 
equatorial proton 13 and any proton 14. 
 
Figure 6.8: COSY NMR spectrum (500 MHz, CD3CN) of the protonated ligand L14, zoom of the 
aliphatic region with morpholine unit 
 
After this latest discovery, that the complexes C20 and C29 were already isolated in the 
monoprotonated form which was proved via several experiments in this chapter, we were 
also interested in a detailed 1H NMR titration of the ligands L11 and L14 with TFA-D or TfOD. 
We believe that the protonation of the side chain of C20 and C29 had to have happened 
during the work-up of these complexes, most likely in the presence of aqueous ammonium 
hexafluorophosphate. This indicates a very strong basicity of the side chains’ amino units. 
Therefore, for the titration of L11 and L14 we decided to use the weaker acid, TFA-d, to 
monitor the protonation of the side chain and calculate a pK value of this process. In case of 
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the use of the stronger acid (TfOD), this protonation could happen immediately within even 
the first tenth of an equivalent of TfOD.  
The morpholine-substituted ligand L14 was titrated with TFA-d (CF3COOD) and the process 
was monitored with 1H NMR spectra (Figure 6.9). The NMR tube contained a solution of L14 
in CD3CN (c = 5.1610
-3 mol/L, 1.6 mg in 0.5 mL of CD3CN). This was titrated with 0.1 
equivalent increments of diluted TFA-d (c = 33.5110-3 mol/L, 0.8 L in 0.3 mL of CD3CN) 
until 0.8 equivalents of TFA-d (Table 6.4, Spectra 1-9). Then we continued with 0.2 eq. 
increments until 2 equivalents (Table 6.4, Spectra 10-15). 
 
No. of 1H NMR spectrum 1 2 3 4 5 6 7 8 
No. of eq. of TFA-d 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 
No. of 1H NMR spectrum 9 10 11 12 13 14 15  
No. of eq. of TFA-d 0.8 1 1.2 1.4 1.6 1.8 2  
Table 6.4: Titration process of L14 with TFA-d, 1H NMR spectra displayed in Figure 6.9 
 
In the aromatic part of the 1H NMR spectra no significant change was observed until 1 
equivalent of TFA-d was added (Figure 6.9, Spectrum 10). However, in the aliphatic region, 
protons 10, 11, 13 and 14 started steadily shifting to higher ppm values from the beginning 
of the titration. After the addition of 1 eq. of TFA-d these protons stopped shifting to the 
higher ppm values, and the protons 13 and 14 started to split to the typical set of four 
signals for axial and equatorial protons. After the addition of 1 eq. of TFA-d, protons in the 
aromatic region started to shift, most significantly protons C2 and C3, indicating that 
protonation happens at this site next. Altogether this proves that protonation happens first 
on the side chain, showing that this is the most basic nitrogen atom. The titration was 
stopped after the addition of 2 eq. of TFA-d because we were mainly interested in the first 
part, the protonation of the side chain. 
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Figure 6.9: Stacked 1H NMR spectra (500 MHz, CD3CN) of titration of the morpholine-substituted 
ligand L14 with TFA-d, aromatic region (top), aliphatic region (bottom) 
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Figure 6.10: Stacked 1H NMR spectra (500 MHz, CD3CN) of titration of the diethyamino-substituted 
ligand L11 with TFA-d, aromatic region (top), aliphatic region (bottom) 
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The diethylamino-substituted ligand L11 was titrated with TFA-d (CF3COOD) and the process 
was monitored with 1H NMR spectra (Figure 6.10). The NMR tube contained a solution of 
L11 in CD3CN (c = 5.1610
-3 mol/L, 1.5 mg in 0.5 mL of CD3CN). This was titrated with 0.1 
equivalent increments of diluted TFA-d (c = 33.5110-3 mol/L, 0.8 L in 0.3 mL of CD3CN) 
until 0.6 equivalents of TFA-d (Table 6.5, Spectra 1-7). Then we continued with 0.2 eq. 
increments until 2 equivalents (Table 6.5, Spectra 8-14). 
 
No. of 1H NMR 
spectrum 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 
No. of eq. of TFA-d 0 0.1 0.2 0.3 0.4 0.5 0.6 0.8 1 1.2 1.4 1.6 1.8 2 
Table 6.5: Titration process of L11 with TFA-d, 1H NMR spectra displayed in Figure 6.10 
 
As for L14, in the aromatic part of the 1H NMR spectra no significant change was observed 
until 1 equivalent of TFA-d was used (Figure 6.10, Spectrum 9). However, in the aliphatic 
region, protons 10, 11, 13 and 14 started steadily shifting to higher ppm values from the 
beginning of the titration. At the point of 1 eq. of TFA-d (Figure 6.10, Spectrum 9), protons in 
the aromatic region started to shift, most significantly protons C2 and C3, which indicates 
that the protonation happens next on the nitrogen atom of the pendant pyridyl unit C. These 
titrations of ligands L11 and L14 prove that the protonation happens first on the side chains, 
which means that the most basic nitrogen atom is located there. As for L14, this titration was 
also stopped at 2 eq. of TFA-d, because we were mainly interested in the first part, the 
protonation of the side chain. 
The protonation processes of the complexes C20 and C29 and of the ligands L11 and L14 
were evaluated from non-linear least squares fitting of the chemical shift of proton C3 (C20 
and C29), 11 (L14) or 13 (L11) to appropriate equations by using WinEQNMR2 (by Michael J. 
Hynes)1. The equilibrium constants were calculated for a logarithmic fitting process. As an 
input pK values of conjugate acids of the appropriate amines were used: Et3N (9.11), 
piperidine (11.22), morpholine (8.36), pyridine (5.25). In this case, we neglected the fact that 
these are tabulated for water. The output of this fit was then used as the input for a linear fit 
to determine the equilibrium constants of the protonation process. 
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    [L11] + [H+]  [L11…H]     pK = 7.92     (pK of the side chain) 
    [L14] + [H+]  [L14…H]     pK = 8.85     (pK of the side chain) 
    [C20] + [H+]  [C20…H]     pK = 5.06     (pK of the pendant pyridyl unit) 
    [C29] + [H+]  [C29…H]     pK = 4.54     (pK of the pendant pyridyl unit) 
 
After all, when considering the tabulated and the calculated pK values, it is clear why the 
side chain was protonated first and then the pendant pyridyl units. The regression of the 
linear fit of protonation of the side chain of the ligand L11 is shown in Figure 6.11.  
 
Figure 6.11: Regression of the linear fit of the diethyamino-substituted ligand L11 (protonation of 
its side chain unit) 
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Conclusion 
In this chapter, NMR studies of ruthenium(II) complexes C20 and C29 and of their free 
ligands L11 and L14 under acidic and basic conditions were carried out and the processes 
were monitored with 1H NMR spectra. We were investigating which nitrogen atoms are 
possible to protonate, and in which sequence. We were also interested in examining the 
stability of the side amino chains under these acidic conditions and found that the side 
chains stayed attached to the Ru(II) complex. The results of these NMR studies reveal and 
clarify that all the Ru(II) complexes with three protonation sites were synthesized and 
isolated already in the mono-protonated form - on the amino group of the side chains 
(which most likely happened during the work-up with ammonium hexafluorophosphate). 
Therefore, the only protonation happening during the NMR titrations of the Ru(II) complexes 
was on the pendant pyridyl units. The ligands L11 and L14 were titrated with TFA-d to 
monitor the side chain protonation and prove that this amino unit is protonated first. From 
these processes we calculated pK values which points at basicity of the side chain amines.  
 
 
Literature 
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Chapter 7 
 
Ruthenium(II) complexes with a short amino-
substituted side chain containing three or five carbons 
 
 
7.1 Introduction 
 
 
Scheme 7.1: Towards ruthenium(II) complexes with a long or short side chain linked via an ester 
group or via an ether group bearing three protonation sites 
 
In Chapter 2 and 3, pytpy ligands with long (11 carbon atoms) side amino-chains linked via 
an ester or an ether group L10-14 and L17-20 were prepared. In Chapter 4, ruthenium(II) 
complexes of these ligands were synthesized (C17-20 and C22-25). The amino group 
attached to the side chain and the two pendant pyridyl groups bring to the molecule three 
protonation sites. In this chapter, synthetic strategies towards ligands with short side amino-
chains (3 – 5 carbon atoms) and towards ruthenium(II) complexes of these ligands are 
reported (Scheme 7.1). Such ruthenium(II) complexes are very interesting and useful 
materials for further photophysical studies. In the Ru(II) complexes with long side chains, 
there is the possibility of a photo-induced electron transfer or a proton transfer, intra-
molecular via the chain or via space (between the pendant pyridyl unit and the amino 
group), respectively. However, the Ru(II) complexes with an appropriately short side chain (3 
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– 5 carbons) will only have the option of photo-induced electron transfer via the chain (i.e. 
not through space as the chain is too short). All photophysical studies are carried out with 
highly diluted solutions so prevent any inter-molecular communication options. 
 
 
7.2 Results and Discussion 
 
7.2.1 Towards heteroleptic ruthenium(II) complexes of pytpy ligands with an 
amino-substituted 3-carbon-side chain 
For the synthesis of the pytpy ligands with the short side chain linked via an ester group 1 
(Scheme 7.2), the same reaction conditions as those successfully used for the synthesis of 
L10-14 in Chapter 3 (Scheme 3.8) were applied.1  
 
 
Scheme 7.2: Synthesis of a pytpy ligand with a 3-carbon-side chain linked via an ester group 
 
The precursor was the COOH-substituted pytpy (L8) and this was prepared according to the 
procedure reported by Krebs (Chapter 3, Scheme 3.6)2 and was converted to the 
corresponding acid chloride L8b. L8 was refluxed in thionyl chloride for 3 hours under an 
inert atmosphere to give a yellowish solution. The excess of thionyl chloride was evaporated 
under reduced pressure and the residue was dried. The acid chloride L8b was obtained as a 
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yellowish powder, and was assumed to be formed in quantitative yield. It was immediately 
used for esterification without any further purification (Scheme 7.2). It was refluxed with the 
base 2,6-lutidine in toluene for 15 minutes under nitrogen. Commercially available 3-
aminopropan-1-ol was added and the reaction mixture was refluxed for 16 hours under 
nitrogen. The crude reaction mixture was evaporated, dissolved in chloroform and extracted 
with saturated aqueous sodium hydrogen carbonate and water. Formation of the target 
ester 1 was monitored by recording the 1H NMR spectrum and looking for the triplet 
(expected   4.5 ppm) of the first CH2 group next to the carboxyl group. The residue was 
purified with a short chromatography column (SiO2, eluted with EtOAc/MeOH/Et3N = 60:2:1 
and 30:2:1) and two oily fractions (A and B) were obtained. The identity of fraction A was 
not clarified. However, in the electrospray mass spectrum of fraction B, two intense peaks 
were observed. The first peak with m/z = 434.1 with intensity 60% was assigned to [M+Na]+ 
of the ligand 1. The second peak with m/z = 770.2 with intensity 95% was assigned to 
[M+Na]+ of the molecule 3. As the product of a “double substitution”, 3 was expected 
because the acid chloride L8b is a very reactive species and the starting 3-aminopropan-1-ol 
offers both options (formation of the ester or the amide). Therefore, with the same 
probability, we expect also the presence of the amide 2 in fraction B. 
 
 
Scheme 7.3: Synthesis of a pytpy ligand L15 with a 3-carbon-side chain linked via an ester group 
 
The esterification attempt with 3-aminopropan-1-ol was abandoned, and for the next 
reaction commercially available 3-dimethylamino-1-propanol was used instead (Scheme 
7.3). The product was purified by crystallisation from a mixture of cold ethanol-cyclohexane. 
L15 was obtained as a pale brown powder in 51% yield. In the electrospray mass spectrum of 
L15, peaks with m/z = 440.2 and m/z = 462.1 (assigned to [M+H]+ and [M+Na]+, respectively) 
with intensities of only 8% and 4%, respectively, were observed. However, a peak with m/z = 
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391.1 with intensity 100% was observed, which was assigned to [M-CH2CH2NMe2+Na]
+. This 
fact points to the fragility of the short side chain when exposed to a “stress situation”, which 
would also explain the complications during all further complexation attempts. However, the 
identity of L15 was confirmed with elemental analysis and with 1D and 2D NMR spectra. The 
1H NMR spectrum and the electronic absorption spectrum of L15 will be discussed together 
with those of ligands L16 and L21-22 (Section 7.2.2). 
 
 
Scheme 7.4: Synthesis of a pytpy ligand L21 with a 3-carbon-side chain linked via an ether group 
 
For the synthesis of the alkoxy-substituted pytpy ligand L21, the same harsh reaction 
conditions (Scheme 7.4), reported by Halcrow et al. in 2001, were applied as those that had 
been successfully used for the synthesis of L17-20 in Chapter 2 (Scheme 2.12).3 Freshly 
ground potassium hydroxide was suspended in DMSO, and L6 and 3-dimethylamino-1-
propanol were added and the mixture was heated at 60 °C for 12 hours. This reddish-brown 
solution was then cooled to room temperature. Addition of ice-cold water gave a brown 
precipitate, which was purified by extraction with chloroform-water. A large amount of 
water during extraction was necessary for DMSO removal. L21 was isolated nearly pure in 
39% yield, but there was a trace amount of unreacted starting amino alcohol. This was an 
improvement on the situation with the alkoxy-substituted ligands L17-20, where a certain 
amount (19-56%) of unreacted alcohol was always detected in the isolated products. 
However, because of the impurity in L21, elemental analysis and absorption spectra were 
not measured. In the electrospray mass spectrum of L21, a peak with m/z = 412.2 (assigned 
to [M+H]+) with intensity 100% and also a peak with m/z = 434.2 (assigned to [M+Na]+) with 
intensity 47% were observed. The 1H NMR spectrum of L21 will be discussed together with 
those of ligands L15-16 and L22 (Section 7.2.2). 
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Scheme 7.5: Towards the ruthenium(II) complex of the ligand L15 
 
For the synthesis of the heteroleptic Ru(II) complex 4 containing pytpy ligand L15 (Scheme 
7.5), the same four-step “one-pot” microwave-assisted reaction conditions were applied as 
those successfully used for the synthesis of C18-20, i.e. the complexes containing the pytpy 
ligands with the long side chains (Chapter 4, Scheme 4.4). The first ligand (L21) is 
coordinated to form the [Ru(L21)Cl3] complex, which is then activated with silver 
hexafluorophosphate. The complex reacts with the second ligand (L3) in a presence of a 
catalytic amount of N-ethylmorpholine, used as a reducing agent to convert Ru(III) to Ru(II). 
The product is then precipitated as a PF6
- salt and purified by column chromatography (SiO2, 
eluted with MeCN/saturated aqueous KNO3/H2O = 7:1:0.5) and by crystallisation from 
MeCN-Et2O. Two main fractions (A and B) were collected and their 
1H NMR spectra 
recorded. However, neither of them was the desired complex 4. The structure of B 
(according to the very low Rf value on a TLC plate, due to the NMR spectrum and ESI MS 
spectrum) was assigned as the product of ester hydrolysis C21. In the 1H NMR spectrum of 
fraction A, a set of only 7 peaks in the aromatic region and 4 peaks in the aliphatic part were 
observed. After realizing that the ester chain had cleaved, we concluded that the product 
had structure 5 (Scheme 7.5). However, this idea was incorrect. If the pendant pyridyl 
positions were alkylated, the protons of the pendant pyridyl unit would be shifted to the 
higher ppm values ( 8.6 – 9.0 ppm) and the first alkyl CH2 group next to the pyridyl nitrogen 
atom would appear around  4.7 ppm (instead of being around  3.5 ppm) (see complex C13 
in Figure 1.4, Chapter 1). The structure of fraction A was finally assigned to compound C8, 
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when it was realized that its 1H NMR spectrum matched exactly with the 1H NMR spectrum 
of the previously synthesized C8. The four aliphatic signals the 1H NMR spectrum, mentioned 
above, were assumed to belong to the protons of the cleaved side chain. The identities of 
fractions A and B were also confirmed with ESI MS spectrum and we noted that they had the 
same Rf values on a TLC plate as formerly prepared complexes C8 and C21. The synthesis in 
Scheme 7.5 was also carried out the other way round (complex with L3 first and then L15). 
However, even this trial failed and only products of decomposition (C8 and C21) were 
obtained. 
 
 
Scheme 7.6: Towards the ruthenium(II) complex 4 via trans-esterification 
 
As a next option to obtain the ester-substituted ruthenium(II) complex 4 with the short side 
chain, we tried trans-esterification of the methyl ester-substituted complex C7 with 3-
dimethylamino-1-propanol (Scheme 7.6). The same reaction conditions were applied as 
those successfully used for the synthesis of C17-18 (Chapter 1, Scheme 1.15), i.e. reflux in 
DMF in a presence of a catalytic amount of p-toluenesulfonic acid monohydrate (Scheme 
7.6, B). Milder conditions, i.e. reflux in acetone for 20 hours, were also tried (Scheme 7.6, 
route A). Reactions were monitored with TLC plates (SiO2, eluted with MeCN/saturated 
aqueous KNO3/H2O = 10:0.5:1.5) and 
1H NMR spectra. However, only products resulting 
from a decomposition to C8 and C21 were observed. 
We tried also to synthesize the heteroleptic ruthenium(II) complex 6 of the alkoxy-
substituted pytpy ligand L21 (Scheme 7.7). The same reaction conditions were applied as 
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those used for the synthesis of C18-20 of the pytpy ligands with the long side chain (Chapter 
4, Scheme 4.4). However, this attempt also failed.  
 
Scheme 7.7: Towards the ruthenium(II) complex of the ligand L21 
 
 
7.2.2 Towards heteroleptic ruthenium(II) complexes of pytpy ligands with an 
amino-substituted 5-carbon-side chain 
The synthetic attempts towards ruthenium(II) complexes with the 3-carbon-side chain were 
abandoned, due to the hydrolysis liability of this short side ester chain during all the reaction 
conditions tested. As the next option, we decided to synthesize pytpy ligands with a 5-
carbon side chain and investigate their robustness during synthesis of their ruthenium(II) 
complexes. 
 
Scheme 7.8: Synthesis of the amino alcohol with a 5-carbon-chain P19 
 
For synthesis of 5-diethylamino-1-pentanol P19 (Scheme 7.8), the same reaction conditions 
were applied as those successfully used for the synthesis of 11-diethylamino-1-undecanol 
P16 (Chapter 1, Scheme 1.11).This reaction strategy, reported by Wetter et al. in 1974, is a 
very facile two-step synthetic route to such amino alcohols, and is suitable for various chain 
lengths.4 We started with methyl 5-bromovalerate, which in the first step reacts with 
diethylamine. The latter functions both as a reagent and solvent. The bromo group is 
164 
 
quantitatively substituted with a diethylamino group. The white precipitate of 
diethylammonium bromide as a side product is simply removed by filtration. The desired 
product P15 was purified using vacuum distillation. In the second step, the methyl ester 
group was reduced by LiAlH4 to a methylene hydroxy group. Sodium sulfate decahydrate was 
used as a suitable agent for quenching the reaction mixture. A precipitate of LiOH and an 
excess of sodium sulfate was removed by filtration, and the solvent removed under reduced 
pressure giving the amino alcohol P19 as a yellowish oil in quantitative yield. 
For the synthesis of the pytpy ligands with a 5-carbon chain linked via an ester group L16 
(Scheme 7.9), the same reaction conditions as those successfully used for the synthesis of 
pytpy ligands with the long side chains L10-14 (Chapter 3, Scheme 3.8) or for L15 with a 3-
carbon chain (Scheme 7.3), were applied.1,2 L16 was purified using column chromatography 
(SiO2, eluted with EtOAc/MeOH/Et3N = 60:3:1 and 30:3:1) and was obtained as a pale brown 
solid in 51% yield. In the electrospray mass spectrum of L16, a peak with m/z = 496.3 
(assigned to [M+H]+) with intensity 100% and also peaks with m/z = 518.3 and 534.3 
(assigned to [M+Na]+ and [M+K]+, respectively) both with intensity 5% were observed. 
 
 
Scheme 7.9: Synthesis of the pytpy ligand L16 with a 5-carbon-side chain linked via an ester group 
 
For the synthesis of the alkoxy-substituted pytpy ligand L22, the same harsh reaction 
conditions (Scheme 7.10), reported by Halcrow et al., were applied as those successfully 
used for the synthesis of L17-20 in Chapter 2 (Scheme 2.12) or for the synthesis of L21 
(Scheme 7.4).3 Freshly ground potassium hydroxide was suspended in DMSO, and L6 and 5-
diethylamino-1-pentanol were added; the mixture was heated at 60 °C for 17 hours. The 
reddish-brown solution was then cooled to room temperature. Addition of ice-cold water 
gave a brown precipitate, which was purified by extraction with chloroform-water. A large 
amount of water during extraction was necessary to remove all the DMSO. L22 was isolated 
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virtually pure in 52% yield, but a small amount of unreacted starting amino alcohol remained 
with the product and could not be separated. Consequently, elemental analysis and an 
absorption spectrum were not recorded for L22. In the electrospray mass spectrum of L22, a 
peak with m/z = 468.3 (assigned to [M+H]+) with intensity 100% and also peaks with m/z = 
490.2 and 506.2 (assigned to [M+Na]+ and [M+K]+, respectively) with intensity 12% and 5%, 
respectively, were observed. 
 
 
Scheme 7.10: Synthesis of the pytpy ligand L22 with a 5-carbon-side chain linked via an ether group 
 
 
Figure 7.1: 1H NMR spectra (400 MHz, CDCl3) of the ester-substituted pytpy ligands L15 (blue) and  
L16 (red) and the alkoxy-substituted pytpy ligands L21 (cyan) and L22 (orange) 
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All four new short-chain-substituted pytpy ligands L15-16 and L21-22 were characterised 
with 1H and 13C NMR spectra using COSY, HMQC and HMBC methods. In the aromatic part of 
1H NMR spectra of ligands L15-16, it is possible to see the typical distribution of peaks of the 
ester-substituted pytpy, and this is nearly the same as observed for L11. (Compare Figures 
7.1 and 3.4 in Chapter 3.) In the aromatic part of 1H NMR spectra of ligands L21-22, it is 
possible to see the typical distribution of peaks of the ether-substituted pytpy, and this looks 
very much like the spectrum of the dodecyloxy-substituted L17. (Compare Figures 7.1 and 
2.5 in Chapter 2). However, there are some significant differences in the aliphatic part of the 
spectra of all 4 ligands, in comparison with the ligands with the long diethylamino-
substituted chain linked via an ester group L11 or via an ether group L18. The first methylene 
group 1 in the ester chain of L15 has a chemical shift  4.51 ppm ( 4.43 ppm in L11 or in 
L16). The first methylene group 1 in the ether chain of L21 has a chemical shift  4.21 ppm ( 
4.14 ppm in L18 or in L22). The methylene group 2 of L15 or of L21 is shifted to  2.08 ppm, 
but in L16 or in L22 it appears typically at  1.87 ppm (as in L11 or L18). The methylene group 
3 of L15 and L21 has a typical peak around  2.5 ppm, as well as methylene groups 5 and 7 of 
L16 and L22. The methylene group 3 of L21 overlaps with the signal arising from residual 
DMSO, but the existence of the methylene group 3 of L21 was confirmed with a COSY NMR 
spectrum. The methyl groups 5 of L15 and L21 are represented with a singlet around  2.3 
ppm. 
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Figure 7.2: UV/Vis absorption spectra (CH3CN) of the ester-substituted pytpy ligands L15  
(6.0710-5M, blue), L16 (5.3810-5M, red) 
 
Ligand c / 10-5 mol dm-3 max/nm (max/10
3 dm3 mol-1 cm-1) 
L15 6.07 242 (63.6) 281 (32.8) 316 (18.7 sh) 
L16 5.38 242 (34.0) 281 (16.7) 316 (9.8 sh) 
Table 7.1: UV/Vis absorption spectra (CH3CN) of the pytpy ligands L15 and L16 (Figure 7.2) 
 
The electronic absorption spectra of acetonitrile solutions of the 3- and 5-carbon chain 
ester-substituted pytpy ligands L15 and L16 are shown in Figure 7.2. The ligands exhibit high 
energy absorption bands at 242 nm with high extinction coefficients (34.0 and 63.3103 dm3 
mol-1 cm-1) and at 281 nm with a shoulder at about 316 nm with lower extinction coefficients 
(10 to 33103 dm3 mol-1 cm-1). The bands arise from ligand-centred * transitions (Table 
7.1). 
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We also tried to synthesize the heteroleptic ruthenium(II) complex 7 of the alkoxy-
substituted pytpy ligand L22 (Scheme 7.11). The same reaction conditions were applied as 
those used for the synthesis of C23-25 of the pytpy ligands with the long side chain (Chapter 
4, Scheme 4.5). However, this attempt also failed just like the attempt with the ligand L21 
(Scheme 7.7). At first, the 1H NMR spectrum of the crude reaction mixture looked promising 
for the presence of the product 7. It was possible to see the characteristic triplet with  4.15 
ppm (typical of the methylene group 1 of the side chain) and two multiplets around  3 ppm 
(typical of the methylene groups 5 and 7 which are closest to the protonated amine of the 
side chain). Three fractions were collected from the chromatography column. But one 
fraction was again the side product C8 and the other two were products of decomposition, 
of the side-chain cleavage. 
 
 
Scheme 7.11: Towards the ruthenium(II) complex of the ligand L22 
 
 
7.2.3 Synthesis of ruthenium(II) complexes with a short side chain via a 
combination of mild and “harsh microwave-assisted” reaction conditions 
All the following attempts to make ruthenium(II) complexes with short amino-substituted 
side chains were carried out using milder reaction conditions or a combination of harsher 
and mild reaction conditions. 
Classical harsh conditions towards ruthenium(II) complexes via RuCl33H2O or [Ru(tpy)Cl3] 
require the use of boiling ethylene glycol or DMF to achieve reduction of Ru(III) to Ru(II) in 
situ.5 In 2004, Ziessel et al. reported a useful precursor cis-[Ru(2,2':6',2''-
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terpyridine)(DMSO)Cl2] for the synthesis of various heteroleptic terpyridine complexes under 
mild conditions.6 These reaction conditions were first tried out with the model ligand L10 
(Scheme 7.12). 
 
Scheme 7.12: Towards the model Ru(II) complex C17 via mild reaction conditions with 
[Ru(L3)(DMSO)Cl2] complex 8 
 
A suspension of L3 and [Ru(DMSO)4Cl2] in dry degassed CH2Cl2 was heated to reflux for 6 
hours. The brown solution was then concentrated until a brown precipitate of 8 formed. This 
was then collected on a frit and washed with Et2O. A mixture of 8 and AgBF4 in degassed dry 
MeOH was heated at 80 °C for 7 hours. The precipitate of AgCl was removed by filtration and 
the red solution was allowed to react with L10 for 16 hours at 80 °C. After this, aqueous 
ammonium hexafluorophosphate was added and the reddish-brown product precipitated as 
a PF6
- salt. However, C17 was isolated in only a trace amount, along with a trace amount of 
the homoleptic complex C28. The main reason for this failure was found to be in the starting 
ligand L3. In contrast to compounds used in the reported procedure,6 L3 has the extra 
pendant pyridyl unit C, which competes with the tpy unit during reaction with the 
[Ru(DMSO)4Cl2] complex. This can lead to various side products, which are possible to see in 
the 1H NMR spectrum of 8. One can distinguish in the 1H NMR spectrum between the free 
and coordinated pendant pyridyl unit C and between the free and coordinated tpy unit. The 
coordinated pyridyl unit has the protons C shifted to the higher ppm and coordinated tpy 
unit has the protons B shifted slightly to the lower ppm (due to the orientation of the A-rings 
and its nitrogen atoms in the free ligand versus the complexed form). 
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The first reaction step from Scheme 7.12 was repeated, but with pytpy ligand L4 which has 
the pendant pyridyl unit protected with a methyl group (Scheme 7.13). 1H NMR and COSY 
spectra were measured and it was possible to see that all the aromatic proton signals were 
shifted by about 0.04 ppm to higher magnetic field. Only the singlet of the methyl group 
stayed at  4.43 ppm. However, the singlet of the two methyl groups of the coordinated 
DMSO (expected to be at  3.3 - 3.6 ppm)6 was not observed. This methodology was 
abandoned, due to doubts about its reproducibility. 
 
 
Scheme 7.13: Synthesis of the [Ru(L4)(DMSO)Cl2] complex 9 with a protected pendant pyridyl 
position 
 
As a next trial to synthesize complexes containing ligands with short side chains, we tried a 
combination of harsh microwave-assisted conditions with a milder heating in a fume-hood 
(Scheme 7.14). [Ru(pytpy)Cl3] (C2) was first heated in a microwave reactor with AgPF6 in 
EtOH at 130 °C for 5 minutes and then overnight with ligand L22. According to the 1H NMR 
spectrum, the desired complex 7 was not achieved, but the spectrum was consistent with a 
complex 10 containing two L22 ligands coordinated to the metal centre with both the tpy 
unit and pyridyl unit. However, 10 looks a very unlikely as a product, because 10 is only 4- 
coordinate. The positive news about this reaction is that the side chain of L22 was not 
cleaved and all its signals were in the 1H NMR observed The amino group of the chain was 
protonated because of the third reaction step with aqueous ammonium 
hexafluorophosphate.  
171 
 
 
Scheme 7.14: Another trial towards the Ru(II) complex 7, but via a combination of microwave-
assisted and milder reaction conditions 
 
 
Scheme 7.15: Towards the model Ru(II) complex C17, but via a combination of microwave-assisted 
and milder reaction conditions 
 
The reaction conditions from Scheme 7.14 were tried again but this time with a mixture of 
solvents EtOH-DMF (1:1). These reaction conditions were tested using model ligand L10 
(Scheme 7.15). In the third reaction step, the reaction mixture was heated at 90 °C for 20 
hours and turned slightly purple. C17 was isolated in only a trace amount, along with a trace 
amount of the homoleptic complex C28 (Scheme 7.15, A). In the option B (Scheme 7.15), 
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only DMF was used as a solvent. In the third step, the reaction mixture was heated to reflux 
for 20 hours and turned red. This was purified with a chromatography column (SiO2, eluted 
with a solvent mixture of MeCN/saturated aqueous KNO3/H2O = 10:1.5:0.5). C17 was 
isolated in 22% yield, along with the homoleptic complex C28 in 30% yield (Scheme 7.15, B). 
The reaction conditions B from Scheme 7.15 were then tried with L22 with the 5-carbon side 
chain linked via an ether group (Scheme 7.16). The 1H NMR spectrum of the crude reaction 
mixture looked promising and the first band on the chromatography column was collected 
(SiO2, eluted with a solvent mixture of MeCN/saturated aqueous KNO3/H2O = 10:0.5:1.5). 
However, according to the 1H NMR spectrum after the column, the product seemed to be 
decomposing. In the electrospray mass spectrum of the product 7, peaks with m/z = 1024.3 
and with m/z = 439.6 (assigned to [M-2PF6]
2+ of the complex 7 in the neutral form) both with 
11% intensity were observed. However, there were also present two intense peaks with a 
typical Ru isotope pattern at m/z = 882.1 and m/z = 368.6 with intensity 100% and 82%, 
respectively. These were assigned to an ion formed after side-chain cleavage, i.e. [M-PF6-
(CH2)5NEt2]
+ and [M-2PF6-(CH2)5NEt2]
2+, respectively. 
 
Scheme 7.16: Application of the milder reaction conditions from Scheme 7.15 on synthesis of the 
complex 7 
 
Scheme 7.17 shows another trial, this time using milder reaction conditions. A mixture of L3 
and RuCl33H2O in EtOH was irradiated in a microwave reactor at 130 °C for 10 minutes. The 
mixture was then refluxed with AgBF4 in acetone for 2 hours. This was then filtered, solvent 
evaporated and the brown residue refluxed with L16 in EtOH for 16 hours. However, after a 
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work-up, only a brown-orange solid was obtained, which according to the 1H NMR spectrum, 
seemed to be just protonated starting L16.  
 
 
Scheme 7.17: Towards the Ru(II) complex 11 via a combination of microwave-assisted and milder 
reaction conditions 
 
Scheme 7.18 shows the last trial towards the heteroleptic Ru(II) complexes with a short side 
chain, via the COOH-substituted complex C21 and esterification of its corresponding acid 
chloride. For the synthesis of the heteroleptic Ru(II) complex C21 of the COOH-substituted 
pytpy ligand L8 (Scheme 7.5), the same four-step “one-pot” microwave-assisted reaction 
conditions were applied as those successfully used for the synthesis of C18-20 of the pytpy 
ligands with the long side chain (Chapter 4, Scheme 4.4). The product C21 was purified using 
a chromatography column (SiO2, eluted with a solvent mixture of MeCN/saturated aqueous 
KNO3/H2O = 7:2:2) and obtained in 51% yield. In the electrospray mass spectrum of C21, a 
peak with m/z = 911.2 (assigned to [M-PF6]
+) with 96% intensity and a peak with m/z = 383.1 
(assigned to [M-2PF6]
2+) with 51% intensity were observed. For esterification of C21 (Scheme 
7.18, A), the same reaction conditions as those successfully used for the synthesis of pytpy 
ligand L16 (Scheme 7.9) were applied. In the case B in Scheme 7.18, a small amount of MeCN 
as solvent was used to support the solubility of C21 in thionyl chloride. However, neither the 
NMR nor mass spectrum revealed the presence of the desired complex 11.  
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Scheme 7.18: Towards complex 11 via –COOH-substituted Ru(II) complex C21 and corresponding 
acid chloride 
 
We also tried to synthesize the homoleptic ruthenium(II) complex C27 using mild conditions. 
A mixture of L2 and [Ru(DMSO)4Cl2] in methanol were refluxed for 5 hours, until the reaction 
mixture turned from ochre to reddish colour (Scheme 7.19, A). However, after work-up, C27 
was obtained in only a trace amount. Conditions B in Scheme 7.19 involve refluxing the 
reaction mixture in MeOH for 21 hours. With conditions C, the reaction mixture was refluxed 
in DMF for 7 hours. However, C27 was still obtained in only a trace amount. After these 
failures, we abandoned any further synthetic attempts towards ruthenium(II) complexes 
with short side chains. 
 
 
Scheme 7.19: Synthesis of the model homoleptic Ru(II) complex C27 using [Ru(DMSO)4Cl2] 
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Conclusion 
In this chapter, pytpy ligands with short (3 and 5 carbon atoms) amino-substituted side 
chains linked via an ester group L15-16 or an ether group L21-22 were synthesized. All four 
ligands were characterised with 1D and 2D NMR spectroscopies, electrospray ionisation 
mass spectrometry and infrared spectroscopy. L15-16 were also characterised with 
elemental analysis and UV-vis absorption spectroscopy. Numerous attempts to synthesize 
ruthenium(II) complexes of these ligands failed and led only to trace amounts of the desired 
products or to products of decomposition (side chain cleavage). Several reactions under mild 
conditions were applied. One worked well for the synthesis of the model complex C17, but 
similar reaction conditions failed when applied to complexation of the ligands with short side 
chains. These results point to the lability of the short side chain during exposure to acidic or 
basic conditions.  
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Conclusions 
 
 
In this PhD thesis, numerous synthetic strategies towards new ruthenium(II) complexes of 
polypyridine ligands with a long amino-substituted side chain are reported. The first 
approach involves the complexation of methyl 4'-(pyridin-4-yl)-[2,2':6',2''-terpyridine]-4-
carboxylate (L2) followed by trans-esterification of the methyl ester group with a long side 
chain. However this reaction gives the desired complexes in very poor yields, along with the 
complex with a free carboxylic acid – a product of the side chain cleavage. Owing to these 
reasons, an alternative route to obtain long side chain-substituted complexes was 
developed: trans-esterification of N-methylated complexes (protected against possible side 
reactions) followed by a final demethylation to remove the protecting group. However, the 
trans-esterification step again was the problematic one, therefore this strategy was 
abandoned. 
Another synthetic route to obtain Ru(II) complexes of 4'-(pyridin-4-yl)-2,2':6',2''-terpyridine 
ligands (pytpy) substituted in 4-position with an amino side-chain involved Sonogashira 
cross-coupling and “click reaction”. This allowed a wide range of reactants to be used as starting 
materials and gave access to several different funcitonal groups. The precursor, chloro-
substituted pytpy ligand L6, successfully synthesized, but all further alkynylation attempts 
failed. L6 was transhalogenated to the more reactive iodo-derivative. Unfortunately, the 
conversion proceeded in only 30%. However, another application was found for L6, namely 
the synthesis of ligands with an amino-substituted side chain linked via an ether group (L17-
20). 
The next attempted route to obtain Ru(II) complexes of pytpy ligands with an amino side-
chain appended the side chain to the ligand first and subsequently formed the complex. Four 
different ways to synthetize pytpy ligands with the long amino side-chain linked via an ester 
L10-14 were tried. Hydrolysis of L2 to free carboxylic acid L8, followed by esterification via 
the corresponding acid chloride was successful whereas direct Steglich esterification of 
carboxylic acid L8 did not work due to the insolubility of L8. Further complexation of ligands 
L10-14 was the more successful alternative to the original idea of complex synthesis by the 
trans-esterification of C7. Heteroleptic and homoleptic ruthenium(II) complexes with pytpy 
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ligands with an amino-substituted side chain (diethylamine, piperidine and morpholine), 
linked via an ester or an ether group were successfully synthesized. In order to have model 
compounds for use in the photophysical studies, ruthenium(II) complexes with 4'-phenyl-
2,2':6',2''-terpyridine ligands (Phtpy) substituted in 4-possition with the same side chains 
were also prepared. Pytpy ligands with short (3 and 5 carbon atoms) amino-substituted side 
chains linked via an ester group (L15-16) or an ether group (L21-22) were synthesized and 
characterised. Numerous attempts to synthesize ruthenium(II) complexes of these ligands 
failed and led only to trace amounts of the desired products or to decomposition (i.e., side 
chain cleavage). Several reactions under mild conditions were attempted. One worked well 
for the synthesis of the model complex C17, but similar reaction conditions failed when 
applied to complexation of the ligands with short side chains. These results point to the 
lability of the short side chain during exposure to acidic or basic conditions.  
All complexes were characterised with 1D and 2D NMR spectroscopy, electrospray or MALDI 
TOF mass spectrometry, infrared spectroscopy, elemental analysis, UV-vis and 
photoluminescence spectroscopy. Detailed photophysical of the new ruthenium(II) 
complexes were carried out in collaboration with the photochemistry research group of Prof. 
Alberto Credi from the University of Bologna in Italy. Ruthenium(II) complexes were analysed 
in terms of their photophysical properties and compared in groups according to the pendant 
substituents of the tpy unit, the linker group of the side chain and also considering 
substituents on the side chains. The complexes with the ester linker exhibit similar behaviour 
in the absorption and emission spectra as reported for the model complex C8. Complexes 
with the ether linker are very weak emitters. However they exhibit a continuous red shift in 
their emission spectra during titration with acid, in contrast to complexes with ester linkers 
or C8. Complexes of Phtpy ligands were also found to be very weak emitters, which 
corresponds with known ruthenium(II) complexes of tpy ligands. Homoleptic ruthenium(II) 
complexes of ester-substituted ligands exhibit are the strongest emitters  of all the analysed 
complexes.  
Unfortunately, the actual effect of the amino-substituent on the side chain was not 
investigated, due to the fact that such complexes were isolated already in their side-chain 
protonated form. Unfortunately, this fact was discovered nearly at the end of this work, 
after all the photophysical studies were carried out. Therefore, there was not enough time 
to develop a sufficient methodology to convert the mono-protonated Ru(II) complexes to 
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the de-protonated form and examine the complexes in terms of the originally suggested full-
adder. It was also found that some molecules exhibit unexpected anomalies during 
photophysical measurements. Namely, an unusual kinetic effect in the absorption and 
photoluminescence spectra during titration of C20 with TfOH or too small amount of acid 
consumed to complete titrations of some complexes (C29).  
Therefore, NMR studies of ruthenium(II) complexes C20 and C29 and of their free ligands 
L11 and L14 under acidic and basic conditions were carried out and the processes monitored 
by 1H NMR spectroscopy. Protonation possibilities of the nitrogen atoms were investigated 
and the stability of the side amino chains under these acidic conditions was examined. It was 
observed that the side chains stay attached to the Ru(II) complex. The results of these NMR 
studies reveal and confirm that all Ru(II) complexes with three protonation sites were 
synthesized and isolated in the mono-protonated form - on the amino group of the side 
chains (which most likely occurred during the work-up with ammonium 
hexafluorophosphate). Therefore, the only protonation happening during the NMR titrations 
of the Ru(II) complexes was on the pendant pyridyl units. The ligands L11 and L14 were 
titrated with TFA-d to monitor the side chain protonation and prove that this amino unit is 
protonated first. From these processes we calculated pK values which points at basicity of 
the side chain amines. 
In this PhD thesis, 25 new substituted pytpy or Phtpy ligands and 30 new Ru(II) complexes of 
these ligands were synthesized and characterised.  
Moving forward, it would be interesting to investigate the influence of other side chain 
linkers, such as amide or carbonyl groups, and develop a sufficient technique to complex the 
pytpy ligands bearing a short side chain (L15-16 and L21-22). 
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Experimental 
 
 
General Experimental 
1H, 13C, COSY, HMQC, HMBC, NOESY NMR spectra were recorded on Bruker AM 400 or DRX 500 
spectrometers. The chemical shifts were referenced to residual solvent peaks with respect to 
(TMS) = 0 ppm. 
Infrared spectra were recorded on a Shimadzu FTIR 8400 S Fourier‐transform 
spectrophotometer with Golden Gate accessory for solid samples. 
Solution UV/vis spectroscopic measurements (carried out in Basel) were recorded using an 
Agilent 8453 spectrophotometer or a Varian Cary 5000 spectrophotometer. Emission spectra 
were recorded on a Shimadzu 5301PC spectrofluorophotometer (carried out in Basel). 
Electrospray ionization (ESI) mass spectra were measured using a Bruker esquire 3000plus mass 
spectrometer. MALDI (Matrix-assisted laser desorption/ionization) spectra were recorded on 
Voyager-DE-Pro or Bruker Microflex with p-nitroaniline or 2,5-dihydroxybenzoic acid as 
matrixes. 
The microanalyses were performed with a Vario Micro Cube microanalyser by Sylvie 
Mittelheisser. 
Microwave reactions were carried out in a Biotage InitiatorTM 8 reactor. Absolute solvents 
were used for all reactions (Sigma‐Aldrich or ACROS crown capped bottles).  
Fluka silica 60 and Merck alumina 90 were used for column chromatography. 
NH4PF6 was purchased from Alfa Aesar or ACROS Organics and used without further 
purification. Starting materials were purchased from ACROS Organics, Sigma‐Aldrich, or 
Fluorochem and were used without further purification. Deuterated solvents for NMR were 
purchased from Cambridge Isotope Laboratories, Inc. 
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Precursors 
 
 
(E)-3-(dimethylamino)-1-(pyridin-2-yl)prop-2-en-1-one  (P1) 
 
A solution of 2-acetylpyridine (20 g, 0.165 mol) and N,N-dimethylformamide dimethyl acetal 
(24 g, 0.201 mol) in toluene (100 mL) was heated to reflux. Methanol formed was removed by 
azeotropic distillation on a Dean-Stark apparatus. The reaction mixture was heated until no 
more methanol distilled over (ca. 50 hours). Toluene was removed in vacuo. The product was 
crystallized out by addition of cyclohexane. The yellow crystals of (19.42 g, 110.20 mmol, 67%) 
were collected by filtration on a glass frit and air dried. The NMR data match those published.1 
1H NMR (400 MHz, CDCl3, TMS) /ppm 8.61 (ddd, J = 4.8, 1.6, 0.8 Hz, 1H, H
6), 8.13 (d, J = 7.9 Hz, 
1H, H3), 7.90 (d, J = 12.7 Hz, 1H, H), 7.78 (td, J = 7.7, 1.8 Hz, 1H, H4), 7.34 (ddd, J = 7.5, 4.8, 1.3 
Hz, 1H, H5), 6.43 (d, J = 12.7 Hz, 1H, H), 3.16 (s, 3H, HMe), 2.98 (s, 3H, HMe), 1.91 (s, 0H). 
 
Methyl 2-acetylisonicotinate  (P2) 
 
Methyl isonicotinate (41 g, 0.30 mol) was added to a solution of an excess of paraldehyde 
(200 g, 6.66 mol) in acetonitrile (700 mL). To this solution iron(II) sulfate heptahydrate (1.4 g, 
5 mmol), trifluoroacetic acic (35 g, 0.31 mol) and tert-butyl hydroperoxide (70% in water, 75 g, 
0.83 mol) were added and the reaction mixture was heated for 4 hours at reflux. Solvent was 
then removed under reduced pressure. The residue was neutralized with saturated aqueous 
sodium carbonate (500 mL) and extracted with toluene. The organic phase was washed with 
brine, dried over magnesium sulfate, filtered through a glass frit and solvent evaporated. The 
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crude mixture containing mono- and bisacetylated isonicotinate was purified with column 
chromatography (SiO2, EtOAc/hexane = 1:2), which afforded the product as yellow solid (22.4 g, 
0.12 mol, 42%). The NMR data match those published.2 
1H NMR (400 MHz, CDCl3, TMS) /ppm 8.82 (dd, J = 4.9, 0.7 Hz, 1H, H
6), 8.54 (dd, J = 1.4, 0.7 Hz, 
1H, H3), 8.01 (dd, J = 4.9, 1.6 Hz, 1H, H5), 3.97 (s, 3H, HMe2), 2.74 (s, 3H, HMe1). 
 
1-(4-Chloropyridin-2-yl)ethanone  (P3) 
 
A 50mL round bottom flask was heated with a heatgun and cooled down on a Schlenk line. 
4-Chloro-2-pyridine carbonitrile (1 g, 7.22 mmol) ground to a powder was added, the flask 
sealed with a septum and flushed with nitrogen. Dry diethyl ether (20 mL) was added with a 
syringe via a septum and the reaction mixture cooled to 0 °C in an ice bath. Methylmagnesium 
iodide (3M in Et2O, 5.99 g, 36 mmol) was added dropwise via a syringe. The resulting yellow 
solution was stirred for 4 hours at room temperature and turned greenish. This was poured 
onto saturated aqueous ammonium chloride (30 mL) while cooling in an ice bath. The colour 
changed to ochre and the pH was adjusted with concentrated HCl to pH=1. The ochre solution 
was stirred overnight at room temperature, then neutralized with ammonium hydroxide (32%), 
stirred 2 hours and extracted with diethyl ether. The organic phase was dried over sodium 
sulfate, filtered and solvent evaporated to give a yellow oil. Purification with column 
chromatography (SiO2, EtOAc/hexane = 1:2) afforded product as yellow crystals (0.87 g, 5.61 
mmol, 78%). The NMR data match those published.3 
1H NMR (400 MHz, CDCl3, TMS) /ppm 8.58 (d, J = 5.2 Hz, 1H, H
6), 8.04 (d, J = 2.0 Hz, 1H, H3), 
7.47 (dd, J = 5.2, 2.1 Hz, 1H, H5), 2.72 (s, 3H, HMe). 
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1-(4-Methylpyridin-2-yl)ethanone  (P4) 
 
4-Picoline (7.6 g, 82 mmol) was added to a solution of an excess of paraldehyde (54 g, 0.41 mol) 
in acetonitrile (150 mL). To this solution iron(II) sulfate heptahydrate (0.38 g, 1.3 mmol), 
trifluoroacetic acid (9.5 g, 83 mmol) and tert-butyl hydroperoxide (80% in water, 15.8 g, 
0.12 mol) were added and the reaction mixture was heated for 4 hours at reflux. Solvent was 
removed under reduced pressure. The residue was neutralized with saturated aqueous sodium 
carbonate (150 mL) and extracted with toluene (5times 150 mL). The organic phase was dried 
over sodium sulfate, filtered through a glass frit and solvent evaporated to give a black oil. The 
residue was purified with column chromatography (SiO2, EtOAc/hexane = 1:2), which afforded 
the product as yellow oil (2.62 g, 19.38 mmol, 24%). The NMR data match those published.4 
1H NMR (400 MHz, CDCl3, TMS) /ppm 8.53 (m, 1H, H
6), 7.87 (s, 1H, H3), 7.28 (m, 1H, H5), 2.71 
(s, 3H, HMe1), 2.42 (s, 3H, HMe2). 
 
1-(2-(4-(Methoxycarbonyl)pyridin-2-yl)-2-oxoethyl)pyridin-1-ium iodide  (P5) 
 
Iodine (14 g, 56 mmol) was dissolved in dry pyridine (67 mL) and the solution heated at 100 °C 
for 15 minutes under a nitrogen atmosphere. Then methyl 2-acetylisonicotinate P2 (10 g, 
56 mmol) was added in a single portion and the resulting brown mixture was heated for 1 hour 
at reflux. A brown precipitate formed on cooling, which was collected on a glass frit, washed 
with chloroform and diethylether. This was suspended in hot ethanol containing 5 (w/w)% of 
activated charcole, heated to reflux and filtered hot under reduced pressure. The orange 
filtrate was partly evaporated and left in a freezer to crystallize. The yellow-ochre crystals 
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(7.7 g, 20 mmol, 36%) were collected on a glass frit, washed with cold ethanol and air dried. The 
NMR data match those published.5 
1H NMR (400 MHz, DMSO-d6) δ/ppm 9.08 (dd, J = 5.0, 0.8 Hz, 1H, H
6), 8.98 (dd, J = 6.7, 1.2 Hz, 
2H, H2‘), 8.72 (tt, J = 7.9, 1.3 Hz, 1H, H4‘), 8.34 (dd, J = 1.6, 0.8 Hz, 1H, H3), 8.27 (dd, J = 7.8, 6.7 
Hz, 2H, H3‘), 8.23 (dt, J = 7.1, 3.6 Hz, 1H, H5), 6.50 (s, 2H, HCH2), 3.94 (s, 3H, HCH3). 
 
1-(2-(4-Chloropyridin-2-yl)-2-oxoethyl)pyridin-1-ium iodide   (P6) 
 
Iodine (1.16 g, 4.58 mmol) was dissolved in dry pyridine (16 mL) and the solution was heated at 
100 °C for 15 minutes under a nitrogen atmosphere. Then 1-(4-chloropyridin-2-yl)ethanone P3 
(0.71 g, 4.58 mmol) was added in a single portion and the resulting brown mixture was heated 
for 1 hour at reflux. A brown microcrystalline powder (1.52 g, 4.22 mmol, 92%) formed on 
cooling and was collected on a glass frit, washed with chloroform, diethyl ether and air dried. 
1H NMR (400 MHz, DMSO-d6) δ/ppm 8.99 (dd, J = 6.7, 1.3 Hz, 2H, H
2‘),8.87 (dd, J = 5.3, 0.6 Hz, 
1H, H6), 8.74 (tt, J = 7.9, 1.3 Hz, 1H, H4‘),8.29 (dd, J = 7.8, 6.8 Hz, 2H, H3‘),8.11 (dd, J = 2.1, 0.6 Hz, 
1H, H3), 8.01 (dd, J = 5.3, 2.1 Hz, 1H, H5), 6.49 (s, 2H, HCH2). 13C {1H} NMR (126 MHz, DMSO-d6) 
/ppm 190.5 (CC=O), 151.9 (C2), 151.1 (C6), 146.4 (C4‘), 146.4 (C2‘), 144.8 (C4), 128.8 (C5), 127.8 
(C3‘), 121.2 (C3), 26.6 (CCH2). MP 223 °C. ESI MS (MeOH/CHCl3): m/z 233.44 [M-I]
+ (100%, calc. 
233.05). IR (solid, /cm-1) 3105 (w), 1725 (m), 1643 (w), 1553 (w), 1518 (w), 1533 (m), 1440 (w), 
1383 (w), 1294 (m), 1276 (m), 1229 (w), 1190 (w), 974 (w), 875 (w), 830 (s), 799 (w), 772 (w), 
699 (w), 618 (w), 555 (s). EA found: C, 40.04; H, 2.76; N, 8.27%. C12H10ClIN2O requires C, 39.97; 
H, 2.80; N, 7.77%. 
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1-(2-(4-Methylpyridin-2-yl)-2-oxoethyl)pyridin-1-ium iodide   (P7) 
 
Iodine (2.04 g, 8.01 mmol) was dissolved in dry pyridine (12 mL) and the solution was heated at 
100 °C for 15 minutes under a nitrogen atmosphere. Then 1-(4-methylpyridin-2-yl)ethanone P4 
(1.08 g, 8.01 mmol) was added in a single portion and the resulting black mixture was heated 
for 1 hour at reflux. A dark brown powder (0.97 g, 2.85 mmol, 36%) formed on cooling and was 
collected on a glass frit, washed with a mixture of chloroform and ethanol, diethylether and air 
dried. Analytical data match those published.5 
ESI MS: m/z 213.1 [M-I]+ 
 
1-(2-Oxo-2-(pyridin-2-yl)ethyl)pyridin-1-ium iodide  (P8) 
 
Iodine (3.05 g, 12 mmol) was dissolved in dry pyridine (67 mL) and the solution was heated at 
100 °C for 15 minutes under a nitrogen atmosphere. Then 2-acetylpyridine (1.45 g, 12 mmol) 
was added in a single portion and the resulting brown mixture was heated for 1 hour at reflux. 
Grey needle-like crystals (2.65 g, 8.15 mmol, 68%) formed on cooling, and were collected on a 
glass frit, washed with chloroform, diethylether and air dried. The NMR data match those 
published.5 
1H NMR (400 MHz, DMSO-d6) δ/ppm 9.02 (dd, J = 6.7, 1.2 Hz, 2H, H
2‘), 8.88 (ddd, J = 6.4, 3.2, 2.4 
Hz, 1H, H6), 8.74 (tt, J = 8.0, 1.2 Hz, 1H, H4‘), 8.29 (dd, J = 7.7, 6.7 Hz, 2H, H3‘), 8.15 (td, J = 7.7, 
1.7 Hz, 1H, H4), 8.09 (dt, J = 7.8, 1.1 Hz, 1H, H3), 7.85 (ddd, J = 7.5, 4.8, 1.4 Hz, 1H, H5), 6.52 (s, 
2H, HCH2). 
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(E)-1-(pyridin-2-yl)-3-(pyridin-4-yl)prop-2-en-1-one  (P9) 
 
2-Acetylpyridine (3.60 g, 30 mmol) and pyridine-4-carboxaldehyde (3.21 g, 30 mmol) were 
added to a 100mL round bottom flask containing alumina (30 g) and tetrahydrofuran (30 mL). 
The mixture was heated in a domestic microwave oven (second lowest setting, 300 W) for 
approx. 5 minutes until it turned yellow. The alumina was filtered off on a glass frit, and washed 
with chloroform (500 mL). Solvent was reduced to approx. 5 mL and 5 mL of ethanol were 
added and the yellow solution was left in a freezer overnight to crystallize. The resulting yellow 
needle-like crystals (5.81 g, 27.63 mmol, 93%) were collected on a glass frit and washed with 
cold diethyl ether. The NMR data match those published.5 
1H NMR (400 MHz, CDCl3, TMS) /ppm 8.75 (d, J = 4.8 Hz, 1H, H
6), 8.67 (dd, J = 4.5, 1.6 Hz, 2H, 
H2‘), 8.45 (d, J = 16.1 Hz, 1H, H), 8.19 (dt, J = 7.9, 1.0 Hz, 1H, H3), 7.90 (td, J = 7.7, 1.7 Hz, 1H, 
H4), 7.80 (d, J = 16.1 Hz, 1H, H), 7.55 (dd, J = 4.7, 1.5 Hz, 2H, H3‘), 7.52 (m, 1H, H5). 
 
(E)-1-(4-methylpyridin-2-yl)-3-(pyridin-4-yl)prop-2-en-1-one   (P10) 
 
1-(4-Methylpyridin-2-yl)ethanone P4 (2.02 g, 14.95 mmol) and pyridine-4-carboxaldehyde (1.60 
g, 14.95 mmol) were mixed with methanol (26 mL) in a 50mL round bottom flask. Piperidine 
(1.40 g, 16.45 mmol) and acetic acid (0.99 g, 16.45 mmol) were added to this yellow reaction 
mixture, which was heated at reflux for 6.5 hours and the colour turned red. This solution was 
cooled to room temperature, solvent concentrated in vacuo and the residue left for 3 days in a 
freezer to crystallize. The orange needle-like crystals (1.19 g, 5.31 mmol, 36%) were collected 
on a glass frit, washed with cold water and air dried.  
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1H NMR (500 MHz, CDCl3, TMS) /ppm 8.65 (dd, J = 4.4, 1.7 Hz, 2H, H
2‘), 8.58 (d, J = 4.9 Hz, 1H, 
H6), 8.42 (d, J = 16.1 Hz, 1H, H), 7.99 (s, 1H, H3), 7.77 (d, J = 16.1 Hz, 1H, H), 7.53 (m, 2H, H3‘), 
7.31 (d, J = 4.9 Hz, 1H, H5), 2.44 (s, 3H, HMe). 13C {1H} NMR (126 MHz, CDCl3) /ppm 189.5 (C
C=O), 
153.5 (C2), 150.6 (C2‘), 148.9 (C6), 148.7 (C4), 142.5 (C4‘), 141.2 (C), 128.3 (C5), 125.5 (C), 124.0 
(C3), 122.4 (C3‘), 21.24 (CMe). ESI MS (MeOH/CHCl3): m/z 247.0 [M+Na]
+ (9%, calc. 247.1), 225.0 
[M+H]+ (100%, calc. 225.1). IR (solid, /cm-1) 3405 (w), 2948 (w), 1678 (s), 1615 (s), 1591 (s), 
1568 (m), 1548 (s), 1410 (m), 1382 (m), 1338 (w), 1309 (m), 1285 (m), 1258 (w), 1229 (m), 1156 
(m), 1043 (m), 985 (s), 961 (m), 858 (s), 837 (m), 804 (s), 775 (m), 652 (w), 560 (s), 539 (s). EA 
found: C, 67.64; H, 5.75; N, 11.38%. C14H12N2O1.3H2O requires C, 67.89; H, 5.94; N, 11.31%. 
 
(E)-3-phenyl-1-(pyridin-2-yl)prop-2-en-1-one   (P11) 
 
2-Acetylpyridine (2.42 g, 20 mmol) and freshly distilled benzaldehyde (2.12 g, 20 mmol) were 
dissolved in ethanol (70 mL). Potassium hydroxide (2.24 g, 40 mmol) dissolved in 50 mL of 
water was added to the solution, which slowly turned yellow. Water was added in 10mL 
portions to the reaction mixture until a milky precipitate formed (approx. 300 mL). The 
suspension was stirred at the room temperature for 4 hours. A yellowish precipitate formed 
and was collected on a glass frit, washed with water (100 mL) and air dried. The product was 
isolated as a pale yellow powder (4.08 g, 19.50 mmol, 97%). The NMR data match those 
published.6 
1H NMR (500 MHz, CDCl3, TMS) /ppm 8.77 (ddd, J = 4.7, 1.7, 0.9 Hz, 1H, H
6), 8.33 (d, J = 16.0 
Hz, 1H, H), 8.22 (dt, J = 7.9, 1.1 Hz, 1H, H3), 7.97 (d, J = 16.0, 1H, H), 7.90 (td, J = 7.7, 1.7 Hz, 
1H, H4), 7.76 (m, 2H, H2‘), 7.52 (ddd, J = 7.6, 4.8, 1.2 Hz, 1H, H5), 7.44 (m, 3H, H2‘+4‘). 
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Methyl 11-(diethylamino)undecanoate   (P12) 
 
A mixture of methyl 11-bromoundecanoate (0.50 g, 1.79 mmol) and diethylamine (0.79 g, 
10.75 mmol) was heated at 55 °C for 18 hours. The white precipitate of diethylamonium 
bromide was filtered off on a glass frit and washed with diethyl ether. The solvent and an 
excess of diethylamine was removed in vacuo to give an orange oil. The crude material was 
purified by vacuum distillation (80 °C, 0.05 mbar) to give the product as a yellowish oil (0.47 g, 
1.73 mmol, 97%). The NMR data match those published.7 
1H NMR (400 MHz, CDCl3, TMS) /ppm 3.66 (s, 3H, H
Me), 2.60 (m, 4H, H13), 2.47 (m, 2H, H11), 
2.29 (t, J = 7.6 Hz, 2H, H2), 1.61 (m, 2H, H3), 1.48 (m, 2H, H10), 1.27 (s, 12H, H4-9), 1.07 (t, J = 7.1 
Hz, 6H, H14). 
 
Methyl 11-(piperidin-1-yl)undecanoate   (P13) 
 
A mixture of methyl 11-bromoundecanoate (1.49 g, 5.35 mmol) and piperidine (3.64 g, 
42.76 mmol) was heated at 55 °C for 7 hours. The white precipitate of piperidinium bromide 
was filtered off on a glass frit and washed with diethyl ether. The solvent was removed in vacuo 
to give an orange oil. The crude material was purified by vacuum distillation (85 °C, 910-3 mbar) 
to give a product as a yellowish oil (1.40 g, 4.94 mmol, 92%). The NMR data match those 
published. 7 
1H NMR (400 MHz, CDCl3, TMS) /ppm 3.66 (s, 3H, H
Me), 2.35 (br s, 4H, H13), 2.27 (m, 4H, H2+11), 
1.59 (m, 6H, H3+14), 1.44 (m, 4H, H10+15), 1.27 (m, 12H, H4-9). 
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Methyl 11-morpholinoundecanoate  (P14) 
 
A mixture of methyl 11-bromoundecanoate (0.50 g, 1.79 mmol) and morpholine (1.23 g, 
14.17 mmol) was heated at 55 °C for 6 hours. The white precipitate of morpholinium bromide 
was filtered off on a glass frit and washed with diethyl ether. The solvent was removed in vacuo 
to give orange oil. The crude material was purified by vacuum distillation (120 °C, 1.510-2 mbar) 
to give a product as a yellow oil (0.51 g, 1.79 mmol, 99%). 
1H NMR (500 MHz, CDCl3, TMS) /ppm 3.70 (t, J = 4.7 Hz, 4H, H
14), 3.64 (s, 3H, HMe), 2.41 (m, 
4H, H13), 2.28 (m, 4H, H2+11), 1.59 (m, 2H, H3), 1.45 (m, 2H, H10), 1.27 (m, 12H, H4-9). 13C {1H} 
NMR (126 MHz, CDCl3) /ppm 165.5 (C
C=O), 67.1 (C14), 59.4 (C11), 53.9 (C13), 51.6 (CMe), 34.2 (C2), 
29.7, 29.6, 29.5, 29.3, 29.2 (C4-8), 27.6 (C9), 26.7 (C10), 25.1 (C3). ESI MS (MeOH/CHCl3): m/z 
308.2 [M+Na]+ (5%, calc. 308.2), 286.2 [M+H]+ (100%, calc. 286.2). IR (solid, /cm-1) 2925 (s), 
2852 (m), 2803 (w), 1739 (s), 1455 (m), 1439 (m), 1356 (w), 1272 (w), 1255 (w), 1167 (m), 1136 
(m), 1117 (s), 1007 (m), 866 (s), 725 (w), 512 (s). EA found: C, 66.91; H, 10.75; N, 4.98%. 
C16H31NO3 requires C, 67.33; H, 10.95; N, 4.91%. 
 
Methyl 5-(diethylamino)pentanoate  (P15) 
 
A mixture of methyl 5-bromovalerate (2.73 g, 13.98 mmol) and diethylamine (8.18 g, 
111.81 mmol) was heated at 55 °C for 17 hours. The white precipitate of diethylamonium 
bromide was filtered off on a glass frit and washed with tetrahydrofuran. The solvent and an 
excess of diethylamine was removed in vacuo to give orange oil. The crude material was 
purified by vacuum distillation (47 °C, 0.02 mbar) to give a product as colorless oil (2.51 g, 
13.40 mmol, 96%). The NMR data match those published. 7 
1H NMR (400 MHz, CDCl3, TMS) /ppm 3.66 (s, 3H, H
Me), 2.50 (q, J = 7.2 Hz, 4H, H7), 2.42 (m, 2H, 
H5), 2.33 (t, J = 7.4 Hz, 2H, H2), 1.63 (m, 2H, H3), 1.47 (m, 2H, H4), 1.00 (t, J = 7.2 Hz, 6H, H8). 
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11-(Diethylamino)undecan-1-ol  (P16) 
 
Methyl 11-(diethylamino)undecanoate P12 (0.94 g, 3.47 mmol) in 2 mL of dry tetrahydrofuran 
was added dropwise with a syringe via a septum to a mixture of lithium aluminium hydride 
(1.06 g, 27.79 mmol) in dry tetrahydrofuran (8 mL) in a two necked round bottom flask, while 
stirring under an inert atmosphere. The reaction mixture was refluxed for 19 hours and cooled 
to room temperature. An excess of the lithium aluminium hydride was quenched by careful 
addition of sodium sulfate decahydrate, while stirred in an ice bath until the reaction mixture 
turned white. The white precipitate of lithium hydroxide was filtered off on a glass frit and 
washed with diethyl ether. The organic phase was dried over magnesium sulfate, filtered and 
solvent evaporated in vacuo to give the product as a colourless oil (0.77 g, 3.17 mmol, 91%). 
The NMR data match those published. 7 
1H NMR (400 MHz, CDCl3, TMS) /ppm 3.64 (t, J = 6.6 Hz, 2H, H
1), 2.52 (q, J = 7.2 Hz, 4H, H13), 
2.39 (m, 2H, H11), 1.56 (m, 2H, H2), 1.30 (m, 16H, H3-9), 1.02 (t, J = 7.2 Hz, 6H, H14). 
 
11-(Piperidin-1-yl)undecan-1-ol  (P17) 
 
Methyl 11-(piperidin-1-yl)undecanoate P13 (1.40 g, 4.94 mmol) in 4 mL of dry tetrahydrofuran 
was added dropwise with a syringe via a septum to a mixture of lithium aluminium hydride 
(0.77 g, 24.70 mmol) in dry tetrahydrofuran (16 mL) in a two necked round bottom flask, while 
stirring under an inert atmosphere. The reaction mixture was refluxed for 19 hours and cooled 
to room temperature. An excess of the lithium aluminium hydride was quenched by careful 
addition of sodium sulfate decahydrate, while stirred in an ice bath until the reaction mixture 
turned white. The white precipitate of lithium hydroxide was filtered off on a glass frit and 
washed with diethyl ether. The organic phase was dried over magnesium sulfate, filtered and 
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solvent evaporated in vacuo to give the product as a pale yellow solid (1.25 g, 4.89 mmol, 99%). 
The NMR data match those published. 7 
1H NMR (500 MHz, CDCl3, TMS) /ppm 3.57 (t, J = 6.7 Hz, 2H, H
1), 2.33 (br s, 4H, H13), 2.23 (m, 
2H, H11), 1.53 (m, 6H, H2+14), 1.45 (m, 2H, H10), 1.41 (m, 2H, H15), 1.27 (m, 14H, H3-9). 13C {1H} 
NMR (126 MHz, CDCl3) /ppm 62.7 (C
1), 59.8 (C11), 54.7 (C13), 32.9 (C2), 30.4, 29.7, 29.6 (C5-8), 
29.5 (C4), 27.9 (C9), 26.9 (C10), 25.9 (C3+14), 24.6 (C15). 
 
11-morpholinoundecan-1-ol  (P18) 
 
Methyl 11-morpholinoundecanoate P14 (0.92 g, 3.22 mmol) in 3 mL of dry tetrahydrofuran was 
added dropwise with a syringe via a septum to a mixture of lithium aluminium hydride (0.62 g, 
16.12 mmol) in dry tetrahydrofuran (13 mL) in a two necked round bottom flask, while stirring 
under an inert atmosphere. The reaction mixture was refluxed for 19 hours and cooled to room 
temperature. An excess of the lithium aluminium hydride was quenched by careful addition of 
sodium sulfate decahydrate, while stirred in an ice bath until the reaction mixture turned white. 
The white precipitate of lithium hydroxide was filtered off on a glass frit and washed with 
tetrahydrofuran. The organic phase was dried over magnesium sulfate, filtered and solvent 
evaporated in vacuo to give the product as a pale yellow solid (0.82 g, 3.19 mmol, 98%). The 
NMR data match those published. 7 
1H NMR (500 MHz, CDCl3, TMS) /ppm 3.83 (br s, 4H, H
14), 3.57 (m, 2H, H1), 2.62 (br s, 4H, H13), 
2.50 (m, 2H, H11), 1.58 (m, 4H, H2+10), 1.30 (m, 14H, H3-9). 
 
5-(Diethylamino)pentan-1-ol  (P19) 
 
Methyl 5-(diethylamino)pentanoate P15 (2.00 g, 10.68 mmol) in 5 mL of dry tetrahydrofuran 
was added dropwise with a syringe via a septum to a mixture of lithium aluminium hydride 
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(2.03 g, 53.40 mmol) in dry tetrahydrofuran (35 mL) in a 100mL two necked round bottom flask, 
while stirring under an inert atmosphere. The reaction mixture was refluxed for 16 hours and 
cooled to room temperature. This was poured to a 500mL round bottom flask and an excess of 
the lithium aluminium hydride was quenched by careful addition of sodium sulfate 
decahydrate, while stirred in an ice bath until the reaction mixture turned white. The white 
precipitate of lithium hydroxide was filtered off on a glass frit and washed with diethyl ether. 
The organic phase was dried over magnesium sulfate, filtered and solvent evaporated in vacuo 
to give the product as a yellowish oil (1.65 g, 10.36 mmol, 99%). The NMR data match those 
published. 7 
1H NMR (400 MHz, CDCl3, TMS) /ppm 3.64 (t, J = 6.4 Hz, 2H, H
1), 2.53 (q, J = 7.2 Hz, 4H, H7), 
2.43 (dd, J = 8.2, 6.5 Hz, 2H, H5), 1.59 (m, 2H, H2), 1.49 (m, 2H, H4), 1.38 (m, 2H, H3), 1.02 (t, J = 
7.2 Hz, 6H, H8). 
 
 
Ligands 
 
 
2,2':6',2''-Terpyridine  (L1) 
 
A nitrogen flushed 500 mL round-bottomed flask was charged with potassium tert-butoxide 
(10.04 g, 90.0 mmol) in 220 mL of dry tetrahydrofuran. To this solution 2-acetylpyridine (5.45 g, 
45.0 mmol) was added and the reaction mixture was allowed to stir for 2 hours. Ketone P1 
(7.88 g, 45.0 mmol) was added in a single portion. The yellow solution, which gradually turned 
deep red, was allowed to stir for 20 hours at room temperature. Then the solution was slowly 
treated with an excess of ammonium acetate (35.0 g, 0.45 mol) and acetic acid (113 mL). The 
mixture produced fumes and the colour changed to dark orange-brown and it was left to stir 
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overnight. Tetrahydrofuran and acetic acid were partly removed in vacuo and the black-oil 
residue was treated with water (220 mL). Sodium carbonate was added slowly until the 
reaction mixture stopped producing bubbles. This was extracted with dichloromethane (5 times 
200 mL). The organic phase was dried over anhydrous sodium sulfate and solvent removed in 
vacuo to give black oil. This was purified on a short column of alumina, eluted with toluene and 
solvent removed in vacuo, which afforded the product (3.30 g, 14.15 mmol, 32%) as a pale 
brown solid. The NMR data match those published.1 
1H NMR (400 MHz, CDCl3, TMS) /ppm 8.71 (ddd, J = 4.8, 1.8, 0.9 Hz, 2H, H
A6), 8.63 (dt, J = 8.0, 
1.0 Hz, 2H, HA3), 8.46 (d, J = 7.8 Hz, 2H, HB3), 7.96 (t, J = 7.8 Hz, 1H, HB4), 7.86 (td, J = 7.7, 1.8 Hz, 
2H, HA4), 7.33 (ddd, J = 7.5, 4.8, 1.2 Hz, 2H, HA5). 
 
Methyl 4'-(pyridin-4-yl)-[2,2':6',2''-terpyridine]-4-carboxylate  (L2) 
 
An excess of ammonium acetate (13 g, 160 mmol) was dissolved in methanol (150 mL). 
Chalcone P9 (0.92 g, 4.38 mmol) and PPI salt P5 (2.01 g, 5.25 mmol) were added and this brown 
suspension was heated at reflux for 7 hours and the solids slowly dissolved. The white 
precipitate which formed was collected on a glass frit, washed with cold methanol and diethyl 
ether, and air dried to give the product as a white powder (1.43 g, 3.88 mmol, 89%). 
1H NMR (500 MHz, CDCl3, TMS) /ppm 9.15 (dd, J = 1.6, 0.9 Hz, 1H, H
D3), 8.86 (dd, J = 5.0, 0.9 
Hz, 1H, HD6), 8.78 (d, J = 1.7 Hz, 1H, HB3), 8.76 (m, 3H, HC2+B5), 8.72 (m, 2H, HA6+A3), 7.92 (m, 2H, 
HA4+D5), 7.80 (dd, J = 4.5, 1.7 Hz, 2H, HC3), 7.39 (ddd, J = 7.5, 4.8, 1.3 Hz, 1H, HA5), 4.04 (s, 3H, 
HMe). 13C {1H} NMR (126 MHz, CDCl3) /ppm 165.9 (C
C=O), 156.9 (CD2), 156.7 (CB2), 155.6 (CB6), 
155.5 (CA2), 150.6 (CC2), 150.0 (CD6), 149.3 (CA6), 147.6 (CB4), 145.9 (CC4), 138.5 (CD4), 137.2 (CA4), 
124.3 (CA5), 123.2 (CD5), 121.7 (CC3), 121.6 (CA3), 120.7 (CD3), 119.1 (CB3), 118.9 (CB5), 53.0 (CMe). 
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MP 216-217 °C (from MeOH).  ESI MS (MeOH/CHCl3): m/z 391.1 [M+Na]
+ (100%, calc. 391.1),  
369.2 [M+H]+ (16%, calc. 369.1). IR (solid, /cm-1) 3020 (w), 2961 (w), 1731 (s), 1583 (m), 1559 
(m), 1538 (m), 1533 (m), 1475 (m), 1436 (m), 1378 (m), 1309 (w), 1292 (w), 1270 (m), 1263 (w), 
1218 (m), 1211 (m), 1130 (w), 973 (w), 895 (w), 821 (m), 795 (s), 770 (s), 736 (w), 682 (m), 669 
(m), 660 (m), 618 (m), 533 (m). UV/VIS max/nm (4.2210
-5 mol dm-3, MeCN) 242 (/ dm3 mol-1 
cm-1 33000), 281 (16000), 316 (10000 sh). EA found: C, 70.96; H, 4.44; N, 15.19%. 
C22H16N4O20.25H2O requires C, 70.86; H, 4.46; N, 15.02%. 
 
4'-(Pyridin-4-yl)-2,2':6',2''-terpyridine  (L3) 
 
2-Acetylpyridine (4.89 g, 40.40 mmol) was mixed with a solution of pyridine-4-carboxaldehyde 
(2.16 g, 20.20 mmol) in ethanol (100 mL). Potassium hydroxide pellets (2.72 g, 48.50 mmol) and 
aqueous ammonia (30%, 0.86 g, 50.5 mmol) were added to the solution, which was allowed to 
stir for 4 hours at room temperature. The off-white solid, which formed, was collected by 
filtration and washed with ethanol. This was suspended in hot methanol and chloroform added 
until all the solid dissolved. Upon cooling in a freezer, white needle-like crystals (2.97 g, 9.58 
mmol, 48%) were collected by filtration and washed with ethanol. The NMR data match those 
published.8 
1H NMR (400 MHz, CDCl3, TMS) /ppm 8.77 (m, 4H, H
B3+C2), 8.73 (m, 2H, HA6), 8.67 (d, J = 8.0 Hz, 
2H, HA3), 7.89 (td, J = 7.7, 1.8 Hz, 2H, HA4), 7.82 (dd, J = 4.6, 1.7 Hz, 2H, HC3), 7.38 (ddd, J = 7.5, 
4.8, 1.1 Hz, 2H, HA5). UV/VIS max/nm (5.9710
-5 mol dm-3, MeCN) 242 (/ dm3 mol-1 cm-1 
44000), 277 (29000), 314 (9000). 
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Ligand  (L4) 
 
An excess of methyl iodide (2.74 g, 19.28 mmol) was added to a suspension of L3 (0.50 g, 1.61 
mmol) in acetonitrile (150 mL) and the reaction mixture was heated at reflux for 7 hours, while 
L3 slowly dissolved and a yellow precipitate formed. This was then cooled to the room 
temperature and 2/3 of solvent removed in vacuo. An aqueous solution of ammonium 
hexafluorophosphate was added to this solution with the dark yellow precipitate, which turned 
bright yellow and was left in a freezer, then collected on a frit, washed with water, ethanol and 
diethyl ether and air dried to give the product as a yellow powder (0.62 g, 1.31 mmol, 81%). The 
NMR data match those published.9 
1H NMR (500 MHz, DMSO-d6) /ppm 9.15 (d, J = 6.3 Hz, 2H, H
C2), 8.89 (s, 2H, HB3), 8.79 (d, J = 
4.2 Hz, 2H, HA6), 8.76 (d, J = 6.4 Hz, 2H, HC3), 8.69 (d, J = 7.9 Hz, 2H, HA3), 8.07 (t, J = 7.6 Hz, 2H, 
HA4), 7.58 (m, 2H, HA5), 4.44 (s, 3H, HNMe). 
 
Ligand  (L5) 
 
An excess of methyl iodide (2.74 g, 19.28 mmol) was added to a white suspension of L2 (0.59 g, 
1.61 mmol) in acetonitrile (130 mL) and the reaction mixture was heated at reflux for 13 hours, 
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while L2 slowly dissolved. This was then cooled to room temperature and 2/3 of solvent 
removed in vacuo, giving a precipitate. The dark yellow suspension was mixed with an aqueous 
solution of ammonium hexafluorophosphate. The rest of the acetonitrile was removed in vacuo 
from the green solution, while an olive-green precipitate formed. This was collected on a frit, 
washed with water, ethanol and diethyl ether and air dried to give the product as a pale olive-
green powder (0.79 g, 1.50 mmol, 93%). 
1H NMR (500 MHz, DMSO-d6) /ppm 9.16 (d, J = 6.7 Hz, 2H, H
C2), 9.00 (m, 2H, HD3+D6), 8.94 (s, 
1H, HB3), 8.93 (s, 1H, HB5), 8.80 (m, 3H, HA6+C3), 8.60 (d, J = 7.9 Hz, 1H, HA3), 8.13 (td, J = 7.8, 1.6 
Hz, 1H, HA4), 8.01 (dd, J = 4.7, 1.5 Hz, 1H, HD5), 7.61 (ddd, J = 7.7, 4.8, 1.2 Hz, 1H, HA5), 4.43 (s, 
1H, HNMe), 4.00 (s, 1H, HOMe). 13C {1H} NMR (126 MHz, DMSO-d6) /ppm 165.1 (C
C=O), 156.7 (CB2), 
156.5 (CB6), 155.5 (CD2), 154.1 (CA2), 150.0 (CC4), 150.8 (CD6), 149.5 (CA6), 142.0 (CC2), 144.0 (CB4), 
138.5 (CD4), 137.9 (CA4), 125.6 (CC3), 125.2 (CA5), 123.6 (CD5), 121.1 (CA3), 119.6 (CD3), 118.9, 119.4 
(CB3), 119.1 (CB5), 53.1 (COMe), 47.6 (CNMe). MP 225 °C. ESI MS (MeOH/CHCl3): m/z 383.2 [M-PF6]
+ 
(100%, calc. 383.2). IR (solid, /cm-1) 3105 (w), 1725 (m), 1643 (w), 1553 (w), 1518 (w), 1440 
(w), 1383 (w), 1294 (m), 1276 (m), 1230 (w), 1191 (w), 975 (w), 876 (m), 830 (s), 799 (s), 772 
(m), 699 (m), 618 (w), 555 (s). UV/VIS max/nm (3.9310
-5 mol dm-3, MeCN) 255 (/dm3 mol-1 
cm-1 30000), 276 (24000 sh), 333 (4000 sh). EA found: C, 48.33; H, 3.86; N, 9.93%. 
C23H19N4O2P2.5H2O requires C, 48.17; H, 4.22; N, 9.77%. 
 
4-Chloro-4'-(pyridin-4-yl)-2,2':6',2''-terpyridine   (L6) 
 
An excess of ammonium acetate (6.0 g, 77.92 mmol) was dissolved in methanol (60 mL). 
Chalcone P9 (0.73 g, 3.46 mmol) and PPI salt P6 (1.40 g, 3.88 mmol) were added and this black 
suspension was heated at reflux for 6 hours, while all slowly dissolved. Then the reaction 
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mixture was cooled to room temperature and placed in the freezer overnight. The brown 
precipitate which formed was collected on a glass frit, washed with cold methanol and diethyl 
ether and air dried to give the product as a brown powder (1.10 g, 3.19 mmol, 92%). 1H NMR 
(500 MHz, CDCl3, TMS) /ppm 8.78 (d, J = 1.7 Hz, 1H, H
B3), 8.77 (dd, J = 4.4, 1.7 Hz, 2H, HC2), 8.73 
(m, 2H, HA6+B5), 8.66 (m, 2H, HA3+D3), 8.61 (dd, J = 5.2, 0.5 Hz, 1H, HD6), 7.92 (td, J = 7.9, 1.8 Hz, 
1H, HA4), 7.78 (dd, J = 4.5, 1.7 Hz, 2H, HC3), 7.39 (m, 2H, HA5+D5). 13C {1H} NMR (126 MHz, CDCl3) 
/ppm 157.3 (CD2), 156.7 (CB2), 155.5 (CA2), 155.2 (CB6), 150.6 (CC2), 150.2 (CD6), 149.4 (CA6), 
147.7 (CB4), 146.0 (CC4), 145.4 (CD4), 137.3 (CA4), 124.4 (CA5+D5), 121.9 (CC3), 121.8 (CD3), 121.6 
(CA3), 119.4 (CB3), 119.1 (CB5). MP at 210 °C decomposes. ESI MS (MeOH/CHCl3): m/z 367.1 
[M+Na]+ (100%, calc. 367.1), 345.1 [M+H]+ (86%, calc. 345.1). IR (solid, /cm-1) 3051 (w), 1705 
(s), 1584 (m), 1568 (s), 1554 (s), 1533 (s), 1464 (m), 1323 (w), 1261 (w), 1230 (w), 1064 (w), 988 
(m), 875 (m), 815 (s), 788 (s), 733 (s), 673 (m), 659 (m), 619 (s), 582 (m). UV/VIS max/nm 
(4.0810-5 mol dm-3, MeCN) 244 (/ dm3 mol-1 cm-1 38000), 276 (21000), 313 (8000). EA found: 
C, 63.05; H, 3.75; N, 15.04%. C20H13ClN42H2O requires C, 63.08; H, 4.50; N, 14.71%.
 
 
4-Methyl-4'-(pyridin-4-yl)-2,2':6',2''-terpyridine  (L7) 
 
An excess of ammonium acetate (1.52 g, 19.71 mmol) was dissolved in methanol (13 mL). 
Chalcone P10 (0.17 g, 0.76 mmol) and PPI salt P8 (0.30 g, 0.91 mmol) were added and this 
brown suspension was heated to reflux for 6 hours, while all slowly dissolved. Then the reaction 
mixture was cooled to room temperature, filtered on a glass frit and the brown filtrate placed 
in the freezer overnight. The pale brown precipitate which formed was collected on a glass frit, 
washed with cold methanol and diethyl ether and air dried to give the product as a pale brown 
powder (0.20 g, 0.62 mmol, 93%). 
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1H NMR (500 MHz, CDCl3, TMS) /ppm 8.74 (dd, J = 4.5, 1.7 Hz, 2H, H
C2), 8.72 (m, 3H, HB3+B5+A6), 
8.66 (dt, J = 8.0, 1.1 Hz, 1H, HA3), 8.56 (d, J = 4.9 Hz, 1H, HD6), 8.45 (br s, 1H, HD3), 7.88 (td, J = 
7.7, 1.8 Hz, 1H, HA4), 7.76 (dd, J = 4.5, 1.7 Hz, 1H, HC3), 7.35 (ddd, J = 7.4, 4.7, 1.2 Hz, 1H, HA5), 
7.17 (m, 1H, HD5), 2.49 (s, 3H, HMe). 13C {1H} NMR (126 MHz, CDCl3) /ppm 156.7 (C
B6), 156.4 
(CB2), 155.8 (CA2), 155.6 (CD2), 150.6 (CC2), 149.3 (CA6), 149.1 (CD6), 148.2 (CD4), 147.5 (CB4), 146.1 
(CC4), 137.1 (CA4), 125.2 (CD5), 124.2 (CA5), 122.2 (CD3), 121.8 (CC3), 121.5 (CA3), 118.9, 118.7 (CB3+ 
B5), 21.5 (CMe). MP 173-174 °C (from MeOH). MALDI TOF MS: m/z 324.90 [M]+ (78%, calc. 
324.2). IR (solid, /cm-1) 3052 (w), 2877 (w), 1747 (w), 1711 (w), 1582 (m), 1564 (w), 1469 (w), 
1412 (w), 1379 (m), 1327 (m), 1227 (w), 1063 (w), 995 (m), 890 (w), 820 (s), 876 (s), 691 (m), 
668 (s), 660 (m), 619 (s). UV/VIS max/nm (4.8010
-5 mol dm-3, MeCN) 243 (/ dm3 mol-1 cm-1 
50000), 277 (31000), 315 (11000). EA found: C, 76.91; H, 4.93; N, 17.54%. C21H16N41/4H2O 
requires C, 76.69; H, 5.06; N, 17.04%. 
 
4'-(Pyridin-4-yl)-[2,2':6',2''-terpyridine]-4-carboxylic acid  (L8) 
 
Methyl 4'-(pyridin-4-yl)-[2,2':6',2''-terpyridine]-4-carboxylate L2 (0.15 g, 0.41 mmol) was 
suspended in hot methanol (4.5 mL). Then aqueous sodium hydroxide (1M, 0.81 mL, 0.81 
mmol) was added and the reaction mixture was heated at reflux for 20 hours, while the milky 
white suspension turned to pale brown solution. This was cooled to room temperature and 
acidified with hydrochloric acid (0.5M) to pH4. The white precipitate which formed was 
collected on a glass frit, washed thoroughly with water and air dried to give the product as an 
off-white powder (0.14 g, 0.40 mmol, 97%). 
1H NMR (500 MHz, DMSO-d6) /ppm 13.93 (br s, 1H, OH), 9.04 (dd, J = 1.5, 0.8 Hz, 1H, H
D3), 9.02 
(d, J = 6.5 Hz, 2H, HC2), 8.98 (dd, J = 4.9, 0.8 Hz, 1H, HD6), 8.91 (d, J = 1.6 Hz, 1H, HB3), 8.90 (d, J = 
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1.7 Hz, 1H, HB5), 8.83 (dd, J = 4.8, 0.8 Hz, 1H, HA6), 8.67 (d, J = 7.9 Hz, 1H, HA3), 8.48 (d, J = 5.0 Hz, 
2H, HC3), 8.20 (td, J = 7.8, 1.6 Hz, 1H, HA4), 7.99 (dd, J = 4.9, 1.6 Hz, 1H, HD5), 7.65 (dd, J = 7.4, 4.9 
Hz, 1H, HA5). 13C {1H} NMR (126 MHz, DMSO-d6) /ppm 166.5 (C
C=O), 156.1 (CB2+B6), 155.9 (CD2), 
154.1 (CA2), 151.3 (CC4), 151.1 (CD6), 149.5 (CA6), 146.0 (CB4), 145.5 (CC2), 140.2 (CD4), 139.2 (CA4), 
125.7 (CA5), 124.7 (CC3), 124.3 (CD5), 121.9 (CA3), 120.4 (CD3), 119.8 (CB3+B5). MP >350 °C. MALDI 
TOF MS: m/z 780.2 [2M]+ (100%, calc. 780.2), 354.9 [M]+ (5%, 354.1, neutral form). IR (solid, 
/cm-1) 3378 (s), 1703 (m), 1586 (m), 1557 (m), 1468 (w), 1383 (w), 1287 (w), 1218 (w), 1069 
(w), 829 (m), 791 (w), 770 (w), 667 (m), 629 (m), 567 (s), 519 (s). EA found: C, 59.50; H, 4.22; N, 
13.59%. C21H15ClN4O22H2O requires C, 59.09; H, 4.49; N, 13.13%. 
 
Ligand  (L9) 
 
Ligand L5 (0.22 g, 0.41 mmol) was suspended in hot methanol (3 mL). Then aqueous sodium 
hydroxide (1M, 0.81 mL, 0.81 mmol) was added and the reaction mixture was heated at reflux 
for 22 hours, while the greenish suspension turned to dark red-brown solution. This was cooled 
to the room temperature and acidified with hydrochloric acid (0.5M) to pH4. The brown 
precipitate which formed was collected on a glass frit, washed thoroughly with water, 
suspended in an aqueous solution of ammonium hexafluorophosphate, collected again on a 
frit, washed with water and air dried to give the product as a brown powder (73 mg, 0.14 mmol, 
35%). 
1H NMR (500 MHz, DMSO-d6) /ppm 9.14 (br s, 2H, H
C2), 8.88 (m, 4H, HA6+B3+B5+D3), 8.74 (m, 3H, 
HC3+D6), 8.56 (m, 1H, HA3), 8.07 (m, 1H, HA4), 7.93 (br s, 1H, HD5), 7.56 (m, 1H, HA5), 4.42 (s, 3H, 
HMe). 13C {1H} NMR (126 MHz, DMSO-d6) /ppm 166.8 (C
C=O), 150.1 (CD6), 150.8 (CA6), 146.8 
(CC2), 138.2 (CA4), 125.8 (CC3), 125.4 (CA5), 124.2 (CD5), 121.4 (CA3), 119.4 (CD3), 120.4 (CB3+B5), 
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48.0 (CNMe), (Cq were not observed due to the poor solubility of the ligand). MP at 210 °C 
decomposes. MALDI TOF MS: m/z 368.8 [M-PF6]
+ (84%, calc. 369.1), 324.7 [M-PF6-CO2]
+ (24%, 
calc. 324.8). IR (solid, /cm-1) 3073 (s), 1717 (m), 1588 (m), 1548 (m), 1369 (m), 1225 (w), 1076 
(m), 835 (s), 784 (m), 775 (m), 663 (m). 
 
Dodecyl 4'-(pyridin-4-yl)-[2,2':6',2''-terpyridine]-4-carboxylate  (L10) 
 
4'-(Pyridin-4-yl)-[2,2':6',2''-terpyridine]-4-carboxylic acid L8 (0.11 g, 0.31 mmol) was refluxed in 
an excess of thionyl chloride (14 mL) under an inert atmosphere for 4 hours, and it became a 
yellow solution. This was cooled to room temperature and thionyl chloride evaporated to give 
4'-(pyridin-4-yl)-[2,2':6',2''-terpyridine]-4-carbonyl chloride as a yellow powder, which was used 
in the next step without further purification and characterization. This was refluxed with 
triethylamine (63 mg, 0.62 mmol) in toluene (9 mL) under an inert atmosphere for 30 minutes 
to give a greenish suspension. Then dodecanol (0.12 g, 0.62 mmol) was added. The reaction 
mixture turned dark brown and was refluxed for 15 hours. Then solvent was removed in vacuo 
and the brown residue dissolved in chloroform and extracted with an aqueous solution of 
sodium hydrogencarbonate and then with water. The organic phase was dried over sodium 
sulfate, filtered and evaporated to give a dark brown solid, which was recrystallized from cold 
mixture of ethanol - diethyl ether to afford the product as an off-white powder (0.12 g, 0.23 
mmol, 75%).  
1H NMR (500 MHz, CDCl3, TMS) /ppm 9.17 (d, J = 1.5 Hz, 1H, H
D3), 8.86 (d, J = 4.9 Hz, 1H, HD6), 
8.79 (d, J = 1.8 Hz, 1H, HB3), 8.77 (d, J = 1.8 Hz, 1H), 8.76 (m, 3H, HC2+B5), 8.73 (m, 1H, HA6), 8.72 
(d, J = 7.8 Hz, 1H, HA3), 7.91 (m, 2H, HD5+A4), 7.78 (dd, J = 4.5, 1.6 Hz, 2H, HC3), 7.38 (m, 1H, HA5), 
4.43 (t, J = 6.6 Hz, 2H, H1), 1.84 (m, 2H, H2), 1.51 (m, 2H, H3), 1.40 (m, 2H, H4), 1.29 (m, 14H, H5-
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11), 0.86 (t, J = 6.9 Hz, 3H, H12). 13C {1H} NMR (126 MHz, CDCl3) /ppm 165.5 (C
C=O), 157.0 (CD2), 
156.7 (CB2), 155.7 (CB6), 155.6 (CA2), 150.7 (CC2), 150.0 (CD6), 149.3 (CA6), 147.7 (CC4), 145.9 (CB4), 
139.0 (CD4), 137.2 (CA4), 124.4 (CA5), 123.2 (CD5), 121.8 (CC3), 121.6 (CA3), 120.9 (CD3), 119.2 (CB5), 
118.9 (CB3), 66.1 (C1), 32.0 (C10), 29.8, 29.7, 29.5 (C5-9), 29.4 (C4), 28.8 (C2), 26.2 (C3), 22.8 (C11), 
14.3 (C12). MP 97-98 °C (from EtOH-Et2O). ESI MS (MeOH/CH2Cl2): m/z 561.3 [M+K]
+ (27%, calc. 
561.3), 545.4 [M+Na]+ (100%, calc. 545.4), 523.4 [M+H]+ (45%, calc. 523.3). IR (solid, /cm-1) 
3063 (w), 2951 (w), 2914 (s), 2850 (m), 1733 (s), 1584 (s), 1560 (m), 1533 (m), 1471 (m), 1381 
(m), 1347 (w), 1290 (m), 1285 (m), 1269 (s), 1217 (m), 1210 (m), 1134 (w), 1127 (w), 1105 (w), 
964 (w), 890 (w), 816 (s), 788 (s), 770 (s), 730 (s), 716 (m), 684 (s), 669 (m), 660 (s), 621 (m), 519 
(s). UV/VIS max/nm (4.3910
-5 mol dm-3, MeCN) 243 (/ dm3 mol-1 cm-1 38000), 281 (19000), 
317 (11000 sh). EA found: C, 75.09; H, 7.25; N, 10.81%. C33H38N4O20.5H2O requires C, 74.55; H, 
7.39; N, 10.54%. 
 
11-(Diethylamino)undecyl 4'-(pyridin-4-yl)-[2,2':6',2''-terpyridine]-4-carboxylate (L11) 
 
4'-(Pyridin-4-yl)-[2,2':6',2''-terpyridine]-4-carboxylic acid L8 (0.11 g, 0.31 mmol) was refluxed in 
an excess of thionyl chloride (14 mL) under an inert atmosphere for 4 hours, and it became a 
yellow solution. This was cooled to room temperature and thionyl chloride evaporated to give 
4'-(pyridin-4-yl)-[2,2':6',2''-terpyridine]-4-carbonyl chloride as a yellow powder, which was used 
in the next step without further purification and characterization. This was refluxed with 
triethylamine (63 mg, 0.62 mmol) in toluene (9 mL) under an inert atmosphere for 30 minutes 
to give a greenish suspension. Then 11-(diethylamino)undecan-1-ol P16 (0.12 g, 0.47 mmol) 
was added. The reaction mixture turned dark brown and was refluxed for 15 hours. Then 
solvent was removed in vacuo and the brown residue dissolved in chloroform and extracted 
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with an aqueous solution of sodium hydrogencarbonate and then with water. The organic 
phase was dried over sodium sulfate, filtered and evaporated to give a dark brown solid, which 
was purified with column chromatography (SiO2, eluted with EtOAc/MeOH/Et3N = 30:2:1) and 
afforded the product as a pale brown solid (0.11 g, 0.19 mmol, 63%).  
1H NMR (500 MHz, CDCl3, TMS) /ppm 9.17 (dd, J = 1.6, 0.9 Hz, 1H, H
D3), 8.85 (dd, J = 5.0, 0.9 
Hz, 1H, HD6), 8.79 (d, J = 1.7 Hz, 1H, HB3), 8.76 (m, 3H, HB5+C2), 8.72 (ddd, J = 4.8, 1.8, 0.9 Hz, 1H, 
HA6), 8.70 (dt, J = 8.0, 1.1 Hz, 1H, HA3), 7.89 (m, 2H, HA4+D5), 7.78 (dd, J = 4.5, 1.7 Hz, 2H, HC3), 
7.38 (ddd, J = 7.5, 4.7, 1.2 Hz, 1H, HA5), 4.42 (t, J = 6.7 Hz, 2H, H1), 2.53 (q, J = 7.1 Hz, 4H, H13), 
2.40 (m, 2H, H11), 1.83 (m, 2H, H2), 1.50 (m, 2H, H3), 1.39 (m, 4H, H4+10), 1.28 (m, 10H, H5-9), 1.01 
(t, J = 7.2 Hz, 6H, H14). 13C {1H} NMR (126 MHz, CDCl3) /ppm 165.5 (C
C=O), 157.0 (CD2), 156.7 
(CB2), 155.7 (CB6), 155.6 (CA2), 150.7 (CC2), 150.0 (CD6), 149.3 (CA6), 147.7 (CC4), 145.9 (CB4), 139.0 
(CD4), 137.2 (CA4), 124.4 (CA5), 123.2 (CD5), 121.8 (CC3), 121.6 (CA3), 120.9 (CD3), 119.2 (CB5), 118.9 
(CB3), 66.2 (C1), 53.0 (C11), 46.9 (C13), 29.7 (C5-8), 29.4 (C4), 28.8 (C2), 27.8 (C9), 26.9 (C10), 26.2 
(C3), 11.6 (C14). ESI MS (MeOH/CH2Cl2): m/z 580.4 [M+H]
+ (100%, calc. 580.4). IR (solid, /cm-1) 
3060 (w), 2921 (s), 2853 (m), 2798 (w), 1725 (s), 1592 (m), 1584 (s), 1560 (m), 1533 (m), 1470 
(m), 1380 (s), 1324 (w), 1287 (m), 1268 (s), 1217 (s), 1209 (s), 1131 (m), 1096 (w), 987 (w), 896 
(w), 815 (s), 788 (s), 769 (s), 730 (s), 684 (m), 660 (s), 621 (s), 507 (s). UV/VIS max/nm (3.8310
-
5 mol dm-3, MeCN) 242 (/ dm3 mol-1 cm-1 52000), 281 (25000), 316 (15000 sh). EA found: C, 
74.26; H, 7.94; N, 11.89%. C36H45N5O2 requires C, 74.58; H, 7.82; N, 12.08%. 
 
2-(2-(2-Ethoxyethoxy)ethoxy)ethyl 4'-(pyridin-4-yl)-[2,2':6',2''-terpyridine]-4-
carboxylate  (L12) 
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4'-(Pyridin-4-yl)-[2,2':6',2''-terpyridine]-4-carboxylic acid L8 (0.11 g, 0.31 mmol) was refluxed in 
an excess of thionyl chloride (14 mL) under an inert atmosphere for 4 hours, and it became a 
yellow solution. This was cooled to the room temperature and thionyl chloride evaporated to 
give 4'-(pyridin-4-yl)-[2,2':6',2''-terpyridine]-4-carbonyl chloride as a yellow powder, which was 
used in the next step without further purification and characterization. This was refluxed with 
triethylamine (63 mg, 0.62 mmol) in toluene (8 mL) under an inert atmosphere for 30 minutes 
to give a greenish suspension. Then triethylene glycol monoethyl ether (87 mg, 0.47 mmol) was 
added. The reaction mixture turned dark brown and was refluxed for 16 hours. Then solvent 
was removed in vacuo and the brown residue dissolved in chloroform and extracted with an 
aqueous solution of sodium hydrogencarbonate and then with water. The organic phase was 
dried over sodium sulfate, filtered and evaporated to give a dark brown solid, which was 
purified with column chromatography (SiO2, eluted with EtOAc/MeOH/Et3N = 30:2:1) and 
afforded the product as a pale brown solid (87 mg, 0.17 mmol, 54%).  
1H NMR (500 MHz, CDCl3, TMS) /ppm 9.15 (dd, J = 1.6, 0.9 Hz, 1H, H
D3), 8.84 (dd, J = 5.0, 0.9 
Hz, 1H, HD6), 8.77 (d, J = 1.7 Hz, 1H, HB3), 8.76 (dd, J = 4.5, 1.7 Hz, 2H, HC2), 8.74 (d, J = 1.7 Hz, 1H, 
HB5), 8.71 (ddd, J = 4.8, 1.8, 0.9 Hz, 1H, HA6), 8.68 (dt, J = 7.9, 1.1 Hz, 1H, HA3), 7.90 (m, 2H, 
HD5+A4), 7.79 (dd, J = 4.5, 1.7 Hz, 2H, HC3), 7.37 (ddd, J = 7.5, 4.8, 1.2 Hz, 1H, HA5), 4.58 (m, 2H, 
H1), 3.90 (m, 2H, H2), 3.75 (m, 2H, H4), 3.68 (m, 2H, H5), 3.63 (m, 3H, H7), 3.54 (m, 2H, H8), 3.47 
(q, J = 7.0 Hz, 2H, H10), 1.16 (t, J = 7.0 Hz, 3H, H11). 13C {1H} NMR (126 MHz, CDCl3) /ppm 165.4 
(CC=O), 156.9 (CD2), 156.7 (CB2), 155.7 (CB6), 155.5 (CA2), 150.4 (CC2), 150.0 (CD6), 149.3 (CA6), 147.5 
(CC4), 146.2 (CB4), 138.6 (CD4), 137.3 (CA4), 124.4 (CA5), 123.3 (CD5), 121.9 (CC3), 121.6 (CA3), 120.9 
(CD3), 119.2 (CB3), 118.9 (CB5), 70.9 (C4), 70.8 (C5), 70.7 (C7), 69.9 (C8), 69.1 (C2), 66.7 (C10), 65.1 
(C1), 15.2 (C11). ESI MS (MeOH/CHCl3): m/z 553.2 [M+K]
+ (27%, calc. 553.2), 537.3 [M+Na]+ 
(100%, calc. 537.2), 515.3 [M+H]+ (28%, calc. 515.2). IR (solid, /cm-1) 3413 (m), 3059 (w), 2966 
(w), 2860 (m), 1723 (s), 1649 (s), 1583 (s), 1562 (s), 1535 (m), 1470 (m), 1447 (w), 1381 (s), 1348 
(m), 1288 (m), 1268 (s), 1236 (w), 1209 (m), 1100 (s), 1078 (s), 1066 (m), 1033 (m), 945 (w), 815 
(s), 789 (s), 769 (s), 730 (s), 621 (s), 588 (m), 522 (m). UV/VIS max/nm (5.7610
-5 mol dm-3, 
MeCN) 243 (/ dm3 mol-1 cm-1 39000), 283 (31000). EA found: C, 65.51; H, 5.53; N, 11.06%. 
C29H30N4O50.75H2O requires C, 65.40; H, 6.06; N, 10.52%. 
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11-(Piperidin-1-yl)undecyl 4'-(pyridin-4-yl)-[2,2':6',2''-terpyridine]-4-carboxylate (L13) 
 
4'-(Pyridin-4-yl)-[2,2':6',2''-terpyridine]-4-carboxylic acid L8 (0.52 g, 1.47 mmol) was refluxed in 
an excess of thionyl chloride (50 mL) under an inert atmosphere for 3 hours, and it became a 
yellow solution. This was cooled to the room temperature and thionyl chloride evaporated to 
give 4'-(pyridin-4-yl)-[2,2':6',2''-terpyridine]-4-carbonyl chloride as a yellow powder, which was 
used in the next step without further purification and characterization. This was refluxed with 
2,6-lutidine (0.79 g, 7.34 mmol) in toluene (30 mL) under an inert atmosphere for 30 minutes to 
give a greenish suspension. Then 11-(piperidin-1-yl)undecan-1-ol P17 (0.56 g, 2.20 mmol) was 
added. The reaction mixture turned dark brown and was refluxed for 17 hours. Then solvent 
was removed in vacuo and the brown residue dissolved in chloroform and extracted with 
aqueous sodium hydrogencarbonate and then with water. The organic phase was dried over 
sodium sulfate, filtered and evaporated to give a dark brown solid, which was purified with 
column chromatography (SiO2, eluted with EtOAc/MeOH/Et3N = 60:2:1) and afforded the 
product as a pale brown solid (0.45 g, 0.75 mmol, 52%). 
1H NMR (500 MHz, CDCl3, TMS) /ppm 9.13 (s, 1H, H
D3), 8.82 (dd, J = 4.9, 0.9 Hz, 1H, HD6), 8.76 
(d, J = 1.7 Hz, 1H, HB3), 8.74 (dd, J = 4.4, 1.7 Hz, 2H, HC2), 8.72 (d, J = 1.7 Hz, 1H, H B5), 8.70 (m, 
1H, HA6), 8.66 (d, J = 7.9 Hz, 1H, HA3), 7.87 (m, 2H, HA4+D5), 7.75 (dd, J = 4.5, 1.7 Hz, 2H, HC3), 7.35 
(ddd, J = 7.5, 4.8, 1.3 Hz, 1H, HA5), 4.40 (t, J = 6.7 Hz, 2H, H1), 2.36 (m, 4H, H13), 2.26 (m, 2H, H11), 
1.81 (m, 2H, H2), 1.56 (m, 4H, H14), 1.47 (m, 4H, H3+10), 1.38 (m, 4H, H4+15), 1.25 (m, 10H, H5-9). 
13C {1H} NMR (126 MHz, CDCl3) /ppm 165.4 (C
C=O), 156.9 (CD2), 156.6 (CB2), 155.6 (CB6), 155.5 
(CA2), 150.8 (CC2), 150.0 (CD6), 149.3 (CA6), 147.6 (CC4), 145.8 (CB4), 138.9 (CD4), 137.1 (CA4), 124.3 
(CA5), 123.1 (CD5), 121.7 (CC3), 121.5 (CA3), 120.8 (CD3), 119.1 (CB3), 118.8 (CB5), 66.10 (C1), 59.6 
(C11), 54.7 (C13), 29.7 (C5-8), 29.4 (C4), 28.7 (C2), 27.8 (C9), 26.8 (C10), 26.1 (C3), 25.9 (C14), 24.4 
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(C15). MP 90-91 °C. ESI MS (MeOH/CHCl3): m/z 592.4 [M+H]
+ (100%, calc. 592.4). IR (solid, /cm-
1) 3060 (w), 2922 (s), 2851 (m), 1725 (s), 1676 (w), 1592 (m), 1583 (s), 1560 (m), 1533 (m), 1470 
(m), 1380 (s), 1348 (w), 1324 (m), 1287 (m), 1268 (s), 1210 (s), 1127 (m), 1100 (m), 987 (w), 896 
(w), 815 (s), 788 (s), 767 (s), 684 (m), 668 (s), 660 (s), 621 (m), 504 (s). UV/VIS max/nm 
(4.1310-5 mol dm-3, MeCN) 242 (/ dm3 mol-1 cm-1 60000), 281 (29000), 316 (17000 sh). EA 
found: C, 70.95; H, 7.02; N, 11.44%. C37H45N5O21/3CHCl3 requires C, 71.04; H, 7.24; N, 11.10%. 
 
11-Morpholinoundecyl 4'-(pyridin-4-yl)-[2,2':6',2''-terpyridine]-4-carboxylate  (L14) 
 
4'-(Pyridin-4-yl)-[2,2':6',2''-terpyridine]-4-carboxylic acid L8 (0.30 g, 0.85 mmol) was refluxed in 
an excess of thionyl chloride (25 mL) under an inert atmosphere for 3 hours, and it became a 
yellow solution. This was cooled to the room temperature and thionyl chloride evaporated to 
give 4'-(pyridin-4-yl)-[2,2':6',2''-terpyridine]-4-carbonyl chloride as a yellow powder, which was 
used in the next step without further purification and characterization. This was refluxed with 
2,6-lutidine (0.45 g, 4.23 mmol) in toluene (24 mL) under an inert atmosphere for 15 minutes to 
give a greenish suspension. Then 11-morpholinoundecan-1-ol P18 (0.33 g, 1.27 mmol) was 
added. The reaction mixture turned dark brown and was refluxed for 17 hours. Then solvent 
was removed in vacuo and the brown residue dissolved in chloroform and extracted with an 
aqueous solution of sodium hydrogencarbonate and then with water. The organic phase was 
dried over sodium sulfate, filtered and evaporated to give a dark brown solid, which was 
purified with column chromatography (SiO2, eluted with EtOAc/MeOH/Et3N = 60:2:1) and 
afforded the product as a pale brown solid (0.24 g, 0.41 mmol, 45%). 
1H NMR (500 MHz, CDCl3, TMS) /ppm 9.19 (dd, J = 1.6, 0.8 Hz, 1H, H
D3), 8.88 (dd, J = 5.0, 0.9 
Hz, 1H, HD6), 8.82 (d, J = 1.7 Hz, 1H, HB3), 8.79 (m, 3H, HB5+C2), 8.73 (m, 2H, HA3+A6), 7.92 (m, 2H, 
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HA4+D5), 7.80 (dd, J = 4.5, 1.7 Hz, 2H, HC3), 7.40 (ddd, J = 7.5, 4.8, 1.2 Hz, 1H, HA5), 4.44 (t, J = 6.7 
Hz, 2H, H1), 3.72 (br s, 4H, H14), 2.43 (br s, 4H, H13), 2.31 (br s, 2H, H11), 1.85 (m, 2H, H2), 1.50 (m, 
2H, H3), 1.41 (m, 2H, H10), 1.27 (m, 12H, H4-9). 13C {1H} NMR (126 MHz, CDCl3) /ppm /ppm 
165.5 (CC=O), 157.0 (CD2), 156.6 (CB2), 155.6 (CA2+B2), 150.7 (CC2), 150.1 (CD6), 149.3 (CA6), 147.6 
(CB4), 146.0 (CC4), 139.0 (CD4), 137.1 (CA4), 124.4 (CA5), 123.2 (CD5), 121.8 (CC3), 121.5 (CA3), 120.9 
(CD3), 119.1 (CB3), 118.9 (CB5), 66.6 (C14), 66.2 (C1), 59.2 (C11), 53.6 (C13), 29.7, 29.6 (C4-8), 28.9 
(C2), 27.4 (C9), 26.2 (C10), 26.1 (C3). MP 89-90 °C. ESI MS (MeOH/CHCl3): m/z 616.3 [M+Na]
+ 
(12%, calc. 616.3), 594.3 [M+H]+ (100%, calc. 594.3). IR (solid, /cm-1) 3060 (w), 2921 (s), 2852 
(m), 1725 (s), 1660 (m), 1584 (s), 1560 (m), 1533 (m), 1467 (m), 1457 (m), 1380 (s), 1287 (m), 
1268 (s), 1209 (s), 1116 (s), 1100 (m), 987 (w), 896 (w), 860 (s), 814 (m), 788 (s), 767 (s), 730 (s), 
683 (m), 660 (s), 621 (m). UV/VIS max/nm (3.9910
-5 mol dm-3, MeCN) 243 (/ dm3 mol-1 cm-1 
51000), 281 (25000), 316 (15000 sh). EA found: C, 70.67; H, 6.78; N, 11.48%. 
C36H43N5O30.2CHCl3 requires C, 70.40; H, 7.05; N, 11.34%. 
 
3-(Dimethylamino)propyl 4'-(pyridin-4-yl)-[2,2':6',2''-terpyridine]-4-carboxylate 
 (L15) 
 
4'-(Pyridin-4-yl)-[2,2':6',2''-terpyridine]-4-carboxylic acid L8 (0.40 g, 0.85 mmol) was refluxed in 
an excess of thionyl chloride (40 mL) under an inert atmosphere for 3 hours, and it became a 
yellow solution. This was cooled to room temperature and thionyl chloride evaporated to give 
4'-(pyridin-4-yl)-[2,2':6',2''-terpyridine]-4-carbonyl chloride as a yellow powder, which was used 
in the next step without further purification and characterization. This was refluxed with 2,6-
lutidine (0.61 g, 5.64 mmol) in toluene (23 mL) under an inert atmosphere for 30 minutes to 
give a greenish suspension. Then 3-dimethylamino-1-propanol (0.18 g, 1.69 mmol) was added. 
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The reaction mixture turned dark brown and was refluxed for 16 hours. Then solvent was 
removed in vacuo and the brown residue dissolved in chloroform and extracted with an 
aqueous solution of sodium hydrogencarbonate and then with water. The organic phase was 
dried over sodium sulfate, filtered and evaporated to give a dark brown solid, which was 
recrystallized from a mixture of cold ethanol – cyclohexane. This yielded the product as a pale 
brown powder (0.25 g, 0.57 mmol, 51%). 
1H NMR (500 MHz, CDCl3, TMS) /ppm 9.16 (dd, J = 1.6, 0.9 Hz, 1H, H
D3), 8.87 (d, J = 4.9, 0.9 Hz, 
1H, HD6), 8.80 (d, J = 1.7 Hz, 1H, HB3), 8.77 (m, 3H, HC2+B5), 8.73 (ddd, J = 4.8, 1.8, 0.9 Hz, 1H, HA6), 
8.70 (dt, J = 7.9, 1.1 Hz, 1H, HA3), 7.91 (m, 2H, HA4+D5), 7.78 (dd, J = 4.5, 1.7 Hz, 2H, HC3), 7.39 
(ddd, J = 7.5, 4.8, 1.2 Hz, 1H, HA5), 4.51 (t, J = 6.5 Hz, 2H, H1), 2.59 (t, 2H, H3), 2.36 (s, 6H, H5), 
2.08 (m, 2H, H2). 13C {1H} NMR (126 MHz, CDCl3) /ppm 165.4 (C
C=O), 157.0 (CD2), 156.8 (CB2), 
155.7 (CB6), 155.6 (CA2), 150.8 (CC2), 150.1 (CD6), 149.4 (CA6), 147.7 (CC4), 145.9 (CB4), 138.8 (CD4), 
137.2 (CA4), 124.4 (CA5), 123.2 (CD5), 121.8 (CC3), 121.6 (CA3), 120.8 (CD3), 119.2 (CB3), 119.0 (CB5), 
64.2 (C1), 56.2 (C3), 45.3 (C4), 26.7 (C2). MP 118-120 °C (from EtOH-cyclohexane). ESI MS 
(MeOH/CHCl3): m/z 478.1 [M+K]
+ (8%, calc. 478.2), 462.1 [M+Na]+ (4%, calc. 462.2), 440.2 
[M+H]+ (3%, calc. 440.2). IR (solid, /cm-1) 3066 (w), 2957 (w), 2759 (w), 1720 (s), 1583 (m), 
1538 (s), 1532 (m), 1471 (m), 1436 (w), 1380 (s), 1287 (w), 1266 (m), 1209 (m), 1132 (w), 1096 
(w), 1038 (w), 895 (w), 814 (m), 788 (s), 769 (s), 730 (s), 684 (m), 668 (s), 660 (s), 619 (m). 
UV/VIS max/nm (6.0710
-5 mol dm-3, MeCN) 242 (/ dm3 mol-1 cm-1 64000), 281 (33000), 316 
(19000 sh). EA found: C, 65.33; H, 5.25; N, 14.95%. C26H25N5O20.35CHCl3 requires C, 65.76; H, 
5.31; N, 14.55%. 
 
5-(Diethylamino)pentyl 4'-(pyridin-4-yl)-[2,2':6',2''-terpyridine]-4-carboxylate  (L16) 
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4'-(Pyridin-4-yl)-[2,2':6',2''-terpyridine]-4-carboxylic acid L8 (0.20 g, 0.56 mmol) was refluxed in 
an excess of thionyl chloride (15 mL) under an inert atmosphere for 4 hours, and it became a 
yellow solution. This was cooled to the room temperature and thionyl chloride evaporated to 
give 4'-(pyridin-4-yl)-[2,2':6',2''-terpyridine]-4-carbonyl chloride as a yellow powder, which was 
used in the next step without further purification and characterization. This was refluxed with 
2,6-lutidine (0.30 g, 2.82 mmol) in toluene (10 mL) under an inert atmosphere for 20 minutes to 
give a greenish suspension. Then 5-diethylamino-1-pentanol P19 (0.14 g, 0.85 mmol) was 
added. The reaction mixture turned dark brown and was refluxed for 17 hours. Then solvent 
was removed in vacuo and the brown residue dissolved in chloroform and extracted with an 
aqueous solution of sodium hydrogencarbonate and then with water. The organic phase was 
dried over sodium sulfate, filtered and evaporated to give a dark brown solid, which was 
purified with column chromatography (SiO2, eluted with EtOAc/MeOH/Et3N = 60:3:1 and 
30:3:1) and afforded the product as a pale brown solid (0.14 g, 0.29 mmol, 51%). 
1H NMR (500 MHz, CDCl3, TMS) /ppm 9.16 (dd, J = 1.7, 0.9 Hz, 1H, H
D3), 8.84 (dd, J = 5.0, 0.9 
Hz, 1H, HD6), 8.79 (d, J = 1.7 Hz, 1H, HB3), 8.76 (dd, J = 4.4, 1.7 Hz, 2H, HC2), 8.75 (d, J = 1.7 Hz, 1H, 
HB5), 8.72 (m, 1H, HA6), 8.69 (dt, J = 8.0, 1.1 Hz, 1H, HA3), 7.90 (m, 2H, HA4+D5), 7.78 (dd, J = 4.4, 
1.7 Hz, 2H, HC3), 7.37 (ddd, J = 7.5, 4.7, 1.2 Hz, 1H, HA5), 4.43 (t, J = 6.7 Hz, 2H, H1), 2.53 (q, J = 
7.1 Hz, 4H, H7), 2.47 (m, 2H, H5), 1.87 (m, 2H, H2), 1.56 (m, 2H, H4), 1.50 (m, 2H, H3), 1.01 (t, J = 
7.2 Hz, 3H, H8). 13C {1H} NMR (126 MHz, CDCl3) /ppm 165.5 (C
C=O), 157.0 (CD2), 156.7 (CA2), 
155.7 (CB6), 155.6 (CB2), 150.7 (CC2), 150.0 (CD6), 149.3 (CA6), 147.7 (CC4), 145.9 (CB4), 138.9 (CD4), 
137.2 (CA4), 124.4 (CA5), 123.2 (CD5), 121.8 (CC3), 121.6 (CA3), 120.9 (CD3), 119.2 (CB3), 118.9 (CB5), 
66.0 (C1), 52.9 (C5), 47.0 (C7), 28.8 (C2), 26.8 (C4), 24.2 (C3), 11.7 (C8). ESI MS (MeOH/CHCl3): m/z 
534.3 [M+K]+ (4%, calc. 534.3), 518.3 [M+Na]+ (5%, calc. 518.3), 496.3 [M+H]+ (100%, calc. 
496.3). IR (solid, /cm-1) 3060 (w), 2964 (m), 2926 (s), 2860 (m), 2795 (m), 1723 (s), 1592 (m), 
1583 (s), 1560 (m), 1534 (m), 1470 (m), 1434 (m), 1381 (s), 1348 (w), 1324 (w), 1287 (m), 1267 
(s), 1208 (s), 1130 (m), 1095 (m), 1086 (w), 1077 (w), 1067 (w), 987 (w), 968 (w), 896 (w), 814 
(s), 788 (s), 768 (s), 769 (s), 749 (m), 742 (m), 730 (s), 714 (m), 684 (m), 668 (s), 660 (s), 620 (s). 
UV/VIS max/nm (5.3810
-5 mol dm-3, MeCN) 242 (/ dm3 mol-1 cm-1 34000), 281 (17000), 316 
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(10000 sh). EA found: C, 72.38; H, 6.90; N, 13.59%. C30H33N5O2 requires C, 72.70; H, 6.71; N, 
14.13%. 
 
4-(Dodecyloxy)-4'-(pyridin-4-yl)-2,2':6',2''-terpyridine  (L17) 
 
A white suspension of freshly ground potassium hydroxide (122 mg, 2.17 mmol) and dodecanol 
(81 mg, 0.44 mmol) in dimethyl sulfoxide (3 mL) was stirred at 50 °C for 30 minutes. 4-Chloro-
4'-(pyridin-4-yl)-2,2':6',2''-terpyridine L6 (80 mg, 0.22 mmol) was added and the reddish-brown 
suspension was heated at 65 °C for 19 hours. This was cooled to room temperature and cold 
water (10 mL) was added. The fine orange-brown precipitate which formed was collected on a 
filter paper, washed with cold water and air dried to give the product as a brown solid (53 mg, 
0.11 mmol, 49%). 
1H NMR (500 MHz, CDCl3, TMS) /ppm 8.76 (m, 5H, H
A6+B3+B5+C2), 8.67 (d, J = 7.9 Hz, 1H, HA3), 
8.54 (d, J = 5.7 Hz, 1H, HD6), 8.19 (d, J = 2.6 Hz, 1H, HD3), 7.90 (t, J = 7.0 Hz, 1H, HA4), 7.79 (d, J = 
5.3 Hz, 2H, HC3), 7.38 (m, 1H, HA5), 6.89 (d, J = 3.2 Hz, 1H, HD5), 4.17 (t, J = 6.4 Hz, 2H, H1), 1.89 
(m, 2H, H2), 1.55 (m, 2H, H3), 1.29 (m, 16H, H4-11), 0.88 (t, J = 6.5 Hz, 3H, H12). 13C {1H} NMR 
(126 MHz, CDCl3) /ppm 166.4 (C
D4), 157.7(CD2), 156.6 (CB2), 156.4 (CB6), 156.0 (CA2), 150.7 
(CC2+D6), 149.4 (CA6), 147.7 (CB4), 146.2 (CC4), 137.2 (CA4), 124.3 (CA5), 121.8 (CC3), 121.5 (CA3), 
119.1 (CB5), 118.9 (CB3), 110.7 (CD5), 108.1 (CD3), 68.3 (C1), 32.1 (C10), 29.8, 29.7, 29.6 (C5-9), 29.5 
(C4), 28.8 (C2), 26.2 (C3), 22.9 (C11), 14.3 (C12). ESI MS (MeOH/CH2Cl2): m/z 517.3 [M+Na]
+ (100%, 
calc. 517.2), 495.3 [M+H]+ (23%, calc. 495.3). IR (solid, /cm-1) 2915 (s), 2849 (m), 1585 (s), 1567 
(m), 1471 (m), 1386 (m), 1303 (w), 1195 (w), 1092 (m), 1064 (s), 1044 (s), 1023 (s), 1006 (s), 999 
(s), 988 (s), 972 (m), 907 (m), 897 (m), 877 (m), 798 (m), 670 (m), 617 (m), 557 (m). UV/VIS max 
/ nm (3.0310-5 mol dm-3, MeCN) 242 (/ dm3 mol-1 cm-1 55 000), 281 (30 000), 315 (13 000). 
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N,N-Diethyl-11-((4'-(pyridin-4-yl)-[2,2':6',2''-terpyridin]-4-yl)oxy)undecan-1-amine L18) 
 
A white suspension of freshly ground potassium hydroxide (0.33 g, 5.80 mmol) and 
11-(diethylamino)undecan-1-ol P16 (0.28 g, 1.16 mmol) in dimethyl sulfoxide (7 mL) was stirred 
at 50 °C for 30 minutes. 4-Chloro-4'-(pyridin-4-yl)-2,2':6',2''-terpyridine L6 (0.20 g, 0.58 mmol) 
was added and the dark brown suspension was heated at 65 °C for 16 hours. This was cooled to 
room temperature and cold water (10 mL) was added. The fine orange-brown precipitate which 
formed was dissolved in chloroform (100 mL) and thoroughly extracted with water (four times 
100 mL) to remove all dimethyl sulfoxide. The organic phase was dried over sodium sulfate, 
filtered and solvent evaporated to give the product as a brown oil (0.15 g, 0.26 mmol, 46%). 
1H NMR (500 MHz, CDCl3, TMS) /ppm 8.72 (d, J = 1.6 Hz, 2H, H
C2), 8.71 (d, J = 1.7 Hz, 1H, HB3), 
8.70 (d, J = 1.7 Hz, 1H, HB5), 8.69 (ddd, J = 4.8, 1.7, 1.0 Hz, 1H, HA6), 8.62 (dt, J = 7.9, 1.0 Hz, 1H, 
HA3), 8.49 (d, J = 5.6 Hz, 1H, HD6), 8.15 (d, J = 2.5 Hz, 1H, HD3), 7.86 (td, J = 7.6, 1.8 Hz, 1H, HA4), 
7.76 (dd, J = 4.5, 1.7 Hz, 2H, HC3), 7.34 (ddd, J = 7.5, 4.8, 1.2 Hz, 1H, HA5), 6.85 (dd, J = 5.6, 2.6 Hz, 
1H, HD5), 4.13 (t, J = 6.5 Hz, 2H, H1), 2.49 (q, J = 7.2 Hz, 4H, H13), 2.37 (m, 2H, H11), 1.85 (m, 2H, 
H2), 1.40 (m, 2H, H3), 1.39 (m, 2H, H10), 1.25 (m, 12H, H4-9), 0.98 (t, J = 7.2 Hz, 6H, H14). 13C {1H} 
NMR (126 MHz, CDCl3) /ppm 166.3 (C
D4), 157.4 (CD2), 156.3 (CB2+B6), 155.7 (CA2), 150.5 (CC2+D6), 
149.2 (CA6), 147.4 (CB4), 146.0 (CC4), 137.1 (CA4), 124.2 (CA5), 121.8 (CC3), 121.5 (CA3), 118.9 (CB5), 
118.8 (CB3), 110.6 (CD5), 108.0 (CD3), 68.2 (C1), 53.0 (C11), 46.9 (C13), 29.7, 29.6 (C5-7), 29.5 (C8), 
29.4 (C4), 29.1 (C2), 27.8 (C9), 26.8 (C10),26.1 (C3), 11.6 (C14). ESI MS (MeOH/CHCl3): m/z 590.3 
[M+K]+ (32%, calc. 590.4), 574.4 [M+Na]+ (56%, calc. 574.4), 552.4 [M+H]+ (100%, calc. 552.4). IR 
(solid, /cm-1) 2966 (w), 2922 (s), 2852 (m), 2797 (w), 1663 (w), 1583 (s), 1565 (s), 1556 (m), 
1539 (m), 1468 (m), 1383 (s), 1297 (m), 1202 (m), 1125 (w), 1061 (m), 987 (m), 867 (w), 817 
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(m), 790 (s), 659 (m), 618 (s), 502 (m). UV/VIS max / nm (3.0010
-5 mol dm-3, MeCN) 241 (/ 
dm3 mol-1 cm-1 58 000), 281 (27 000), 314 (12 000). 
 
4-((11-(Piperidin-1-yl)undecyl)oxy)-4'-(pyridin-4-yl)-2,2':6',2''-terpyridine  (L19) 
 
A white suspension of freshly ground potassium hydroxide (0.24 g, 4.35 mmol) and 
11-(piperidin-1-yl)undecan-1-ol P17 (0.13 g, 0.52 mmol) in dimethyl sulfoxide (5 mL) was stirred 
at 50 °C for 30 minutes. 4-Chloro-4'-(pyridin-4-yl)-2,2':6',2''-terpyridine L6 (0.15 g, 0.44 mmol) 
was added and the reddish-brown suspension was heated at 65 °C for 18 hours. This was 
cooled to room temperature and cold water (15 mL) was added. The fine orange-brown 
precipitate which formed was dissolved in chloroform (100 mL) and thoroughly extracted with 
water (four times 100 mL) to remove all dimethyl sulfoxide. The organic phase was dried over 
sodium sulfate, filtered and solvent evaporated to give the product as a brown oil (94 mg, 
0.17 mmol, 38%). 
1H NMR (500 MHz, CDCl3, TMS) /ppm 8.75 (dd, J = 1.6, 1.0 Hz, 2H, H
C2), 8.74 (d, J = 1.7 Hz, 1H, 
HB3), 8.73 (d, J = 1.7 Hz, 1H, HB5), 8.72 (ddd, J = 4.8, 1.8, 1.0 Hz, 1H, HA6), 8.65 (dt, J = 8.0, 1.1 Hz, 
1H, HA3), 8.52 (d, J = 5.6 Hz, 1H, HD6), 8.17 (d, J = 2.5 Hz, 1H, HD3), 7.89 (td, J = 7.7, 1.8 Hz, 1H, 
HA4), 7.78 (dd, J = 4.4, 1.7 Hz, 2H, HC3), 7.37 (ddd, J = 7.6, 4.8, 1.2 Hz, 1H, HA5), 6.87 (dd, J = 5.6, 
2.6 Hz, 1H, HD5), 4.15 (t, J = 6.5 Hz, 2H, H1), 2.37 (m, 4H, H13), 2.25 (m, 2H, H11), 1.86 (m, 2H, H2), 
1.56 (m, 4H, H14), 1.48 (m, 4H, H3+10), 1.35 (m, 2H, H15), 1.29 (m, 12H, H4-9). 13C {1H} NMR 
(126 MHz, CDCl3) /ppm 166.4 (C
D4), 157.5 (CD2), 156.4 (CB2+B6), 155.8 (CA2), 150.6 (CC2), 150.6 
(CD6), 149.3 (CA6), 147.5 (CB4), 146.1 (CC4), 137.1 (CA4), 124.3 (CA5), 121.8 (CC3), 121.5 (CA3), 119.0 
(CB5), 118.8 (CB3), 110.6 (CD5), 108.0 (CD3), 68.3 (C1), 59.8 (C11), 54.7 (C13), 29.7, 29.6, 29.5 (C5-8), 
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29.4 (C4), 29.2 (C2), 27.9 (C9), 27.1 (C10), 26.0 (C3), 25.9 (C14), 24.6 (C15). ESI MS (MeOH/CHCl3): 
m/z 602.3 [M+K]+ (15%, calc. 602.3), 586.3 [M+Na]+ (100%, calc. 586.4), 564.4 [M+H]+ (46%, calc. 
564.4). IR (solid, /cm-1) 2923 (s), 2911 (s), 2849 (s), 2812 (w), 2782 (w), 1665 (w), 1582 (s), 
1564 (s), 1537 (m), 1470 (m), 1381 (m), 1299 (m), 1267 (w), 1197 (m), 1057 (m), 1038 (s), 1023 
(s), 1016 (s), 988 (m), 952 (w), 824 (m), 793 (m), 668 (m), 618 (s), 503 (s). UV/VIS max / nm 
(2.4810-5 mol dm-3, MeCN) 243 (/ dm3 mol-1 cm-1 65 000), 281 (37 000), 314 (14 000 sh). 
 
4-(11-((4'-(Pyridin-4-yl)-[2,2':6',2''-terpyridin]-4-yl)oxy)undecyl)morpholine  (L20) 
 
A white suspension of freshly ground potassium hydroxide (0.24 g, 4.35 mmol) and 
11-morpholinoundecan-1-ol P18 (0.13 g, 0.52 mmol) in dimethyl sulfoxide (5 mL) was stirred at 
50 °C for 30 minutes. 4-Chloro-4'-(pyridin-4-yl)-2,2':6',2''-terpyridine L6 (0.15 g, 0.44 mmol) was 
added and the reddish-brown suspension was heated at 65 °C for 18 hours. This was cooled to 
room temperature and cold water (15 mL) was added. The fine orange-brown precipitate which 
formed was dissolved in chloroform (100 mL) and thoroughly extracted with water (four times 
100 mL) to remove all dimethyl sulfoxide. The organic phase was dried over sodium sulfate, 
filtered and solvent evaporated to give the product as a brown oil (0.12 g, 0.21 mmol, 49%). 
1H NMR (500 MHz, CDCl3, TMS) /ppm 8.72 (dd, J = 1.7, 0.8 Hz, 2H, H
C2), 8.71 (d, J = 1.7 Hz, 1H, 
HB3), 8.70 (d, J = 1.7 Hz, 1H, HB5), 8.69 (m, 1H, HA6), 8.62 (dt, J = 8.0, 1.1 Hz, 1H, HA3), 8.49 (d, J = 
5.6 Hz, 1H, HD6), 8.14 (d, J = 2.5 Hz, 1H, HD3), 7.86 (td, J = 7.7, 1.8 Hz, 1H, HA4), 7.76 (dd, J = 4.5, 
1.7 Hz, 2H, HC3), 7.34 (ddd, J = 7.5, 4.8, 1.2 Hz, 1H, HA5), 6.85 (dd, J = 5.7, 2.6 Hz, 1H, HD5), 4.13 (t, 
J = 6.5 Hz, 2H, H1), 3.69 (m, 4H, H14), 2.39 (m, 4H, H13), 2.27 (m, 2H, H11), 1.84 (m, 2H, H2), 1.51 
(m, 2H, H3), 1.44 (m, 2H, H10), 1.27 (m, 12H, H4-9). 13C {1H} NMR (126 MHz, CDCl3) /ppm 166.3 
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(CD4), 157.4 (CD2), 156.3 (CB2+B6), 155.7 (CA2), 150.5 (CC2+D6), 149.2 (CA6), 147.4 (CB4), 146.0 (CB4), 
137.1 (CA4), 124.2 (CA5), 121.8 (CC3), 121.5 (CA3), 118.9 (CB5), 118.8 (CB3), 110.5 (CD5), 108.0 (CD3), 
68.2 (C1), 67.0 (C14), 59.3 (C11), 53.8 (C13), 29.7, 29.6 (C5-8), 29.5 (C4), 29.1 (C2), 27.6 (C9), 26.5 
(C10), 26.1 (C3). ESI MS (MeOH/CHCl3): m/z 604.3 [M+K]
+ (41%, calc. 604.3), 588.4 [M+Na]+ 
(100%, calc. 588.3), 566.4 [M+H]+ (6%, calc. 566.8). IR (solid, /cm-1) 2921 (m), 2911 (s), 2894 
(m), 2849 (m), 2809 (m), 1582 (s), 1560 (m), 1474 (m), 1382 (m), 1299 (m), 1198 (w), 1135 (m), 
1127 (m), 1112 (s), 1076 (m), 1070 (m), 1038 (m), 1031 (m), 1007 (m), 910 (m), 883 (m), 864 (s), 
822 (m), 806 (m), 792 (s), 745 (m), 715 (m), 616 (s). UV/VIS max / nm (5.3010
-5 mol dm-3, 
MeCN) 242 (/ dm3 mol-1 cm-1 48 000), 281 (23 000 sh), 314 (10 000). 
 
N,N-Dimethyl-3-((4'-(pyridin-4-yl)-[2,2':6',2''-terpyridin]-4-yl)oxy)propan-1-amine (L21) 
 
A white suspension of freshly ground potassium hydroxide (0.33 g, 5.80 mmol) and 
3-dimethylamino-1-propanol (0.07 g, 0.70 mmol) in dimethyl sulfoxide (6 mL) was stirred at 
50 °C for 30 minutes. 4-Chloro-4'-(pyridin-4-yl)-2,2':6',2''-terpyridine L6 (0.20 g, 0.58 mmol) was 
added and the dark brown suspension was heated at 60 °C for 12 hours. This was cooled to 
room temperature and cold water (15 mL) was added. The fine orange-brown precipitate which 
formed was dissolved in chloroform (100 mL) and thoroughly extracted with water (four times 
100 mL) to remove all dimethyl sulfoxide. The organic phase was dried over sodium sulfate, 
filtered and solvent evaporated to give the product as a brown oil (93 mg, 0.23 mmol, 39%). 
1H NMR (500 MHz, CDCl3, TMS) /ppm 8.71 (m, 5H, H
C2+B3+B5+A6), 8.63 (dt, J = 8.0, 1.1 Hz, 1H, 
HA3), 8.50 (d, J = 5.6 Hz, 1H, HD6), 8.16 (d, J = 2.6 Hz, 1H, HD3), 7.87 (td, J = 7.7, 1.8 Hz, 1H, HA4), 
7.75 (m, 2H, HC3), 7.35 (ddd, J = 7.5, 4.8, 1.2 Hz, 1H, HA5), 6.87 (dd, J = 5.7, 2.6 Hz, 1H, HA5), 4.21 
(t, J = 6.3 Hz, 2H, H1), 2.53 (t, J = 7.2 Hz, 2H, H3), 2.29 (s, 6H, H5), 2.04 (m, 2H, H2). 13C {1H} NMR 
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(126 MHz, CDCl3) /ppm 166.2 (C
D4), 157.4 (CD2), 156.4 (CB2), 156.3 (CB6), 155.7 (CA2), 150.6 (CC2), 
150.5 (CD6), 149.3 (CA6), 147.4 (CC4), 146.0 (CB4), 137.1 (CA4), 124.2 (CA5), 121.8 (CC3), 121.5 (CA3), 
118.9 (CB5), 118.8 (CB3), 110.6 (CD5), 108.0 (CD3), 66.3 (C1), 56.2 (C3), 45.5 (C4), 27.3 (C2). ESI MS 
(MeOH/CHCl3): m/z 450.1 [M+K]
+ (6%, calc. 450.2), 434.2 [M+Na]+ (47%, calc. 434.2), 412.2 
[M+H]+ (100%, calc. 412.2). IR (solid, /cm-1) 2949 (m), 2858 (w), 2765 (w), 1582 (s), 1560 (s), 
1537 (m), 1448 (m), 1412 (w), 1383 (s), 1352 (w), 1297 (m), 1272 (w), 1258 (w), 1198 (w), 1040 
(m), 1031 (m), 1008 (m), 968 (w), 882 (w), 822 (m), 790 (s), 745 (m), 668 (m), 659 (m), 618 (s). 
UV/VIS max / nm (4.8610
-5 mol dm-3, MeCN) 242 (/ dm3 mol-1 cm-1 28 000), 281 (13 000 sh), 
314 (6 000). 
 
N,N-Diethyl-5-((4'-(pyridin-4-yl)-[2,2':6',2''-terpyridin]-4-yl)oxy)pentan-1-amine (L22) 
 
A white suspension of freshly ground potassium hydroxide (0.33 g, 5.80 mmol) and 
5-diethylamino-1-pentanol P19 (0.19 g, 1.16 mmol) in dimethyl sulfoxide (7 mL) was stirred at 
50 °C for 30 minutes. 4-Chloro-4'-(pyridin-4-yl)-2,2':6',2''-terpyridine L6 (0.20 g, 0.58 mmol) was 
added and the dark brown suspension was heated at 60 °C for 17 hours. This was cooled to 
room temperature and cold water (15 mL) was added. The fine orange-brown precipitate which 
formed was dissolved in chloroform (100 mL) and thoroughly extracted with water (four times 
100 mL) to remove all dimethyl sulfoxide. The organic phase was dried over sodium sulfate, 
filtered and solvent evaporated to give the product as a brown oil (0.14 g, 0.30 mmol, 52%). 
1H NMR (500 MHz, CDCl3, TMS) /ppm 8.72 (m, 3H, H
C2+B3), 8.70 (m, 2H, HA6+B5), 8.63 (dt, J = 8.0, 
1.0 Hz, 1H, HA3), 8.50 (d, J = 5.6 Hz, 1H, HA6), 8.15 (d, J = 2.5 Hz, 1H, HA3), 7.87 (m, 1H, HA4), 7.75 
(dd, J = 4.5, 1.7 Hz, 2H, HC3), 7.34 (ddd, J = 7.5, 4.8, 1.2 Hz, 1H, HA5), 6.85 (dd, J = 5.6, 2.6 Hz, 1H, 
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HD5), 4.14 (t, J = 6.4 Hz, 2H, H1), 2.52 (q, J = 7.1 Hz, 4H, H7), 2.46 (m, 2H, H5), 1.88 (m, 2H, H2), 
1.55 (m, 4H, H3+4), 1.01 (t, J = 7.2 Hz, 3H, H8). 13C {1H} NMR (126 MHz, CDCl3) /ppm 166.3 (C
D4), 
157.4 (CD2), 156.4 (CB2+B6), 155.8 (CA2), 150.6 (CC2), 150.5 (CD6), 149.3 (CA6), 147.4 (CC4), 146.0 
(CB4), 137.1 (CA4), 124.2 (CA5), 121.8 (CC3), 121.5 (CA3), 118.9 (CB5), 118.8 (CB3), 110.6 (CD5), 108.0 
(CD3), 68.1 (C1), 52.9 (C5), 50.0 (C7), 29.1 (C2), 26.5 (C4), 24.2 (C3), 11.7 (C8). ESI MS 
(MeOH/CHCl3): m/z 506.2 [M+K]
+ (5%, calc. 506.2), 490.2 [M+Na]+ (12%, calc. 490.3), 468.3 
[M+H]+ (100%, calc. 468.2). IR (solid, /cm-1) 2964 (w), 2930 (m), 2859 (w), 2794 (w), 1582 (s), 
1564 (s), 1537 (m), 1467 (m), 1448 (w), 1383 (m), 1298 (m), 1265 (w), 1197 (m), 1067 (m), 1040 
(m), 1033 (m), 1025 (m), 988 (m), 884 (w), 864 (s), 823 (m), 793 (s), 744 (m), 618 (s). UV/VIS 
max / nm (8.5510
-5 mol dm-3, MeCN) 244 (/ dm3 mol-1 cm-1 45 000), 281 (25 000 sh), 315 (11 
000). 
 
4'-Phenyl-2,2':6',2''-terpyridine  (L23) 
 
An excess of ammonium acetate (7.36 g, 95.58 mmol) was dissolved in methanol (70 mL). 
Chalcone P11 (1.00 g, 4.78 mmol) and PPI salt P8 (1.83 g, 5.74 mmol) were added and this 
brown suspension was heated at reflux for 19 hours, while all slowly dissolved. Then the 
reaction mixture was cooled to room temperature and placed to the freezer overnight. The pale 
brown precipitate which formed was collected on a glass frit, washed with cold methanol and 
air dried to give the product as a pale brown powder (0.73 g, 2.35 mmol, 49%). The NMR data 
match those published. 8 
1H NMR (400 MHz, CDCl3, TMS) /ppm 8.75 (s, 2H, H
B3), 8.73 (ddd, J = 4.8, 1.9, 1.0 Hz, 2H, HA6), 
8.68 (dt, J = 7.9, 1.1 Hz, 2H, HA3), 7.91 (d, J = 7.9 Hz, 2H, HC2), 7.87 (td, J = 7.8, 1.8 Hz, 2H, HA4), 
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7.52 (m, 2H, HC3), 7.46 (m, 1H, HC4), 7.35 (ddd, J = 7.5, 4.8, 1.2 Hz, 2H, HA5). UV/VIS max/nm 
(4.5510-5 mol dm-3, MeCN) 252 (/dm3 mol-1 cm-1 40000), 276 (37000), 313 (10000 sh). 
 
Methyl 4'-phenyl-[2,2':6',2''-terpyridine]-4-carboxylate  (L24) 
 
An excess of ammonium acetate (9.60 g, 124.68 mmol) was dissolved in methanol (110 mL). 
Chalcone P11 (1.00 g, 4.76 mmol) and PPI salt P5 (2.21 g, 5.71 mmol) were added and the 
brown solution was heated at reflux for 16 hours, during which time a brown precipitate 
formed. Then the reaction mixture was cooled to room temperature and placed to the freezer 
overnight. The brown precipitate was collected on a glass frit, washed with cold methanol and 
air dried to give the product as a pale brown powder (0.56 g, 1.53 mmol, 33%). 
1H NMR (500 MHz, CDCl3, TMS) /ppm 9.16 (dd, J = 1.7, 0.9 Hz, 1H, H
D3), 8.86 (dd, J = 5.0, 0.9 
Hz, 1H, HD6), 8.78 (d, J = 1.7 Hz, 1H, HB3), 8.75 (d, J = 1.7 Hz, 1H, HB5), 8.74 (ddd, J = 4.7, 1.9, 1.0 
Hz, 1H, HA6), 8.72 (dt, J = 7.9, 1.1 Hz, 1H, HA3), 7.90 (m, 4H, HA4+C2+D5), 7.52 (m, 2H, HC3), 7.47 (m, 
1H, HC4),7.37 (ddd, J = 7.5, 4.8, 1.2 Hz, 1H, HA5), 4.04 (s, 3H, HMe). 13C {1H} NMR (126 MHz, CDCl3) 
/ppm 166.1 (CC=O), 157.6 (CD2), 156.2 (CA2), 156.1 (CB2), 155.3 (CB6), 150.6 (CB4), 150.0 (CD6), 
149.2 (CA6), 138.5 (CC1), 138.4 (CD4), 137.2 (CA4), 129.3 (CC4), 129.1 (CC3,5), 127.5 (CC2,6), 124.1 
(CA5), 122.9 (CD5), 121.7 (CA3), 120.8 (CD3), 119.5 (CB5), 119.3 (CB3), 52.9 (CMe). MP 197-198 °C 
(from MeOH). ESI MS (MeOH/CHCl3): m/z 390.0 [M+Na]
+ (24%, calc. 390.1), 368.0 [M+H]+ 
(100%, calc. 368.1). IR (solid, /cm-1) 3051 (w), 2969 (w), 1723 (s), 1583 (m), 1548 (m), 1467 (w), 
1432 (m), 1378 (s), 1268 (s), 1218 (s), 1132 (w), 1099 (w), 989 (m), 887 (w), 800 (m), 775 (m), 
764 (s), 754 (s), 731 (s), 707 (s), 694 (s), 681 (s), 662 (s), 620 (s), 517 (s). UV/VIS max/nm 
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(4.4410-5 mol dm-3, MeCN) 253 (/dm3 mol-1 cm-1 35000), 276 (27000 sh), 310 (13000 sh). EA 
found: C, 74.41; H, 4.67; N, 11.22%. C23H17N3O20.25H2O requires C, 74.28; H, 4.74; N, 11.30%. 
 
4'-Phenyl-[2,2':6',2''-terpyridine]-4-carboxylic acid  (L25) 
 
Methyl 4'-phenyl-[2,2':6',2''-terpyridine]-4-carboxylate L24 (0.30 g, 0.82 mmol) was suspended 
in hot methanol (6 mL). Then aqueous solution of sodium hydroxide (1M, 1.63 mL, 1.63 mmol) 
was added and the reaction mixture was heated to reflux for 18 hours, while the greenish 
suspension dissolved and turned to a brown solution. This was cooled to room temperature 
and acidified with hydrochloric acid (0.5M) to pH4. The off-white precipitate which formed 
was collected on a glass frit, washed thoroughly with water and air dried to give the product as 
a grey powder (0.28 g, 0.80 mmol, 98%). 
1H NMR (500 MHz, DMSO-d6) /ppm 13.87 (br s, 1H, OH), 9.03 (dd, J = 1.6, 0.8 Hz, 1H, H
D3), 8.95 
(dd, J = 4.9, 0.8 Hz, 1H, HD6), 8.79 (ddd, J = 4.8, 1.7, 0.9 Hz, 1H, HA6), 8.75 (s, 2H, HB3+B5), 8.62 (d, J 
= 7.9 Hz, 1H, HA3), 8.13 (td, J = 7.7, 1.8 Hz, 1H, HA4), 7.95 (m, 3H, HC2+D5), 7.61 (m, 2H, HC3), 7.57 
(m, 2H, HA5+C4). 13C {1H} NMR (126 MHz, DMSO-d6) /ppm 168.7 (C
D4), 156.0 (CB2), 155.4 (CB6), 
154.9 (CA2), 154.5 (CD2), 150.7 (CD6), 150.2 (CB4), 149.2 (CA6), 138.2 (CA4), 137.8 (CC1), 129.7 (CC4), 
129.5 (CC3), 127.0 (CC2), 124.8 (CA5), 123.5 (CD5), 121.0 (CA3), 119.7 (CD3), 119.7 (CB5), 118.4 (CB3). 
MP 321-322 °C. MALDI TOF MS: m/z 353.8 [M]+ (93%, calc. 353.1), 309.8 [M-CO2]
+ (100%, calc. 
309.2). IR (solid, /cm-1) 3061 (w), 2378 (m), 1708 (s), 1591 (m), 1549 (m), 1464 (w), 1381 (s), 
1346 (w), 1296 (m), 1282 (m), 1268 (s), 1255 (m), 1217 (m), 1206 (m), 1076 (w), 1010 (w), 989 
(w), 882 (m), 863 (m), 830 (w), 758 (m), 752 (m), 744 (m), 732(m), 702 (m), 688 (m), 662 (m), 
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619 (m). EA found: C, 71.53; H, 4.34; N, 11.53%. C33H39N3OH2O requires C, 71.15; H, 4.61; N, 
11.31%. 
 
Dodecyl 4'-phenyl-[2,2':6',2''-terpyridine]-4-carboxylate  (L26) 
 
4'-Phenyl-[2,2':6',2''-terpyridine]-4-carboxylic acid L25 (0.15 g, 0.41 mmol) was refluxed in an 
excess of thionyl chloride (13 mL) under an inert atmosphere for 4 hours, and it became a 
yellow solution. This was cooled to room temperature and thionyl chloride evaporated to give 
4'-phenyl-[2,2':6',2''-terpyridine]-4-carbonyl chloride as a yellow powder, which was used in the 
next step without further purification and characterization. This was refluxed with 2,6-lutidine 
(0.22 g, 2.07 mmol) in toluene (12 mL) under an inert atmosphere for 20 minutes to give a 
greenish suspension. Then dodecanol (0.15 g, 0.83 mmol) was added. The reaction mixture 
turned dark brown and was refluxed for 17 hours. Then solvent was removed in vacuo and the 
brown residue dissolved in chloroform and extracted with an aqueous solution of sodium 
hydrogencarbonate and then with water. The organic phase was dried over sodium sulfate, 
filtered and evaporated to give a dark brown solid, which was recrystallized from a mixture of 
cold ethanol - diethyl ether to afford the product as a pale brown powder (0.17 g, 0.32 mmol, 
78%). 
1H NMR (500 MHz, CDCl3, TMS) /ppm 9.18 (br s, 1H, H
D3), 8.86 (dd, J = 4.9, 0.9 Hz, 1H, HD6), 
8.78 (d, J = 1.7 Hz, 1H, HB3), 8.75 (d, J = 1.7 Hz, 1H, HB5), 8.72 (m, 2H, HA6+A3), 7.90 (m, 4H, 
HA4+C2+D5), 7.52 (m, 2H, HC3), 7.46 (m, 1H, HC4),7.36 (ddd, J = 7.5, 4.8, 1.3 Hz, 1H, HA5), 4.43 (t, J = 
6.6 Hz, 2H, H1), 1.84 (m, 2H, H2), 1.51 (m, 2H, H3), 1.40 (m, 2H, H4), 1.28 (m, 14H, H5-11), 0.87 (t, J 
= 6.9 Hz, 3H, H12). 13C {1H} NMR (126 MHz, CDCl3) /ppm 165.6 (C
C=O), 157.5 (CD2), 156.2 (CA2), 
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156.1 (CB2), 155.3 (CB6), 150.6 (CB4), 150.0 (CD6), 149.3 (CA6), 138.9 (C D4), 138.5 (CC1), 137.1 (CA4), 
129.2 (CC4), 129.1 (CC3), 127.5 (CC2), 124.1 (CA5), 122.9 (CD5), 121.6 (CA3), 120.9 (CD3), 119.4 (CB5), 
119.2 (CB3), 66.1 (C1), 32.0 (C10), 29.8, 29.7, 29.5 (C5-9), 29.5 (C4), 28.8 (C2), 26.2 (C3),22.8 (C11), 
14.3 (C12). MP 79 °C (from EtOH-Et2O). ESI MS (MeOH/CHCl3): m/z 544.2 [M+Na]
+ (100%, calc. 
544.3), 522.2 [M+H]+ (66%, calc. 522.3). IR (solid, /cm-1) 2916 (s), 2850 (m), 1733 (s), 1583 (s), 
1551 (m), 1466 (m), 1431 (m), 1379 (s), 1282 (m), 1270 (s), 1217 (s), 1136 (w), 1105 (m), 995 
(w), 893 (s), 856 (m), 797 (s), 761 (s), 745 (s), 734 (s), 709 (s), 692 (m), 682 (m), 663 (s), 620 (s). 
UV/VIS max/nm (4.2610
-5 mol dm-3, MeCN) 254 (/dm3 mol-1 cm-1 26000), 280 (19000), 310 
(9000 sh). EA found: C, 78.90; H, 7.61; N, 8.36%. C34H39N3O2 requires C, 78.28; H, 7.54; N, 
8.05%. 
 
11-(Diethylamino)undecyl 4'-phenyl-[2,2':6',2''-terpyridine]-4-carboxylate  (L27) 
 
4'-Phenyl-[2,2':6',2''-terpyridine]-4-carboxylic acid L25 (0.18 g, 0.50 mmol) was refluxed in an 
excess of thionyl chloride (12 mL) under an inert atmosphere for 4 hours, and it became a 
yellow solution. This was cooled to room temperature and thionyl chloride evaporated to give 
4'-phenyl-[2,2':6',2''-terpyridine]-4-carbonyl chloride as a yellow powder, which was used in the 
next step without further purification and characterization. This was refluxed with 2,6-lutidine 
(0.27 g, 2.49 mmol) in toluene (13 mL) under an inert atmosphere for 30 minutes to give a 
greenish suspension. Then 11-(diethylamino)undecan-1-ol P16 (0.24 g, 1.00 mmol) was added. 
The reaction mixture turned dark brown and was refluxed for 16 hours. Then solvent was 
removed in vacuo and the brown residue dissolved in chloroform and extracted with an 
aqueous solution of sodium hydrogencarbonate and then with water. The organic phase was 
dried over sodium sulfate, filtered and evaporated to give a dark brown solid, which was 
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purified with column chromatography (SiO2, eluted with EtOAc/Et3N = 99:1) and afforded the 
product as a yellow oil (0.16 g, 0.28 mmol, 57%). 
1H NMR (500 MHz, CDCl3, TMS) /ppm 9.18 (dd, J = 1.7, 0.9 Hz, 1H, H
D3), 8.85 (dd, J = 4.9, 0.9 
Hz, 1H, HD6), 8.78 (d, J = 1.7 Hz, 1H, HB3), 8.75 (d, J = 1.7 Hz, 1H, HB5), 8.72 (m, 2H, HA3+A6), 7.89 
(m, 4H, HA4+C2+D5), 7.51 (m, 2H, HC3), 7.45 (m, 1H, HC4), 7.36 (ddd, J = 7.5, 4.7, 1.2 Hz, 1H, HA5), 
4.42 (t, J = 6.7 Hz, 2H, H1), 2.51 (m, 4H, H13), 2.39 (dd, J = 8.9, 6.7 Hz, 2H, H11), 1.84 (m, 2H, H2), 
1.50 (m, 2H, H3), 1.41 (m, 4H, H4+10), 1.23 (m, 10H, H5-9), 1.01 (t, J = 7.2 Hz, 6H, H14). 13C {1H} 
NMR (126 MHz, CDCl3) /ppm 165.6 (C
C=O), 157.5 (CD2), 156.2 (CB2), 156.1 (CA2), 155.3 (CB6), 
150.6 (CB4), 150.0 (CD6), 149.3 (CA6), 138.9 (C D4), 138.5 (CC1), 137.1 (CA4), 129.2 (CC4), 129.1 (CC3), 
127.4 (CC2), 124.0 (CA5), 122.9 (CD5), 121.6 (CA3), 120.9 (CD3), 119.4 (CB3), 119.2 (CB5), 66.1 (C1), 
53.1 (C11), 47.0 (C13), 29.8, 29.7 (C5-8), 29.4 (C4), 28.8 (C2), 27.8 (C9), 27.0 (C10),26.2 (C3), 11.7 
(C14). ESI MS (MeOH/CHCl3): m/z 601.2 [M+Na]
+ (4%, calc. 601.4), 579.2 [M+H]+ (100%, calc. 
579.4). IR (solid, /cm-1) 2965 (w), 2919 (s), 2851 (m), 2792 (w), 1721 (s), 1584 (m), 1550 (m), 
1466 (m), 1430 (m), 1379 (s), 1345 (w), 1283 (s), 1266 (s), 1214 (s), 1133 (m), 1101 (m), 1077 
(m), 891 (m), 796 (m), 763 (s), 751 (s), 745 (s), 731 (s), 709 (s), 699 (s), 682 (s), 663 (s), 621 (s). 
UV/VIS max/nm (3.9710
-5 mol dm-3, MeCN) 254 (/dm3 mol-1 cm-1 32000), 280 (24000 sh), 313 
(12000 sh). EA found: C, 75.52; H, 8.15; N, 9.29%. C37H46N4O20.5H2O requires C, 75.60; H, 8.06; 
N, 9.53%. 
 
4-Chloro-4'-phenyl-2,2':6',2''-terpyridine  (L28) 
 
An excess of ammonium acetate (4.09 g, 53.16 mmol) was dissolved in methanol (30 mL). 
Chalcone P11 (0.48 g, 2.31 mmol) and PPI salt P6 (1.00 g, 2.77 mmol) were added and this 
brown suspension was heated at reflux for 23 hours, while all slowly dissolved. Then the 
220 
 
reaction mixture was cooled to room temperature and placed to the freezer overnight. The pale 
brown precipitate which formed was collected on a glass frit, washed with cold methanol and 
diethyl ether, and air dried to give the product as a pale brown powder (0.30 g, 0.87 mmol, 
37%). 
1H NMR (500 MHz, CDCl3, TMS) /ppm 8.77 (d, J = 1.7 Hz, 1H, H
B3), 8.74 (m, 2H, HA6+B5), 8.67 (m, 
2H, HD3+A3), 8.60 (d, J = 5.2 Hz, 1H, HD6), 7.90 (m, 3H, HA4+C2+C6), 7.51 (m, 2H, HC3+C5), 7.47 (m, 1H, 
HC4),7.36 (m, 2H, HA5+D5). 13C {1H} NMR (126 MHz, CDCl3) /ppm 157.9 (C
D2), 156.2 (CA2), 156.1 
(CB2), 154.7 (CB6), 150.6 (CB4), 150.1 (CD6), 149.3 (CA6), 145.2 (CD4), 138.4 (CC1), 137.1 (CA4), 129.3 
(CC4), 129.1 (CC3,5), 127.5 (CC2,6), 124.1 (CA5, D5), 121.8 (CD3), 121.5 (CA3), 119.6 (CB3), 119.3 (CB5). 
MP 161-162 °C (from MeOH). ESI MS (MeOH/CHCl3): m/z 383.1 [M+K]
+ (19%, calc. 382.1), 366.1 
[M+Na]+ (100%, calc. 366.1), 344.1 [M+H]+ (57%, calc. 344.1). IR (solid, /cm-1) 3056 (w), 2914 
(w), 2853 (w), 1582 (m), 1566 (m), 1549 (m), 1464 (m), 1373 (m), 1341 (w), 1074 (w), 887 (m), 
873 (w), 831 (m), 796 (m), 764 (s), 730 (s), 684 (m), 662 (m), 619 (s), 565 (s), 557 (m). UV/VIS 
max/nm (3.8810
-5 mol dm-3, MeCN) 254 (/dm3 mol-1 cm-1 35000), 276 (32000), 313 (8000 sh). 
EA found: C, 70.54; H, 4.06; N, 12.08%. C21H14ClN30.75H2O requires C, 70.59; H, 4.37; N, 
11.76%. 
 
4-(Dodecyloxy)-4'-phenyl-2,2':6',2''-terpyridine  (L29) 
 
A white suspension of freshly ground potassium hydroxide (78 mg, 1.40 mmol) and dodecanol 
(52 mg, 0.28 mmol) in dimethyl sulfoxide (2 mL) was stirred at 50 °C for 15 minutes. 4-Chloro-
4'-phenyl-2,2':6',2''-terpyridine L28 (48 mg, 0.14 mmol) was added and the reddish-brown 
suspension was heated at 60 °C for 16 hours. This was cooled to room temperature and cold 
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water (10 mL) was added. The fine orange-brown precipitate which formed was dissolved in 
chloroform (100 mL) and thoroughly extracted with water (four times 100 mL) to remove all 
dimethyl sulfoxide. The organic phase was dried over sodium sulfate, filtered and solvent 
evaporated to give the product as a brown solid (46 mg, 0.09 mmol, 66%). 
1H NMR (500 MHz, CDCl3, TMS) /ppm 8.67 (d, J = 1.8 Hz, 1H, H
B5), 8.66 (m, 2H, HA6+B3), 8.59 (dt, 
J = 7.9, 1.1 Hz, 1H, HA3), 8.46 (d, J = 5.6 Hz, 1H, HD6), 8.12 (d, J = 2.5 Hz, 1H, HD3), 7.83 (m, 3H, 
HA4+C2), 7.45 (m, 2H, HC3), 7.39 (m, 1H, HC4), 7.29 (ddd, J = 7.5, 4.8, 1.2 Hz, 1H, HA5), 6.80 (dd, J = 
5.6, 2.6 Hz, 1H, HD5), 4.09 (t, J = 6.5 Hz, 2H, H1), 1.80 (m, 2H, H2), 1.47 (m, 2H, H3), 1.25 (m, 16H, 
H4-11), 0.87 (t, J = 6.9 Hz, 3H, H12). 13C {1H} NMR (126 MHz, CDCl3) /ppm 166.1 (C
 D4), 157.8 
(CD2), 156.1 (CA2), 155.8 (CB2+B6), 150.3 (C D6), 150.2 (CB4), 149.1 (CA6), 138.4 (CC1), 136.9 (CA4), 
129.0 (CC4), 128.9 (CC3), 127.3 (CC2), 123.8 (CA5), 121.3 (CA3), 119.0 (CB3), 118.9 (CB5), 110.3 (CD5), 
107.7 (CD3), 68.1 (C1), 31.9 (C10), 29.7, 29.6, 29.5 (C6-9), 29.5 (C4), 29.3 (C5), 29.0 (C2), 26.0 
(C3),22.7 (C11), 14.1 (C12). ESI MS (MeOH/CHCl3): m/z 516.3 [M+Na]
+ (34%, calc. 516.3), 494.4 
[M+H]+ (100%, calc. 494.3). IR (solid, /cm-1) 3063 (w), 2918 (s), 2848 (m), 1584 (s), 1562 (s), 
1551 (m), 1467 (m), 1453 (m), 1382 (m), 1297 (s), 1195 (m), 1115 (w), 1029 (s), 1004 (m), 880 
(m), 797 (s), 765 (s), 756 (s), 733 (m), 722 (m), 698 (s), 688 (s), 661 (m), 619 (s). UV/VIS max / 
nm (4.0510-5 mol dm-3, MeCN) 255 (/ dm3 mol-1 cm-1 75 000), 278 (63 000 sh), 309 (20 000). 
 
N,N-Diethyl-11-((4'-phenyl-[2,2':6',2''-terpyridin]-4-yl)oxy)undecan-1-amine  (L30) 
 
A white suspension of freshly ground potassium hydroxide (0.16 g, 2.91 mmol) and 
11-(diethylamino)undecan-1-ol P16 (0.14 g, 0.58 mmol) in dimethyl sulfoxide (7 mL) was stirred 
at 50 °C for 15 minutes. 4-Chloro-4'-phenyl-2,2':6',2''-terpyridine L28 (0.10 g, 0.29 mmol) was 
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added and the reddish-brown suspension was heated at 65 °C for 16 hours. This was cooled to 
room temperature and cold water (10 mL) was added. The fine orange-brown precipitate, 
which formed, was dissolved in chloroform (100 mL) and thoroughly extracted with water (four 
times 100 mL) to remove all dimethyl sulfoxide. The organic phase was dried over sodium 
sulfate, filtered and solvent evaporated to give the product as a brown solid (39 mg, 0.07 mmol, 
25%). 
1H NMR (500 MHz, CDCl3, TMS) /ppm 8.59 (d, J = 2.0 Hz, 1H, H
B3), 8.56 (m, 2H, HB5+A6), 8.51 (dt, 
J = 7.8, 1.1 Hz, 1H, HA3), 8.39 (d, J = 5.6 Hz, 1H, HD6), 8.04 (d, J = 2.5 Hz, 1H, HD3), 7.76 (m, 3H, 
HA4+C2), 7.36 (m, 2H, HC3), 7.33 (m, 1H, HC4), 7.23 (m, 1H, HA5), 6.74 (dd, J = 5.6, 2.5 Hz, 1H, HD5), 
4.02 (t, J = 6.5 Hz, 2H, H1), 2.39 (q, J = 7.1, 4H, H13), 2.27 (m, 2H, H11), 1.74 (m, 2H, H2), 1.40 (m, 
2H, H3), 1.30 (m, 2H, H10), 1.16 (m, 12H, H4-9), 0.89 (t, J = 7.2, 6H, H14). 13C {1H} NMR (126 MHz, 
CDCl3) /ppm 166.0 (C
 D4), 157.6 (CD2), 155.9 (CA2), 155.6 (CB2+B6), 150.2 (C D6), 149.9 (CB4), 148.9 
(CA6), 138.1 (CC1), 136.7 (CA4), 129.0 (CC4), 128.7 (CC3), 127.1 (CC2), 123.7 (CA5), 121.2 (CA3), 118.9 
(CB5), 118.7 (CB3), 110.1 (CD5), 107.6 (CD3), 67.9 (C1), 52.7 (C11), 46.5 (C13), 29.4, 29.3 (C5-8), 29.3 
(C4), 28.8 (C2), 27.5 (C9), 26.5 (C10),25.8 (C3), 11.3 (C14). ESI MS (MeOH/CHCl3): m/z 589.2 [M+K]
+ 
(7%, calc. 589.3), 573.2 [M+Na]+ (23%, calc. 573.4), 551.2 [M+H]+ (100%, calc. 551.4). IR (solid, 
/cm-1) 2921 (s), 2852 (m), 1583 (s), 1565 (m), 1551 (m), 1466 (m), 1455 (m), 1383 (m), 1298 
(m), 1196 (w), 1059 (m), 1043 (m), 989 (m), 884 (w), 794 (m), 766 (m), 694 (m), 620 (s). UV/VIS 
max / nm (3.6310
-5 mol dm-3, MeCN) 255 (/ dm3 mol-1 cm-1 71 000), 278 (53 000 sh), 312 (17 
000 sh). 
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Complexes 
 
 
[Ru(L1)]Cl3 (C1) 
 
2,2':6',2''-Terpyridine L1 (0.59 g, 2.53 mmol) and RuCl33H2O (0.66 g, 2.53 mmol) were 
suspended in ethanol (250 mL). The black reaction mixture was heated to reflux for 3.5 hours, 
while all reactants dissolved. The brown solid which formed was filtered off, washed with 
ethanol and diethyl ether and air dried to give a dark brown powder (1.0 g, 2.23 mmol, 90%). 
The product was submitted for the next step without further purification and characterization. 
 
[Ru(L3)]Cl3 (C2) 
 
Terpyridine L3 (0.60 g, 1.94 mmol) and RuCl33H2O (0.51 g, 1.94 mmol) were suspended in 
ethanol (200 mL). The black reaction mixture was heated to reflux for 3.5 hours, while all 
reactants dissolved. The black solid which formed was filtered off, washed with ethanol and 
diethyl ether and air dried to give a black powder (0.91 g, 1.76 mmol, 91%). The product was 
submitted for the next step without further purification and characterization. 
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[Ru(L2)(L1)][PF6]2 (C3) 
 
The ligand L2 (0.20 g, 0.54 mmol) and the Ru(III) complex C1 (0.24 g, 0.54 mmol) were 
suspended in ethylene glycol (20 mL) in a 50mL round bottomed flask and this dark brown 
suspension was treated in a domestic microwave oven at the highest setting for 2 minutes. The 
resulting dark red solution was poured into 250 mL of aqueous ammonium 
hexafluorophosphate to give a fine red precipitate, which was collected on Celite® and washed 
with cold water (500 mL), cold ethanol (20 mL) and diethyl ether (20 mL). The residue was 
redissolved in acetonitrile and solvent removed in vacuo to give a dark red solid, which was 
purified by column chromatography (SiO2, eluted with MeCN/saturated aqueous KNO3/H2O = 
10:1.5:0.5). The first red band was collected, aqueous ammonium hexafluorophosphate added 
and solvent evaporated until a red precipitate formed. This was collected on Celite® and 
washed thoroughly with cold water (500 mL), cold ethanol (15 mL) and diethyl ether (10 mL). 
The red residue was redissolved in acetonitrile and solvent removed in vacuo to give the 
product as a dark red powder (0.37 g, 0.37 mmol, 69%). 
1H NMR (500 MHz, CD3CN) δ/ppm 9.21 (s, 1H, H
B5), 9.14 (s, 1H, HD3), 9.10 (s, 1H, HB3), 8.93 (d, J 
= 5.2 Hz, 2H, HC2), 8.81 (d, J = 8.1 Hz, 2H, HF3), 8.72 (d, J = 8.2 Hz, 1H, HA3), 8.54 (d, J = 8.1 Hz, 2H, 
HE3), 8.48 (t, J = 8.1 Hz, 1H, HF4), 8.18 (d, J = 5.0 Hz, 2H, HC3), 8.00 (t, J = 8.0 Hz, 1H, HA4), 7.95 (t, J 
= 7.8 Hz, 2H, HE4), 7.62 (m, 2H, HD5+D6), 7.43 (d, J = 5.4 Hz, 3H, HA6+E6), 7.24 (m, 1H, HA5), 7.19 (m, 
2H, HE5), 3.93 (s, 3H, HMe). 13C {1H} NMR (101 MHz, CD3CN) /ppm 164.8 (C
C=O), 160.2 (CD2), 
158.9 (CE2), 158.8 (CA2), 157.0 (CB2), 156.5 (CB6), 156.1 (CF2), 154.5 (CD6), 153.6 (CE6), 153.5 (CA6), 
152.0 (CC2), 146.4 (CB4), 145.0 (CC4), 139.6 (CA4), 139.4 (CD4+E4), 137.5 (CF4), 128.8 (CA5), 128.5 
(CE5), 127.3 (CD5), 125.8 (CA3), 125.6 (CE3), 124.9 (CF3), 124.5 (CD3), 123.3 (CB5), 123.1 (CB3+C3), 54.0 
(CMe). ESI MS (MeCN): m/z 848.1 [M-PF6]
+ (100%, calc. 848.1), 351.5 [M-2PF6]
2+ (94%, 351.6). IR 
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(solid, /cm-1) 3060 (w), 1731 (m), 1599 (m), 1448 (m), 1441 (w), 1406 (w), 1389 (w), 1311 (m), 
1266 (m), 1246 (w), 1240 (w), 1120 (w), 1029 (w), 878 (w), 830 (s), 827 (s), 822 (s), 816 (s), 800 
(m), 785 (m), 760 (m), 751 (m), 739 (m), 726 (m), 705 (w), 690 (w), 645 (w), 638 (w), 601 (w). EA 
found: C, 44.45; H, 3.12; N, 10.31%. C37H27F12N7O2P2Ru requires C, 44.77; H, 2.74; N, 9.88%. 
UV/VIS max/nm (3.02 x 10
-5mol dm-3, MeCN) 271 (/dm3 mol-1 cm-1 58000), 286 (54000), 306 
(62000), 327 (50000, sh), 488 (21000). Luminescence (MeCN, 3.02 x 10-5mol dm-3, λex = 488 
nm): λem = 665 nm.  
 
[Ru(L10)(L1)][PF6]2 (C4) 
 
The ruthenium(II) complex C3 (0.20 g, 0.20 mmol) was dissolved in N,N-dimethylformamide 
(2.5 mL). Dodecanol (0.19 g, 1.01 mmol) and a catalytic amount of p-toluenesulfonic acid 
monohydrate (3.8 mg, 0.02 mmol) were added. The red reaction mixture was heated at reflux 
for 21 hours and the formation of the product was monitored by thin layer chromatography 
(SiO2, eluted with MeCN/saturated aqueous KNO3/H2O = 10:1.5:0.5). Solvent was removed in 
vacuo and the crude product was purified by flash column chromatography (SiO2, eluted with 
MeCN/saturated aqueous KNO3/H2O = 10:1.5:0.5). The first red band was collected, aqueous 
ammonium hexafluorophosphate added and solvent evaporated until a red precipitate formed. 
This was collected on Celite® and washed thoroughly with cold water (250 mL) and diethyl 
ether (10 mL). The red residue was redissolved in acetonitrile and solvent removed in vacuo to 
give the product as a dark red powder (76 mg, 0.07 mmol, 33%). 
1H NMR (400 MHz, CD3CN) δ/ppm 9.19 (s, 1H, H
B5), 9.07 (m, 2H, HB3+D3), 8.97 (d, J = 3.7 Hz, 2H, 
HC2), 8.77 (d, J = 8.2 Hz, 2H, HF3), 8.67 (d, J = 8.1 Hz, 1H, HA3), 8.50 (d, J = 8.1 Hz, 2H, HE3), 8.46 (t, 
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J = 8.2 Hz, 1H, HF3), 8.18 (d, J = 3.9 Hz, 2H, HC3), 7.98 (td, J = 8.0, 1.4 Hz, 1H, HA4), 7.93 (td, J = 8.0, 
1.4 Hz, 2H, HE4), 7.59 (dd, J = 5.8, 1.6 Hz, 1H, HD5), 7.55 (d, J = 5.8 Hz, 1H, HD6), 7.38 (m, 3H, 
HA6+E6), 7.21 (m, 1H, HA5), 7.16 (ddd, J = 7.0, 5.6, 1.2 Hz, 2H, HE5), 4.33 (t, J = 6.7 Hz, 2H, H1), 1.73 
(m, 2H, H2), 1.30 (m, 18H, H3-11), 0.86 (t, J = 6.9 Hz, 3H, H12). MALDI TOF MS: m/z 1170.4 [M-
Na]+ (100%, calc. 1170.2), 1025.4 [M-PF6+Na]
+ (77%, 1025.3). UV/VIS max/nm (3.49 x 10
-5mol 
dm-3, MeCN) 272 (/dm3 mol-1 cm-1 51000), 281 (48000), 306 (54000), 326 (45000, sh), 488 
(19000). Luminescence (MeCN, 3.49 x 10-5mol dm-3, λex = 488 nm): λem = 664 nm.  
 
[Ru(HL11)(L1)][PF6]3 (C5) 
 
The ruthenium(II) complex C3 (0.15 g, 0.15 mmol) was dissolved in N,N-dimethylformamide 
(2 mL). 11-(Diethylamino)undecan-1-ol P16 (0.37 g, 1.51 mmol) and a catalytic amount of p-
toluenesulfonic acid monohydrate (3.0 mg, 0.015 mmol) were added. The red reaction mixture 
was heated at reflux for 23 hours and the formation of the product was monitored by thin layer 
chromatography (SiO2, eluted with MeCN/saturated aqueous KNO3/H2O = 10:1.5:0.5). Solvent 
was removed in vacuo and the crude product was purified by flash column chromatography 
(SiO2, eluted with MeCN/saturated aqueous KNO3/H2O = 10:1.5:0.5). The first red band was 
collected, aqueous ammonium hexafluorophosphate added and solvent evaporated until a red 
precipitate formed. This was collected on Celite® and washed thoroughly with cold water (150 
mL) and diethyl ether (10 mL). The red residue was redissolved in acetonitrile and solvent 
removed in vacuo to give the product as a dark red powder (30 mg, 0.02 mmol, 15%). 
1H NMR (500 MHz, CD3CN) δ/ppm 9.19 (d, J = 1.3 Hz, 1H, H
B5), 9.08 (br s, 2H, HB3+D3), 8.96 (d, J = 
4.5 Hz, 2H, HC2), 8.78 (d, J = 8.2 Hz, 2H, HF3), 8.68 (d, J = 8.0 Hz, 1H, HA3), 8.51 (d, J = 8.1 Hz, 2H, 
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HE3), 8.46 (m, 1H, HF4), 8.18 (d, J = 6.0 Hz, 2H, HC3), 7.98 (td, J = 8.0, 1.4 Hz, 1H, HA4), 7.93 (td, J = 
8.1, 1.4 Hz, 2H, HE4), 7.59 (dd, J = 5.8, 1.7 Hz, 1H, HD5), 7.57 (d, J = 5.8 Hz, 1H, HD6), 7.39 (m, 3H, 
HA6+E6), 7.22 (m, 1H, HA5), 7.17 (m, 2H, HE5), 4.33 (t, J = 6.8 Hz, 2H, H1), 3.14 (q, J = 7.0 Hz, 4H, 
H13), 3.02 (br s, 2H, H11), 1.74 (m, 2H, H2), 1.63 (m, 2H, H10), 1.39 (m, 2H, H3), 1.27 (m, 12H, H4-9), 
1.24 (t, J = 7.3 Hz, 6H, H14). 13C {1H} NMR (126 MHz, CD3CN) /ppm 164.3 (C
C=O), 160.1 (CD2), 
158.9 (CE2), 158.8 (CA2), 157.0 (CB2), 156.5 (CB6), 156.1 (CF2), 154.5 (CD6), 153.6 (CE6), 153.5 (CA6), 
151.9 (CC2), 146.3 (CB4), 145.3 (CC4), 139.9 (CD4), 139.4 (CA4+E4), 137.4 (CF4), 128.8 (CA5), 128.5 
(CE5), 127.3 (CD5), 125.8 (CA3), 125.6 (CE3), 124.9 (CF3), 124.4 (CD3), 123.3 (CB5), 123.2 (CC3), 123.1 
(CB3), 67.5 (C1), 53.0 (C11), 48.4 (C13), 30.3, 30.2, 30.1 (C5-7), 29.9 (C4), 29.7 (C8), 29.2 (C2), 27.0 
(C9), 26.5 (C3), 24.4 (C10), 9.1 (C14). ESI MS (MeCN) monoprotonated form: m/z 1205.5 [M-PF6]
+ 
(3%, calc. 1205.3), 530.2 [M-2PF6]
2+ (83%, 530.2), deprotonated form: m/z 1205.5 [M+H]+ (3%, 
1205.3), 1059.3 [M-PF6]
+ (36%, 1059.3). IR (solid, /cm-1) 3632 (w), 3120 (w), 2927 (m), 2850 
(m), 1722 (m), 1716 (m), 1600 (m), 1449 (m), 1407 (w), 1390 (w), 1265 (m), 1248 (m), 1241 (m), 
1166 (w), 1117 (w), 1030 (w), 824 (s), 822 (s), 785 (s), 765 (s), 739 (m), 725 (m), 690 (w), 668 
(w), 657 (w), 644 (m), 601 (m). EA found: C, 45.87; H, 4.74; N, 8.95%. C51H57F18N8O2P3Ru 
requires C, 45.37; H, 4.26; N, 8.30%. UV/VIS max/nm (3.32 x 10
-5mol dm-3, MeCN) 271 (/dm3 
mol-1 cm-1 37000), 283 (35000), 306 (42000), 327 (33000, sh), 488 (15000). Luminescence 
(MeCN, 3.32 x 10-5mol dm-3, λex = 488 nm): λem = 664 nm.  
 
[Ru(L3)]Cl3 (C6) 
 
Terpyridine L2 (0.30 g, 0.81 mmol) and RuCl33H2O (0.21 g, 0.81 mmol) were suspended in 
ethanol (150 mL). The brown reaction mixture was heated to reflux for 3.5 hours, while all 
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reactants dissolved. The brown solid which formed was filtered off, washed with ethanol and 
diethyl ether and air dried to give a dark brown powder (0.44 g, 1.76 mmol, 93%). The product 
was submitted for the next step without further purification and characterization. 
 
[Ru(L2)(L3)][PF6]2 (C7) 
 
The ruthenium(II) complex C6 (56 mg, 0.11 mmol) was suspended in dry 
N,N-dimethylformamide (5 mL) in a 10mL round bottomed flask. Silver hexafluorophosphate 
(122 mg, 0.48 mmol) was added and the black suspension was stirred for 10 minutes at 100 °C 
and then 30 minutes at laboratory temperature under an inert atmosphere in darkness. This 
dark brown solution was filtered on Celite® to remove silver chloride, then washed with 
N,N-dimethylformamide (5 mL) and solvent mostly removed in vacuo. The black residue was 
transferred into a 2mL microwave reactor vial and dissolved in dry N,N-dimethylformamide 
(2 mL). The ligand L3 (30 mg, 0.11 mmol) and N-ethylmorpholine (3 drops) were added and the 
reaction mixture was treated in a microwave reactor at 160 °C for 15 minutes. The resulting 
dark red solution was poured into 250 mL of aqueous ammonium hexafluorophosphate to give 
a fine red precipitate, which was collected on Celite® and washed with cold water (250 mL) and 
diethyl ether (20 mL). The residue was redissolved in acetonitrile and solvent removed in vacuo 
to give a dark red solid, which was purified with column chromatography (SiO2, eluted with 
MeCN/saturated aqueous KNO3/H2O = 7:2:2). The first red band was collected, aqueous 
ammonium hexafluorophosphate added and solvent evaporated until a red precipitate formed. 
This was collected on Celite® and washed thoroughly with cold water (250 mL), cold ethanol (15 
mL) and diethyl ether (15 mL). The red residue was redissolved in acetonitrile and solvent 
removed in vacuo to give the product as a dark red powder (47 mg, 0.044 mmol, 45%). 
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1H NMR (400 MHz, CD3CN) δ/ppm 9.22 (d, J = 1.2 Hz, 1H, H
B5), 9.13 (s, 1H, HD3), 9.10 (d, J = 1.2 
Hz, 1H, HB3), 9.07 (s, 1H, HF3), 9.06 (s, 1H, HF5),8.97 (dd, J = 4.3, 1.9 Hz, 4H, HC2+G2), 8.67 (m, 3H, 
HA3+E3), 8.17 (m, 2H, HC3), 8.14 (d, J = 4.8, 2H, HG3), 8.00 (m, 3H, HA4+E4), 7.61 (m, 2H, HD6+D5), 7.43 
(m, 2H, HE6+A6), 7.20 (m, 3H, HA5+E5), 3.92 (s, 3H, H1). ESI MS (MeCN): m/z 925.3 [M-PF6]
+ (50%, 
calc. 925.1), 390.1 [M-2PF6]
2+ (100%, 390.1). IR (solid, /cm-1) 3645 (w), 3067 (w), 1731 (m), 
1700 (m), 1597 (m), 1474 (w), 1406 (m), 1343 (w), 1312 (m), 1268 (m), 1248 (w), 1246 (w), 1237 
(w), 1163 (w), 1125 (w), 1029 (w), 830 (s), 822 (s), 798 (m), 785 (m), 766 (m), 752 (m), 741 (w), 
730 (w), 637 (w), 602 (w). UV/VIS max/nm (1 x 10
-5mol dm-3, MeCN) 239 (/dm3 mol-1 cm-1 
19000), 277 (28000), 315 (25000), 492 (11000). Luminescence (MeCN, 1 x 10-5mol dm-3, λex = 
492 nm): λem = 661 nm.  
 
[Ru(L3)2][PF6]2 (C8) 
 
The ruthenium(II) complex C8 is formed as a side product during synthesis of C7, C17-C20, C22-
25. 
1H NMR (400 MHz, CD3CN) δ/ppm 9.06 (s, 4H, H
B3), 8.97 (dd, J = 4.4, 1.7 Hz, 4H, HC2), 8.66 (dd, J 
= 8.0, 0.9 Hz, 4H, HA3), 8.13 (dd, J = 4.4, 1.7 Hz, 4H, HC3), 7.97 (td, J = 8.0, 1.5 Hz, 4H, HA4), 7.42 
(ddd, J = 5.6, 1.3, 0.6 Hz, 4H, HA6), 7.20 (ddd, J = 7.5, 5.6, 1.3 Hz, 4H, HA5). UV/VIS max/nm (2.48 
x 10-5mol dm-3, MeCN) 275 (/dm3 mol-1 cm-1 65000), 313 (52000), 489 (26000). Luminescence 
(MeCN, 1.38 x 10-5mol dm-3, λex = 492 nm): λem = 657 nm.  
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[Ru(L3)]Cl3 (C9) 
 
Terpyridine L5 (0.50 g, 0.95 mmol) and RuCl33H2O (0.25 g, 0.95 mmol) were suspended in 
ethanol (125 mL). The brown reaction mixture was heated to reflux for 3 hours, while all 
reactants dissolved. The black solid which formed was filtered off, washed with ethanol and 
diethyl ether and air dried to give a black powder (0.52 g, 0.83 mmol, 75%). The product was 
submitted for the next step without further purification and characterization. 
 
[Ru(L5)(L4)][PF6]4 (C10) 
 
The ruthenium(II) complex C9 (74 mg, 0.10 mmol) was suspended in dry 
N,N-dimethylformamide (4 mL) in a 10mL round bottomed flask. Silver hexafluorophosphate 
(102 mg, 0.40 mmol) was added and the black suspension was stirred for 10 minutes at 100 °C 
and then 30 minutes at laboratory temperature under an inert atmosphere in darkness. This 
dark brown solution was filtered on Celite® to remove silver chloride, then washed with 
N,N-dimethylformamide (5 mL) and solvent mostly removed in vacuo. The black residue was 
transferred into a 2mL microwave reactor vial and dissolved in dry N,N-dimethylformamide 
(2 mL). The ligand L4 (47 mg, 0.10 mmol) and N-ethylmorpholine (3 drops) were added and the 
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reaction mixture was treated in a microwave reactor at 160 °C for 20 minutes. The resulting 
dark red-purple solution was poured into 250 mL of aqueous ammonium hexafluorophosphate 
to give a fine red precipitate, which was collected on Celite® and washed with cold water (250 
mL) and diethyl ether (20 mL). The residue was redissolved in acetonitrile and solvent removed 
in vacuo to give a dark purple-black solid, which was purified with column chromatography 
(SiO2, eluted with MeCN/saturated aqueous KNO3/H2O = 7:2:2). The first red-purple band was 
collected, aqueous ammonium hexafluorophosphate added and solvent evaporated until a red-
purple precipitate formed. This was collected on Celite® and washed thoroughly with cold 
water (250 mL), cold ethanol (15 mL) and diethyl ether (15 mL). The residue was redissolved in 
acetonitrile and solvent removed in vacuo to give the product as a dark red-purple powder (73 
mg, 0.053 mmol, 53%). 
1H NMR (500 MHz, CD3CN) δ/ppm 9.32 (d, J = 1.4 Hz, 1H, H
B5), 9.20 (d, J = 1.4 Hz, 1H, HB3), 9.17 
(m, 3H, HD3+F3), 8.97 (m, 4H, HC2+G2), 8.78 (m, 4H, HC3+G3), 8.72 (m, 3H, HA3+E3), 8.02 (m, 3H, 
HA4+E4), 7.67 (dd, J = 5.8, 0.6 Hz, 1H, HD6), 7.63 (dd, J = 5.8, 1.7 Hz, 1H, HD5), 7.46 (m, 3H, HA6+E6), 
7.25 (m, 3H, HA5+E5), 4.48 (m, 6H, HNMe), 3.93 (s, 3H, HOMe). 13C {1H} NMR (126 MHz, CD3CN) 
/ppm 164.7 (CC=O), 159.6 (CD2), 158.4 (CE2), 158.3 (CA2), 157.1 (CB2), 157.0 (CF2), 156.6 (CB6), 
154.7 (CD6), 153.7 (CE6), 153.6 (CA6), 153.3 (CC2+G2), 147.3 (CC3+G3), 142.5 (CF4), 142.2 (CB4), 140.0 
(CD4), 139.8 (CA4), 139.7 (CE4), 129.5 (CA5+E5), 127.6 (CD5), 126.1 (CE3), 126.0 (CA3), 124.8 (CD3), 
123.9 (CB5), 123.6 (CB3), 123.4 (CF3), 54.1 (COMe), 49.3 (CNMe). MALDI TOF MS (DCM-MeCN): m/z 
1099.6 [M-2PF6]
+ (25%, calc. 1100.1), 954.2 [M-3PF6]
+ (46%, calc. 955.2), 810.9 [M-4PF6]
+ (100%, 
calc. 810.2), 325.3 [L4] + (100%, 325.1). IR (solid, /cm-1) 3107 (w), 1739 (m), 1640 (m), 1635 
(m), 1622 (w), 1616 (w), 1605 (w), 1527 (w), 1469 (w), 1422 (m), 1419 (m), 1364 (m), 1340 (m), 
1317 (m), 1293 (m), 1273 (m), 1250 (w), 1190 (w), 1030 (w), 822 (s), 786 (m), 767 (m), 752 (m), 
740 (m), 733 (m), 723 (w), 711 (w), 652 (w), 618 (w), 600 (w). UV/VIS max/nm (2.88 x 10
-5mol 
dm-3, MeCN) 241 (/dm3 mol-1 cm-1 39000), 277 (53000), 341 (33000), 510 (26000). 
Luminescence (MeCN, 2.88 x 10-5mol dm-3, λex = 510 nm): λem = 710 nm.  
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[Ru(L9)(L4)][PF6]4 (C11) 
 
The ruthenium(II) complex C11 is formed as a side product during synthesis of the complex C10. 
The second red-purple band was collected, aqueous ammonium hexafluorophosphate added 
and solvent evaporated until a red-purple precipitate formed. This was collected on Celite® and 
washed with cold water (250 mL), cold ethanol (15 mL) and diethyl ether (15 mL). The residue 
was redissolved in acetonitrile and solvent removed in vacuo to give the product as a dark red-
purple powder (23 mg, 0.016 mmol, 17%). 
1H NMR (500 MHz, CD3CN) δ/ppm 9.34 (s, 1H, H
B5), 9.19 (m, 4H, HD3+B3+F3), 8.97 (m, 4H, HC2+G2), 
8.81 (m, 2H, HC3), 8.78 (m, 2H, HG3), 8.71 (m, 3H, HA3+E3), 8.00 (m, 3H, HA4+E4), 7.60 (m, 1H, HD6), 
7.52 (m, 1H, HD5), 7.45 (m, 3H, HA6+E6), 7.25 (m, 3H, HA5+E5), 4.46 (m, 6H, HNMe). 13C {1H} NMR 
(126 MHz, CD3CN) /ppm 164.5 (C
C=O), 158.8 (CD2), 158.3 (CE2+A2), 157.0 (CB2), 156.9 (CF2+B6), 
153.9 (CD6), 153.7 (CE6), 153.6 (CA6), 153.3 (CC2+G2), 147.3 (CC3+G3), 142.2 (CF4+B4), 140.0 (CD4), 
139.6 (CA4+E4), 129.0 (CA5+E5), 128.2 (CD5), 126.0 (CE3+A3), 123.6 (CD3), 123.4 (CF3+ B3), 123.3 (CB5), 
49.2 (CNMe). ESI MS (MeCN): m/z 369.2 [L9]+ (60%, calc. 369.1), 325.2 [L4] + (100%, 325.1). IR 
(solid, /cm-1) 3089 (w), 1720 (m), 1641 (s), 1635 (m), 1616 (w), 1605 (w), 1527 (w), 1486 (w), 
1471 (w), 1422 (m), 1419 (m), 1409 (w), 1360 (w), 1339 (w), 1321 (w), 1293 (w), 1243 (w), 1228 
(w), 1193 (w), 1163 (w), 1091 (w), 1023 (w), 820 (s), 805 (s), 785 (s), 777 (s), 750 (m), 736 (m), 
730 (m), 709 (m), 697 (w), 683 (w), 653 (w), 602 (m). EA found: C, 34.52; H, 2.61; N, 9.05%. 
C43H34F24N8O2P4RuNH4PF61.5MeCN requires C, 34.52; H, 2.68; N, 9.19%. UV/VIS max/nm (1.45 
x 10-5mol dm-3, MeCN) 241 (/dm3 mol-1 cm-1 40000), 277 (58000), 343 (31000), 511 (28000). 
Luminescence (MeCN, 1.45 x 10-5mol dm-3, λex = 510 nm): λem = 725 nm.  
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Complex C12 
 
The ruthenium(II) complex C7 (50 mg, 0.047 mmol) was dissolved in N,N-dimethylformamide 
(2.5 mL). Methyl 11-bromoundecanoate (0.13 g, 0.47 mmol) and a catalytic amount of p-
toluenesulfonic acid monohydrate (4.4 mg, 0.02 mmol) were added. The red reaction mixture 
was heated at reflux for 2 hours and the formation of the product was monitored by thin layer 
chromatography (SiO2, eluted with MeCN/saturated aqueous KNO3/H2O = 10:1.5:0.5). Solvent 
was removed in vacuo and the crude product was purified on a preparative TLC plate (SiO2, 
eluted with MeCN/saturated aqueous KNO3/H2O = 10:1.5:0.5). The first wine-red band was 
collected, aqueous ammonium hexafluorophosphate added and solvent evaporated until a 
precipitate formed. This was collected on Celite® and washed thoroughly with cold water (250 
mL) and diethyl ether (10 mL). The residue was redissolved in acetonitrile and solvent removed 
in vacuo to give the product as a dark red powder (11 mg, 0.006 mmol, 12%). 
1H NMR (500 MHz, CD3CN) δ/ppm 9.28 (d, J = 1.3 Hz, 1H, H
B5), 9.16 (d, J = 1.3 Hz, 1H, HB3), 9.14 
(m, 3H, HD3+F3), 9.02 (m, 4H, HC2+G2), 8.78 (m, 4H, HC3+G3), 8.69 (m, 3H, HA3+E3), 8.03 (m, 3H, 
HA4+E4), 7.64 (m, 2H, HD6+D5), 7.46 (m, J = 4.9 Hz, 1H, HA6), 7.42 (m, J = 5.6 Hz, 2H, HE6),7.26 (m, 
3H, HA5+E5), 4.69 (t, J = 7.2 Hz, 4H, H1), 4.34 (t, J = 6.7 Hz, 2H, H1’), 3.60 (s, 6H, HMe), 3.58 (s, 3H, 
HMe’), 2.30 (t, J = 7.6 Hz, 4H, H10), 2.25 (m, 2H, H10’), 2.18 (m, 4H, H2), 1.74 (m, 2H, H2’),1.59 (m, 
4H, H9), 1.40 (m, 38H, H3-8, 3’-9’). ESI MS (MeCN): m/z 751.5 [L2-PF6]
+ (60%, calc. 751.4), 509.3 [L1-
PF6]
+ (35%, 509.2). EA found: C, 41.00; H, 4.98; N, 5.68%. C89H96F24N8O8P4Ru2NH4PF6requires 
C, 40.77; H, 4.62; N, 6.17%. UV/VIS max/nm (3.09 x 10
-5mol dm-3, MeCN) 241 (/dm3 mol-1 cm-1 
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46000), 278 (63000), 342 (39000), 511 (32000). Luminescence (MeCN, 3.09 x 10-5mol dm-3, λex = 
510 nm): λem = 708 nm.  
 
Complex C13 
 
The ruthenium(II) complex C13 is formed as a side product during synthesis of the complex C12. 
The second wine-red band was collected, aqueous ammonium hexafluorophosphate added and 
solvent evaporated until a precipitate formed. This was collected on Celite® and washed 
thoroughly with cold water (250 mL) and diethyl ether (10 mL). The residue was redissolved in 
acetonitrile and solvent removed in vacuo to give the product as a dark red powder (19 mg, 
0.011 mmol, 24%). 
1H NMR (500 MHz, CD3CN) δ/ppm 9.13 (s, 4H, H
B3), 9.01(d, J = 6.6 Hz, 4H, HC2), 9.01(d, J = 6.6  
Hz, 4H, HC3), 8.70 (d, J = 8.1 Hz, 4H, HA3), 8.01 (td, J = 7.9, 1.4 Hz, 4H, HA4), 7.45 (dd, J = 5.6, 1.0 
Hz, 4H, HA6), 7.25 (m, 4H, HA5), 4.68 (t, J = 7.5 Hz, 4H, H1), 3.60 (s, 6H, HMe), 2.30 (t, J = 7.5 Hz, 
4H, H10), 2.20 (m, 4H, H2), 1.59 (m, 4H, H9), 1.40 (m, 24H, H3-8). 13C {1H} NMR (126 MHz, CD3CN) 
/ppm 174.9 (CC=O), 158.4 (CA2), 156.9 (CB2), 153.7 (CA6), 153.6 (CC2), 146.3 (CC3), 142.1 (CB4), 
139.6 (CA4), 129.1 (CA5), 126.1 (CA3), 123.3 (CB3), 62.8 (C1), 51.9 (CMe), 34.5 (C10), 31.9 (C2), 31.9 
(C4-8), 26.5 (C3), 25.5 (C9). ESI MS (MeCN): m/z 705.3 [L2-PF6]
+ (29%, calc. 705.3), 509.3 [L-PF6]
+ 
(100%, 509.2). EA found: C, 39.41; H, 4.45; N, 6.85%. C64H74F24N8O4P4Ru1.5NH4PF6requires C, 
39.53; H, 4.15; N, 6.84%. UV/VIS max/nm (3.23 x 10
-5mol dm-3, MeCN) 241 (/dm3 mol-1 cm-1 
56000), 278 (88000), 342 (44000), 511 (42000). Luminescence (MeCN, 3.23 x 10-5mol dm-3, λex = 
510 nm): λem = 708 nm.  
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[Ru(L6)(L3)][PF6]2 (C14) 
 
The ligand L6 (50 mg, 0.15 mmol) and RuCl3.3H2O (38 mg, 0.15 mmol) were suspended in 
ethylene glycol (8 mL) in a 25mL round bottomed flask and this dark brown suspension was 
treated in a domestic microwave oven at the highest setting for 4 minutes. The ligand L3 (45 
mg, 0.15 mmol) was added and the reaction mixture was threated in a domestic microwave 
oven at the highest setting for 4 minutes. The resulting dark red solution was poured into 250 
mL of aqueous ammonium hexafluorophosphate to give a fine red precipitate, which was 
collected on Celite® and washed with cold water (200 mL), cold ethanol (20 mL) and diethyl 
ether (20 mL). The residue was redissolved in acetonitrile and solvent removed in vacuo to give 
a dark red solid, which was purified by column chromatography (SiO2, eluted with 
MeCN/saturated aqueous KNO3/H2O = 7:2:2). The second red band was collected, aqueous 
ammonium hexafluorophosphate added and solvent evaporated until a red precipitate formed. 
This was collected on Celite® and washed thoroughly with cold water (500 mL), cold ethanol (15 
mL) and diethyl ether (10 mL). The red residue was redissolved in acetonitrile and solvent 
removed in vacuo to give the product as a dark red powder (80 mg, 0.076 mmol, 53%). 
1H NMR (400 MHz, CD3CN) δ/ppm 9.08 (s, 1H, H
B5), 9.07 (s, 1H, HB3), 9.07 (s, 2H, HF3), 8.99 (m, 
4H, HC2+G2), 8.77 (dd, J = 2.3, 0.5 Hz, 1H, HD3), 8.67 (m, 3H, HA3+E3), 8.17 (m, 4H, HC3+G3), 7.98 (m, 
3H, HA4+E4), 7.44 (m, 2H, HE6+A6), 7.37 (dd, J = 6.1, 0.5 Hz, 1H, HD6), 7.26 (dd, J = 6.1, 2.2 Hz, 1H, 
HD5), 7.21 (m, 3H, HA5+E5). ESI MS (MeCN): m/z 901.2 [M-PF6]
+ (28%, calc. 901.1), 378.1 [M-
2PF6]
2+ (100%, 378.1). IR (solid, /cm-1) 3645 (w), 3073 (w), 1597 (m), 1530 (w), 1477 (w), 1464 
(w), 1429 (m), 1407 (m), 1386 (w), 1355 (w), 1288 (w), 1245 (w), 1233 (w), 1164 (w), 1029 (m), 
968 (w), 878 (w), 830 (s), 820 (s), 785 (s), 749 (s), 741 (m), 733 (m), 723 (m), 711 (m), 694 (w), 
680 (w), 663 (w), 652 (m), 636 (m), 626 (w), 601 (m). EA found: C, 44.44; H, 2.97; N, 10.65%. 
236 
 
C40H27ClF12N8P2Ru2H2O requires C, 44.39; H, 2.89; N, 10.35%. UV/VIS max/nm (3.35 x 10
-5mol 
dm-3, MeCN) 239 (/dm3 mol-1 cm-1 66000), 276 (103000), 312 (90000), 490 (44000). 
Luminescence (MeCN, 3.35 x 10-5mol dm-3, λex = 490 nm): λem = 658 nm.  
 
[Ru(L6)2][PF6]2 (C15) 
 
The ligand L6 (50 mg, 0.15 mmol) and RuCl3.3H2O (38 mg, 0.15 mmol) were suspended in 
ethylene glycol (8 mL) in a 25mL round bottomed flask and this dark brown suspension was 
treated in a domestic microwave oven at the highest setting for 4 minutes. The second aliquot 
of L6 (50 mg, 0.15 mmol) was added and the reaction mixture was threated in a domestic 
microwave oven at the highest setting for 4 minutes. The resulting dark red solution was 
poured into 250 mL of aqueous ammonium hexafluorophosphate to give a fine red precipitate, 
which was collected on Celite® and washed with cold water (200 mL), cold ethanol (20 mL) and 
diethyl ether (20 mL). The residue was redissolved in acetonitrile and solvent removed in vacuo 
to give a dark red solid, which was purified by column chromatography (SiO2, eluted with 
MeCN/saturated aqueous KNO3/H2O = 7:2:2). The second red band was collected, aqueous 
ammonium hexafluorophosphate added and solvent evaporated until a red precipitate formed. 
This was collected on Celite® and washed thoroughly with cold water (500 mL), cold ethanol (15 
mL) and diethyl ether (10 mL). The red residue was redissolved in acetonitrile and solvent 
removed in vacuo to give the product as a dark red powder (30 mg, 0.028 mmol, 19%). 
1H NMR (400 MHz, CD3CN) δ/ppm 9.08 (d, J = 1.4, 2H, H
B5), 9.07 (d, J = 1.4, 2H, HB3), 8.97 (dd, J 
= 4.4, 1.7 Hz, 2H, HC2), 8.77 (d, J = 2 Hz, 2H, HD3), 8.67 (m, 2H, HA3), 8.15 (dd, J = 4.4, 1.7 Hz, 4H, 
HC3), 8.01 (m, 2H, HA4), 7.41 (ddd, J = 5.8, 1.4, 0.7 Hz, 2H, HA6), 7.36 (dd, J = 6.1 Hz, 2H, HD6), 7.27 
(dd, J = 6.1, 2.2Hz, 2H, HD5), 7.22 (ddd, J = 7.5, 5.6, 1.3 Hz, 2H, HA5). ESI MS (MeCN): m/z 935.1 
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[M-PF6]
+ (13%, calc. 935.0), 395.1 [M-2PF6]
2+ (100%, 395.1). UV/VIS max/nm (3.24 x 10
-5mol dm-
3, MeCN) 276 (/dm3 mol-1 cm-1 86000), 313 (80000), 492 (34000). Luminescence (MeCN, 3.24 x 
10-5mol dm-3, λex = 492 nm): λem = 666 nm.  
 
[Ru(pytpy-CO2(CH2)2OH)(L3)][PF6]2 (C16) 
 
C16 formed as a trans-esterification-product during reactions when ethylene glycol was used as 
a solvent. 
1H NMR (400 MHz, CD3CN) δ/ppm 9.25 (dd, J = 5.2, 1.4 Hz, 1H, H
B5), 9.15 (s, 1H, HD3), 9.10 (dd, J 
= 4.3, 1.4 Hz, 1H, HB3), 9.07 (s, 1H, HF3), 9.06 (s, 1H, HF5),8.99 (m, 4H, HC2+G2), 8.65 (m, 3H, 
HA3+E3), 8.17 (m, 4H, HC3+G3), 8.00 (m, 3H, HA4+E4), 7.60 (m, 2H, HD6+D5), 7.41 (m, 2H, HE6+A6), 7.20 
(m, 3H, HA5+E5), 4.42 (m, 2H, H1), 3.79 (m, 2H, H2). ESI MS (MeCN): m/z 955.2 [M-PF6]
+ (12%, calc. 
955.2), 405.1 [M-2PF6]
2+ (100%, 405.1). IR (solid, /cm-1) 3388 (w), 3097 (w), 2930 (w), 1722 
(m), 1717 (m), 1703 (w), 1599 (m), 1407 (m), 1362 (w), 1267 (m), 1247 (m), 1235 (w), 1164 (w), 
1129 (m), 1073 (w), 1030 (w), 820 (s), 785 (s), 752 (m), 739 (m), 717 (w), 601 (m). EA found: C, 
41.95; H, 3.29; N, 9.22%. C40H27F12N8P2Ru2H2O0.5NH4PF6 requires C, 42.43; H, 3.15; N, 9.78%. 
UV/VIS max/nm (1.82 x 10
-5mol dm-3, MeCN) 238 (/dm3 mol-1 cm-1 46000), 278 (66000), 316 
(54000), 493 (26000). Luminescence (MeCN, 1.82 x 10-5mol dm-3, λex = 493 nm): λem = 662 nm.  
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[Ru(L10)(L3)][PF6]2 (C17) 
 
L10 (50 mg, 0.10 mmol) and RuCl3.3H2O (25 mg, 0.10 mmol) were suspended in dry 
N,N-dimethylformamide (5 mL) in a microwave reactor vial. The reaction mixture was treated in 
a microwave reactor at 130 °C for 10 minutes. Silver hexafluorophosphate (73 mg, 0.29 mmol) 
was added and the black suspension was heated in a microwave reactor at 130 °C for 3 
minutes. The ligand L3 (30 mg, 0.10 mmol) and N-ethylmorpholine (3 drops) were added and 
the reaction mixture was treated in a microwave reactor at 160 °C for 15 minutes. The resulting 
dark red solution was poured into 250 mL of aqueous ammonium hexafluorophosphate to give 
a fine red precipitate, which was collected on Celite® and washed with cold water (250 mL) and 
diethyl ether (20 mL). The residue was redissolved in acetonitrile and solvent removed in vacuo 
to give a dark red solid, which was purified with column chromatography (SiO2, eluted with 
MeCN/saturated aqueous KNO3/H2O = 5:1:1). The second red band was collected, aqueous 
ammonium hexafluorophosphate added and solvent evaporated until a red precipitate formed. 
This was collected on Celite® and washed thoroughly with cold water (250 mL), cold ethanol (15 
mL) and diethyl ether (15 mL). The residue was redissolved in acetonitrile and solvent removed 
in vacuo to give the product as a red powder (44 mg, 0.036 mmol, 38%). 
1H NMR (500 MHz, CD3CN) δ/ppm 9.21 (d, J = 1.4 Hz, 1H, H
B5), 9.11 (d, J = 1.7 Hz, 1H, HD3), 9.09 
(d, J = 1.4 Hz, 1H, HB3), 9.08 (s, 2H, HF3), 8.97 (dd, J = 5.5, 1.3 Hz, 4H, HC2+G2), 8.67 (dd, J = 8.1, 4.9 
Hz, 3H, HA3+E3), 8.17 (dd, J = 4.6, 1.4 Hz, 2H, HC3), 8.15 (dd, J = 4.6, 1.4 Hz, 2H, HG3), 8.00 (m, 3H, 
HA4+E4), 7.62 (d, J = 5.8 Hz, 1H, HD6), 7.60 (dd, J = 5.8, 1.8 Hz, 1H, HD5), 7.48 (dd, J = 5.6, 1.4 Hz, 
1H, HA6), 7.44 (dd, J = 5.7, 1.4 Hz, 2H, HE6), 7.23 (m, 3H, HA5+E5), 4.33 (t, J = 6.6 Hz, 2H, H1), 1.73 
(m, 2H, H2), 1.38 (m, 2H, H3), 1.25 (m, 16H, H4-11), 0.84 (t, J = 6.9 Hz, 3H, H12). 13C {1H} NMR 
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(126 MHz, CD3CN) /ppm 164.3 (C
C=O), 160.1 (CD2), 158.8 (CE2), 158.7 (CA2), 156.9 (CB2), 156.7 
(CF2), 156.4 (CB6), 154.5 (CD6), 153.7 (CE6), 153.5 (CA6), 151.8 (CG2), 151.7 (CC2), 146.7 (CF4), 146.6 
(CB4), 145.3 (CC4+G4), 140.1 (CD4), 139.5 (CA4), 139.4 (CE4), 128.8 (CA5), 128.7 (CE5), 127.3 (CD5), 
125.9 (CA3+E3), 124.5 (CD3), 123.4 (CB5), 123.2 (CC3), 123.1 (CB3+G3), 122.9 (CF3), 67.5 (C1), 32.6 
(C10), 30.3, 30.2, 30.0 (C5-9), 29.9 (C4), 29.2 (C2), 26.5 (C3), 23.4 (C11), 14.4 (C12). ESI MS: m/z 
1079.3 [M-PF6]
+ (5%, calc. 1079.3), 467.2 [M-2PF6]
2+ (100%, 467.2). IR (solid, /cm-1) 3105 (w), 
2918 (m), 2851 (m), 1729 (m), 1596 (m), 1543 (m), 1476 (w), 1459 (w), 1428 (w), 1406 (m), 1343 
(w), 1307 (w), 1291 (w), 1261 (m), 1246 (w), 1166 (w), 1124 (w), 1113 (w), 1030 (w), 976 (w), 
830 (s), 817 (s), 803 (s), 785 (m), 765 (m), 751 (m), 740 (m), 730 (m), 722 (m), 713 (w), 708 (w), 
696 (w), 684 (w), 636 (w). EA found: C, 46.22; H, 4.19; N, 8.11%. C53H52F12N8O2P2RuHPF6 
requires C, 46.46; H, 3.90; N, 8.18%. UV/VIS max/nm (1.80 x 10
-5mol dm-3, MeCN) 277 (/dm3 
mol-1 cm-1 65000), 316 (43000), 493 (20000). Luminescence (MeCN, 1.80 x 10-5mol dm-3, λex = 
487 nm): λem = 673 nm.  
 
[Ru(HL11)(L3)][PF6]3 (C18) 
 
L11 (56 mg, 0.10 mmol) and RuCl3.3H2O (25 mg, 0.10 mmol) were suspended in dry 
N,N-dimethylformamide (5 mL) in a microwave reactor vial. The reaction mixture was treated in 
a microwave reactor at 130 °C for 10 minutes. Silver hexafluorophosphate (73 mg, 0.29 mmol) 
was added and the black suspension was heated in a microwave reactor at 130 °C for 3 
minutes. The ligand L3 (30 mg, 0.10 mmol) and N-ethylmorpholine (3 drops) were added and 
the reaction mixture was treated in a microwave reactor at 160 °C for 15 minutes. The resulting 
dark red solution was poured into 250 mL of aqueous ammonium hexafluorophosphate to give 
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a fine red precipitate, which was collected on Celite® and washed with cold water (250 mL) and 
diethyl ether (20 mL). The residue was redissolved in acetonitrile and solvent removed in vacuo 
to give a dark red solid, which was purified with column chromatography (SiO2, eluted with 
MeCN/saturated aqueous KNO3/H2O = 10:1.5:0.5). The second red band was collected, aqueous 
ammonium hexafluorophosphate added and solvent evaporated until a red precipitate formed. 
This was collected on Celite® and washed thoroughly with cold water (250 mL), cold ethanol (15 
mL) and diethyl ether (15 mL). The residue was redissolved in acetonitrile and solvent removed 
in vacuo to give the product as a red powder (39 mg, 0.027 mmol, 29%). 
1H NMR (500 MHz, CD3CN) δ/ppm 9.21 (d, J = 1.5 Hz, 1H, H
B5), 9.10 (m, 2H, HB3+D3), 9.08 (s, 2H, 
HF3), 8.96 (dd, J = 5.0, 0.9 Hz, 4H, HC2+G2), 8.70 (m, 3H, HA3+E3), 8.20 (dd, J = 4.4, 1.7 Hz, 2H, HC3), 
8.18 (dd, J = 4.4, 1.8 Hz, 2H, HG3), 7.99 (m, 3H, HA4+E4), 7.66 (d, J = 5.8 Hz, 1H, HD6), 7.62 (dd, J = 
5.8, 1.7 Hz, 1H, HD5), 7.48 (dd, J = 5.7, 1.4 Hz, 1H, HA6), 7.43 (m, 2H, HE6), 7.23 (m, 3H, HA5+E5), 
4.33 (t, J = 6.7 Hz, 2H, H1), 3.16 (m, 4H, H13), 3.04 (m, 2H, H11), 1.75 (m, 2H, H2), 1.61 (m, 2H, 
H10), 1.39 (m, 2H, H3), 1.26 (m, 18H, H4-9+14). 13C {1H} NMR (126 MHz, CD3CN) /ppm 164.3 
(CC=O), 160.1 (CD2), 158.8 (CE2), 158.7 (CA2), 156.9 (CB2), 156.7 (CF2), 156.4 (CB6), 154.5 (CD6), 153.7 
(CE6), 153.5 (CA6), 151.8 (CG2+C2), 146.7 (CF4), 146.5 (CB4), 145.4 (CC4+G4), 140.0 (CD4), 139.5 (CA4), 
139.4 (CE4), 128.8 (CA5), 128.7 (CE5), 127.3 (CD5), 125.9 (CA3+E3), 124.5 (CD3), 123.4 (CB5), 123.3 
(CC3), 123.2 (CB3), 123.1 (CG3), 123.0 (CF3), 67.5 (C1), 53.1 (C11), 48.6 (C13), 30.2, 30.1, 30.0 (C5-7), 
29.9 (C4), 29.7 (C8), 29.2 (C2), 27.0 (C9), 26.6 (C3), 24.5 (C10), 9.2 (C14). ESI MS (MeCN) 
deprotonated form: m/z 495.7 [M-2PF6]
2+ (100%, calc. 495.7), 480.7 [M-2PF6-Me]
2+ (94%, 
480.8). IR (solid, /cm-1) 2928 (m), 2854 (w), 1725 (m), 1600 (m), 1464 (w), 1407 (m), 1264 (m), 
1233 (w), 1164 (w), 1117 (w), 1031 (w), 819 (s), 785 (m), 752 (m), 740 (m), 730 (m), 601 (w). EA 
found: C, 44.15; H, 4.15; N, 8.32%. C56H60F18N9O2P3Ru0.5NH4PF6 requires C, 44.58; H, 4.14; N, 
8.82%. UV/VIS max/nm (2.35 x 10
-5mol dm-3, MeCN) 277 (/dm3 mol-1 cm-1 60000), 316 
(47000), 494 (23000). Luminescence (MeCN, 2.35 x 10-5mol dm-3, λex = 491 nm): λem = 682 nm.  
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[Ru(HL13)(L3)][PF6]3 (C19) 
 
L13 (50 mg, 0.08 mmol) and RuCl3.3H2O (22 mg, 0.08 mmol) were suspended in dry 
N,N-dimethylformamide (5 mL) in a microwave reactor vial. The reaction mixture was treated in 
a microwave reactor at 130 °C for 10 minutes. Silver hexafluorophosphate (64 mg, 0.25 mmol) 
was added and the black suspension was heated in a microwave reactor at 130 °C for 3 
minutes. The ligand L3 (26 mg, 0.08 mmol) and N-ethylmorpholine (3 drops) were added and 
the reaction mixture was treated in a microwave reactor at 160 °C for 15 minutes. The resulting 
dark red solution was poured into 250 mL of aqueous ammonium hexafluorophosphate to give 
a fine red precipitate, which was collected on Celite® and washed with cold water (250 mL) and 
diethyl ether (20 mL). The residue was redissolved in acetonitrile and solvent removed in vacuo 
to give a dark red solid, which was purified with column chromatography (SiO2, eluted with 
MeCN/saturated aqueous KNO3/H2O = 5:1:1). The second red band was collected, aqueous 
ammonium hexafluorophosphate added and solvent evaporated until a red precipitate formed. 
This was collected on Celite® and washed thoroughly with cold water (250 mL), cold ethanol (15 
mL) and diethyl ether (15 mL). The residue was redissolved in acetonitrile and solvent removed 
in vacuo to give the product as a red powder (61 mg, 0.042 mmol, 51%). 
1H NMR (500 MHz, CD3CN) δ/ppm 9.23 (d, J = 1.4 Hz, 1H, H
B5), 9.12 (d, J = 1.4 Hz, 1H, HB3), 9.11 
(d, J = 1.7 Hz, 1H, HD3), 9.11 (s, 2H, HF3), 9.01 (br s, 4H, HC2+G2), 8.70 (m, 3H, HA3+E3), 8.31 (m, 4H, 
HC3+G3), 8.00 (m, 3H, HA4+E4), 7.66 (d, J = 5.9 Hz, 1H, HD6), 7.62 (dd, J = 5.8, 1.7 Hz, 1H, HD5), 7.48 
(d, J = 4.9 Hz, 1H, HA6), 7.44 (dd, J = 5.6, 0.7 Hz, 2H, HE6), 7.23 (m, 3H, HA5+E5), 4.33 (t, J = 6.7 Hz, 
2H, H1), 3.45 (d, J = 12.4 Hz, 2H, H13eq), 2.98 (t, J = 8.3 Hz, 2H, H11), 2.83 (m, 2H, H13ax), 1.88 (d, J 
= 14.2 Hz, 2H, H14eq), 1.73 (m, 4H, H2+14ax), 1.65 (m, 2H, H10), 1.44 (m, 2H, H15), 1.37 (m, 2H, H3), 
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1.27 (m, 12H, H4-9). 13C {1H} NMR (126 MHz, CD3CN) /ppm 164.3 (C
C=O), 160.0 (CD2), 158.8 (CE2), 
158.7 (CA2), 156.9 (CB2), 156.7 (CF2), 156.4 (CB6), 154.5 (CD6), 153.7 (CE6), 153.5 (CA6), 150.4 (CC2), 
150.3 (CG2), 147.1 (CF4+B4), 146.1 (CG4), 145.9 (CC4), 140.1 (CD4), 139.5 (CA4), 139.4 (CE4), 128.9 
(CA5), 128.8 (CE5), 127.4 (CD5), 125.9 (CA3+E3), 124.5 (CD3), 123.9 (CC3+G3), 123.5 (CB5), 123.3 (CB3), 
123.1 (CF3), 67.6 (C1), 58.1 (C11) , 54.3 (C13), 30.2, 30.1, 30.0 (C5-7), 29.9 (C4), 29.6 (C8), 29.2 (C2), 
27.0 (C9), 26.5 (C3), 24.5 (C10), 23.8 (C14), 22.2 (C15). ESI MS (MeCN) monoprotonated form: m/z 
1294.2 [M-PF6]
+ (7%, calc. 1294.3), 574.7 [M-2PF6]
2+ (23%, 574.7), deprotonated form: m/z 
1294.2 [M+H]+ (7%, calc. 1294.3), 1148.3 [M-PF6]
+ (5%, 1148.4), 501.7 [M-2PF6]
2+ (85%, 501.7). 
IR (solid, /cm-1) 3323 (w), 2930 (m), 2853 (w), 1722 (m), 1712 (m), 1635 (w), 1602 (m), 1464 
(w), 1409 (m), 1307 (w), 1293 (w), 1264 (m), 1237 (w), 1167 (w), 1121 (w), 1031 (m), 817 (s), 
785 (s), 773 (s), 768 (s), 753 (s), 740 (m), 730 (m), 718 (w), 714 (w), 698 (w). EA found: C, 41.83; 
H, 4.09; N, 8.33%. C57H60F18N9O2P3RuH2ONH4PF6 requires C, 42.26; H, 4.11; N, 8.65%. UV/VIS 
max/nm (2.50 x 10
-5mol dm-3, MeCN) 277 (/dm3 mol-1 cm-1 61000), 316 (47000), 494 (23000). 
Luminescence (MeCN, 2.21 x 10-5mol dm-3, λex = 492 nm): λem = 672 nm.  
 
[Ru(HL14)(L3)][PF6]3 (C20) 
 
L14 (50 mg, 0.08 mmol) and RuCl3.3H2O (22 mg, 0.08 mmol) were suspended in dry 
N,N-dimethylformamide (5 mL) in a microwave reactor vial. The reaction mixture was treated in 
a microwave reactor at 130 °C for 10 minutes. Silver hexafluorophosphate (64 mg, 0.25 mmol) 
was added and the black suspension was heated in a microwave reactor at 130 °C for 3 
minutes. The ligand L3 (26 mg, 0.08 mmol) and N-ethylmorpholine (3 drops) were added and 
the reaction mixture was treated in a microwave reactor at 160 °C for 15 minutes. The resulting 
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dark red solution was poured into 250 mL of aqueous ammonium hexafluorophosphate to give 
a fine red precipitate, which was collected on Celite® and washed with cold water (250 mL) and 
diethyl ether (20 mL). The residue was redissolved in acetonitrile and solvent removed in vacuo 
to give a dark red solid, which was purified with column chromatography (SiO2, eluted with 
MeCN/saturated aqueous KNO3/H2O = 5:1:1). The second red band was collected, aqueous 
ammonium hexafluorophosphate added and solvent evaporated until a red precipitate formed. 
This was collected on Celite® and washed thoroughly with cold water (250 mL), cold ethanol (15 
mL) and diethyl ether (15 mL). The residue was redissolved in acetonitrile and solvent removed 
in vacuo to give the product as a red powder (40 mg, 0.028 mmol, 33%). 
1H NMR (500 MHz, CD3CN) δ/ppm 9.21 (d, J = 1.5 Hz, 1H, H
B5), 9.10 (m, 2H, HB3+D3), 9.08 (s, 2H, 
HF3), 8.97 (d, J = 5.2 Hz, 4H, HC2+G2), 8.69 (m, 3H, HA3+E3), 8.21 (dd, J = 4.4, 1.7 Hz, 2H, HC3), 8.19 
(dd, J = 4.5, 1.6 Hz, 2H, HG3), 7.98 (m, 3H, HA4+E4), 7.64 (d, J = 5.8 Hz, 1H, HD6), 7.61 (dd, J = 5.8, 
1.7 Hz, 1H, HD5), 7.46 (dd, J = 5.6, 0.7 Hz, 1H, HA6), 7.42 (dd, J = 5.6, 1.4 Hz, 2H, HE6), 7.20 (m, 3H, 
HA5+E5), 4.33 (t, J = 6.7 Hz, 2H, H1), 4.00 (d, J = 13.3 Hz, 2H, H14eq), 3.72 (t, J = 12.0 Hz, 2H, H14ax), 
3.41 (d, J = 12.8 Hz, 2H, H13eq), 3.04 (m, 4H, H11+13ax), 1.74 (m, 2H, H2), 1.67 (m, 2H, H10), 1.38 (m, 
2H, H3), 1.27 (m, 12H, H4-9). 13C {1H} NMR (126 MHz, CD3CN) /ppm 164.3 (C
C=O), 160.1 (CD2), 
158.8 (CE2), 158.7 (CA2), 156.9 (CB2), 156.7 (CF2), 156.4 (CB6), 154.5 (CD6), 153.7 (CE6), 153.5 (CA6), 
151.6 (CG2+C2), 146.7 (CF4), 146.5 (CB4), 145.4 (CC4+G4), 140.0 (CD4), 139.5 (CA4), 139.4 (CE4), 128.8 
(CA5), 128.7 (CE5), 127.3 (CD5), 125.8 (CA3+E3), 124.5 (CD3), 123.4 (CB5), 123.3 (CB3), 123.2 (CC3+G3), 
123.0 (CF3), 67.6 (C1), 64.6 (C14), 58.5 (C11) , 53.1 (C13), 30.2, 30.1, 30.0 (C5-7), 29.9 (C4), 29.6 (C8), 
29.2 (C2), 26.9 (C9), 26.6 (C3), 24.1 (C10). ESI MS (MeCN) monoprotonated form: m/z 575.7 
[M-2PF6]
2+ (3%, calc. 575.7), deprotonated form: m/z 1150.3 [M-PF6]
+ (7%, 1150.3), 502.7 
[M-2PF6]
2+ (100%, 502.7). IR (solid, /cm-1) 3096 (w), 2927 (m), 2850 (w), 1722 (m), 1700 (m), 
1637 (w), 1597 (w), 1464 (w), 1407 (m), 1394 (w), 1388 (w), 1307 (w), 1293 (w), 1263 (m), 1246 
(w), 1237 (w), 1165 (w), 1119 (w), 1029 (m), 817 (s), 802 (s), 783 (s), 767 (s), 753 (s), 740 (s), 729 
(m), 719 (w), 711 (w), 686 (w), 609 (w), 601 (w). EA found: C, 43.49; H, 4.22; N, 8.77%. 
C56H58F18N9O3P3Ru5H2O requires C, 43.93; H, 4.48; N, 8.23%. UV/VIS max/nm (1 x 10
-5mol dm-3, 
MeCN) 278 (/dm3 mol-1 cm-1 75000), 316 (61000), 494 (29000). Luminescence (MeCN, 1 x 10-
5mol dm-3, λex = 494 nm): λem = 662 nm.  
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[Ru(L8)(L3)][PF6]2 (C21)
 
 
L8 (57 mg, 0.16 mmol) and RuCl3.3H2O (42 mg, 0.16 mmol) were suspended in dry 
N,N-dimethylformamide (5 mL) in a microwave reactor vial. The reaction mixture was treated in 
a microwave reactor at 130 °C for 10 minutes. Silver hexafluorophosphate (122 mg, 0.48 mmol) 
was added and the black suspension was heated in a microwave reactor at 130 °C for 3 
minutes. The ligand L3 (50 mg, 0.16 mmol) and N-ethylmorpholine (3 drops) were added and 
the reaction mixture was treated in a microwave reactor at 160 °C for 15 minutes. The resulting 
dark red solution was poured into 250 mL of aqueous ammonium hexafluorophosphate to give 
a fine red precipitate, which was collected on Celite® and washed with cold water (250 mL) and 
diethyl ether (20 mL). The residue was redissolved in acetonitrile and solvent removed in vacuo 
to give a dark red solid, which was purified with column chromatography (SiO2, eluted with 
MeCN/saturated aqueous KNO3/H2O = 7:2:2). The second red band was collected, aqueous 
ammonium hexafluorophosphate added and solvent evaporated until a red precipitate formed. 
This was collected on Celite® and washed thoroughly with cold water (250 mL), cold ethanol (15 
mL) and diethyl ether (15 mL). The residue was redissolved in acetonitrile and solvent removed 
in vacuo to give the product as a red powder (87 mg, 0.082 mmol, 51%). 
1H NMR (500 MHz, CD3CN) δ/ppm 9.21 (d, J = 1.4 Hz, 1H, H
B5), 9.12 (br s, 1H, HD3), 9.08 (d, J = 
1.4 Hz, 1H, HB3), 9.07 (s, 2H, HF3), 8.96 (m, 4H, HC2+G2), 8.67 (m, 3H, HA3+E3), 8.17 (dd, J = 4.4, 1.6 
Hz, 2H, HC3), 8.14 (dd, J = 4.4, 1.6 Hz, 2H, HG3), 7.98 (m, 3H, HA4+E4), 7.61 (s, 2H, HD5+D6), 7.44 
(ddd, J = 5.6, 1.4, 0.6 Hz, 1H, HA6), 7.41 (ddd, J = 5.6, 1.4, 0.6 Hz, 2H, HE6), 7.20 (m, 3H, HA5+E5). 
13C {1H} NMR (126 MHz, CD3CN) /ppm 164.4 (C
C=O), 154.3 (CD6), 153.6 (CE6), 153.4 (CA6), 151.9 
(CC2+G2), 139.4 (CA4+E4), 128.6 (CA5+E5), 127.5 (CD5), 125.7 (CA3+E3), 124.8 (CD3), 123.3 (CB5), 123.0 
(CB3+C3+G3), 122.9 (CF3), (Cq were not recorded due to the poor solubility of the complex). ESI MS 
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(MeCN): m/z 911.2 [M-PF6]
+ (96%, calc. 911.1), 383.1 [M-2PF6]
2+ (51%, 383.1). IR (solid, /cm-1) 
3221 (m), 3076 (m), 1763 (m), 1598 (w), 1364 (s), 1354 (s), 1343 (s), 1244 (m), 1233 (m), 1229 
(m), 1221 (m), 1213 (m), 1187 (m), 1161 (w), 1143 (w), 823 (s), 786 (m), 715 (w). 
 
[Ru(L17)(L3)][PF6]2 (C22) 
 
L17 (87 mg, 0.16 mmol) and RuCl3.3H2O (42 mg, 0.18 mmol) were suspended in dry 
N,N-dimethylformamide (5 mL) in a microwave reactor vial. The reaction mixture was treated in 
a microwave reactor at 130 °C for 10 minutes. Silver hexafluorophosphate (134 mg, 0.53 mmol) 
was added and the black suspension was heated in a microwave reactor at 130 °C for 3 
minutes. The ligand L3 (55 mg, 0.18 mmol) and N-ethylmorpholine (3 drops) were added and 
the reaction mixture was treated in a microwave reactor at 160 °C for 15 minutes. The resulting 
dark red solution was poured into 250 mL of aqueous ammonium hexafluorophosphate to give 
a fine red precipitate, which was collected on Celite® and washed with cold water (250 mL) and 
diethyl ether (20 mL). The residue was redissolved in acetonitrile and solvent removed in vacuo 
to give a dark red solid, which was purified with column chromatography (SiO2, eluted with 
MeCN/saturated aqueous KNO3/H2O = 10:0.5:1.5). The second red band was collected, aqueous 
ammonium hexafluorophosphate added and solvent evaporated until a red precipitate formed. 
This was collected on Celite® and washed thoroughly with cold water (250 mL), cold ethanol (15 
mL) and diethyl ether (15 mL). The residue was redissolved in acetonitrile and solvent removed 
in vacuo to give the product as a red powder (54 mg, 0.045 mmol, 26%). 
1H NMR (500 MHz, CD3CN) δ/ppm 9.06 (s, 4H, H
B3+B5+F3), 8.97 (m, 4H, HC2+G2), 8.67 (d, J = 8.2 Hz, 
3H, HA3+E3), 8.20 (m, 5H, HC3+D3+G3), 7.96 (m, 3H, HA4+E4), 7.45 (d, J = 4.9 Hz, 2H, HE6), 7.40 (d, J = 
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4.9 Hz, 1H, HA6), 7.21 (m, 3H, HA5+E5), 7.16 (d, J = 6.6 Hz, 1H, HD6), 6.72 (dd, J = 6.5, 2.7 Hz, 1H, 
HD5), 4.13 (t, J = 6.6 Hz, 2H, H1), 1.74 (m, 2H, H2), 1.39 (m, 2H, H3), 1.27 (m, 16H, H4-11), 0.85 (t, J 
= 6.9 Hz, 2H, H12). 13C {1H} NMR (126 MHz, CD3CN) /ppm 167.9 (C
D4), 159.8 (CD2), 158.9 (CA2+E2), 
156.8 (CF2), 156.7 (CB2+B6), 154.0 (CD6), 153.6 (CA6), 153.4 (CE6), 151.4 (CC2+G2), 146.1 (CF4), 145.9 
(CB4), 145.8 (CC4+G4), 139.1 (CE4), 139.0 (CA4), 128.6 (CA5+E5), 125.7 (CA3), 125.6 (CE3), 123.2 (CC3+G3), 
122.9 (CB5), 122.8 (CB3+F3), 114.7 (CD5), 113.3 (CD3), 70.8 (C1), 32.6 (C10), 30.3, 30.2, 30.0 (C5-9), 
29.8 (C4), 29.3 (C2), 26.3 (C3), 23.4 (C11), 14.4 (C12). ESI MS (MeCN): m/z 1051.3 [M-PF6]
+ (100%, 
calc. 1051.3), 453.2 [M-2PF6]
2+ (25%, 453.2). IR (solid, /cm-1) 3322 (w), 2924 (m), 2847 (w), 
1984 (w), 1608 (m), 1597 (m), 1428 (m), 1406 (m), 1385 (w), 1355 (w), 1317 (w), 1290 (w), 1225 
(w), 1218 (w), 1029 (m), 876 (m), 831 (s), 817 (s), 804 (s), 780 (s), 750 (m), 740 (m), 735 (m), 721 
(w), 601 (w). EA found: C, 45.24; H, 4.18; N, 9.22%. C52H52F12N8OP2Ru0.5H2ONH4PF6 requires C, 
45.65; H, 4.20; N, 9.21%. UV/VIS max/nm (0.80 x 10
-5mol dm-3, MeCN) 274 (/dm3 mol-1 cm-1 
56000), 312 (48000), 492 (23000). Luminescence (MeCN, 0.95 x 10-5mol dm-3, λex = 496 nm): λem 
= 681 nm.  
 
[Ru(HL18)(L3)][PF6]3 (C23) 
 
L18 (52 mg, 0.10 mmol) and RuCl3.3H2O (25 mg, 0.10 mmol) were suspended in dry 
N,N-dimethylformamide (5 mL) in a microwave reactor vial. The reaction mixture was treated in 
a microwave reactor at 130 °C for 10 minutes. Silver hexafluorophosphate (72 mg, 0.28 mmol) 
was added and the black suspension was heated in a microwave reactor at 130 °C for 3 
minutes. The ligand L3 (29 mg, 0.10 mmol) and N-ethylmorpholine (3 drops) were added and 
247 
 
the reaction mixture was treated in a microwave reactor at 160 °C for 15 minutes. The resulting 
dark red solution was poured into 250 mL of aqueous ammonium hexafluorophosphate to give 
a fine red precipitate, which was collected on Celite® and washed with cold water (250 mL) and 
diethyl ether (20 mL). The residue was redissolved in acetonitrile and solvent removed in vacuo 
to give a dark red solid, which was purified with column chromatography (SiO2, eluted with 
MeCN/saturated aqueous KNO3/H2O = 10:0.5:1.5). The second red band was collected, aqueous 
ammonium hexafluorophosphate added and solvent evaporated until a red precipitate formed. 
This was collected on Celite® and washed thoroughly with cold water (250 mL), cold ethanol (15 
mL) and diethyl ether (15 mL). The residue was redissolved in acetonitrile and solvent removed 
in vacuo to give the product as a red powder (27 mg, 0.019 mmol, 21%). 
1H NMR (500 MHz, CD3CN) δ/ppm 9.06 (s, 4H, H
B3+B5+F3), 8.97 (m, 4H, HC2+G2), 8.68 (d, J = 8.1 Hz, 
3H, HA3+E3), 8.18 (m, 5H, HC3+D3+G3), 7.96 (m, 3H, HA4+E4), 7.46 (d, J = 5.5 Hz, 2H, HE6), 7.41 (d, J = 
5.5 Hz, 1H, HA6), 7.20 (m, 3H, HA5+E5+D6), 6.72 (dd, J = 6.6, 2.7 Hz, 1H, HD5), 4.14 (t, J = 6.6 Hz, 1H, 
H1), 3.12 (m, 4H, H13), 3.00 (m, 2H, H11), 1.75 (m, 2H, H2), 1.61 (m, 2H, H10), 1.39 (m, 2H, H3), 
1.30 (m, 12H, H4-9), 1.23 (t, J = 7.3 Hz, 6H, H14). 13C {1H} NMR (126 MHz, CD3CN) /ppm 167.9 
(CD4), 159.8 (CD2), 158.9 (C A2+E2), 156.8 (CF2), 156.7 (CB2+B6), 154.0 (CD6), 153.5 (CA6), 153.4 (CE6), 
151.8 (C C2+G2), 146.3 (CB4), 146.0 (CF4), 145.4 (CC4+G4), 139.1 (CE4), 139.0 (CA4), 128.6 (CA5+E5), 
125.7 (CA3), 125.6 (CE3), 122.7 (CC3+G3+B3+B5+F3), 114.7 (CD5), 113.2 (CD3), 67.5 (C1), 52.9 (C11), 48.2 
(C13), 30.2, 30.1, 30.0 (C5-7), 29.9 (C4), 29.7 (C8), 29.3 (C2), 27.1 (C9), 26.4 (C3), 24.4 (C10), 9.0 (C14). 
ESI MS (MeCN) monoprotonated form: m/z 1254.3 [M-PF6]
+ (2%, calc. 1254.3), 554.7 [M-2PF6]
2+ 
(11%, 554.7), 321.5 [M-3PF6]
3+ (13%, 321.5), deprotonated form: m/z 1254.3 [M+H]+ (2%, 
1254.3), 1108.3 [M-PF6]
+ (5%, 1108.4), 481.7 [M-2PF6]
2+ (100%, 481.7). IR (solid, /cm-1) 3409 
(w), 2929 (m), 2855 (w), 1980 (w), 1639 (w), 1598 (m), 1575 (w), 1486 (w), 1464 (w), 1456 (w), 
1441 (w), 1429 (w), 1409 (m), 1393 (w), 1387 (w), 1316 (w), 1292 (w), 1258 (w), 1227 (w), 1218 
(w), 1162 (w), 1029 (m), 993 (w), 818 (s), 800 (s), 783 (s), 750 (m), 740 (m), 734 (m), 719 (w), 
704 (w), 659 (w), 602 (w). EA found: C, 44.81; H, 4.23; N, 9.03%. C55H60F18N9O2P3Ru0.5NH4PF6 
requires C, 44.62; H, 4.22; N, 8.99%. UV/VIS max/nm (0.82 x 10
-5mol dm-3, MeCN) 274 (/dm3 
mol-1 cm-1 53000), 312 (48000), 491 (23000). Luminescence (MeCN, 1.07 x 10-5mol dm-3, λex = 
495 nm): λem = 689 nm.  
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[Ru(HL19)(L3)][PF6]3 (C24) 
 
L19 (50 mg, 0.09 mmol) and RuCl3.3H2O (23 mg, 0.09 mmol) were suspended in dry 
N,N-dimethylformamide (5 mL) in a microwave reactor vial. The reaction mixture was treated in 
a microwave reactor at 130 °C for 10 minutes. Silver hexafluorophosphate (67 mg, 0.27 mmol) 
was added and the black suspension was heated in a microwave reactor at 130 °C for 3 
minutes. The ligand L3 (26 mg, 0.08 mmol) and N-ethylmorpholine (3 drops) were added and 
the reaction mixture was treated in a microwave reactor at 160 °C for 15 minutes. The resulting 
dark red solution was poured into 250 mL of aqueous ammonium hexafluorophosphate to give 
a fine red precipitate, which was collected on Celite® and washed with cold water (250 mL) and 
diethyl ether (20 mL). The residue was redissolved in acetonitrile and solvent removed in vacuo 
to give a dark red solid, which was purified with column chromatography (SiO2, eluted with 
MeCN/saturated aqueous KNO3/H2O = 10:0.5:1.5). The second red band was collected, aqueous 
ammonium hexafluorophosphate added and solvent evaporated until a red precipitate formed. 
This was collected on Celite® and washed thoroughly with cold water (250 mL), cold ethanol (15 
mL) and diethyl ether (15 mL). The residue was redissolved in acetonitrile and solvent removed 
in vacuo to give the product as a red powder (35 mg, 0.025 mmol, 31%). 
1H NMR (500 MHz, CD3CN) δ/ppm 9.06 (m, 4H, H
B3+B5+F3), 8.97 (d, J = 4.5 Hz, 4H, HC2+G2), 8.66 (d, 
J = 8.1 Hz, 3H, HA3+E3), 8.18 (m, 5H, HC3+D3+G3), 7.96 (m, 3H, HA4+E4), 7.44 (d, J = 4.9 Hz, 2H, HE6), 
7.39 (d, J = 5.5 Hz, 1H, HA6), 7.20 (m, 3H, HA5+E5), 7.16 (d, J = 6.5 Hz, 1H, HD6), 6.71 (dd, J = 6.5, 
2.7 Hz, 1H, HD5), 4.13 (t, J = 6.6 Hz, 2H, H1), 3.43 (d, J = 11.6 Hz, 2H, H13eq), 2.95 (m, 2H, H11), 2.78 
(t, J = 12.3 Hz, 2H, H13ax), 1.85 (d, J = 15.1 Hz, 2H, H14eq), 1.74 (dd, J = 13.5, 9.5 Hz, 4H, H2+14ax), 
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1.66 (m, 2H, H10), 1.42 (m, 4H, H3+15), 1.27 (m, 12H, H4-9). 13C {1H} NMR (126 MHz, CD3CN) 
/ppm 167.9 (CD4), 159.9 (CD2), 158.9 (C A2+E2), 156.7 (CB2+B6+F2), 154.0 (CD6), 153.5 (CA6), 153.4 
(CE6), 152.1 (C C2+G2), 146.4 (CB4), 146.1 (CF4), 145.1 (CC4+G4), 139.1 (CE4), 138.9 (CA4), 128.6 (CA5), 
128.5 (CE5), 125.6 (CA3+E3), 123.0 (CC3+G3), 122.9 (CF3), 122.8 (CB3+B5), 114.7 (CD5), 113.2 (CD3), 70.8 
(C1), 58.2 (C11), 54.3 (C13), 30.2, 30.1, 30.0 (C5-7), 29.9 (C4), 29.7 (C8), 29.3 (C2), 27.1 (C9), 26.4 
(C3), 24.6 (C10), 23.8 (C14), 22.2 (C15). ESI MS (MeCN) monoprotonated form: m/z 1266.3 [M-
PF6]
+ (15%, calc. 1266.3), 560.7 [M-2PF6]
2+ (48%, 560.7), 325.5 [M-3PF6]
3+ (18%, 325.5), 
deprotonated form: m/z 1266.3 [M+H]+ (15%, 1266.3), 1120.3 [M-PF6]
+ (3%, 1120.4), 487.7 [M-
2PF6]
2+ (35%, 487.7). IR (solid, /cm-1) 3635 (w), 2925 (m), 2851 (w), 1636 (w), 1602 (m), 1464 
(w), 1458 (w), 1429 (w), 1409 (m), 1393 (w), 1318 (w), 1291 (w), 1229 (w), 1218 (w), 1029 (m), 
819 (s), 779 (s), 752 (m), 739 (m), 734 (m), 713 (w). EA found: C, 41.87; H, 4.13; N, 8.46%. 
C56H60F18N9O2P3RuH2ONH4PF6 requires C, 42.25; H, 4.18; N, 8.80%. UV/VIS max/nm (2.25 x 10
-
5mol dm-3, MeCN) 274 (/dm3 mol-1 cm-1 63000), 312 (58000), 491 (28000). Luminescence 
(MeCN, 1.31 x 10-5mol dm-3, λex = 495 nm): λem = 675 nm.  
 
[Ru(HL20)(L3)][PF6]3 (C25) 
 
L20 (48 mg, 0.08 mmol) and RuCl3.3H2O (22 mg, 0.08 mmol) were suspended in dry 
N,N-dimethylformamide (5 mL) in a microwave reactor vial. The reaction mixture was treated in 
a microwave reactor at 130 °C for 10 minutes. Silver hexafluorophosphate (64 mg, 0.25 mmol) 
was added and the black suspension was heated in a microwave reactor at 130 °C for 3 
minutes. The ligand L3 (26 mg, 0.08 mmol) and N-ethylmorpholine (3 drops) were added and 
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the reaction mixture was treated in a microwave reactor at 160 °C for 15 minutes. The resulting 
dark red solution was poured into 250 mL of aqueous ammonium hexafluorophosphate to give 
a fine red precipitate, which was collected on Celite® and washed with cold water (250 mL) and 
diethyl ether (20 mL). The residue was redissolved in acetonitrile and solvent removed in vacuo 
to give a dark red solid, which was purified with column chromatography (SiO2, eluted with 
MeCN/saturated aqueous KNO3/H2O = 10:0.5:1.5). The second red band was collected, aqueous 
ammonium hexafluorophosphate added and solvent evaporated until a red precipitate formed. 
This was collected on Celite® and washed thoroughly with cold water (250 mL), cold ethanol (15 
mL) and diethyl ether (15 mL). The residue was redissolved in acetonitrile and solvent removed 
in vacuo to give the product as a red powder (37 mg, 0.026 mmol, 31%). 
1H NMR (500 MHz, CD3CN) δ/ppm 9.08 (m, 4H, H
B3+B5+F3), 9.03 (br m, 4H, HC2+G2), 8.67 (dd, J = 
8.1, 0.6 Hz, 3H, HA3+E3), 8.36 (br s, 4H, HC3+G3), 8.17 (d, J = 2.6 Hz, 1H, HD33), 7.97 (m, 3H, HA4+E4), 
7.45 (d, J = 5.6 Hz, 2H, HE6), 7.40 (d, J = 4.9 Hz, 1H, HA6), 7.21 (m, 3H, HA5+E5), 7.17 (d, J = 6.5 Hz, 
1H, HD6), 6.72 (dd, J = 6.5, 2.7 Hz, 1H, HD5), 4.13 (t, J = 6.5 Hz, 2H, H1), 3.99 (d, J = 12.0 Hz, 2H, 
H14eq), 3.71 (t, J = 12.4 Hz, 2H, H14ax), 3.39 (d, J = 12.5 Hz, 2H, H13eq), 3.03 (m, 4H, H11+13ax), 1.74 
(m, 2H, H2), 1.65 (m, 2H, H10), 1.40 (m, 2H, H3), 1.28 (m, 12H, H4-9). 13C {1H} NMR (126 MHz, 
CD3CN) /ppm 168.0 (C
D4), 159.9 (CD2), 158.8 (C A2+E2), 156.8 (CB2+B6+F2), 154.0 (CD6), 153.6 (CA6), 
153.5 (CE6), 148.6 (CB4+F4), 147.5 (CC4+G4), 139.2 (CE4), 139.1 (CA4), 128.7 (CA5+E5), 125.8 (CA3+E3), 
124.4 (CC3+G3), 123.0 (CB3+B5+F3), 114.8 (CD5), 113.3 (CD3), 70.8 (C1),63.5 (C14), 58.4 (C11), 53.0 (C13), 
30.2, 30.1, 30.0 (C5-7), 29.9 (C4), 29.6 (C8), 29.2 (C2), 26.8 (C9), 26.3 (C3), 24.0 (C10), (CC2+G2 not 
recorded). ESI MS (MeCN) monoprotonated form: m/z 1268.1 [M-PF6]
+ (3%, calc. 1268.3), 561.6 
[M-2PF6]
+ (5%, 561.7), 326.1 [M-3PF6]
3+ (3%, 326.1), deprotonated form: m/z 1268.1 [M+H]+ 
(3%, 1268.3), 1122.3 [M-PF6]
+ (8%, 1122.3), 488.7 [M-2PF6]
2+ (100%, 488.7). IR (solid, /cm-1) 
3314 (m), 2925 (w), 2854 (w), 1634 (w), 1605 (m), 1426 (m), 1413 (m), 1318 (w), 1229 (w), 1029 
(m), 810 (s), 797 (s), 787 (s), 771 (s), 754 (m), 740 (m), 720 (m), 700 (m), 704 (w), 693 (w), 658 
(w), 647 (w), 609 (w), 601 (w). EA found: C, 27.80; H, 3.40; N, 7.88%. 
C55H58F18N9O2P3Ru2H2O5.5NH4PF6 requires C, 28.16; H, 3.61; N, 8.66%. UV/VIS max/nm (1 x 
10-5mol dm-3, MeCN) 241 (/dm3 mol-1 cm-1 38000), 274 (53000), 312 (50000), 492 (25000). 
Luminescence (MeCN, 1 x 10-5mol dm-3, λex = 492 nm): λem = 665 nm.  
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[Ru(HL22)(L3)][PF6]3 (C26) 
 
L3 (22 mg, 0.07 mmol) and RuCl3.3H2O (22 mg, 0.08 mmol) were suspended in dry 
N,N-dimethylformamide (5 mL) in a microwave reactor vial. The reaction mixture was treated in 
a microwave reactor at 130 °C for 10 minutes. Silver hexafluorophosphate (60 mg, 0.23 mmol) 
was added and the black suspension was heated in a microwave reactor at 130 °C for 3 
minutes. The ligand L21 (37 mg, 0.07 mmol) and N-ethylmorpholine (3 drops) were added and 
the reaction mixture was treated in a microwave reactor at 160 °C for 15 minutes. The resulting 
dark red solution was poured into 250 mL of aqueous ammonium hexafluorophosphate to give 
a fine red precipitate, which was collected on Celite® and washed with cold water (250 mL) and 
diethyl ether (20 mL). The residue was redissolved in acetonitrile and solvent removed in vacuo 
to give a dark red solid, which was purified with column chromatography (SiO2, eluted with 
MeCN/saturated aqueous KNO3/H2O = 10:0.5:1.5). The second red band was collected, aqueous 
ammonium hexafluorophosphate added and solvent evaporated until a red precipitate formed. 
This was collected on Celite® and washed thoroughly with cold water (250 mL), cold ethanol (15 
mL) and diethyl ether (15 mL). The residue was redissolved in acetonitrile and solvent removed 
in vacuo to give the product as a red powder in a trace amounth. 
ESI MS (MeCN) deprotonated form: m/z 1024.3 [M-PF6]
+ (12%, calc. 1024.3), 882.1 [M-PF6-
(CH2)5NEt2]
+ (100%, 882.1), 439.7 [M-2PF6]
2+ (16%, 439.7), 368.6 [M-2PF6-(CH2)5NEt2]
2+ (82%, 
calc. 368.6). 
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[Ru(L2)2][PF6]2 (C27) 
 
L2 (50 mg, 0.14 mmol) and RuCl3.3H2O (36 mg, 0.14 mmol) were suspended in dry 
N,N-dimethylformamide (5 mL) in a microwave reactor vial. The reaction mixture was treated in 
a microwave reactor at 130 °C for 10 minutes. Silver hexafluorophosphate (103 mg, 0.41 mmol) 
was added and the black suspension was heated in a microwave reactor at 130 °C for 3 
minutes. The ligand L2 (50 mg, 0.14 mmol) and N-ethylmorpholine (3 drops) were added and 
the reaction mixture was treated in a microwave reactor at 160 °C for 15 minutes. The resulting 
dark red solution was poured into 250 mL of aqueous ammonium hexafluorophosphate to give 
a fine red precipitate, which was collected on Celite® and washed with cold water (250 mL) and 
diethyl ether (20 mL). The residue was redissolved in acetonitrile and solvent removed in vacuo 
to give a dark red solid, which was purified with column chromatography (SiO2, eluted with 
MeCN/saturated aqueous KNO3/H2O = 10:0.5:1.5). The first red band was collected, aqueous 
ammonium hexafluorophosphate added and solvent evaporated until a red precipitate formed. 
This was collected on Celite® and washed thoroughly with cold water (250 mL), cold ethanol (15 
mL) and diethyl ether (15 mL). The residue was redissolved in acetonitrile and solvent removed 
in vacuo to give the product as a red powder (54 mg, 0.048 mmol, 35%). 
1H NMR (500 MHz, CD3CN) δ/ppm 9.25 (d, J = 1.2 Hz, 2H, H
B5), 9.15 (dd, J = 1.6, 0.7 Hz, 2H, HD3), 
9.13 (d, J = 1.2 Hz, 2H, HB3), 8.98 (br s, 4H, HC2), 8.71 (d, J = 7.9 Hz, 2H, HA3), 8.26 (d, J = 5.3 Hz, 
4H, HC3), 8.01 (m, 2H, HA4), 7.63 (dd, J = 5.8, 0.6 Hz, 2H, HD6), 7.61 (dd, J = 5.8, 1.7 Hz, 2H, HD5), 
7.44 (dd, J = 5.6, 0.8 Hz, 2H, HA6), 7.23 (ddd, J = 7.5, 5.6, 1.3 Hz, 2H, HA5), 3.93 (s, 6H, HMe). 
13C {1H} NMR (126 MHz, CD3CN) /ppm 164.7 (C
C=O), 160.2 (CD2), 158.6 (CA2), 156.8 (CB2), 156.5 
(CB6), 154.7 (CD6), 153.6 (CA6), 151.0 (CC2), 146.6 (CC4), 145.1 (CB4), 140.0 (CD4), 139.7 (CA4), 128.9 
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(CA5), 127.4 (CD5), 126.0 (CA3), 124.7 (CD3), 123.6 (C C3+B5), 123.3 (CB3), 54.0 (CMe). ESI MS (MeCN): 
m/z 983.0 [M-PF6]
+ (12%, calc. 983.1), 419.1 [M-2PF6]
2+ (100%, 419.1). IR (solid, /cm-1) 3650 
(w), 3076 (w), 1716 (m), 1700 (m), 1597 (m), 1471 (w), 1429 (w), 1404 (m), 1344 (w), 1313 (m), 
1270 (m), 1254 (m), 1236 (w), 1118 (w), 1030 (m), 966 (w), 818 (s), 802 (s), 782 (m), 767 (m), 
759 (m), 750 (m), 742 (m), 728 (m), 717 (w), 638 (w). EA found: C, 43.00; H, 3.03; N, 9.96%. 
C44H32F12N8O4P2RuH2O0.5NH4PF6 requires C, 43.06; H, 2.96; N, 9.70%. UV/VIS max/nm (1.10 x 
10-5mol dm-3, MeCN) 287 (/dm3 mol-1 cm-1 77000), 323 (59000), 497 (28000). Luminescence 
(MeCN, 1.10 x 10-5mol dm-3, λex = 493 nm): λem = 662 nm.  
 
[Ru(L10)2][PF6]2 (C28) 
 
L10 (72 mg, 0.14 mmol) and RuCl3.3H2O (36 mg, 0.14 mmol) were suspended in dry 
N,N-dimethylformamide (5 mL) in a microwave reactor vial. The reaction mixture was treated in 
a microwave reactor at 130 °C for 10 minutes. Silver hexafluorophosphate (103 mg, 0.41 mmol) 
was added and the black suspension was heated in a microwave reactor at 130 °C for 3 
minutes. The ligand L10 (72 mg, 0.14 mmol) and N-ethylmorpholine (3 drops) were added and 
the reaction mixture was treated in a microwave reactor at 160 °C for 15 minutes. The resulting 
dark red solution was poured into 250 mL of aqueous ammonium hexafluorophosphate to give 
a fine red precipitate, which was collected on Celite® and washed with cold water (250 mL) and 
diethyl ether (20 mL). The residue was redissolved in acetonitrile and solvent removed in vacuo 
to give a dark red solid, which was purified with column chromatography (SiO2, eluted with 
MeCN/saturated aqueous KNO3/H2O = 10:0.5:0.5). The first red band was collected, aqueous 
ammonium hexafluorophosphate added and solvent evaporated until a red precipitate formed. 
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This was collected on Celite® and washed thoroughly with cold water (250 mL), cold ethanol (15 
mL) and diethyl ether (15 mL). The residue was redissolved in acetonitrile and solvent removed 
in vacuo to give the product as a red powder (75 mg, 0.052 mmol, 38%). 
1H NMR (500 MHz, CD3CN) δ/ppm 9.23 (d, J = 1.4 Hz, 2H, H
B5), 9.12 (d, J = 1.4 Hz, 4H, HB3+D3), 
8.97 (m, 4H, HC2), 8.71 (d, J = 7.9 Hz, 2H, HA3), 8.22 (dd, J = 4.5, 1.6 Hz, 4H, HC3), 8.01 (m, 2H, 
HA4), 7.63 (dd, J = 5.8, 0.7 Hz, 2H, HD6), 7.60 (dd, J = 5.8, 1.7 Hz, 2H, HD5), 7.45 (ddd, J = 5.6, 1.4, 
0.6 Hz, 2H, HA6), 7.23 (ddd, J = 7.5, 5.6, 1.3 Hz, 2H, HA5), 4.33 (t, J = 6.6 Hz, 4H, H1), 1.72 (m, 4H, 
H2), 1.37 (m, 4H, H3), 1.24 (m, 32H, H4-11), 0.84 (t, J = 7.0 Hz, 6H, H12). 13C {1H} NMR (126 MHz, 
CD3CN) /ppm 164.2 (C
C=O), 160.0 (CD2), 158.6 (CA2), 156.8 (CB2), 156.3 (CB6), 154.6 (CD6), 153.6 
(CA6), 151.5 (CC2), 146.8 (CB4), 145.7 (CC4), 140.2 (CD4), 139.7 (CA4), 128.9 (CA5), 127.4 (CD5), 126.0 
(CA3), 124.6 (CD3), 123.5 (CB5), 123.4 (CC3), 123.3 (CB3), 67.6 (C1), 32.6 (C10), 30.3, 30.2, 30.0 (C5-9), 
29.9 (C4), 29.1 (C2), 26.5 (C3), 23.4 (C11), 14.4 (C12). ESI MS (MeCN): m/z 1291.3 [M-PF6]
+ (2%, 
calc. 1291.5), 573.2 [M-2PF6]
2+ (100%, 573.3). IR (solid, /cm-1) 3087 (w), 2921 (m), 2851 (m), 
1987 (w), 1706 (m), 1700 (m), 1635 (w), 1597 (m), 1464 (w), 1456 (w), 1423 (w), 1407 (m), 1307 
(w), 1295 (w), 1265 (m), 1250 (m), 1237 (w), 1168 (w), 1117 (w), 1031 (w), 870 (w), 820 (s), 783 
(m), 760 (m), 740 (m), 729 (m), 720 (w), 658 (w), 638 (w). EA found: C, 50.40; H, 4.97; N, 7.83%. 
C66H76F12N8O4P2Ru0.8NH4PF6 requires C, 50.60; H, 5.10; N, 7.87%. UV/VIS max/nm (093 x 10
-
5mol dm-3, MeCN) 287 (/dm3 mol-1 cm-1 80000), 323 (62000), 497 (28000). Luminescence 
(MeCN, 1.13 x 10-5mol dm-3, λex = 494 nm): λem = 663 nm.  
 
[Ru(HL11)2][PF6]4 (C29) 
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L11 (79 mg, 0.14 mmol) and RuCl3.3H2O (36 mg, 0.14 mmol) were suspended in dry 
N,N-dimethylformamide (5 mL) in a microwave reactor vial. The reaction mixture was treated in 
a microwave reactor at 130 °C for 10 minutes. Silver hexafluorophosphate (103 mg, 0.41 mmol) 
was added and the black suspension was heated in a microwave reactor at 130 °C for 3 
minutes. The ligand L11 (79 mg, 0.14 mmol) and N-ethylmorpholine (3 drops) were added and 
the reaction mixture was treated in a microwave reactor at 160 °C for 15 minutes. The resulting 
dark red solution was poured into 250 mL of aqueous ammonium hexafluorophosphate to give 
a fine red precipitate, which was collected on Celite® and washed with cold water (250 mL) and 
diethyl ether (20 mL). The residue was redissolved in acetonitrile and solvent removed in vacuo 
to give a dark red solid, which was purified with column chromatography (SiO2, eluted with 
MeCN/saturated aqueous KNO3/H2O = 10:0.5:1.5). The first red band was collected, aqueous 
ammonium hexafluorophosphate added and solvent evaporated until a red precipitate formed. 
This was collected on Celite® and washed thoroughly with cold water (250 mL), cold ethanol (15 
mL) and diethyl ether (15 mL). The residue was redissolved in acetonitrile and solvent removed 
in vacuo to give the product as a red powder (91 mg, 0.049mmol, 37%). 
1H NMR (500 MHz, CD3CN) δ/ppm 9.22 (d, J = 1.5 Hz, 2H, H
B5), 9.11 (d, J = 1.3 Hz, 2H, HB3), 9.10 
(br s, 2H, HD3), 8.97 (br s, 4H, HC2), 8.70 (d, J = 8.0 Hz, 2H, HA3), 8.20 (d, J = 4.0 Hz, 4H, HC3), 8.00 
(td, J = 7.9, 1.5 Hz, 2H, HA4), 7.62 (d, J = 5.9 Hz, 2H, HD6), 7.60 (dd, J = 5.9, 1.7 Hz, 2H, HD5), 7.44 
(dd, J = 5.6, 0.7 Hz, 2H, HA6), 7.23 (ddd, J = 7.2, 5.6, 1.3 Hz, 2H, HA5), 4.33 (t, J = 6.7 Hz, 4H, H1), 
3.15 (m, 8H, H13), 3.03 (m, 4H, H11), 1.74 (m, 4H, H2), 1.61 (m, 3H, H10), 1.39 (m, 4H, H3), 1.30 (m, 
24H, H4-9), 1.24 (t, J = 7.3 Hz, 12H, H14). 13C {1H} NMR (126 MHz, CD3CN) /ppm 164.2 (C
C=O), 
160.0 (CD2), 158.7 (CA2), 156.8 (CB2), 156.3 (CB6), 154.7 (CD6), 153.5 (CA6), 151.8 (CC2), 146.9 (CB4), 
145.3 (CC4), 140.2 (CD4), 139.7 (CA4), 128.9 (CA5), 127.4 (CD5), 125.9 (CA3), 124.6 (CD3), 123.5 (CB5), 
123.3 (CC3+B3), 67.6 (C1), 53.0 (C11), 48.4 (C13), 30.2, 30.1, 30.0 (C5-7), 29.9 (C4), 29.7 (C8), 29.2 
(C2), 27.0 (C9), 26.5 (C3), 24.4 (C10), 9.1 (C14). ESI MS (MeCN): m/z 1697.5 [M-PF6]
+ (2%, calc. 
1697.5), 776.3 [M-2PF6]
2+ (43%, 776.3). IR (solid, /cm-1) 2928 (m), 2853 (w), 1994 (w), 1722 
(m), 1595 (m), 1464 (w), 1406 (m), 1308 (m), 1293 (w), 1265 (m), 1248 (m), 1238 (m), 1165 (w), 
1129 (w), 1031 (w), 819 (s), 800 (s), 782 (s), 776 (m), 765 (m), 758 (m), 751 (w), 738 (w), 730 
(w), 711 (m), 601 (m). EA found: C, 45.23; H, 5.01; N, 8.07%. C72H92F24N10O4P4Ru0.5NH4PF6 
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requires C, 44.95; H, 4.92; N, 7.64%. UV/VIS max/nm (0.97 x 10
-5mol dm-3, MeCN) 287 (/dm3 
mol-1 cm-1 80000), 323 (62000), 498 (29000). Luminescence (MeCN, 0.97 x 10-5mol dm-3, λex = 
494 nm): λem = 667 nm.  
 
[Ru(L17)2][PF6]2 (C30) 
 
L17 (67 mg, 0.14 mmol) and RuCl3.3H2O (36 mg, 0.14 mmol) were suspended in dry 
N,N-dimethylformamide (5 mL) in a microwave reactor vial. The reaction mixture was treated in 
a microwave reactor at 130 °C for 10 minutes. Silver hexafluorophosphate (103 mg, 0.41 mmol) 
was added and the black suspension was heated in a microwave reactor at 130 °C for 3 
minutes. The ligand L17 (67 mg, 0.14 mmol) and N-ethylmorpholine (3 drops) were added and 
the reaction mixture was treated in a microwave reactor at 160 °C for 15 minutes. The resulting 
dark red solution was poured into 250 mL of aqueous ammonium hexafluorophosphate to give 
a fine red precipitate, which was collected on Celite® and washed with cold water (250 mL) and 
diethyl ether (20 mL). The residue was redissolved in acetonitrile and solvent removed in vacuo 
to give a dark red solid, which was purified with column chromatography (SiO2, eluted with 
MeCN/saturated aqueous KNO3/H2O = 10:0.5:1.5). The first red band was collected, aqueous 
ammonium hexafluorophosphate added and solvent evaporated until a red precipitate formed. 
This was collected on Celite® and washed thoroughly with cold water (250 mL), cold ethanol (15 
mL) and diethyl ether (15 mL). The residue was redissolved in acetonitrile and solvent removed 
in vacuo to give the product as a red powder (110 mg, 0.080 mmol, 59%). 
1H NMR (500 MHz, CD3CN) δ/ppm 9.05 (d, J = 0.8 Hz, 4H, H
B3+B5), 8.96 (br s, 4H, HC2), 8.68 (d, J = 
8.1 Hz, 2H, HA3), 8.18 (m, 6H, HC3+D3), 7.95 (td, J = 8.0, 1.4 Hz, 2H, HA4), 7.43 (d, J = 5.0 Hz, 2H, 
HA6), 7.20 (m, 4H, HA5+D6), 6.74 (dd, J = 6.5, 2.7 Hz, 2H, HD5), 4.14 (t, J = 6.6 Hz, 4H, H1), 1.75 (m, 
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2H, H2), 1.40 (m, 2H, H3), 1.27 (m, 32H, H4-11), 0.84 (t, J = 6.8 Hz, 6H, H12). 13C {1H} NMR 
(126 MHz, CD3CN) /ppm 167.8 (C
D4), 159.9 (CD2), 159.0 (CA2), 156.7 (CB2+B6), 153.8 (CD6), 153.4 
(CA6), 151.8 (CC2), 145.9 (CB4), 145.4 (CC4), 138.8 (CA4), 128.5 (CA5), 125.6 (CA3), 123.0 (CC3), 122.8 
(CB5), 122.7 (CB3), 114.7 (CD5), 113.1 (CD3), 70.8 (C1), 32.6 (C10), 30.3, 30.2, 30.0 (C5-9), 29.9 (C4), 
29.3 (C2), 26.3 (C3), 23.4 (C11), 14.4 (C12). ESI MS (MeCN): m/z 1235.3 [M-PF6]
+ (47%, calc. 
1235.5), 545.2 [M-2PF6]
2+ (100%, 545.3). IR (solid, /cm-1) 3076 (w), 2917 (m), 2850 (w), 1993 
(w), 1609 (m), 1597 (m), 1464 (w), 1429 (w), 1408 (m), 1318 (m), 1262 (w), 1227 (m), 1026 (m), 
822 (s), 818 (s), 782 (m), 757 (m), 739 (w), 601 (w). EA found: C, 53.95; H, 5.41; N, 8.25%. 
C64H76F12N8O2P2Ru2H2O requires C, 54.27; H, 5.69; N, 7.91%. UV/VIS max/nm (0.97 x 10
-5mol 
dm-3, MeCN) 274 (/dm3 mol-1 cm-1 60000), 311 (64000), 493 (29000). Luminescence (MeCN, 
1.10 x 10-5mol dm-3, λex = 497 nm): λem = 680 nm. 
 
 
[Ru(HL19)2][PF6] 4 (C32) 
 
C32 was isolated in a trace amount as a side product of C24. 
ESI MS (MeCN) bisprotonated form: m/z 760.3 [M-2PF6]
2+ (26%, calc. 760.3), monoprotonated 
form: m/z 687.3 [M-2PF6]
2+ (17%, 687.3), 410.0 [M-3PF6]
3+ (37%, 409.9). 
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[Ru(L23)2][PF6]2 (C33) 
 
L23 (30 mg, 0.10 mmol) and RuCl3.3H2O (25 mg, 0.10 mmol) were suspended in dry 
N,N-dimethylformamide (5 mL) in a microwave reactor vial. The reaction mixture was treated in 
a microwave reactor at 130 °C for 10 minutes. Silver hexafluorophosphate (74 mg, 0.29 mmol) 
was added and the black suspension was heated in a microwave reactor at 130 °C for 3 
minutes. The ligand L23 (30 mg, 0.10 mmol) and N-ethylmorpholine (3 drops) were added and 
the reaction mixture was treated in a microwave reactor at 160 °C for 15 minutes. The resulting 
dark red solution was poured into 250 mL of aqueous ammonium hexafluorophosphate to give 
a fine red precipitate, which was collected on Celite® and washed with cold water (250 mL) and 
diethyl ether (20 mL). The residue was redissolved in acetonitrile and solvent removed in vacuo 
to give a dark red solid, which was purified by recrystallization from MeCN-Et2O. The product 
was obtained as a red powder (76 mg, 0.075 mmol, 78%). 
1H NMR (400 MHz, CD3CN) δ/ppm 9.02 (s, 4H, H
B3), 8.66 (d, J = 8.1 Hz, 4H, HA3), 8.21 (dd, J = 7.2, 
1.3 Hz, 4H, HC2), 7.95 (td, J = 7.9, 1.5 Hz, 4H, HA4), 7.77 (t, J = 7.5 Hz, 4H, HC3), 7.69 (m, 2H, HC4), 
7.44 (dd, J = 5.6, 0.7 Hz, 4H, HA6), 7.18 (ddd, J = 7.4, 5.6, 1.2 Hz, 4H, HA5). UV/VIS max/nm (1.12 x 
10-5mol dm-3, MeCN) 283 (/dm3 mol-1 cm-1 76000), 311 (62000), 488 (24000). Luminescence 
(MeCN, 0.64 x 10-5mol dm-3, λex = 489 nm): λem = 644 nm.  
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[Ru(L26)(L23)][PF6]2 (C34) 
 
L26 (44 mg, 0.08 mmol) and RuCl3.3H2O (22 mg, 0.08 mmol) were suspended in dry 
N,N-dimethylformamide (5 mL) in a microwave reactor vial. The reaction mixture was treated in 
a microwave reactor at 130 °C for 10 minutes. Silver hexafluorophosphate (64 mg, 0.25 mmol) 
was added and the black suspension was heated in a microwave reactor at 130 °C for 3 
minutes. The ligand L3 (26 mg, 0.08 mmol) and N-ethylmorpholine (3 drops) were added and 
the reaction mixture was treated in a microwave reactor at 160 °C for 15 minutes. The resulting 
dark red solution was poured into 250 mL of aqueous ammonium hexafluorophosphate to give 
a fine red precipitate, which was collected on Celite® and washed with cold water (250 mL) and 
diethyl ether (20 mL). The residue was redissolved in acetonitrile and solvent removed in vacuo 
to give a dark red solid, which was purified with column chromatography (SiO2, eluted with 
MeCN/saturated aqueous KNO3/H2O = 10:0.5:0.5). The second red band was collected, aqueous 
ammonium hexafluorophosphate added and solvent evaporated until a red precipitate formed. 
This was collected on Celite® and washed thoroughly with cold water (250 mL), cold ethanol (15 
mL) and diethyl ether (15 mL). The residue was redissolved in acetonitrile and solvent removed 
in vacuo to give the product as a red powder (42 mg, 0.034 mmol, 41%). 
1H NMR (500 MHz, CD3CN) δ/ppm 9.17 (d, J = 1.5 Hz, 1H, H
B5), 9.08 (dd, J = 1.8, 0.7 Hz, 1H, HD3), 
9.06 (d, J = 1.5 Hz, 1H, HB3), 9.04 (s, 2H, HF3), 8.68 (m, 3H, HA3+E3), 8.24 (m, 4H, HC2+G2), 7.97 (ddd, 
J = 15.7, 7.7, 1.5 Hz, 3H, HA4+E4), 7.78 (t, J = 7.8 Hz, 4H, HC3+G3), 7.70 (t, J = 7.4 Hz, 2H, HC4+G4), 
7.64 (dd, J = 5.8, 0.6 Hz, 1H, HD6), 7.59 (dd, J = 5.8, 1.7 Hz, 1H, HD5), 7.47 (m, 1H, HA6), 7.43 (m, 
2H, HE6), 7.20 (m, 3H, HA5+E5), 4.33 (t, J = 6.6 Hz, 2H, H1), 1.73 (m, 2H, H2), 1.38 (m, 2H, H3), 1.25 
(m, 16H, H4-11), 0.85 (t, J = 7.0 Hz, 3H, H12). 13C {1H} NMR (126 MHz, CD3CN) /ppm 164.3 (C
C=O), 
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160.4 (CD2), 159.1 (CA2+E2), 156.5 (CB2), 156.4 (CF2), 156.1 (CB6), 154.3 (CD6), 153.6 (CE6), 153.4 
(CA6), 149.7 (CF4), 149.6 (CB4), 139.4 (CD4), 139.3 (CA4), 139.2 (CE4), 137.7 (CC1+G1), 131.5 (CC4), 
131.4 (CG4), 130.7 (CC3), 130.6 (CG3), 129.0 (CC2), 128.8 (CG2), 128.6 (CA5), 128.5 (CE5), 127.1 (CD5), 
125.6 (CA3+E3), 124.3 (CD3), 123.2 (CB5), 123.0 (CB3), 122.8 (CF3), 67.5 (C1), 32.6 (C10), 30.3, 30.2, 
30.0 (C5-9), 29.9 (C4), 29.1 (C2), 26.5 (C3), 23.4 (C11), 14.4 (C12). ESI MS (MeCN): m/z 1077.4 
[M-PF6]
+ (100%, calc. 1077.3). IR (solid, /cm-1) 3094 (w), 2915 (m), 2844 (w), 1985 (w), 1722 
(m), 1717 (m), 1609 (m), 1464 (w), 1404 (m), 1305 (w), 1260 (m), 1119 (w), 1034 (w), 826 (s), 
763 (m), 730 (m), 695 (m), 512 (m). EA found: C, 52.36; H, 4.82; N, 7.00%. 
C55H54F12N6O2P2Ru2H2O requires C, 52.51; H, 4.65; N, 6.68%. UV/VIS max/nm (1.20 x 10
-5mol 
dm-3, MeCN) 285 (/dm3 mol-1 cm-1 71000), 311 (58000), 494 (22000). Luminescence (MeCN, 
0.50 x 10-5mol dm-3, λex = 494 nm): λem = 673 nm.  
 
[Ru(HL27)(L23)][PF6]3 (C35) 
 
L27 (42 mg, 0.07 mmol) and RuCl3.3H2O (19 mg, 0.07 mmol) were suspended in dry 
N,N-dimethylformamide (5 mL) in a microwave reactor vial. The reaction mixture was treated in 
a microwave reactor at 130 °C for 10 minutes. Silver hexafluorophosphate (55 mg, 0.22 mmol) 
was added and the black suspension was heated in a microwave reactor at 130 °C for 3 
minutes. The ligand L3 (23 mg, 0.07 mmol) and N-ethylmorpholine (3 drops) were added and 
the reaction mixture was treated in a microwave reactor at 160 °C for 15 minutes. The resulting 
dark red solution was poured into 250 mL of aqueous ammonium hexafluorophosphate to give 
a fine red precipitate, which was collected on Celite® and washed with cold water (250 mL) and 
diethyl ether (20 mL). The residue was redissolved in acetonitrile and solvent removed in vacuo 
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to give a dark red solid, which was purified with column chromatography (SiO2, eluted with 
MeCN/saturated aqueous KNO3/H2O = 10:0.5:0.5). The second red band was collected, aqueous 
ammonium hexafluorophosphate added and solvent evaporated until a red precipitate formed. 
This was collected on Celite® and washed thoroughly with cold water (250 mL), cold ethanol (15 
mL) and diethyl ether (15 mL). The residue was redissolved in acetonitrile and solvent removed 
in vacuo to give the product as a red powder (46 mg, 0.033 mmol, 45%). 
1H NMR (500 MHz, CD3CN) δ/ppm 9.16 (d, J = 1.4 Hz, 1H, H
B5), 9.07 (dd, J = 1.7, 0.6 Hz, 1H, HD3), 
9.05 (d, J = 1.4 Hz, 1H, HB3), 9.04 (s, 2H, HF3), 8.67 (m, 3H, HA3+E3), 8.24 (td, J = 8.3, 1.2 Hz, 4H, 
HC2+G2), 7.96 (ddd, J = 15.7, 7.7, 1.5 Hz, 3H, HA4+E4), 7.77 (t, J = 7.6 Hz, 4H, HC3+G3), 7.69 (m, 2H, 
HC4+G4), 7.65 (dd, J = 5.8, 0.6 Hz, 1H, HD6), 7.59 (dd, J = 5.8, 1.7 Hz, 1H, HD5), 7.47 (ddd, J = 5.6, 
1.4, 0.6 Hz, 1H, HA6), 7.43 (ddd, J = 5.6, 1.6, 0.7 Hz, 2H, HE6), 7.20 (m, 3H, HA5+E5), 4.32 (t, J = 6.7 
Hz, 2H, H1), 3.14 (m, 4H, H13), 3.01 (m, 2H, H11), 1.74 (m, 2H, H2), 1.61 (m, 2H, H10), 1.39 (m, 2H, 
H3), 1.29 (m, 12H, H4-9), 1.23 (t, J = 7.3 Hz, 6H, H14). 13C {1H} NMR (126 MHz, CD3CN) /ppm 
164.3 (CC=O), 160.4 (CD2), 159.1 (CA2+E2), 156.6 (CB2), 156.4 (CF2), 156.1 (CB6), 154.4 (CD6), 153.6 
(CE6), 153.4 (CA6), 149.7 (CF4), 149.6 (CB4), 139.8 (CD4), 139.3 (CA4), 139.2 (CE4), 137.8 (CC1+G1), 
131.4 (CC4+G4), 130.7 (CC3), 130.6 (CG3), 128.9 (CC2), 128.8 (CG2), 128.6 (CA5), 128.5 (CE5), 127.1 
(CD5), 125.6 (CA3+E3), 124.3 (CD3), 123.2 (CB5), 123.0 (CB3), 122.8 (CF3), 67.5 (C1), 53.0 (C11), 48.2 
(C13), 30.2, 30.1, 30.0 (C5-7), 29.9 (C4), 29.7 (C8), 29.2 (C2), 27.0 (C9), 26.5 (C3), 24.4 (C10), 9.1 (C14). 
ESI MS (MeCN) deprotonated form: m/z 1280.4 [M+H]+ (100%, calc. 1280.3), 1134.4 [M-PF6]
+ 
(20%, 1134.4). IR (solid, /cm-1) 3329 (w), 3207 (w), 2921 (m), 2852 (m), 1995 (w), 1717 (m), 
1703 (w), 1610 (w), 1541 (w), 1463 (w), 1419 (m), 1404 (m), 1308 (w), 1269 (m), 1120 (w), 1012 
(m), 820 (s), 763 (s), 753 (m), 740 (m), 728 (m), 720 (m), 702 (m), 682 (m), 555 (s), 513 (m), 505 
(m). EA found: C, 38.02; H, 4.12; N, 7.46%. C58H62F18N7O2P3Ru2.5NH4PF6 requires C, 38.01; H, 
3.96; N, 7.26%. UV/VIS max/nm (1.17 x 10
-5mol dm-3, MeCN) 285 (/dm3 mol-1 cm-1 68000), 311 
(56000), 494 (22000). Luminescence (MeCN, 0.46 x 10-5mol dm-3, λex = 494 nm): λem = 668 nm.  
 
 
 
 
262 
 
[Ru(L29)(L23)][PF6]2 (C36) 
 
L29 (45 mg, 0.09 mmol) and RuCl3.3H2O (24 mg, 0.09 mmol) were suspended in dry 
N,N-dimethylformamide (5 mL) in a microwave reactor vial. The reaction mixture was treated in 
a microwave reactor at 130 °C for 10 minutes. Silver hexafluorophosphate (69 mg, 0.27 mmol) 
was added and the black suspension was heated in a microwave reactor at 130 °C for 3 
minutes. The ligand L3 (28 mg, 0.09 mmol) and N-ethylmorpholine (3 drops) were added and 
the reaction mixture was treated in a microwave reactor at 160 °C for 15 minutes. The resulting 
dark red solution was poured into 250 mL of aqueous ammonium hexafluorophosphate to give 
a fine red precipitate, which was collected on Celite® and washed with cold water (250 mL) and 
diethyl ether (20 mL). The residue was redissolved in acetonitrile and solvent removed in vacuo 
to give a dark red solid, which was purified with column chromatography (SiO2, eluted with 
MeCN/saturated aqueous KNO3/H2O = 10:0.5:0.5). The second red band was collected, aqueous 
ammonium hexafluorophosphate added and solvent evaporated until a red precipitate formed. 
This was collected on Celite® and washed thoroughly with cold water (250 mL), cold ethanol (15 
mL) and diethyl ether (15 mL). The residue was redissolved in acetonitrile and solvent removed 
in vacuo to give the product as a red powder (55 mg, 0.046 mmol, 51%). 
1H NMR (500 MHz, CD3CN) δ/ppm 9.02 (m, 4H, H
B3+B5+F3), 8.67 (m, 3H, HA3+E3), 8.23 (m, 4H, 
HC2+G2), 8.17 (d, J = 2.7 Hz, 1H, HD3), 7.94 (m, 3H, HA4+E4), 7.77 (td, J = 7.7, 1.6 Hz, 4H, HC3+G3), 
7.69 (m, 2H, HC4+G4), 7.47 (m, 2H, HE6), 7.42 (dd, J = 5.6, 0.7 Hz, 1H, HA6), 7.19 (m, 4H, HA5+E5+D6), 
6.71 (dd, J = 6.5, 2.7 Hz, 1H, HD5), 4.13 (t, J = 6.6 Hz, 2H, H1), 1.75 (m, 2H, H2), 1.40 (m, 2H, H3), 
1.27 (m, 16H, H4-11), 0.85 (t, J = 6.9 Hz, 3H, H12). 13C {1H} NMR (126 MHz, CD3CN) /ppm 167.8 
(CD4), 160.2 (CD2), 159.2 (CA2+E2), 156.5 (CF2), 156.4 (CB2+B6), 153.9 (CD6), 153.4 (CA6), 153.3 (CE6), 
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149.3 (CF4), 149.0 (CB4), 138.9 (CE4), 138.7 (CA4), 137.9 (CC1+G1), 131.3 (CC4+G4), 130.6 (CC3+G3), 
128.8 (CC2+G2), 128.4 (CE5), 128.3 (CA5), 125.5 (CA3), 125.4 (CE3), 122.8 (CB5), 122.7 (CB3), 122.6 
(CF3),114.6 (CD5), 113.0 (CD3), 70.7 (C1), 32.6 (C10), 30.3, 30.2, 30.0 (C5-9), 29.8 (C4), 29.4 (C2), 26.3 
(C3), 23.4 (C11), 14.4 (C12). ESI MS (MeCN): m/z 1049.4 [M-PF6]
+ (100%, calc. 1049.3). IR (solid, 
/cm-1) 2924 (m), 2849 (w), 1996 (w), 1607 (m), 1464 (w), 1419 (m), 1407 (m), 1315 (w), 1222 
(w), 1160 (w), 1032 (w), 875 (w), 823 (s), 789 (m), 761 (m), 754 (m), 740 (m), 690 (m), 553 (m), 
521 (s). EA found: C, 50.41; H, 4.22; N, 7.49%. C54H54F12N6O2P2Ru0.5NH4PF6 requires C, 50.85; 
H, 4.43; N, 7.14%. UV/VIS max/nm (0.84 x 10
-5mol dm-3, MeCN) 284 (/dm3 mol-1 cm-1 69000), 
310 (63000), 490 (25000). Luminescence (MeCN, 0.46 x 10-5mol dm-3, λex = 490 nm): λem = 652 
nm. 
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